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 Substance use and their consequences account for substantial public 
spending in Great Britain and Europe. However, alcohol and drug policy change 
is often based on the harms attributed to a single drug, when polydrug use (the 
use of more than one drug) is common and may increase associated harm. This 
research has employed advances in statistical analysis to create typologies of 
polydrug use including alcohol and illicit drugs at a general population level in 
the 2000 National Psychiatric Morbidity Survey to better inform risks associated 
with these substances. Alcohol and drug use patterns were determined 
separately and then in an integrated model using latent class analysis. The 
relationship between the classes, demographic, and psychological status was 
assessed through multinomial logistic regression. Three drug classes, wide 
range, moderate range and no drug use represented illicit polydrug use. Six 
alcohol classes were found, most of which followed a continuum of increased 
consumption relating to increased related problems, with one exception who 
experienced problems with low alcohol consumption. Any drug use elevated the 
risk for psychological conditions compared with the no drug use class, and 
increased levels of alcohol consumption were related to increased risk of 
generalised anxiety disorder and lifetime suicide attempts. Two integrated 
alcohol and illicit drug polydrug use models were proposed, one with eight and 
one with 18 classes. Further investigation of these models found two main 
conclusions. First, illicit polydrug classes change when measured with alcohol 
use, and the three classes were now ‘no drug’ use, ‘cannabis only’ and 
‘polydrug users’. This in turn affected relationship with demographic variables 
and psychological status. Second, whilst alcohol use patterns do not change 
dramatically when measured in the presence of illicit drug use, there were 
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changes in relationships of alcohol with current psychological status as a 
consequence accounting for illicit drug use. Risk of poorer psychological health 
is elevated in heavier patterns of alcohol use who also consume illicit drugs 
compared to the same alcohol pattern without illicit drug use. In conclusion, 
latent class analysis is a useful way in which to model population level polydrug 
use. Through this methodology the consequences of separating alcohol and 
illicit drug use in research have been shown. Research into either alcohol or 
illicit drug use should consider modelling both in the same model. The 
presentation of polydrug use in this context may be able to show some of the 
ambiguities in the literature regarding demographic differences and risk relating 
to poorer psychological health. 
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1. Introduction  
Research in this thesis will explore and measure patterns of polydrug use 
in the general population. It will also assess how these patterns relate to 
demographic criteria and current psychological status. To enable an 
understanding of polydrug use, this chapter will first outline the population 
prevalence of alcohol and illicit drugs in Europe, providing context for the 
dataset used throughout. Attention will then be drawn to polydrug use. The 
different definitions of polydrug use will be explored and a lexicon determined 
for this work. This will be followed by a discussion of the issues polydrug use 
raises in the drug field. This chapter will then discuss how polydrug use limits 
progress in drug and alcohol research, using examples from the ecstasy use 
literature. 
1.1.  Prevalence rates of illicit drug use in Europe 
The data presented in this section refers to prevalence rates of drug use 
reported in Europe, to provide some context for the National Psychiatric 
Morbidity Survey (NPMS; Singleton, Bumpstead, O’Brien, Lee, & Meltzer, 
2001a; 2001b), the dataset which will be used throughout this thesis. European 
data was sourced from the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) Annual report (EMCDDA, 2008). The EMCDDA is a 
Lisbon based, European Union de-centralised agency. It was founded in 1993 
to provide drug related information of the countries in the European Union and 
Norway. It aims to provide policy makers, politicians, researchers and health 
professionals with a reliable, consistently measured evidence base on existing 
and emerging trends in European illicit drug use.  
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Information on the trends reported in this section is fed to the EMCDDA 
through the activities of ‘Reitox’ centres. These are national monitoring centres, 
present in 30 countries which provide requested information on illicit drug use 
and related information using similar methodologies. This ensures comparability 
in the Annual Report. All countries participating in this survey were randomly 
sampled whether simple, or multi-stage. In the former method every unit in a 
given population had the same probability of inclusion. Multi-stage random 
sampling is a method of random sampling between different units of 
measurement. For example, a participant in a study from the UK could be 
selected with a given probability from their Council area, postcode sector, 
household and from the residents living in the address. All participating 
countries also weighted their data to attempt to minimise response bias in their 
percentage estimates because of non-response.  
The use of random sampling is important when estimating population 
trends. If we are interested in the characteristic of a given population, such as 
an opinion, we try to find out the parameter which represents the magnitude of 
that opinion. However, unless we ask questions of all members of the 
population, we can only make estimates as to what the ‘parameter’ or true value 
of that opinion might be. Instead, if a random sample of the population is taken 
we can find a statistic which approximates to the opinion of the sample. 
However, a given sample drawn randomly from the population of interest will 
vary in their opinion to another given sample. This is one of the causes of error 
in an estimate (other causes may arise from non-sampling related issues such 




 In random sampling, estimations of this error can be derived. Random 
samples have a given probability of a unit (or individual) being selected. Thus 
inferences can be made as to the representative nature of the statistic in 
relation to the population parameter through 95% confidence intervals. This 
contrasts with opportunity samples. These are individuals selected by their 
availability and thus error can arise through considerable self-selection bias. It is 
also impossible to estimate the probability of a volunteer being selected into the 
sample. Inferences to the general (or otherwise) population are not possible. 
However, they can provide some context to findings. Opportunity sampling is 
common in illicit drug research due to the clustering of drug use in certain 
situations such as night clubs1. 
European countries sampled in this report varied in their data collection 
method. The majority used face to face computer-based interview techniques 
recommended by the EMCDDA, however, for reasons of cost some used 
telephone interviewing. This is a potential source of bias. Telephone surveys 
typically have lower estimates of illicit drug use and higher response of ‘don’t 
know’ (Aquilino, 1992; 1994). Another source of bias was inconsistency in data 
collection years but the majority of studies were collected in 2004-2006. Despite 
these methodological limitations, which might be expected of a survey of this 
kind, the Annual Report provides a useful indicator of European trends in illicit 
drug use.  
                                            
1 These are often referred to as ‘dance drug’, ‘rave’, ‘nightclub’ or ‘party drug’ populations and 
may include those who attend both licensed and unlicensed venues for dancing and drug 
consumption. Attendees are traditionally more likely to consume illicit drugs than the general 
population (Deehan & Saville, 2003; Release, 1997). A common way to sample these 
populations are through ‘snowball’ techniques (Solowij, Hall & Lee, 1992), ‘privileged access 
interviewing’ (Griffiths, Gossop, Powis & Strang, 1993) or ‘purposive sampling’ (Topp, Hando, 
Dillon, Roche & Solowij, 1999). These are methods which use contacts known to the 
researchers, who then in turn refer their contacts to participate in the study. Whilst a common 
way in which to find illicit substance users, it introduces considerable response bias, in a similar 
way to opportunity sampling. 
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Cannabis is reported to have been used by 23 million adults in Europe in 
the past year (EMCDDA, 2008).  As can be seen in Table 1, cannabis 
prevalence had the widest range between countries. The difference between 
the largest and smallest was 10.4%. The largest prevalence was in found in the 
general population of Italy (11.2% in the past year). The country with the least 
percentage of cannabis use was Malta with .8% of the population estimated to 
use this drug in the past year. The prevalence in the population of Great Britain 
was 8%. This is a greater percentage than 15 of the 18 studies illustrated in 
Table 1. Only prevalence rates of cannabis use in the Czech Republic, France 
and Italy were of greater magnitude. Prevalence of cannabis use in Great 
Britain is therefore high in the context of European trends. 
 Estimates of cocaine use in the NPMS were also high in comparison to 
other European countries. Great Britain had a prevalence of 1.5% for use of 
cocaine in the past 12 months. Only Italy and Ireland had a higher prevalence 
with 2.2% and 1.7% respectively. The lowest prevalence of cocaine use was 
found in a sample of the Greek population representing .1%. Note four million 
European adults are considered to have consumed cocaine in the past 12 
months; a considerably lower estimate than cannabis. In addition, the range of 
prevalence rates were smaller (.1 to 3%) 
The use of amphetamines in the past year ranged between .0 and 1.5%. 
Great Britain had the highest rate of consumption in Europe with 1.5%. Malta, 
which also had the lowest prevalence rate of cannabis use, had a prevalence 
rate of amphetamine use of less than .0. Norway and Latvia were the only 
countries using amphetamines with a prevalence of greater than 1%. Two 




The highest prevalence of ecstasy use in Europe was found in the Czech 
Republic. Of the surveyed sample, 3.5% were using ecstasy in the past year. 
Great Britain was the second most prevalent user of this drug with 1.6%, 
followed by Latvia and Norway with prevalence of 1.1%. Greece and Malta had 
the lowest prevalence of use in Europe. Approximately 2.6 million European 
citizens used ecstasy in the past year. 
Finally, LSD had the lowest overall prevalence. No featured country had a 
prevalence of greater than .6%. The majority of countries had prevalence rates 
of .1% using this drug in the past year. As was for cannabis and cocaine use, 
Italy had the highest prevalence of LSD use in featured European countries 
(.6%). This was closely followed by Cyprus and Latvia. The populations of these 
countries had an estimated .5% prevalence of LSD use in the past year. Great 
Britain had a prevalence of .3% of LSD use in a 12 month period representing a 
modal position in the prevalences of Europe. 
In summary, Great Britain tends to have higher prevalence rates of 
cannabis, ecstasy, cocaine, amphetamines and LSD (in descending order of 
prevalence compared to most countries in the European Union (and Norway).
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Table 1: Frequency of cannabis, cocaine, amphetamines, ecstasy and LSD use in Europe2. 
Country, year of survey, age range and sample size Cannabis Cocaine Amphetamines Ecstasy LSD 
Finland, 2006, 15-64 years, n=2802 3.6 .5 .6 .5 .1 
Bulgaria, 2005, 18-60 years, n=1036 1.5 .3 .4 .5 .2 
Czech Republic, 2004, 18-64 years, n=3526 9.3 .2 .7 3.5 .4 
Denmark, 2005, 18-64 years, n=13310 5.2 1.0 .7 .3 .1 
Germany, 2006, 18-64 years, n=7912 4.7 .6 .5 .4 .1 
Ireland, 2006-2007, 15-64 years, n=4967 6.3 1.7 .4 1.2 .2 
Greece, 2004, 15-64 years, n=4351 1.7 .1 .0 .2 .1 
Norway, 2004, 15-64 years, n=2669 4.6 .8 1.1 .5 .2 
France, 2005, 15-64 years, n=25879 8.6 .6 .1 .4 .1 
Italy, 2005, 15-64 years, n=27995 11.2 2.2 .4 .5 .6 
Cyprus, 2006, 15-64 years, n=3504 2.1 .6 .3 1 .5 
Latvia, 2003, 15-64 years, n=4534 3.8 .2 1.1 .8 .5 
Lithuania, 2004, 15-64 years, n=4207 2.2 .3 .3 .4 .1 
Portugal, 2007, 15-64 years, n=12202 3.6 .6 .2 .4 .1 
Poland, 2006, 15-64 years, n=2859 2.7 .2 .7 .3 .1 
Austria, 2004, 15-64 years, n=3980 7.5 .9 .8 .9 .2 
Netherlands, 2005, 15-64 years, n=4516 5.4 .6 .3 1.2 .1 
Malta, 2001, 18-64 years, n=1755 .8 .3 0 .2 .1 
Great Britain, 2000, 16-74 years, n=8580 8.0 1.5 1.5 1.6 .3 
                                            
2 Includes only those who had an estimate of prevalence of all five substances, or provided the number of respondents who took part in the survey. Total n=132,004 
for studies in the EMCDDA Annual report (EMCDDA, 2008). Great Britain data from Singleton et al. (2001a; 2001b) 
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1.1.1. Drug use percentage: representative of the population? 
UK prevalences provided to the EMCDDA for comparison are usually 
derived from the latest British Crime Survey- Drug Misuse Declared and these 
prevalences are notably absent from the comparisons in section 1.1. However, 
this section aims to assess the substance use in more depth to assess 
representativeness of the NPMS to prevalences at the time it was collected and 
the most recent survey. Therefore, Great Britain (NPMS) prevalences will be 
compared to those in the UK from 2000 and 2008. It is worth noting, given the 
legal status of many of the drugs included in this thesis, there are often 
concerns regarding representativeness and disclosure of illicit polydrug use 
behaviours (Anthony & Wagner, 2000). Adolescent studies have also illustrated 
that less socially desirable substances are more likely to be underestimated in 
prevalence rates (for example, Percy, McAlister, Higgins, McCrystal & Thornton, 
2005).  
 As Figure 1 shows, frequencies of use of illicit drug use were similar to 
the British Crime Survey- Drug Misuse Declared at 2000 (DMD 2000; Ramsey, 
Baker, Goulden, Sharp & Sandhi, 2001), but most were closely related to British 
Crime Survey- Drug Misuse Declared 2007/8 (DMD 2007/8; Hoare & Flatley, 
2008) figures. Yearly rates of cannabis use in the NPMS (Singleton et al. 
2001a; 2001b) were around 8%, and this is mirrored in the percentage of the 
DMD 2007/8. This is less however than the DMD 2000 which finds the 
percentage yearly use at just over 10%. The use of cocaine amongst these 
three groups spans 1.5% in the NPMS to 2% in the DMD 2000 and 2.3% in 
DMD 2007/8, suggesting that the NPMS has the lowest reported use. In 
contrast, the percentage of sample respondents using ecstasy across all three 
studies is relatively similar. Other less prevalent drugs like magic mushrooms, 
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heroin, methadone, anabolic steroids and glue also find broad similarities 
between the percentages of respondents using these items over the past year. 
The use of LSD appears to be more frequent in the DMD 2000 survey 
than either of the other two studies illustrated. This trend is also found in the 
yearly prevalence of amphetamines. For both drugs, the NPMS shares a similar 
percentage with DMD 2007/8. Amyl nitrate use in the NPMS is considerably 
lower than that of either of the DMD studies. They had a similar percentage rate 
at 1.3% and 1.5% for the DMD 2000 and DMD 2007/8 respectively. 
 However, despite the similarities between this current survey and the 
DMD 2007/8, the latter has a slightly higher percentage of any drug used in the 
past year, with a percentage difference of .4%. Whilst this might seem small, it 
becomes more significant when extrapolated to numbers of individuals in the 
population of Great Britain. It is also worth noting that the DMD surveys were 
conducted in England and Wales only, whereas the survey used in this thesis 




Figure 1: Graph illustrating percentage of illicit drug comparisons of respondents aged 16-59 with the Drug Misuse Declared in 2000 




1.2. Prevalence rates of alcohol use in Europe 
Data presented in this section is representative of a recent Eurobarometer 
study by the European Commission (EC) assessing attitudes to alcohol use in 
member states (EC, 2007). These have assessed trends in frequency in the 
past year, typical frequency and quantity in the past month and frequency of 
heavy drinking occasions. These are frequently asked questions to assess 
alcohol consumption (Dawson, 2003). They are also like those found in the 
commonly used Alcohol Use Disorder Identification Test (AUDIT: Saunders & 
Aasland, 1987) which features in the analyses presented in later chapters. Data 
from this survey will be reported in this section and compared with Great Britain 
estimates in section 1.3. 
Data reported was collected in October and November 2006 by the market 
research company ‘TNS Opinion and Social’. It was uniformly sampled using 
multi-stage random probability techniques.  Weighting was also applied 
according to national statistics from a surveyed country to improve 
representativeness of collected data. All surveys were conducted using 
Computer Assisted Personal Interviewing (CAPI) techniques face to face with 
the respondent. There were 25 countries included in the total EU estimate 
(these will be commonly referred to in the text as EU 25). The total number of 
European citizens sampled were 28,584. Of this total, 1375 were from the UK. 
Whilst this survey assesses information relating to the use of alcohol in certain 
demographic groups for EU 25, no significance tests were performed. Thus any 
reference to demographic trends must be interpreted with caution.  
The first question relates to any alcohol consumption in the past year. The 
majority of European citizens had consumed alcohol in this time frame (75%). 
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Highest abstention rates were found in Italy (40%) and the lowest were in 
Denmark (7%). The UK prevalence rate of abstention was 19% in the year prior 
to data collection. Abstention was more common in females living in Europe; 
32% of females had not consumed alcohol in the past year compared with 16% 
of males. Alcohol consumption in the past year was also broadly associated 
with higher educational attainment and managerial employment status.  
Those who had consumed alcohol in the past year were then asked their 
frequency of drinking in the past month. The majority of those who drank in the 
past year also drank at least once in the past month (87% in the EU; 86% in the 
UK). Prevalence rates representing the frequency of consumption in the past 
month are presented below in Table 2. 
 
Table 2: Frequency of alcohol consumption in the past month in the EU and UK 
 Once a 
month 





2 - 3 times 
per week 




EU 25 13 17 25 23 8 13 
UK 9 14 26 33 9 8 
 
The most frequent consumption patterns in the past month represent 
consumption either once, twice or three times per week. The European 
prevalence estimate for daily use was higher than the UK, but this does not infer 
the quantity per occasion. Portugal had the highest percentage of daily drinking 
in the European Union (47%), with the least frequent in Latvia (1%). UK drinkers 
were more likely to drink alcohol two to three times per week compared with the 
EU estimate. They were also less likely to drink once, twice or three times per 
month.  
Typical amounts consumed on occasion are presented in Table 3. 
Residents of the UK consume more than four drinks on a typical consumption 
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occasion more frequently than EU estimates. However, the majority of 
European and UK citizens drink one or two drinks in a typical occasion. This 
would suggest that predominantly, consumers in both samples had a moderate 
typical intake. Ireland had the highest typical quantity of the European Union; 
34% of the sample typically consumed more than four drinks and 36% typically 
drank three or four drinks. By contrast, Bulgaria had the lowest typical 
consumption. Of their sample 1% drank four or more drinks on occasion, and 
8% drank three or four drinks on a typical occasion. 
 
Table 3: Typical quantities of alcohol consumed on an occasion in the EU and 
UK 
 Less than one 
standard drink 
One to two 
drinks 
Three to four 
drinks 
Five or more 
drinks 
EU 25 11 49 29 10 
UK 4 46 25 24 
 
 There were also some demographic trends reported in European use. 
Lower educational attainment (educated up to 15 years) was associated with 
the lowest typical consumption. By contrast, students and unemployed persons 
were most likely to consume three or more drinks on a typical occasion (42% 
each). Those least likely to drink three or more drinks on a typical occasion 
were homemakers and retired persons with 16% and 17%. Males were more 
likely to consume three or more drinks per sitting. Younger age was also 
associated with heavier typical amounts. Of 15 to 24 year olds, 44% were 
drinking above three or more drinks on a typical occasion compared with only 
17% of retired persons. 
 The frequency of ‘binge drinking’ conceptualised as drinking more than 
five drinks on occasion in the past year is presented in Table 4.  Most European 
residents drink this quantity infrequently. Prevalence rates for drinking less than 
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once a month or never were 55% for EU25. Rates for the UK are similar at 
53%. The highest prevalence of drinking five or more drinks, several times per 
week was found in Estonia (28%). This is considerably more than EU25 and UK 
estimates at 13% and 12% respectively. Residents in Ireland were most likely to 
consume five or more drinks on occasion once a week (37%). Highest rates of 
‘never’ drinking this amount were found in Portugal (55%). ‘Never’ drinking five 
or more drinks was also more common in females (41%) than males (22%) and 
in older adults (44%) compared to younger adults (20%). Homemakers and 
retired persons were unlikely to drink five or more drinks on occasion (41% and 
46% respectively stated they would never drink this amount on a drinking 
occasion). 
 
Table 4: Frequency of drinking five or more drinks on occasion in the EU and UK 
 Never Less than 
once a month 
Once a 
month 
Once a week  Two or more 
times a week 
EU 25 31 24 16 15 13 
UK 29 24 16 19 12 
1.3. Alcohol use in Europe: Comparisons with the NPMS 
The questions asked in this European survey were similar to the AUDIT 
questions asked in the NPMS dataset analysed in this thesis (Singleton et al., 
2001a; 2001b). This section will compare trends found in EU 25, and the 
specific estimates for GB with the NPMS data. 
The first question of the AUDIT questionnaire refers to how often an 
individual has consumed alcohol in the past year (how often; see Appendix 1). 
This relates to two questions in the Eurobarometer study (EU, 2007). The first of 
these asks whether an individual has consumed alcohol in the past year. The 
second inquired as to the frequency of use in the past month (for those who had 
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consumed alcohol in the past year). Response options presented in Table 2 
have some comparable ranges to those in the ‘how often’ question in the AUDIT 
questionnaire, but cannot be directly compared. The percentage responses in 
the Eurobarometer study are for those who have said they consume alcohol at 
least monthly. In the NPMS a response to the how often question reflects full 
year patterns, which may include past year abstainers. 
The second main question in the Eurobarometer study concerns typical 
amount consumed on an occasion. The first response category is less than one 
typical drink which is not included on the AUDIT questionnaire. Given the 
prevalence of this in the EU and UK, it is not possible to directly compare the 
frequencies. In an attempt to compare these, it could be suggested that a 
percentage of those endorsing one or two drinks on the AUDIT must also be 
drinking less than one drink. A collapsed category of less than one drink and 
one to two drinks could be considered equivalent to the one or two drink 
response category in the AUDIT. However, the categories of three or four, and 
five or more can be directly compared between studies. They are presented in 
Table 5 below. There were few differences between the UK sample in the 
Eurobarometer study and the population of Great Britain. There were a higher 
percentage of five or more drinks as a typical consumption pattern in the GB 
sample, differences representing 3% of the total population. 
 
Table 5: Comparisons of typical consumption frequencies between the 
Eurobarometer study and NPMS  
 Two or fewer 
drinks 
Three to four 
drinks 
Five or more 
drinks 
EU 25  60 29 10 
UK 50 25 24 




The final main question in the Eurobarometer study examines the 
frequency of drinking five or more drinks on a single occasion in the past year 
conceptualised as ‘binge drinking’. The AUDIT question which is comparable 
asks about consumption of six or more drinks in the past year. Despite this, the 
response categories are directly comparable between studies, and are 
presented in Table 6 below. 
 
Table 6: Comparison of frequencies of drinking five or more drinks 
(Eurobarometer) and six or more drinks on the NPMS  
 Never Less than 
once a month 
Once a 
month 
Once a week  Two or more 
times a week 
EU 25 31 24 16 15 13 
UK 29 24 16 19 12 
NPMS 43 27 14 17 2 
 
 Differences were more pronounced between samples for binge drinking 
on occasion. The Great Britain (GB) sample had a higher percentage of those 
not binge drinking on occasion in the past year compared to the UK and EU 
estimate. They also had the lowest frequency of binge drinking twice or more 
per week. This variation may be due to the conceptualisation of binge drinking 
as five (Eurobarometer) or six drinks (NPMS). However, the difference between 
five and six drinks per occasion is only one standard drink. Therefore, the GB 
percentage for never drinking five or more drinks on occasion is likely to be 
lower than in Table 6. However, there was still a considerable percentage 




1.4. Perceived harm and availability of alcohol and illicit drugs 
As has been illustrated above, the prevalence of alcohol and illicit drugs in 
Europe, UK and Great Britain, varied considerably according to the drug. 
Alcohol was the most commonly used substance, followed by cannabis, 
ecstasy, cocaine, amphetamines and LSD. In part, the reasons for this 
difference may be attributed to perceived harm, benefits and availability of 
drugs (White et al., 2006; Nordentoft & Hjortoj, 2007). This section will primarily 
draw upon a study conducted in May 2008 as part of the Flash Eurobarometer 
survey series (EC, 2008) on attitudes of young people to drug use in 27 EU 
countries. Like the other surveys reported in this section to date, the information 
is based on a multi-stage random sample of the population of Europe which has 
been weighted to better represent the population from which it was sampled. It 
was conducted by the Gallup polling organisation through telephone interviews. 
The total sample size was 12312; the sample size of the UK component was 
500 persons.  
The risk to health perceived by European youth and UK youth are 
presented in Table 7. Very few respondents considered alcohol, cannabis, 
cocaine, ecstasy, or heroin use to be risk free. Cannabis and alcohol were the 
most likely to be perceived as low risk, with higher percentages for UK youth 
compared with the European average (EU 27). Alcohol use was broadly 
considered to be moderately risky by European youth. However, there were 
some differences between EU and UK youth estimates in terms of risk 
attributed to cannabis use. Approximately equal percentages considered 
cannabis to be moderate or high risk at around 40%.  Cannabis was considered 
high risk by more European young people than those in the UK (40% compared 
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with 28%). This is indicative of higher cannabis use frequency for the UK 
compared with the European average (see section 1.1). 
 Of the sampled European youth, 85% and 80% considered cocaine and 
ecstasy use to be high risk. In the sampled UK youth, lower percentages were 
found for these two substances; for both drugs, 76% of the sample considered 
them high risk. Lower percentages of high risk were found for UK youth for 
these two drugs. By far, heroin was considered the most high risk of all the 
drugs surveyed with neither EU youth, nor the UK subsample considering 
heroin risk below moderate. Slightly higher UK youth reported heroin use to be 
high risk compared to EU youth.  
This is reflective of prevalence trends (see section 1.1). Firstly, Great 
Britain estimates were higher than majority of the EMCDDA countries reported 
in Table 1. Second, it is indicative of slight prevalence differences between 
cocaine and ecstasy use in the past year. 
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Table 7: Perceived health risk attributed to the consumption of alcohol and illicit drugs 
  No Risk Low Risk Moderate risk High risk 
 
Alcohol EU 27 1 15 59 24 
 UK 1 22 59 18 
Cannabis EU 27 1 14 42 40 
 UK 2 26 44 28 
Cocaine EU 27 0 1 12 85 
 UK 0 3 20 76 
Ecstasy EU 27 0 2 16 80 
 UK 1 6 17 76 
Heroin EU 27 0 0 4 94 
 UK 0 0 2 97 




Demographic trends were also reported for EU 27 estimates. Young 
females considered drug use to be generally more risky than young males in 
Europe. Cannabis was considered high risk by 46% of females compared to 
35% of males. Conversely, 10% of females considered cannabis to be low risk 
compared with 18% of males. More young males considered alcohol to be low 
risk compared to young females (19% compared with 11%). Older youth were 
more likely to choose high risk compared to the moderate risk for drug use 
compared those who were younger. This would suggest that prevalence rates 
might be higher in young males. However, the relationship with education 
varied. Those with lower educational attainment attributed a higher risk to 
cannabis but not other drugs. 
In the Eurobarometer study, risk perception was related to availability of 
drugs. Attributing a high risk to a given drug was associated with greater 
difficulty in accessing the drug. Alcohol was the easiest to obtain for both EU 
and UK youth. This was followed by cannabis, cocaine, ecstasy and finally 
heroin use.  
Attribution of risk was assessed through a general question: “To what 
extent do you think the following drugs may pose a risk to a person’s health? 
Does named drug pose a high, medium, low or no risk?” (p.21; EC, 2008). 
Therefore, it was difficult to estimate how risk was conceptualised by 
individuals. Recent research by White et al. (2006) explored (any) risk 
perception of ‘party drug’ use in a sample of 273 regular ecstasy users in 
Australia. The majority of respondents’ considered the use of ecstasy and 
amphetamines were risky (90% and 84% respectively). Lower percentages 
attributed risk with cocaine (55%). These would appear to be conservative 
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estimates compared to European youth figures (no risk versus any risk from 
Table 7). However, they also assessed what the perceived risks might be. 
Addiction or dependence was more of a risk for cocaine (44%) followed by 
amphetamine (21%) and ecstasy use (7%). Risk of depression was more likely 
to be attributed to ecstasy use (13%) compared with amphetamine (9%) and 
cocaine use (4%). This was reflected in perceived neurological harm risk.  
Again, ecstasy was most likely to be associated with this harm (12%) compared 
to 8% and 3% of amphetamine and cocaine users respectively. They did not 
estimate risks for heroin or cannabis use in this sample given the low 
percentages of this use in their study. 
In conclusion, risk is generally viewed as highest for heroin, followed by 
cocaine, ecstasy, cannabis and alcohol. Broadly, this reflects prevalence trends 
for these drugs. However, estimates of perceived harms in European youth did 
not describe what these harms might be. Recent research has suggested that 
this perceived harm may be most likely to be concerns regarding neurological 
damage, depression or addiction (White et al., 2006). 
1.5. Polydrug use 
 Polydrug use has been considered “the most important confound in drug 
research” (Gouzoulis-Mayfrank and Daumann, 2006b, p.45) and there are five 
main reasons why this may be the case. The first concerns the lack of isolation 
in a single drug focus. Any relationships with the single drug of focus are 
weakened in an unknown way by other drugs used with the drug of interest. 
Second, given the number of licit and illicit drugs available, there are vast 
numbers of possible combinations of drugs available. Third, methods used to 
measure illicit drugs whether statistical or descriptive are not consistent across 
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studies. Fourth, the impact of polydrug use is also affected by the number and 
range of drugs included. Some studies focus exclusively on specific drugs, 
however, may not account for their high association with other drug use which 
has not been include. Finally, conceptualisation of drug use can vary between 
studies, and across time points.  
 This first section will explore definitions of polydrug use and attempts to 
overcome inconsistent conceptualisation by creation of a lexicon to be used 
throughout this thesis. The second section will explore frequencies in polydrug 
use. Frequencies will be described in the context of caveats relating to possible 
combinations, lack of isolation and the drugs included in percentage estimates. 
The problems arising from measurement will be discussed in chapter two. 
1.5.1. Definitions of polydrug use 
Definitions of polydrug use in the literature have typically varied between 
studies (Brecht, Huang, Evans, & Hser, 2008; Schensul, Convey & Burkholder, 
2005). This is potentially caused by the drugs included, whether specific or 
general, the time frame of usage, and as a function of the effects. Each of these 
will be assessed in turn in arising with the universal definitions in this thesis. 
Johnston (1975) suggested that polydrug use was the use of more than 
one drug by an individual. This broad definition was also adopted by Collins, 
Ellickson and Bell (1998). Whilst this description could encompass both licit and 
illicit drug use, Johnston stated that alcohol should be included.  An EMCDDA 
report (EMCDDA, 2001) stated all illicit drug users are at the very least ‘lifetime’ 
polydrug users. Despite this, the term polydrug has more connotations with illicit 
drug use, than perhaps licit drugs (World Health Organisation [WHO], 2009). 
Martin (2008) used a broader drug definition of alcohol users who used other 
psychoactive drugs, for example tobacco, cannabis, pharmaceuticals, or other 
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illicit drugs. Thus the defining characteristic of this definition was alcohol use (in 
the presence of other drugs). Other classifications based on drugs selected 
particular polydrug use combinations. These included pairings such as ‘alcohol 
and cannabis’ (e.g. Midanik, Tam & Weisner, 2007; Riley & Hayward, 2004) or 
more general ‘alcohol and drugs’ (e.g. Falk, Hsaio-Ye and Hiller-Sturmhofel, 
2008; Feigelman, Gorman & Lee, 1998). Advantages to this approach may be 
the minimisation of other confounding patterns of use. However, patterns of a 
specific pair are typically both hard to find and have low frequencies in the 
population. Broad patterns, for example illicit drugs and alcohol whilst easier to 
find encompasses a multitude of heterogeneity within a group. 
Other approaches have considered timing in their polydrug definitions. 
Johnston (1975) proposed three classifications in this regard. The first concerns 
any use of more than one drug by an individual in the past (‘ever use’). The 
second, was the use of more than one drug by an individual in the past year 
(‘recent use’). The final classification was on occasion, defined as any 
consumption where the mind-altering effects overlap (‘overlapping use’). There 
is some degree of overlap between these categories. ‘Recent use’ and 
‘overlapping use’ classifications are included in ‘ever use’ polydrug patterns. 
‘Overlapping use’ is a specific case of ‘recent use’ polydrug consumption. The 
‘recent use’ classification is also common in those studies focussing on 
particular pairings of licit and illicit drug use such as Falk et al. (2008) or Midanik 
et al. (2007). The definitions offered by Johnston have been developed into two 
more commonly used terms; simultaneous and concurrent polydrug use. The 
first of these is like the ‘overlapping use’. Simultaneous polydrug use is 
therefore defined as the combination of drugs on a single occasion. As 
illustrated above, Johnston (1975) described this as when effects overlap, 
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however, some researchers have put time frames to illustrate close effects. For 
example, Boys, Lenton and Norcross (1997) suggested a four-hour time frame 
was appropriate. Other researchers were broader in their definition, stating that 
simultaneous use was the use of two or more drugs in combination at either the 
same time or in “close temporal proximity” (Martin, 2008; p.96). This type of 
polydrug combination is a special case of concurrent polydrug use which 
reflects Johnston’s ‘recent use’ pattern. Essentially, this is the combination of 
two or more drugs in a specified time period, commonly one year. 
 The final consideration in defining polydrug use often relates to the 
function of drug combinations. Merchant and Macdonald (1994) describe how 
those involved in the 1990’s rave scene had considerable knowledge about 
drugs used, and the product of their combinations. Friends and associates who 
used drugs were often able to elucidate pleasurable combinations with specific 
effects, for example complimenting, increasing or neutralising the effects of 
another drug. Primarily the mixing process is intentional on the part of the user 
(Schensul et al., 2005). However, Johnston (1975) and Martin (2008) caution 
that haphazard patterns are also plausible based on need and availability. 
Decisions are made relative to current or expected effects of consumed drugs, 
their predicted duration, choices of what could be taken next, resultant effects 
and potential for harm.   
 To summarise combinations of polydrug use tend to occur for the 
following reasons. First, combinations may intensify an existing effect. For 
example, the combination of amphetamines and ecstasy may be consumed to 
increase the stimulant high for a more intense experience. The second reason 
could be to suppress an effect, for example, alcohol and cocaine polydrug use 
to curb feelings associated with acute cocaine withdrawal. Third, drugs may be 
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combined in a polydrug use pattern to counteract an effect (Parker & Williams, 
2003). For example cannabis may be used when at home after a night out to 
counteract or neutralise the stimulant effects of ecstasy or amphetamines. 
Fourth, drugs could be combined to create a new psychoactive drug. Alcohol 
and cocaine use together create a metabolite cocaethylene (Jatlow et al., 1991) 
which can enhance and sustain the ‘high’ experience. 
However, whilst the combination of drugs may be intentional, 
unpredictable and unpleasant effects can still occur (EMCDDA, 2001; Merchant 
& Macdonald, 1994). This may be partly explained by the impurity of drugs 
(Green, Mechan, Elliott, O’Shea and Colado, 2003). Levels of purity of ecstasy 
have decreased over time (Cole, Bailey, Sumnall, Wagstaff & King, 2002) and 
there is evidence to suggest that quality of other illicit drugs is also variable 
(Caulkins, 2007). Notably, the duration and severity of both the pleasant and 
unpleasant, expected and unexpected effects will be affected by the half life of 
the ingested drugs, synergistic compounds or psychoactive metabolites (Smit, 
Monshouwer & Verdurmen, 2002).  
In linking these concepts together, it might be suggested that polydrug 
use should be defined from the following three components. The first is the 
widest range of different drugs. The second is a specific time frame (in this case 
1 year) and the third is the intention (less relevant in concurrent polydrug use). 
Given the differences presented above ‘polydrug’ use is defined below in Table 
8. This will enable clear definitions between terms within chapters, with easier 





Table 8: Operational definitions for polydrug use in this thesis  
Term Definition 
Polydrug use The concurrent use of two or more drugs (whether illicit or alcohol 
use) in the past year. 
Illicit polydrug 
use 
The concurrent use of two or more illicit drugs in the past year 
1.6. Frequencies of polydrug use 
The frequencies of polydrug use will now be discussed, firstly presenting 
lifetime, yearly and more frequent patterns of concurrent use. Following this, the 
frequencies of simultaneous polydrug use will be reported. A summary table of 
rates is provided in Table 9.  
 In a time space random sample of 400 Manhattan nightclub attendees, 
Kelly and Parsons (2008) found the mean number of illicit drugs used during the 
lifetime to be 3.57. A further random sample of 3274 male army conscripts from 
Piedmont, Italy measured a variant on the mean number of drugs used to 
estimate illicit polydrug use (Siliquini et al., 2001).  With a focus on specific 
drugs, users of heroin were found to have the greatest mean substances used 
per drug, closely followed by LSD users. In contrast, cannabis users had the 
least number of mean substances used per drug (1.6). In total, 30% of those 
comprising this sample were polydrug users. 
 Opportunistic samples which have estimated lifetime illicit polydrug use 
rates include Webb, Ashton, Kelly and Kamali (1996). They surveyed 3,699 
university undergraduates from a range of faculties and found 34% of their 
sample had used two or more illicit drugs, and 19% had used four or more illicit 
drugs (they did not provide the percentage for three or more illicit drugs). White 
et al. (2006) in a sample of 372 regular ecstasy users in Australia found a 
higher percentage of lifetime illicit polydrug use. The bivariate combination of 
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ecstasy and amphetamines was found in 91% of their sample. The combination 
of ecstasy and cocaine was found in 55% of their sample. Wibberley and Price 
(2000) in a study of 71 opportunistically sampled lifetime illicit drug users found 
that of those who used amphetamines, cocaine, ecstasy or LSD six or more 
times in their lifetime, 100% had used alcohol and 67.6% had used cannabis. 
Topp, Hando, Dillon, Roche & Solowij, (1999) found in their sample of 329 
ecstasy users in Australian cities that the mean number of drugs tried by the 
sample (including licit and illicit drugs) was 10. Adolescent studies such as 
Sutherland and Shepherd (2001) found considerably lower rates. Of their 9742 
adolescents surveyed in Northern England, 12.8% used alcohol and tobacco, 
3.7% used alcohol and illicit drugs, and 11.7% used all three. Lifetime rates of 
polydrug use were provided for specific polydrug combinations from 12th 
Graders from the West Coast of the US as part of the Rand Adolescent Panel 
study (Collins et al., 1998).  The authors found 2.3% of the sample had used 
alcohol and sedatives, 6.7% had used alcohol and stimulants and 5.3% had 
used both cocaine and other drugs.  Overall, they found a lifetime concurrent 
polydrug use rate of 36.9%, which included both alcohol and drugs. Smit et al. 
(2002) found slightly lower rates of polydrug use in their sample of adolescents. 
Including abstainers, 23.7% of this sample had used at least once in their 
lifetime, however, if abstainers were excluded this increased to 41.8%. 
 There were considerably more estimates of polydrug use at a yearly 
level. Falk et al. (2008) found a percentage polydrug rate of 5.6% for the US 
population (illicit drug use and alcohol consumption in the past year). This is like 
the percentage use found in Wadsworth, Moss, Simpson and Smith (2004). 
These authors found that 7.7% of the surveyed adults living in two Welsh 
communities used alcohol and illicit drugs. However, they did find differences 
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when taking tobacco into account. For example, the most frequent illicit drug 
use pattern reflected use of tobacco, alcohol use within recommended weekly 
limits and any illicit drug use (3.5%). In contrast, they found their least prevalent 
group to be those not using alcohol or tobacco, but using illicit drugs (.4%). This 
demonstrates how common polydrug use is amongst illicit drug users. Midanik 
et al. (2007) further subdivided this into specific drug combinations. They found 
that alcohol and cannabis use were the most frequent yearly concurrent 
combination, used by 3.3% of the US population. This percentage was like the 
use of other drugs with alcohol in this sample (also 3.3%). They also note that 
1.7% used painkillers with alcohol in the past year. 
 Hopper et al. (2006) found in a small sample of 22 ecstasy users, that all 
had used alcohol and cannabis. This was a sample opportunistically selected to 
include ecstasy users who had used at least once per month in the past year, 
so it may have limited applicability to general population estimates. High 
percentages were also found between other drugs suggesting further polydrug 
use involvement. Of these individuals, 81.8% had used cocaine, 72.7% had 
used hallucinogens and 54.5% of the sample had used other stimulants (than 
ecstasy). Other drugs were also used by the sample including sedatives and 
opiates, but these were used by comparatively less in the past year.  
 Ecstasy users, comprising 3% of Pedersen and Skrondal’s (1999) 
sample of 10,812 Norwegian adolescents also had a high proportion of polydrug 
use. Specifically, this was most likely to involve cannabis use (65.8%), 
amphetamine use (56.0%) or heroin use (31.5%). They also reported an overall 
sample percentage rate of amphetamine and ecstasy illicit polydrug use (1.6%) 
although concede that the majority of their polydrug users also used cannabis. 
A study by McCrystal, Percy, Higgins, and Thornton (2003) assessed specific 
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combinations of substances in the past year of adolescent post-primary school 
children in Northern Ireland. During the past year alcohol and cannabis use was 
reported by 22% and alcohol and solvents were used by 16% of the sample. 
Current ecstasy use and the relationship with other drugs was the focus of a 
paper by Keyes, Martins and Hasin (2008).  They concluded that this group 
were almost certainly using alcohol (98.4%) but had lower probabilities of 
polydrug use including cocaine (38.1%), opioids (33.8%), tranquillisers (34.2%) 
and sedatives (95.4%). They also assessed the polydrug use behaviours of 
other drug users. These individuals were also highly likely to use alcohol 
(90.3%) but had a lower probability of other drug use such as cocaine (29.1%), 
opioids (11.1%), tranquillisers (4.6%) and sedatives (5.2%). This suggests that 
ecstasy users are more likely to be polydrug users. A study by Topp, Barker 
and Degenhardt (2004) found opportunistically sampled regular ecstasy users 
were likely to have used alcohol (79%), cannabis (82%), amphetamines (85%) 
and to a lesser extent cocaine (44%). Only 4% of these users stated that they 
had used none of these drugs. The mean number of drugs used in the past year 
was 5.1 for this group. This was similar to the yearly mean number of drugs 
used found by Riley, James, Gregory, Dingle and Cadger (2001). In their 
sample of 122 Scottish ‘rave’ attendees, the average number of drugs used 
concurrently within a year was 4.16.  They also reported that 92.6% of their 
sample had used more than one drug in the past year. Similarly, Scheier, 
Abdallah, Inciardi, Copeland and Cottler (2008) found 629 of their ecstasy users 
from had used 4.28 drugs in the past year (excluding ecstasy). This was 
predominantly comprised of non-club drugs, for which the mean number of 
drugs used in the past year were 3.93. Unusually, the mean number of club 
drugs used was .27 by this group. This would not appear to be supported by 
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research reported above, as club drugs appear to be used together in a 
polydrug pattern. 
Fewer studies reported rates of concurrent polydrug use in a shorter time 
frame than one year. Kelly and Parsons (2008) in their Manhattan night club 
sample found the mean drugs being used during the past four months were 
2.07 (includes illicit drugs only). Sterk, Theall and Elifson (2007) reported 
polydrug estimates in the past 90 days, finding that 98.1% of current ecstasy 
users were polydrug users (including both illicit drugs and alcohol). Topp et al. 
(2004) used a wider time frame. They found the majority of their regular ecstasy 
users from the National Drug Strategy Household Survey had used alcohol 
(73%), cannabis (62%), amphetamines (52%) or cocaine (26%) in the past six 
months. Only 12% of this group used none of these. The mean number of drugs 
used within this time frame was 5.4. In contrast, recent ecstasy users (who used 
ecstasy but not monthly in the past six months) from the same study had 
somewhat lower percentages of other drug use. They also had a lower mean 
number of drugs used in the past six months (4.4). Earleywine and Newcomb 
(1997) also assessed polydrug use within the six month time frame. They 
concluded, in the past six months, alcohol and cannabis were used by 31%, 
alcohol and other drugs by 28% and cannabis and other drugs by 22% of the 
sample.  
A recently published study in Ireland using a weighted, multi-stage 
random sample of the populations of Ireland and Northern Ireland found in the 
past month 1.93% of the population of Ireland and 2.11% of the population of 
Northern Ireland were likely to combine any illicit drug with alcohol and tobacco 
(NACD & DAIRU, 2007). Polydrug rates for the specific combination of 
tranquillisers, antidepressants or sedatives and alcohol were 1.37% for Ireland 
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and 2.90% for Northern Ireland. Additionally, of all past month cannabis users 
90% and 92% also used alcohol in Ireland and Northern Ireland. 
 In summary, concurrent polydrug use varies widely in the time frames 
illustrated. Lifetime polydrug use rates are generally higher than those with a 
more recent time frame. Furthermore, differences in measurement are also 
apparent. Some estimates include alcohol use in their estimations, and some do 
not. In addition, some specify polydrug combinations, whilst others describe any 
illicit drug use. Percentages of polydrug use are most commonly reported, 
whether referring to any illicit drug use or specific combinations of use, although 
mean numbers of drugs used are also reported for some studies. 
 Simultaneous use frequencies also vary in measurement, however, are 
most commonly reported as use ‘before, during or after’ or on a ‘single 
occasion’. Fendrich, Wislar, Johnson & Hubbell (2003) in their random sample 
of young adults from Chicago, assessed polydrug use during the last use of a 
club drug. They found that just over one quarter used a club drug solely. 
However, 73% used at least one drug from alcohol, cannabis, cocaine, heroin, 
PCP, hallucinogens, stimulants, tranquillisers or sedatives. Degenhardt, Barker 
and Topp (2004) in a random sample of the Australian population assessed 
percentages of named drug combinations with a focus on ecstasy.  Of those 
who had used ecstasy, alcohol was used by 26.8%, cannabis by 61.6%, 
amphetamines by 52.5% and cocaine by 18.7%. They defined the simultaneous 
occasion within the yearly time frame, assessing whether an individual had 
used at the same time at least once in the past year. Calafat et al. (1992) in a 
dance drug survey of young adults in Europe found the most common 
simultaneous polydrug use pattern to be alcohol and cannabis (50.6%). Of the 
more traditional club drugs, the most common patterns were alcohol and 
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ecstasy (11.1%) and alcohol, cannabis and ecstasy (10.4%). This suggests a 
strong involvement of illicit substances with alcohol. Earleywine and Newcomb 
(1997) in their adolescent study found simultaneous polydrug use rates of 28% 
for alcohol and cannabis, 16% for alcohol and other drugs and 11% for 
cannabis and other drug use. 
Respondents in the 2000 National Alcohol Survey (Midanik et al., 2007) 
reported simultaneous polydrug use rates which were exclusive of concurrent 
use. Occurrence of cannabis and alcohol use represented the most widespread 
simultaneous polydrug use combination (7.0%). Those using illicit drugs (but not 
cannabis) and alcohol were the next most common simultaneous polydrug use 
combination reported (1.7%).  
 Deehan and Saville (2003) in their survey of 760 nightclub attendees in 
South East England found that on a given night, 29% of their opportunity 
sample consumed alcohol with illicit drugs. This was notably lower than the 
occurrences reported by Riley et al. (2001). Their estimates of simultaneous 
polydrug use only included illicit drugs and found 66.3% mixed illicit drugs on a 
single occasion. Of this, 69.1% used two drugs, 24.7% used three drugs and 
26.2% used four or more drugs. Of these, specific patterns were more common 
than others. Ecstasy and amphetamine polydrug use was most frequently 
reported at 63%. Other reported combinations were ecstasy, amphetamines 
and other (LSD, magic mushrooms or cocaine) at 27% and ecstasy and others 
(excluding amphetamines) at 8.6%.  
 Forsyth (1996) assessed simultaneous polydrug use in ‘before, during 
and after’ ecstasy use patterns. Of those using ecstasy on a given occasion, 
3.3% consumed alcohol before ecstasy, 4.2% used during the use of ecstasy 
and 1.7% used alcohol after. This suggests a lower percentage rate than other 
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studies. Cannabis use was the most commonly consumed drug after ecstasy 
use with 4.3%. Typically 2.7% used cannabis during the ecstasy consumption 
and .9% consumed before ecstasy use. However, the most common 
combinations with ecstasy ‘before’ were cocaine use (11.4%) and amphetamine 
use (19.6%). The most commonly reported ‘during’ were cocaine (11.4%), 
amphetamines (12.6%), LSD (16.2%) and amyl nitrate (37.5%). Amphetamine 
use ‘after’ ecstasy ingestion was the only drug with a higher occurrence than 
cannabis (6.3%). Topp et al. (1999) assessed ‘during’ and ‘after’ time frames. 
‘During’ ecstasy use the most common combinations included cannabis (45%), 
amphetamines (43%) and alcohol (40%). However, ‘after’ ecstasy use cannabis 
(64%), alcohol (21%) and benzodiazepines (17%) were more commonly used.  
This shows some differences with Forsyth (1996) study.  
Two studies took a slightly different approach. Verheyden, Henry and 
Curran (2003) in their sample of 466 regular ecstasy users in Manchester and 
London assessed the proportion of ecstasy users who always mixed their 
ecstasy with another drug (including alcohol). They found 59% of ecstasy users 
were always simultaneous polydrug users. Finally, Sterk et al. (2007) assessed 
simultaneous use on the first occasion ever. Of their sample, 47.9% had used 
ecstasy alone, 28.4% had used it with another illicit drug and 10.3% had mixed 
it with alcohol and other illicit drugs. 
As illustrated in concurrent rates of polydrug use, there is some variability 
in measurement of simultaneous polydrug use. Whilst the time frame is less of a 
factor in this case than perhaps concurrent estimates, there is still ambiguity 
around definitions of a simultaneous occasion. In addition, the trend for some 
studies to report particular combinations and others to be broader, it is difficult 
for researchers to determine trends.
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Table 9: Frequency of polydrug use summary table. 
  Concurrent use Simultaneous use Drug* 
  Authors Sample  
(Sampling 
strategy) 











   Same 
occasion 
Alcohol and cannabis 50.6% 
 Alcohol and ecstasy 11.1% 
Alcohol, cannabis and ecstasy 
10.4% 
Cannabis and ecstasy 8.4% 
Alcohol and cocaine 7.8% 
Alcohol, cannabis, ecstasy and 
cocaine 7.8% 












   On a night 29% consumed alcohol with 
illicit drugs 
11% drank 10 units or more 











   Using at 
same time at 
least once in 
past year 
 
Ecstasy and alcohol 26.8% 
Ecstasy and cannabis 61.6% 
Ecstasy and amphetamines 
52.5% 







7th, 8th and 9th 
grade (School 
sample) 
  Past six months 
Alcohol and cannabis 
31% 
Alcohol and other 
drugs 28% 




Alcohol and cannabis 28% 
Alcohol and other drugs 16% 
Cannabis and other drugs 11% 
B 
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59.8% of alcohol users 
did not use with illicit 
drugs 
5.6% of the population 











   Last time 








27.2% used it alone 
73% used at least one other 
drug from alcohol, cannabis, 
cocaine, heroin, PCP, 
hallucinogens, stimulants, 
tranquillisers or sedatives 
B 
Forsyth, 1996 135 Glasgow 
rave attendees 
(Opportunistic) 
   Before, 
during and 
after 
Ecstasy and alcohol 3.3% 
before 4.2% during 1.7% after 
Ecstasy and cannabis 
.9% before 2.6% during 4.3% 
after 
Ecstasy and cocaine 
11.4% before 11.4% during 
2.2% after 
Ecstasy and amphetamines 
19.6% before 12.5% during 
6.3% after 
Ecstasy and LSD 
.9% before, 16.2% during, 0% 
after 
Ecstasy and magic mushrooms 
2.0% before, 4.1% during, 1.0% 
after 
Ecstasy and amyl nitrate 
1.0% before, 37.5% during, 
1.9% after 
B 
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Hopper et al., 
2006  
22 ecstasy 




All used ecstasy, 








Kelly & Parsons, 
2008 




Mean number of drugs 
used in lifetime 3.57  
 During the past four 
months 
Mean number of drugs 
used were 2.07 
 
  I 






users and users 
of other illicit 
drugs (selected 
sample from an 
original random 
sample) 
 Current ecstasy users 
and  





















   B 
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Alcohol and solvents 
16% 
Alcohol and cannabis 
22% 
B 




(2000) US  
(Random) 
 3.3% cannabis and 
alcohol use 
.8% cocaine/crack and 
alcohol  
.7% hallucinogens and 
alcohol 
.8% uppers and 
alcohol 
1.7% pain killers and 
alcohol 
3.3% other drugs (not 
cannabis) with alcohol 
 





7% cannabis and alcohol use  
.9% cocaine and crack 
.5% hallucinogens and alcohol 
.5% uppers and alcohol 
.2% painkillers and alcohol 
1.7% other drugs (not cannabis) 
with alcohol 
B 
NACD & DAIRU, 
2007 





  Alcohol, tobacco and 
any illicit drug  







 2.90% Northern 
Ireland 
 









 Ecstasy users (3% of 
total sample) 65.8% 
cannabis use, 56% 
amphetamines 31.5% 











Riley et al., 2001  122 Scottish 
rave attendees 
(Opportunistic) 
 92.6% used more than 
one drug in the past 
year. Mean number 
used 4.18 drugs 
 ‘mixed on 
occasion’ 
66.3% mixed on occasion 
69.1% 2 drugs 
24.7% 3 drugs 
26.2% 4+ 
Specifically 
Ecstasy and amphetamines 
63%  
Ecstasy, amphetamines and 
other of 
LSD/mushrooms/cocaine 27% 








Miami, St Louis 
and Sydney 
(Opportunistic) 
 Mean number of club 
drugs used .27 
Mean number of other 
non club drugs used 
3.93 
Mean number of drugs 
used except ecstasy 
4.28 
   I 
Siliquini et al., 
2001) 




Mean number of drugs 







30% of the sample 
were polydrug users 
 
    I 
40 
 
Sterk et al., 2007 261 ecstasy 
users from 
Atlanta, Georgia  
(Opportunistic) 
  In the past 90 days, 
98.1% of ecstasy 






Median number of illicit drugs 
used was 3 
 
Alone 47.89% 
With another illicit 28.35% 











12.8% alcohol and 
tobacco 
3.7% alcohol and illicit 
drugs 
11.7% alcohol, 
tobacco and illicit 
drugs 
 
    B 







and 163 regular 
ecstasy users 
(Opportunistic)  
 Regular ecstasy users 
opportunistically 
sampled 
In the past year 
79% used alcohol  
82% used cannabis 
85% used 
amphetamines  
44% used cocaine 
4% used none of these 
 
Mean number of drugs 
used in the past year 
5.1 
In past six months 
Regular ecstasy users 
NDSHS 
73% used alcohol 62% 
used cannabis 52% 
used amphetamines  
26% used cocaine 
12% used none of 
these 
Mean number of drugs 
used in past year 5.4 
Recent ecstasy users 
from NDSHS 
56% used alcohol 34% 
used cannabis 42% 
used amphetamines  
7% used cocaine 
8% used none of these 
Mean number of drugs 
used in the past year 
4.4 
  B 
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Ecstasy and cannabis 45% 
Ecstasy and amphetamines 
(43%) 
Ecstasy and alcohol (40%) 
Ecstasy and LSD 13% 
Ecstasy and amyl nitrate 12% 
 
Ecstasy and cannabis 64% 
Ecstasy and amphetamines 
(7%) 
Ecstasy and alcohol (21%) 





Henry, et al., 
2003 
466 regular 





    ‘always mix’ 59% of ecstasy users always 
mix their ecstasy use with 
another drug (including alcohol) 
B 
Wadsworth, 
Simpson et al., 
2004 
7979 adults 
living in Merthyr 
Tydfil or Cardiff 
(Random) 
 No drugs 16.8% 
No tobacco, alcohol 
above recommended 
limits (alcohol above), 
no illicit drugs (illicits) 
16.4% 
Tobacco, alcohol 
within limits (alcohol 
normal), no illicits 6.6% 
Tobacco, alcohol 
above, no illicits 3.7% 
No tobacco, alcohol 
normal, no illicits 
40.2%  
Tobacco, alcohol 
above, no illicits 3.5% 
Tobacco, alcohol 
   B 
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* I= Illicit drugs only B=Both illicit drugs and alcohol 
normal, illicits 3.2% 
No tobacco, alcohol 
normal, illicit 2.5% 
Tobacco, alcohol 
normal, illicits 2.0% 
Tobacco, no alcohol, 
illicits .7% 
No tobacco, no alcohol 
illicits .4% 
 




34% two or more 
illegal drugs 
19% four or more 
illegal drugs 
 
    I 








Ecstasy and cocaine 
55% 
 Past six months 
Ecstasy and 
amphetamines 74%  
Ecstasy and cocaine 
20% 
 
  I 
Wibberley & 
Price, 2000 
71 drug users  
(Opportunistic) 
Of those who used 
amphetamines , 
cocaine, ecstasy or 
LSD six or more times 
in lifetime 
100% used alcohol  
67.6% had used 
cannabis 
    B 
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1.6.1. The example of ecstasy 
“it is really difficult... to find people who had ever consumed, in their lifetime, 
only ecstasy” (p.90, Schifano, Di Furia, Forza, Minicuci & Bricolo 1998) 
 
 This section will examine selected studies addressing the effects of 
ecstasy use. It is intended to illustrate some of the difficulties the occurrence of 
polydrug use can present when assessing risk of harm to individuals using 
ecstasy. Cohen (1980) describes two cases of suicide that implicate ecstasy as 
the cause. In particular, the first of these two cases, states that no other drugs 
were implicated except alcohol and long-term cannabis use. Notably, the 
person had been using alprazolam, paroxetine, lithium, carbamazepine and 
lorazepam which are all psychoactive licit drugs (if taken upon a doctor’s 
recommendation). In addition, by the time they had committed suicide the 
ecstasy use had ceased. However, despite the lack of isolation spanning not 
just psychoactive licit and illicit drugs but also psychoactive prescription drugs, 
ecstasy use was implicated as the cause. It is more likely that a complex 
aetiology was responsible, and notable that there was no record of whether the 
other drugs used, preceded or anteceded the condition. 
Cohen (1995) in a later paper reports on the subjective reports of the 
effects of ecstasy by users noting “interestingly many users experienced 
depression both immediately following the termination of the drugs’ effects and 
months and even years later” (p.1142). Again, the lack of isolation, and 
additional explanatory factors were neither presented in the article nor explored. 
The self-report which may be based on clinician advice or expectancy effects 
associated with education on the effects of the drug may well have contributed 
to the self-report given.  
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McGuire and Fahy (1991) again attributed the cause of paranoid 
psychosis to ecstasy. This was despite reported polydrug use. The ecstasy 
users were reported to have used occasional cocaine and amphetamines, and 
they stopped taking all drugs approximately six weeks before admission. There 
had also been a history of transient paranoid psychosis. Another of their 
reported cases had used cocaine, LSD and cannabis with nightly use of 
ecstasy. However, on admission to hospital, urine screens were negative for all 
drugs except for cannabis. Even though the authors state polydrug use was 
present; “both our patients developed chronic paranoid psychoses after 
prolonged misuse of ecstasy although they had also misused other drugs on 
occasion” (p.697), ecstasy is described as key to the aetiology. In these studies, 
whilst ecstasy could plausibly play a role, it could also have been a 
consequence of any of the other psychoactive drugs or combinations of drugs in 
either a concurrent or simultaneous way.  
However, problems faced by researchers in accounting for polydrug use 
are not exclusively found in case studies. The need to find ways to describe 
heterogeneity forces arbitrary cut points. This affects two aspects of polydrug 
use, the plethora of patterns of use, and the different ways to measure drug 
use. For example, a recent study by Dafters, Hoshi and Talbot (2004) assessing 
the cognitive effects of ecstasy use comprised four groups for comparison, no 
(illicit) drug using controls, cannabis only, cannabis and ecstasy light use (<50 
tablets in lifetime) and cannabis and ecstasy heavy users (50+ tablets lifetime).  
The groups have a number of mean differences between use levels of alcohol, 
amphetamine, cocaine, heroin and LSD, none of which are assessed as 
contributors to models for deficits.  Thus, the lack of isolation of the drugs in 
these researcher chosen categories, make it difficult to draw conclusions about 
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the groups. A number of studies examining elevated levels of depression in 
ecstasy users also fail to consider that the findings found could be equally 
plausibly related to some of the other drugs used in a polydrug way (Fox, 
Parrott & Turner, 2001; Gamma, Buck, Berthold & Vollenweider, 2001; Verkes 
et al., 2001). Fox et al. (2001) examined four groups of ecstasy users, non-use, 
low, medium and high users finding significant differences in relation to 
cognitive deficits. As an example, the percentage of use of amphetamines 
across all four groups was 55%, 93%, 100% and 100% respectively. Given that 
alcohol, nicotine, amphetamines and other drugs can have as dramatic an 
effect in ecstasy polydrug users as the ecstasy itself, it is difficult to attribute the 
effects to ecstasy (Parrott, 2006) 
In a more recent study into ecstasy use and depression, Guillot and 
Greenway (2006) did not find a significant difference between their ecstasy 
naive controls and ecstasy users. Equally plausibly, the ecstasy naive controls 
could have been called “amphetamine, LSD, mushroom, ketamine, cocaine and 
opiate naive controls” versus the “users of a range of these drugs”.  The issue 
of nomenclature is a fundamental problem in the field. Sumnall, Wagstaff and 
Cole (2004) suggest that studies should avoid placing individuals in artificial 
categories such as ‘an amphetamine user’ and let the data illustrate its own 
categories. Simon and Mattick (2003) support this stating that “researcher 
driven, unvalidated categories” will certainly provide variance in groupings not 
accounted for by the choice of group title. For example, calling a group 
amphetamine user, will semantically attribute any effects to amphetamines 
rather than other possible drugs used. 
A similar study, Roiser, Cook, Cooper, Rubinsztein and Sahakian (2005) 
examined susceptibility to emotional and cognitive effects of ecstasy use. They 
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concluded that heavy ecstasy use contributed to deficits. However, they 
concede that it is difficult to ascribe to ecstasy as the users used a range of 
other drugs. Considering that polydrug use is common, even in ‘novice’ ecstasy 
users (Schuster, Lieb, Lamertz & Wittchen, 1998), researchers have found 
difficulties in accounting for this important issue. The potential influence of other 
drugs is not limited to just illicit polydrug use. Curran and Travill (1997) found in 
a study of 12 ecstasy users versus 12 alcohol users a significant relationship 
with mood and cognitive tests in the ecstasy users. They concede that the 
amount of alcohol taken by some of the ecstasy users was small, but could not 
discount that it may have had some impact on the outcomes of the study.   
However, other methods used to reduce the effect of confounds are not 
always appropriate for illicit polydrug research. As Dafters et al. (2004) state, for 
ethical reasons, double blind placebo controlled repeated dose clinical trials 
cannot be used in illicit drug research. Gouzoulis-Mayfrank and Daumann 
(2006b) call on the use of prospective designs following young children into 
adulthood, however, note that these often entail considerable cost and a 
difficulty in maintaining high response rates. Despite this, there have been some 
notable prospective studies in the area such as Dunedin Multidisciplinary Study 
(Silva, 1978) and Belfast Youth Development Study (Percy, McCrystal, Higgins 
& McSherry, 2002). The use of animal models to assess harm related to 
polydrug use can only allude to part of the picture. There is a lack of complexity 
in these studies to translate from laboratory into real life, controlling for dose, 
and importantly polydrug use (Green et al., 2003). There are also a number of 
additional problems, consumption quantities for illicit drugs are difficult to 
standardise as in the way of alcohol use and deciding on control groups with 
which to compare use to can be problematic. Control groups of polydrug users 
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who do not use ecstasy may display a more moderated pattern of drug use than 
ecstasy polydrug users (Gouzoulis-Mayfrank & Daumann, 2006b).  
Despite these methodological differences, ecstasy has been the second 
most frequently used drug for the majority of the 1990’s to the present day, with  
evidence to suggest it has been recently superseded by cocaine (EMCDDA, 
2008). There is a need to research potential positive and negative effects of this 
and other drugs to try and minimise harm. It is usually difficult to find users of 
just one drug, in the night club literature cannabis, ecstasy, amphetamines, and 
amyl nitrate predominate. In Hammersley, Ditton, Smith and Short (1999), none 
of their ecstasy users had consumed it alone with a more recent study by 
Verheyden, Henry, et al. (2003) illustrating that 59% of ecstasy users in their 
sample always used this drug with other licit and illicit drugs. 
In conclusion, the findings described as a result of ecstasy use when 
polydrug use is apparent, fail to account for what cannot just be described as a 
limitation of the research. Problems with lack of isolation, the wide range of 
patterns, drugs and ways to measure this concept make it difficult for research 
to move forward. Furthermore, it is evident that polydrug use is fundamental to 
both the description and conclusions drawn from the results.   
1.7. Summary and aims of this thesis 
This introduction has described the prevalence of alcohol and illicit drug 
use in general population samples. However, research into either illicit drug or 
alcohol use may not account for, or adequately describe the occurrence of 
polydrug use. Previous research has found it difficult to account for this 
polydrug use for a number of reasons. These include unclear definitions of 
polydrug use, the lack of isolation with other drugs, the large range of possible 
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patterns, different drugs included in the analysis and different ways to account 
for polydrug use through measurement.  
To address the issues arising from polydrug use, the following research 
questions will be addressed: 
1. Can the variability in illicit and alcohol polydrug use patterns be 
accounted for?  
2. Are these valid in relationships with demographic variables? 
3. How does polydrug use relate to psychological status?  
 
To answer (1), latent class analysis will be utilised which will account for 
the lack of isolation between drugs, the wide variety of patterns found in the 
data and include the largest number of drugs possible.  Chapter three will 
assess the patterns of illicit polydrug use in the general population of Great 
Britain using the NPMS (Singleton et al., 2001a; 2001b). It will therefore create 
homogeneous typologies which account for a wide pattern of illicit drug 
behaviour. Chapter four is a validation chapter which will assess the validity of 
these classifications of illicit polydrug use through assessment of quantity of 
illicit drug use in the lifetime. Yearly use may reflect either extensive or 
occasional use and given the way in which drug use is measured it will be 
important to establish both patterns and extent of illicit polydrug use.  Variations 
in patterns of alcohol use and related behaviours will be presented in chapter 
six. Given the strong relationship between illicit drugs and alcohol use, it is 
important to understand variations in alcohol use and related behaviours, first 
before assessing polydrug use. Finally, chapter seven aims to create a unified 
model of polydrug use, encompassing both alcohol and illicit drugs. 
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To address (2), patterns of polydrug use will be regressed on demographic 
criteria which have been shown to be associated with alcohol and illicit drug 
use. This will be included in analyses in chapters three, six and seven. Chapter 
three will validate the latent classes of illicit polydrug use, chapter six will 
validate the alcohol use typologies and chapter seven will validate the 
integrated polydrug use typologies.  
The relationship between polydrug use and psychological status will be 
assessed in chapters five, six and seven to achieve aim (3). Chapter three will 
assess the relationship between illicit polydrug use profiles and key, common 
neurotic disorders including generalised anxiety disorder, depressive episode 
and suicidality. Chapter six will assess the relationship of these disorders with 
the alcohol use typologies. The relationship between psychological health and 
polydrug use will compare the relationships found when these drugs are 
separated, and when they are combined. Note that the estimates of 
relationships with mental health conditions will control for the same 
demographic criteria. This will assess to what extent measuring relationships 
with alcohol or drug use separately differs to measuring within a polydrug use 
model. Given the prominence of the latent class method throughout this thesis, 





This chapter describes the shared methodologies used throughout the 
thesis. Firstly, the NPMS data will be described including detail on sampling 
procedures. Following this, details of the specific variables used in this thesis 
will be presented. Methods to describe polydrug use will be illustrated, with the 
prevailing statistical methodology, latent class analysis, described in detail. 
Particular attention will be paid to the assumptions, model fit considerations and 
software. Finally, multinomial logistic regression will be described; a technique 
which can both validate and describe latent classes. Note that chapters which 
have alternative statistical methodologies have these outlined in the relevant 
chapter’s methodology section. 
2.2. Data 
All of the analyses conducted in this thesis were performed on data from 
the NPMS or “Psychiatric Morbidity among Adults living in Private Households, 
2000” survey (Singleton et al., 2001a; 2001b). This was part of a series of Office 
of National Statistics (ONS) psychiatric morbidity surveys which also covered 
homeless adults, residents of institutions catering for those with mental health 
problems, adults with psychosis, prisoners and adolescents. A similar 
methodology was used across each of these surveys. The household survey 
used is the second wave following trends in psychiatric health of the population 
of Great Britain. The first wave was conducted in 1993 (Meltzer, Gill, Petticrew 
& Hinds, 1995). The dataset and associated documents were downloaded from 
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the UK Economic and Social Research Council Data Archive on the 20th 
October 2004 at the following web address http://tinyurl.com/624ban.  
The aim of this survey (and others in the series) was to collect information 
on the occurrence of mental health problems. It also contained questions on 
additional related areas including service use, intellectual functioning, stressful 
life events, social support, daily living and care needs, socio-demographic 
variables and drug and alcohol use. The data was collected by ONS 
interviewers between March and September 2000. Interviews were conducted 
using Computer Assisted Personal Interviewing (CAPI) and Blaise programming 
technology. Alcohol and drug use were predominantly self-completed by the 
respondent. However, a very small proportion had assistance with the 
interviewer either reading the questions with the interviewee making their 
choice, or the interviewer reading and responding to the question as per the 
interviewee’s answers. Each interview lasted on average 90 minutes. All 
interviewers were trained in both the use of the instrument and adverse 
situations as might be expected by a study of this size, breadth and content. 
2.3. Sampling 
The sampling strategy reflects a stratified two stage probability sample. 
Firstly, the small user postcode address file (PAF) was obtained from Royal 
Mail. This is a list of all delivery points (or addresses) which receive less than 50 
items per day, organised into postcode sectors containing on average 2500 
households. Postcode sectors from the PAF were stratified based on socio-
economic status in a region. Note that a region was defined as a function of the 
current NHS Regional Office area, and the previous Regional Health Authorities 
upon which the 1993 survey was based. This facilitates comparability between 
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waves of data collection. The second stage involved further stratification, based 
on head of household socio-economic status and proportion of households 
without a car as indicated from the 1991 Census data. 
From the full set of stratified postcode sectors 438 were selected with a 
probability proportional to the number of delivery points contained in it as an 
indicator of size. The majority of these were from England (n=370) with 46 from 
Scotland and 22 from Wales. Each sector had 36 delivery points (addresses) 
selected for approach. Note that an embargo had been placed on all addresses 
which have been sampled randomly in the past three years to reduce the 
burden on the public and to encourage participation in both the NPMS, and 
further studies. Interviewers then approached 15,768 addresses. A number of 
these houses were deleted from the list of potential addresses according to the 
inclusion criteria for the study. These included vacant or demolished properties, 
residences with no-one aged between 16-74 years old in the household, 
secondary or holiday homes or small businesses. Consequently, a total of 
12,792 addresses were eligible for inclusion. When the ONS interviewers 
approached the houses to conduct the survey, they would select a person at 
random living in the household who were aged 16-74 using the Kish selection 
method (Kish, 1965). The survey had an overall 69.5% response rate and a 
total of 8580 respondents (Singleton, Lee & Meltzer, 2002). 
2.4. Variables used 
2.4.1. Illicit drug use variables 
Questions were asked about 14 illicit drugs used in the past year, split 
over the two questions presented in Figure 2. The respondents were first asked 
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about their use of cannabis, amphetamines, cocaine, crack, ecstasy, heroin or 
LSD, with the opportunity to enter in any of the numbers corresponding to these 
drugs as their response. A respondent was also able to enter in multiple 
numbers corresponding to the full range of drugs they have consumed from the 
subset presented. They were then asked about their yearly use of a further 
seven drugs, magic mushrooms, methadone, semeron (a fictional drug), 
tranquillisers, amyl nitrate, anabolic steroids, and glue, and again have the 
opportunity of selection of the full range of drugs used. These were recoded into 
14 variables reflecting use in the last year. All were binary variables with ‘0’ 





In the LAST 12 MONTHS have you taken any of these drugs? 
Please type the numbers of ALL those drugs you have used in the LAST 12 MONTHS 
If you have used NONE of them, type ‘8’ 
SET [8] OF 
(1) Cannabis (marijuana, grass, hash, ganja, blow, draw, skunk, weed, spliff) 
(2) Amphetamines (speed, whizz, uppers, billy) 
(3) Cocaine or coke 
(4) Crack (rock, stones) 
(5) Ecstasy (E) 
(6) Heroin (smack, skag, H, brown) 
(7) Acid or LSD 
(8) None of these 
 
YDrug2 
And, in the LAST 12 MONTHS have you taken any of these drugs? 
Please type the numbers of ALL those drugs you have used in the LAST 12 MONTHS 
If you have used NONE of them, type ‘8’ 
SET [8] OF 
(1) Magic mushrooms 
(2) Methadone or physeptone 
(3) Semeron 
(4) Tranquilisers (temazepam, valium) 
(5) Amyl nitrate (poppers) 
(6) Anabolic steroids (steroids) 
(7) Glues, solvents, gas or aerosols (to sniff)  
(8) None of these 
 
Figure 2: Excerpt from the NPMS Questionnaire (p.73; Singleton et al., 2002) 
 
 
Methadone, volatile drugs (glue) and anabolic steroids were excluded 
from the analysis as they had an extremely low frequency of use in the sample 
(.07%, .08% and .06% respectively). The deletion of these drug use variables 
with low probabilities reflect drugs which had effectively been used by less than 
seven individuals in the past year. The decision was taken to delete these as 
without their removal there may have been a substantial impact on model 
identification in the subsequent latent class analysis. Conversely, the inclusion 
of these variables into an analysis of a dataset with 8580 individuals would be to 
the detriment of the latent variable estimation without any relative theoretical 
gain from their inclusion. This follows similar methodologies to other purposively 
or randomly sampled surveys into drug use (e.g. Topp et al., 2004). 
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Two other variables used by very small numbers of respondents were 
heroin and crack. Their percentage of use was 0.16% and 0.14% respectively; 
however, in order to retain these drugs, a composite variable was created 
collapsing the use of either heroin or crack into one category. A different 
rationale was employed in the decision to keep these drugs. Both of these are 
key in terms of health outcomes. In addition, they are associated due to 
behavioural similarities among users of these drugs, in particular, the traditional 
association with abuse and dependence. Thus, there were nine illicit drugs used 
in these analyses, cannabis, amphetamines, cocaine, ecstasy, LSD, magic 
mushrooms, tranquillisers, amyl nitrate and the composite heroin/crack variable.  
‘Semeron’ is a fictional drug and has been placed in this questionnaire to 
highlight a false self-report. It was originally included in the British Crime Survey 
in 1994 (Ramsey & Percy, 1996) and in the National Drug Campaign Survey in 
1995 (McNeill, Raw & Heuston, 1996), and has been one of the most frequently 
used since then (Ramsey & Percy, 1997). It has been endorsed by one person 
in the yearly time frame and three in lifetime. This may indicate a false self-
report. Following the methodology of these and other previous studies using this 
method, e.g. (Riley et al., 2001) who used the variant ‘simeron’, these 
individuals have been removed from the dataset.  
2.4.2. Alcohol use variables 
The alcohol use section commences with two qualifying questions asking the 
respondent whether they were current drinkers. These are presented below in 
Figure 3. Those who answer no to “drink now” were asked to clarify this answer, 
checking that those who drink even very occasionally were included into the 
analysis. Note that this serves two purposes. First to shorten the overall time 
burden if an individual has not consumed alcohol in the past year. Those who 
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were identified as never drinking alcohol were screened out of the section. 
Secondly, those who perhaps have a small number of drinking occasions, and 
may refer to themselves as non-drinkers, as their most common pattern of use, 
were screened into the alcohol use section. Those who do not drink currently or 
have not consumed alcohol in the past year score zero on the total 
questionnaire. For the purposes of these analyses, any of the respondents who 
did not proceed to complete the AUDIT questionnaire were excluded from the 
analysis. This is consistent with other research such as population surveys in 
Ontario, Canada who excluded an older (than 64 years old) cohort who had 
missing items across the alcohol questions of interest (Ogbourne & DeWit, 







Figure 3: Introductory variables to the alcohol section of the questionnaire: 
distinguishing non-use from very occasional use (p.69; Singleton et al., 2002). 
 
After these introductory questions, the alcohol section comprised of two 
main established questionnaires, both which were self-administered by the 
respondent. These were the AUDIT (Alcohol Use Disorder Identification Test: 
Saunders and Aasland, 1987; Babor, de la Fuente, Saunders & Grant, 1992b) 
and the Severity of Dependence Questionnaire (SADQ: Stockwell, Murphy & 
Hodgson, 1983). The SAD-Q is a lay administered measure of alcohol 
dependence. Individuals scoring eight or more on the AUDIT proceeded to 
answer the questions in the SAD-Q. This thesis will only assess patterns of 
DrinkNow 
I’m now going to ask you a few 
questions about what you drink - that 
is if you do drink. 
Do you ever drink alcohol nowadays, 




ASK IF: DRINKNOW = NO 
DrinkAny 
Could I just check, does that mean you 
never have an alcoholic drink 
nowadays, or do you have an alcoholic 
drink very occasionally, perhaps for 
medicinal purposes or on special 
occasions like Christmas or New Year? 





‘use’ in the population rather than alcohol dependence in the past year, and 
thus considers only the AUDIT. 
The AUDIT questionnaire was originally designed by the WHO to screen 
for hazardous drinking in primary care. It is a ten-item questionnaire relating to 
alcohol use in the past year, and was originally designed to screen for 
excessive drinking and to assist the process of brief assessment of drinking 
behaviours. It was primarily designed for health care professionals to highlight 
individuals who might benefit from reducing or ceasing alcohol use. However, 
the questionnaire is simple and easy to use for lay persons to either deliver or 
self-administer. One of the advantages to the AUDIT is that it highlights 
individuals at risk of harm from their alcohol use behaviour rather than applying 
a diagnosis of either abuse or dependence. Consequently, the scale does have 
two main of cut points representing hazardous or risky drinking (eight or more) 
and harmful drinking (20 or more), the latter being more likely to suggest a 
possible alcohol abuse/dependence. This is an advantageous approach when 
examining behaviours in the general population.  
Hazardous drinking increases the risk of medical consequences such as 
mental health problems or social problems. This pattern is more prevalent in the 
general population than those diagnosed with alcohol abuse and dependence. 
As a result, the bulk of alcohol related problems in a given general population 
may be attributed to hazardous drinking (Babor, Higgins-Biddle, Saunders & 
Monteiro, 2001). Therefore, the AUDIT questionnaire is an excellent means by 
which to determine a population estimation of harm caused by alcohol and is a 
more informative estimation of wider public health implications. In addition, 
when the focus is more on the diagnosed alcohol abuse and dependence, the 
instrument has been considered to have good sensitivity and specificity in the 
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prediction of alcohol abuse and dependence (Bohn, Babor & Kranzler, 1995; 
Conigrave, Hall & Saunders, 1995). Therefore, it appears to be suitable for 
general populations where some abuse and dependence may be found. 
For those who have used alcohol and thus proceed to complete the 
AUDIT questionnaire, there were ten items referring to alcohol consumption and 
related problems in the past 12 months. For the chapters in this thesis wishing 
to assess the presence or absence of hazardous drinking, the ten items of the 
questionnaire were summed to give a scale total. Scores of eight or more were 
deemed to represent this threshold of hazardous alcohol use behaviour 
(Saunders & Aasland, 1987). The original AUDIT items were measured on an 
ordered categorical scale from zero to four. Consequently, it was considered 
that it might be useful to treat the indicators as continuous then use latent profile 
analysis, which is a continuous analogue to LCA. However, upon inspection of 
the data, the ordered categorical approach was not a close enough 
approximation to continuous level data. In other words, the data was heavily 
skewed representing extreme levels of endorsement, illustrating an essentially 
binary pattern of response for most items. As the original scale was in the range 
of zero to four for all questions except question nine and ten which had the 
possible options ‘0’, ‘2’ and ‘4’, there would have been numerous empty cells in 
the cross classification tables which would have created model identification 
issues. In order to balance this problem, the variables were collapsed into an 
appropriate binary format for the purposes of latent class analysis. 
Chapters six and seven examine patterns of alcohol use behaviour on all 
the ten indicators recoded from the original items. Note the questionnaire and 
original response categories are presented in Appendix 1. For the purposes of 
these analyses, these were collapsed into two categories, with ‘0’ referring to 
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the option ‘never’ for questions one and three to eight, the option ‘1 or 2’ for 
question two and the option ‘no’ for questions nine and ten with ‘1’ representing 
all other responses for each question.  
2.4.3. Demographic variables 
Demographic variables which have been included in the analyses include 
gender (‘0’=female and ‘1’=male). Respondent age in years was measured as a 
continuous variable, in the range of 16-74 years old in accordance with the 
inclusion criteria of the study. Educational attainment was operationalised as a 
binary variable where ‘0’ indicated education beyond GCSE level and ‘1’, 
education to GCSE or below. In Great Britain, the first age at which adolescents 
are legally allowed to leave full time education is 16 years of age, primarily 
equating to GCSE level qualifications (although it must be noted that this does 
not mean that GCSE qualifications have been obtained). There is no legal 
obligation to remain in school or education past that age. The information used 
to define this variable is derived from the question “How old were you when you 
finished your continuous fulltime education at school or college?” (p. 98; 
Singleton et al., 2002). If a respondent in the study was deemed to have been 
educated to GCSE level or below, this represents those who were continuously 
educated to age 16, regardless of their GCSE performance. If they were aged 
16 at the time of interview, they were deemed not to have passed the threshold 
into further education and were coded as being GCSE level or below. 
Conversely, education beyond GCSE level can include A levels/GCE, 
university, or vocational qualifications e.g. GNVQ or HND. This suggests an 




Economic activity was measured as economically active, i.e. being 
currently employed scoring ‘0’ and economically inactive as ‘1’. This was 
recoded from a three-group variable representing employed individuals, 
unemployed and economically inactive. The latter two of these were combined 
into one economically inactive group, representing those who do not earn a 
taxable income at present. Examples of individuals who may be in the 
economically inactive group would be homemakers, unemployed individuals or 
full-time students. 
Other variables included were area type in which the respondent lived 
(0=rural/semi-rural; 1=urban). This was a variable which was not asked of the 
respondents. Instead this was coded by the interviewer at the beginning of the 
interview based on their observations of the area in which the respondent lived. 
This was another three-group variable, which was recoded to represent rural 
and semi-rural as one category distinct from that of the urban group.  
The predictor ‘current smoker’ was generated through the questions 
“Have you ever smoked” and “Do you smoke now” from the original 
questionnaire. If the respondent never smoked or had smoked but did not at the 
time of the interview, then the participant was given a score of zero. Those who 
had a previous smoking history, but currently did not smoke were also coded 
zero. If they answered ‘yes’ to the question “Do you smoke now” they were 
coded as being a current smoker and scored one. It was not possible to create 
a variable which represented smoking behaviour in the past year, as was 
possible for illicit drugs and alcohol use behaviours; the questions being asked 
were less defined by time ranges; however, this is a typical way to assess 
smoking use behaviour (Wadsworth, Moss, Simpson & Smith, 2004). 
61 
 
2.4.4. Psychological variables. 
Depressive episode, generalised anxiety disorder and mixed anxiety and 
depressive disorder were measured using the Clinical Interview Schedule 
Revised (CIS-R; Lewis and Pelosi, 1990).  This is a standardised interview used 
to assess common psychological conditions designed to be used by lay 
persons. It has 14 sections covering the neurotic symptoms of worry about 
physical health, depression, anxiety, depressive ideas, worry, irritability, 
concentration and forgetfulness, sleep problems, panic, phobias, compulsions, 
obsessions, fatigue and somatic symptoms. Each section is preceded by an 
opening question to assess whether the symptom has been experienced. If yes, 
they will be asked a further four questions primarily relating to the frequency, 
duration, and severity of that symptom over the past seven days. The only 
exception to this is the symptom of depressive ideas which has five items. 
Scores for each question within a section range from zero to four (or zero to five 
for depressive ideas). This can be totalled to give a score in the range of 0-57. 
Scoring 12 or above is indicative of symptomatology of clinical relevance, the 
range of 6-11 indicates some symptomatology and five or below illustrates a 
lack of evidence of psychological problems (Singleton & Lewis, 2003).  
However, in chapters five, six, and seven, psychological status will be 
indicated by the presence or absence of a probable clinical diagnosis. 
Diagnoses of disorders were obtained through the application of algorithms to 
the 14 neurotic symptoms reflecting the ICD-10 diagnostic criteria for research. 
These create variables which express the absence (0) or presence (1) of 
depressive episode, Generalised Anxiety Disorder (GAD) and Mixed Anxiety 
and Depressive Disorder (MAD) amongst other diagnoses (Lewis, Pelosi, Araya 
& Dunn, 1992). It has been considered as a reliable scale in which to measure 
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common mental disorders such as depressive episode, GAD and MAD across a 
severity continuum (Jenkins et al., 1997).  
To assess suicidal behaviour in this sample, participants were asked 
directly about their involvement in such activities. The predictor used in the 
following chapters relates to attempting suicide at least once in an individuals’ 
lifetime. These were coded as ‘0’= no attempts; ‘1’= one or more attempts in 
lifetime. 
If an increased risk of poorer psychological health is found amongst 
polydrug users, it will be interesting to note their help seeking behaviours in 
response to these. This will be measured as visits to a General Practitioner 
(GP) in the past year for a psychological or physical complaint. These were 
coded ‘1’ if an individual had visited their GP for an unspecified physical or 
psychological complaint in the past year and ‘0’ if they had not. As the GP is the 
source to which all non-emergency referrals are made, and the gateway to 
further treatment, if there is an elevated risk of psychological or physical harm, it 
will be important to assess whether they were similarly likely to seek medical 
attention. This will provide valuable information to policy makers relating to 
unmet treatment needs, which is in turn a valuable indicator of health of the 
nation (Demyttenaere et al., 2004).  
2.5. Analyses 
This section will commence with an exploration of other methods to 
attempt to describe polydrug use and highlight the extent to which these may 
not be able to fully exploit the different patterns. This will be followed by a 
description and worked example of latent class analysis; the primary 
methodology used throughout this thesis. Patterns of polydrug use will be 
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subsequently explored using multinomial logistic regression, and an exploration 
of this technique will conclude this section 
2.5.1. Frequencies, correlations and cluster analysis 
One of the primary methodologies used in the literature to explain drug or 
alcohol use is frequencies. Whilst this has utility in clearly illustrating the levels 
of usage of drug use in a particular sample, it is too simplistic to draw 
conclusions about polydrug use. This could be presented as 90% of the sample 
were using alcohol, 20% were using cannabis, 10% ecstasy, and 10% cocaine. 
This is good for summarising information but offers little detail on polydrug 
consumption. However, this method could be extended to cover patterns of 
polydrug use. For example, the frequency of ‘alcohol and cannabis’ use, 
‘alcohol, cannabis and ecstasy’ or ‘alcohol and ecstasy’ could be estimated. In 
practice, to represent all patterns of polydrug use in a dataset, dependent on 
the number of variables measuring drug use, the possible combinations could 
be extremely large. Thus, the ability to draw detailed conclusions is difficult. 
Correlations offer a bivariate model to assess polydrug use patterns. This can 
illustrate the level to which one variable relates to another variable. However, 
this is unable to illustrate relationships beyond a pair of drugs used in a 
polydrug pattern. In addition, this is a variable centred approach, which has less 
utility in illuminating the relationship between individuals (DiStefano & 
Kamphaus, 2006). 
However, there are ‘person centred’ analytical approaches available 
such as latent class analysis and cluster analysis. Cluster analysis assesses the 
similarity and differences in both the magnitude and pattern of data.  However, 
the researcher makes considerably more decisions about the method during the 
analysis which can bias the solution (Aldenderfer & Blashfield, 1984). Vermunt 
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and Magidson (2002) state that the main advantage latent class analysis has 
over cluster analysis as the structure is iteratively derived through maximising 
the loglikelihood function. This is through the utilisation of the expectation 
maximisation algorithm, which is described below.  
2.5.2. Latent class analysis 
The discipline of social science relies on the conceptualisations of traits 
which cannot be directly observed. For example, theoretical constructs such as 
intelligence, motivation, depression, anxiety or sporting ability are used to 
describe differences between individuals but there is no gold standard of 
measurement. Instead, we measure convenient representations of these 
concepts, which allude to these ‘latent’ or unobservable constructs and attempt 
an approximation of measurement. When these directly observable variables 
approximating to the latent constructs are categorical, latent class analysis can 
provide a mathematical model to represent the potentially underlying concept. 
This technique has been applied in many research areas including subtypes of 
depression (e.g. Eaton, McCutcheon, Dryman & Sorensom, 1989), alcohol 
dependence (e.g. Bucholz et al., 1996) or drug abuse or dependence (e.g. 
Agrawal, Lynskey, Madden, Bucholz & Heath, 2007), and a worked example of 
this technique will follow. 
Latent class analysis (LCA) can be used to identify subgroups or classes 
of cases similar to each other on a set of discrete observed variables. This 
modelling strategy estimates the number of classes of an underlying latent 
variable that can explain the covariation amongst observed categorical 
variables (Haagenars & McCutcheon, 2002). In this way, a latent variable be 
measured, and be expressed in a way that captures the heterogeneity, or range 
of different response patterns of endorsement of the observed variables. The 
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model parameters include class membership probabilities per person (or class 
percentage estimates) and class-specific observed variable endorsement 
probabilities (or the probability of a class endorsing a particular drug such as 
cannabis).  
The model to be tested in this hypothetical example is given in Figure 4. 
Conceptual model diagrams like these will be provided for each of the 
empirically based chapters in this thesis using latent class analysis. Circles in a 
model diagram represent latent variables. In this case the latent variable 
represents the concept of yearly drug use, of which there are a given k number 
of classes. The latent variable will be estimated from the observed variables 
which relate to it. Observed, (variables that can be measured) are illustrated by 
boxes. In this case the variables from which the latent variable is estimated are 
yearly use of cannabis, LSD, ecstasy and cocaine. Note the components are 
divided into parts relating to latent and observed variables. 
A table of hypothetical data and relevant results are presented in Table 
10 below. Consider that these four respondents come from a larger 
representative sample from the general population of Great Britain who have 
used any (or none) of four observed drugs in the past year (n=1,000). As 
indicated in the annotation to the table, the grey shaded area corresponds to 
the raw data entered into the analysis, and relates to the observed variables or 
boxes presented in Figure 4, where ‘0’ indicates no use in the past year and ‘1’ 
indicates use in the past year. The information in the table which is both bold 
and italicised represents information generated from a latent class analysis, i.e. 
relating to the circle in Figure 4.  
Consider the observed component which reflects the shaded area in 
Table 10. This is the observed use of a named drug in the past year. A row 
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represents a single participants’ observed pattern of yearly drug use.  
Participant one has used all four drugs in the past year. Participant four has 
used cannabis only. Participant two has used all drugs except LSD and 
participant three has used cannabis and ecstasy. These form a selected 
proportion of respondents in a hypothetical study aiming to create a latent 
variable of polydrug use based on the four observed categorical indicators of 
drug use. This is the information that we are interested in modelling in the latent 
class analysis. A latent variable was considered to be able to explain the 
variability in response patterns to create classes or typologies. From the four 
indicators, there are 16 potential patterns of response in the dataset, from which 
we wish to create as few homogenous groups that represent the variability as 
possible. 
Given that there are fewer classes than observed patterns, a conditional 
probability of membership of a certain class is provided by the procedure. This 
allows assessment of how well (or poorly) the classes represent patterns in the 
dataset. Examining first participant one, they have a .9 conditional probability of 
being in class 1. They express a pattern of response which is representative of 
others in that class, and their pattern of response is associated with 
membership of class two to a low level (.1). Contrasting with participant four, 
who has less representative membership of class 4 (their most likely class), with 
an endorsement probability of (.6).  Note that the proportions of membership all 
sum to one as every individual is included in the classes, and that the 
individuals shown are only illustrative of four members of a larger subset of 
respondents. 
The bottom row of Table 10 represents the size of each of the classes. 
This is a sum of each of the conditional probabilities (i.e. a column) for each 
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class, and output to this effect can be provided by latent class software. Another 
parameter generated by the model is the number of people in each class based 
on their most likely latent class membership. In this example, there is one 
person in each class represented in the table. Comparing the conditional 
probabilities to the most likely latent class membership, it can be seen that 
these two methodologies represent largely similar results, however, there are 
slightly more members of class 1 and 3 when examining at the totals based on 
conditional probabilities. 
Latent class analysis software can create an output file containing both 
the original data (the grey area of the table), the probability of each individual 
belonging to class 1, 2, 3 or 4 and their most likely class. The latter two, as 
outcomes from the latent class analysis are represented in bold in  Table 10. 
When the best fitting model has been identified (see the fit criteria section 
2.5.2.3), either the conditional probabilities of membership or most likely latent 
class can be used for multinomial logistic regression purposes, detailed later in 
this chapter, section 0. For the purposes of all analyses in this thesis, the 
conditional probabilities have been fixed and regressed on demographic or 
mental health variables. In this way, the assignment of individuals to classes is 













Figure 4: Conceptual model of four observed indicators of yearly drug use.  
 
(Note: Highlighted components illustrate a component of the model, whether 




























(Note: that this represents only four respondents in a larger sample of the population of Great Britain). 
Case 
OBSERVED VARIABLES (BOXES) LATENT VARIABLES (CIRCLES) 
Drug used in the past year 
(1= yes; 0=no) 




class Cannabis LSD Ecstasy Cocaine 1 2 3 4 
1 1 1 1 1 .9 .1 0 0 1 
2 1 0 1 1 .2 .7 .1 0 2 
3 1 0 1 0 0 .1 .8 .1 3 
4 1 0 0 0 0 .1 .3 .6 4 
Total conditional probability of being in each 
class, i.e. column totals represent the 
proportion of people in that category 















Cannabis LSD Ecstasy Cocaine
Class one: n=250 (25% of  
sample)
Class two: n=250 (25% of  
sample)
Class three: n=250 (25% of  
sample)
Class four: n=250 (25% of  
sample)
 
  Figure 5: Profile plot of the four latent classes illustrating the probability of endorsement of each observed item in each latent class.
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The other parameters generated by the model are that of the 
probabilities of endorsement of each of the observed items (i.e. cannabis, LSD, 
amphetamines, or ecstasy) for each of the four classes. Figure 5 is an 
illustration of how this can be expressed in practice. The X axis has the 
observed indicators along its axis. The Y axis represents the probability of 
members of each class saying yes to the given observed item. Each class is 
expressed as a separate line on the graph.  
Patterns illustrated on the graph are useful to help name classes 
appropriate to the typical patterns expressed. For example, class 4 have a .9 (or 
90%) chance of using cannabis in the past year and a very low probability of 
using LSD (0.0), ecstasy (.1) and cocaine (0.0). This would indicate most class 
members are cannabis only users, and thus a researcher might wish to name 
the class ‘cannabis only’.  Class 2 in contrast have 100% of their members 
using both cannabis and ecstasy.  Around .6 proportionally are also using 
cocaine, however, there is no use of LSD in this class. Theoretically, this could 
be representative of a “cannabis, ecstasy and cocaine” class. Classes 1 and 3 
are relatively similar to one another, however, class 1 have a higher probability 
of endorsing all of the observed yearly drug use variables. These could be 
potentially part of a continuum where class 1 has a heavier involvement in drug 
use pattern than class 3. In  Figure 5 the continuum is illustrated by almost 
parallel lines in this graph. This raises additional questions. Firstly, it must be 
considered whether two classes add any additional information, or whether the 
model would be more appropriately expressed in a more parsimonious way, 
with classes 1 and 3 merged. Another way to demonstrate the utility of this 
pattern of use is by examining at whether the classes are different on 
extraneous variables, such as demographic information, to illustrate whether 
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they are characteristically the same group. Finally, the probabilities of 
endorsement of each of the items should be inspected. Whilst over half of both 
groups are using both cannabis and LSD, class 3 has less than .3 of endorsing 
either cocaine or ecstasy. The members of class 1 have a 70% chance of being 
either an ecstasy or cocaine user. It might be considered to name class 1 
appropriate to use of all the drugs, whilst class 3 might be considered 
appropriately named as “cannabis and LSD users” only. 
2.5.2.1. Assumptions of conditional independence 
The latent class analysis modelling technique assumes that the observed 
categorical variables are locally independent; the response to one observed 
indicator tells nothing about the response to another once the latent variable 
has been controlled for. This is similar to factor analysis in that the observed 
manifest variables are assumed to be independent of each other once loaded to 
the underlying factors. If a dataset fails to uphold this assumption, there are 
problems with model identification and theoretically irrelevant, meaningless 
latent classes may be generated (Vermunt & Magidson, 2002).  
In practice, this means if an individual uses amphetamines, they are 
likely to use other drugs such as cannabis or ecstasy. However, they are not 
guaranteed to be using these other drugs, and thus the assumption holds. 
Equivalently, if an individual answers never (coded ‘0’) to the initial question of 
the AUDIT, they will all score ‘0’ on the remaining questions. However, if an 
individual answers ‘1’ to this question, they could answer ‘1’ or ‘0’ to any of the 
remaining nine questions and thus the assumption holds. 
2.5.2.2. Determining number of latent classes of the latent variable 
In order to perform a latent class analysis, and determine the optimal 
number of classes, a specific number of latent classes are enforced on the data. 
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In this thesis, estimations of two through nine latent class solutions were 
estimated. These models use a maximum-likelihood estimation approach 
determining the parameters of the model with the Expectation Maximisation 
(EM) algorithm. This is the default algorithm in Mplus for latent variable mixture 
modelling (of which latent class analysis is a specific type), and the process 
takes place in two steps. The first step involves calculation of the expected 
value of log likelihood function for a given number of classes. Therefore, Mplus 
estimates the conditional response probabilities and the endorsement 
probabilities for the given number of latent classes, calculating how well these 
estimates fit the data. A larger loglikelihood value represents a better fit. Step 
two involves increasing the accuracy of the function by adjusting the parameter 
estimates; if the estimates are improved the estimates are kept and improved 
upon, if estimates illustrate a fit deterioration, they are discarded. A cyclical 
repetition of steps one and two continues in this iterative way until the final 
criteria converges or when the iterative process stops improving and the change 
tends to zero. 
 In this process local maximum values may be generated through the 
model process (Haagenars & McCutcheon, 2002). This is when there is a 
change in the loglikelihood value which decreases the loglikelihood function and 
log thus reaching convergence point before the true global maxima. (Muthén & 
Muthén, 1998-2007) recommends using multiple sets of starting values and 
making a comparison of the loglikelihood values. In all latent class models 
performed in this thesis, 100 starting values were used with the best 20 
optimised and the loglikelihood was checked to verify the presence of the global 
maxima. Should the occasion arise where the best loglikelihood is not 
replicated, the number of random starts and optimisations were increased until 
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this status has been reached, and confidence can be placed in the solution. 
Where the number of starts has been increased in any of the chapters, this will 
be indicated in the relevant methods section. 
2.5.2.3. Model fit 
Traditionally the likelihood ratio chi-square (LR2) and the Pearson chi-
square have been used for latent class models. However, this is not suitable for 
larger sample sizes such as those found in this thesis (Markovitz, 2003). In 
addition, the likelihood ratio chi-square statistic is not suitable for testing models 
which are not nested i.e. have differing latent classes (McLachlan & Basford, 
1988) due to low frequencies in the cross tabulations. Alternative fit indices 
include information criteria. The most often used are the AIC (Akaike 
Information Criterion; Akaike, 1987) and the BIC (Bayesian Information 
Criterion; Schwartz, 1978). Geiger, Heckerman, King & Meek (2001) found that 
the BIC is no longer robust with large sample sizes such as those found in the 
NPMS (Singleton et al., 2001a; 2001b) and the sample size adjusted BIC 
(SSABIC; Sclove, 1987), is preferable. Lowest values of this entire information 
criterion indicate superior model fit. 
 Additionally, the Lo-Mendell-Rubin likelihood ratio test which compares 
each model to its predecessor, i.e. k class model to k-1 model- where k is a 
given number of latent classes (Lo, Mendell & Rubin, 2001). If you take a 
hypothetical latent class structure where the latent variable is comprised of four 
classes, the k (4 class) model would be compared to the k-1 (3 class) model. 
This method tests the hypothesis that the null model k-1 is acceptable. If the p 
value is greater than 0.05 the null model cannot be rejected, and the k-1 model 
is acceptable. If the p value is less than 0.05 the estimated k model is superior, 
and the process must be continued by running the model with successive 
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numbers of classes until the k-1 model is superior. This is then the best number 
of classes to explain the heterogeneity of the data. It is also worth noting that 
the last class needs to be the largest class as the first class in the estimated 
model is deleted in the comparison of the two models (k and k-1). This is 
assessed by requesting TECH 11 in the output of Mplus. 
Finally, another method of assessing how well a model fits the data is by 
examining at the bivariate residuals. By asking Mplus to generate TECH 10 
output, the patterns of response are displayed. A significant bivariate residual, 
which is where there is a significant difference between the observed and 
expected frequencies for a particular pattern illustrates the degree to which the 
model does not fit the data. The observed data frequency represents the 
number of times the pattern appears in the raw data. The expected frequency is 
the frequency predicted by the model structure. In using this as a means of 
addressing model suitability, the bivariate residuals of the ten most frequent 
response patterns will be assessed for significance, with a higher number of 
significant residuals indicating a model’s poor fit to the data. In practice, if the 
model cannot replicate the most common patterns of use in the database, then 
the patterns generated by the model will not fit the original data well. 
There is still considerable debate surrounding the relative performance of 
fit indices in latent class modelling, and consequently the agreement of a 
combination of the sample size adjusted information criteria (SSABIC), number 
of significant bivariate residuals and the Lo-Mendell-Rubin likelihood ratio test 
will be used in this research to determine the best model fit.  Entropy is an 
indicator of how the latent classes are distinct and separate from each other 
where a value close to 1 indicates clear classification (Ramaswamy, Desarbo, 
Reibstein & Robinson, 1993). It is a summary measure of the accuracy of 
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placing respondents into classes based on posterior probabilities generated by 
the latent class model 
2.5.3. Multinomial logistic regression 
Once a suitable latent class structure has been selected from the 
information criteria and the Lo-Mendell-Rubin loglikelihood ratio test, the next 
step is to further investigate the characteristics of the latent classes in terms of 
predictor or background variables. This is useful to further develop the profile of 
the classes of latent variable.   
The addition of predictors to the model through multinomial logistic 
regression can affect the formation of the latent classes. Therefore, two options 
exist when adding predictors to the model. Firstly, the addition of predictors can 
be allowed to affect the formation of the latent classes. There are advantages to 
this method in that the interaction between background variables actually 
influence the observed, manifest variables and, therefore, would influence the 
latent variable. 
Conversely, the posterior probabilities can be fixed using the ‘training’ 
function in Mplus and thus the predictors do not affect the latent class formation. 
By fixing the probabilities, as is the case the analyses contained in this thesis, 
the latent classes are purely determined by the licit and illicit drug use 
behaviours in the survey and the background variables act as predictors. In this 
way, it is considered possible to perform ‘weighted’ multinomial logistic 
regression on the data (Muthén & Muthén, 2007) using exact probabilities rather 
than most likely class. Using fixed latent class probabilities has several 
advantages. Firstly, given that the alcohol use model has ten observed 
indicators, the illicit drug has nine and a combined model would have 19 
observed indicators, the models are already computationally demanding. 
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However, to include the number of predictors in this thesis may make these 
computational demands unreasonable and likely result in an unstable or 
misleading solution. Secondly, the issue of classes being identified as with or 
without predictors is one essentially based on belief rather than evidence. No 
systematic simulation work to date supports either method; considering the wish 
to create latent class typologies of drug use, it could be considered 
advantageous to assess the latent variable separately, using the predictors to 
validate and lend theoretical weight to the results. 
In terms of the output of the multinomial logistic regression analysis, 
Mplus calculates the natural log of the odds (beta or β) of an event occurring in 
other classes relative to the reference class (this is usually the last class). In 
addition to the beta estimate, standard error (S.E.) and significance are also 
computed. The significance is a calculation of β/ S.E. which if exceeded 1.96, 
displayed a significant result for that factor. Only the odds ratio with 95% 
confidence intervals will be displayed. The significance of a predictor is also 
indicated if the 95% confidence limits span either side of one. A conceptual 
diagram illustrating the relationships between the variables is presented in 
Figure 6. This illustrates how the demographic variables of gender, age and 













Figure 6: Conceptual model of multinomial logistic regression. 
Latent variable 














2.5.3.1. Optimal model selection  
 This is a variant on the multinomial logistic regression. It primarily runs 
two models. The first estimates the log odds for predictor variables to be freely 
estimated relative to the baseline class. As can be seen in Figure 7, assuming 
illicit polydrug use is a four class latent variable, three log odds will be estimated 
which represent how gender predicts class membership. These are called a1, a2 
and a3. For the other predictors, age and employment status, these log odds 
represent b1, b2 and b3 and c1, c2 and c3. They are all measured in relation to the 
baseline last class (class 4). A second model is then run which constrains or 
fixes the log odds for each predicted relationship (the effect of gender on class) 
to be the same across classes compared to the baseline. Using the example of 
gender, the analysis will be forced to generate log odds for the relationship 
between gender and class which are equal for all three classes compared to the 
baseline class. Therefore, a1= a2 = a3. For the other predictors in the model this 
is b1 = b2 = b3 and c1 = c2 = c3 for the predictors of age and employment status.  
As there are more free parameters (or less relationships to estimate) in this 
model, this is said to be a simpler (parsimonious) solution. 
In order to determine whether the most parsimonious solution fits the 
data better, the 2∆ loglikelihood (2ll) difference was compared. The 
loglikelihood is a measure of fit provided in the output of each of the models 
tested. The difference between the two loglikelihoods is multiplied by two to 
provide an approximation to the chi square distribution. Assessment of chi-
square distribution tables illustrate whether significant differences are found 
between the two models. If the critical value for chi-square is less than the 2ll 
for a given difference in degrees of freedom between the two competing 
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models, then the differences are significant. If there are no significant 
differences between the models the more parsimonious restricted solution is 
favoured.  
If there is a significant difference between these two models, to select the 
optimum multinomial logit model, constraints will be sequentially relaxed from 
model two until the 2ll test shows a model which is both parsimonious in terms 
of constraints but was also a good fit of the data. Modification indices in the 
Mplus output will be used to find the most likely variable to be relaxed testing 
the null (Ho) hypothesis that a model with x-1 parameters is a better fit of the 
data than a model with x parameters. This sequence of constraint relaxations 
continued until the p value was greater than 0.05, therefore, the Ho model 
cannot be rejected and the model with x-1 parameters was then taken as the 
best fit. Significance levels are determined by examining at critical values for a 
given degree of freedom difference in chi-squared tables. The global aims of 
this process are twofold first it creates a parsimonious solution and second it is 




























The primary software used in this thesis to perform latent class analyses 
and subsequent multinomial logistic regressions was Mplus version 5.01 
(Muthén & Muthén, 2007). Notably there are a number of other software 
packages which can perform this kind of function such as Latent Gold (Vermunt 
& Magidson, 2005) or free software such as R http://cran.r-project.org/. Mplus 
was chosen for functionality, flexibility and ability to model complex solutions 
well. Graphical representations are all conducted in Microsoft Excel 2007, and 
all preliminary data analysis, recoding and descriptive statistics were conducted 
using SPSS (SPSS Inc., 2006). 
83 
 
3. The latent class structure of illicit polydrug use in the 
UK: findings from a national household population. 
3.1. Abstract 
Illicit polydrug use is common in the general population but little is known 
about how it is expressed. This chapter aimed to identify typologies of illicit 
polydrug use in Great Britain. A latent class analysis was performed on nine 
indicators of past year drug use (cannabis, cocaine, amphetamines, ecstasy, 
LSD, mushrooms, amyl nitrate, tranquillisers and a composite group of heroin 
and crack use) collected from a large multi-stage probability sample of the 
population of Great Britain (NPMS; n=8538). Multinomial logistic regression was 
used to validate and explore the relationship between class membership and 
demographic variables. Three classes best described patterns of response in 
the data. These were labelled class 1 ‘wide range’, class 2 ‘moderate range’ 
and class 3 ‘no drug use’. The multinomial logistic regression results confirmed 
significant associations between latent classes and gender, education, 
economic activity, smoking status, hazardous drinking and age. Members of 
classes 1 and 2 were significantly more likely to be male, have lower 
educational attainment, be economically inactive, and currently smoking than 
the baseline group. Those in class 1 and 2 were also 11.12 and 2.35 times 
more likely to be drinking hazardously respectively compared to those in the no 
drug use class. Class 1 was characterised as significantly younger than both 
classes 2 and 3. In conclusion, illicit polydrug use in Great Britain can be 
grouped into three distinct classes, which differ on key demographic variables. 
Hazardous alcohol and tobacco use were strong predictors of membership of 
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the illicit drug use classes, highlighting the frequency by which alcohol, tobacco 
and illicit drug use are combined. 
3.2. Introduction 
As chapter two described, illicit polydrug use is frequently found in studies 
of specific subpopulations or in the general population. However, there has 
been little research describing the nature of patterns of illicit polydrug use, and 
the characteristics of users. The overall aim of this chapter is to establish a 
description and typology of illicit polydrug use and identify if patterns are 
associated with demographic criteria. This introduction will review previous 
attempts to describe or model illicit polydrug use. These will be discussed in the 
context of any demographic differences between patterns, focussing on the key 
criteria of age, gender, employment status, education, rural and urban 
differences, hazardous alcohol consumption and smoking status to explore and 
validate classes. 
Some previous research examining illicit polydrug use has focussed on the 
use of a particular substance to determine illicit polydrug users with a named 
primary drug of use. For example Topp et al. (2004) contrasted the 
characteristics of recent and regular ecstasy users in Australia in both purposive 
(dance drug) and random (general population) samples. The authors note that 
past year ecstasy users were predominantly illicit polydrug users. Rates of 
ecstasy illicit polydrug use, dependent on both the sample and the regularity of 
use of ecstasy were in the range of 88-96%. In addition, they found some 
demographic differences between users of ecstasy (who were also 
predominantly illicit polydrug users). Ecstasy users were mostly male (58%-
62%) with a mean age in the range of 24 to 25 years. Furthermore, between 
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53% and 57% had completed post school qualifications, illustrating that these 
differently sampled populations of drug users were relatively well educated.   
Von Sydow, Lieb, Pfister, Hofler and Wittchen (2002) also focussed on the 
primary drug ecstasy and found similar illicit polydrug use patterns to Topp et al. 
(2004). Adolescent former users of ecstasy from a baseline data collection in 
Munich, Germany were compared with those who had never used ecstasy in 
their lifetime. The authors found former ecstasy users were 3.9 times more 
likely to be smokers, 6.3 times more likely to drink alcohol, 12.2 times more 
likely to be using cannabis, and 17.3 times more likely to have used a 
hallucinogenic substance. The study also illustrated that those who had used 
ecstasy continuously in the past four years compared with those who had never 
used ecstasy in their lifetime were 6.9 times more likely to smoke. Continuous 
ecstasy users were also 2.6 times more likely to drink, 18.8 times more likely to 
be cannabis users and 11.6, 219.7, 222.6 times more likely to be using opiates, 
cocaine and hallucinogens respectively. Finally, those who were continuous 
ecstasy users over four years compared with those who were former users of 
ecstasy were 3.2 times more likely to be cannabis users, 14.7 times more likely 
to be cocaine users, 6.5 times more likely to have used hallucinogens, and 13.4 
times more likely to have used inhalants.  All of which demonstrate polydrug 
use as a normative behaviour for ecstasy users. 
A study using the same dataset (Lieb, Schuetz, Pfister, von Sydow & 
Wittchen, 2002) compared lifetime ecstasy, stimulants and hallucinogen 
polydrug users with individuals who had not used these drugs in their lifetime. 
Thus, those who had prolonged use of ecstasy were more likely to use than 
those who used for less continuous time. They found that the ecstasy, stimulant 
and hallucinogen illicit polydrug use grouping were significantly less likely to be 
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university educated (OR=.22) and were more likely to be unemployed 
(OR=4.13). Similarly, there were significant differences between those who 
were lifetime ecstasy, stimulants and hallucinogen illicit polydrug users 
compared with those who used other drugs in their lifetime (but not ecstasy). 
The former were less likely to be university educated (OR=.37) and times more 
likely to be unemployed (OR=3.60).  
Alternative studies focussing on illicit polydrug use of a named drug 
include Kelly and Parsons (2008) study of 400 cocaine using night club 
attendees in Manhattan. The authors compared illicit polydrug cocaine users 
with illicit non-polydrug cocaine users and found that illicit polydrug users were 
more likely to be male (OR=1.66). Cocaine illicit polydrug users and illicit non-
polydrug cocaine users were not significantly different in terms of their AUDIT 
score. The mean AUDIT score for illicit polydrug cocaine users and illicit non-
polydrug cocaine users were 12.49 and 13.64. This illustrates that both groups 
of illicit users were drinking at a hazardous level as defined by Saunders and 
Aasland (1987).  The link between illicit drug use and hazardous levels of 
alcohol use is also supported by other research. Parker and Williams (2003) in 
their cohort of young adults from North West England, found that 34.9% of 
current drug users drank every day, compared with 8.7% of alcohol abstainers.  
In addition, Wadsworth, Simpson et al., (2004) found the most frequent patterns 
of illicit polydrug use for those who had used an illicit drug during the year prior 
included current smoking and alcohol use above the recommended weekly 
limits. This represented 3.5% of their total sampled population of Merthyr Tydfil 
and Cardiff. The second most frequent pattern was similar; however, this group 
did not currently smoke and represented 3.2% of the population. Illicit drug 
users who drank under the recommended weekly limits for males and females 
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represented a slightly lower percentage, with 2.5% of the population engaging 
in these behaviours and currently smoking and 2.0% engaging in these 
behaviours but who were not current smokers. This suggests that illicit drug use 
is related to other drugs, such as tobacco and alcohol. 
Fendrich et al. (2003) in a multi-stage randomly sampled population of 
Chicago (n=627) found of those who had ever used illicit drugs in their lifetime, 
73% were illicit polydrug users. In addition, they found no significant differences 
between those who had ever used ecstasy, ketamine, rohypnol, GHB, LSD and 
methamphetamine and age. This was through the comparison of polydrug rates 
for those aged 30 years or older with two age groups of 26 to 30 and 18 to 25 
years. Where ‘lifetime’ drug consumption was considered, use of illicit drugs 
appears to be common across different age ranges, however, the majority of 
current use was be found in young users, generally of 25 years or younger. 
Riley et al. (2001) in an opportunity sample of ‘dance drug’ users (n=122) 
found in the group of those using illicit drugs, the most frequent pattern of 
simultaneous illicit polydrug use mixing was that of ecstasy and amphetamines 
(63%). The second most common pattern of use with 27% was that of ecstasy, 
amphetamines and other drug use (predominantly LSD, mushrooms and 
cocaine). It is of note, however, that whilst this reflected past year drug use 
patterns, participants were asked to only note the number of drugs that they had 
taken whilst in a nightclub setting. Given that open use of drugs is actively 
discouraged by licensed venues, and the difficulty in concealing cannabis 
smoking, it was infrequent for a participant to have stated they used cannabis in 
this setting. Also predictably, given their sedative effects, tranquillisers had not 
been widely used in the nightclub environment. The study therefore only relates 
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to simultaneous illicit polydrug use, as concurrent (yearly patterns) have not 
been specified by the authors.  
Despite this, the most frequent patterns found in the study are supported 
by research by Verheyden, Henry, et al. (2003). In their opportunity sample of 
466 ecstasy users from Manchester or London, the most frequent pattern of 
illicit polydrug use found was that of tobacco, amphetamines, cannabis and 
ecstasy. However, the authors note that females were more likely to engage in 
concurrent illicit polydrug use using a wider range of drugs; the mean numbers 
of drugs used were 4.77 for females and 3.72 for males.  In addition, females 
were more likely than males to be simultaneous illicit polydrug users. Of the 
females in this sample 76.9% of females used in this way compared to 58% of 
males. However, despite this increased percentage of females engaging in 
simultaneous mixing behaviours, there were no significant differences between 
the numbers of drugs being used. The mean number of drugs being used on 
occasion for both females and males were 2.30 and 2.48 respectively. The 
sample was predominantly (93.4%) in the age range of 18 to 29 years, and 57% 
male. 
A study by Pedersen and Skrondal (1999) assessed demographic 
differences between groups of drug users from an Oslo youth population 
(n=10812). They summarised the patterns of endorsement of drugs in their 
population as ‘no illicit drug users’, ‘cannabis only users’, ‘amphetamine only 
users’, ‘ecstasy only users’ and ‘amphetamine and ecstasy users’. The last 
group, amphetamine and ecstasy users who are illicit polydrug users were most 
likely to be male amongst the groups, suggesting that males are more likely to 
engage in illicit polydrug use. This group was seven times more likely to be a 
current smoker. They were also 1.3 times more likely to have experienced 
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alcohol related problems3 compared to members of the baseline no illicit drug 
use grouping. 
Halkitis, Palamar and Mukherjee (2007) in a purposively sampled group of 
450 gay and bisexual men concluded that illicit polydrug use (over the past four 
months) was common. Using bivariate correlations, the authors found 
amphetamines and ecstasy were the most likely to be combined (53%; r=.21), 
followed by amphetamines and cocaine (49.1%; r=.19). Other common 
comparisons were amphetamines and ketamine (42.2%; r=.32) and 
amphetamines and GHB with 25.6% (r=.36) of the sample engaging in this 
pattern of use. Another study which used bivariate comparisons of lifetime drug 
use was an opportunistic survey of 210 rave attendees in Quebec, Canada. 
This study found significant correlations between lifetime use of certain drugs 
(Gross, Barrett, Shetowsky, & Pihl, 2002). Significant associations were found 
between amphetamines and ecstasy, cannabis and magic mushrooms 
(psilocybin) and LSD and magic mushrooms. However, this does not illustrate 
fully the degree of illicit polydrug use, as it fails to highlight patterns which may 
encompass a wider range of drugs than the two given. For example, psilocybin 
lifetime use correlates with both LSD and cannabis, however, cannabis and 
LSD do not correlate significantly. 
However, there have been some other attempts to group drug use 
together; less a person-centred approach but by location. Forsyth (1996) has 
classified patterns of illicit polydrug use by location of use in a dance drug 
sample of 135 night club attendees. The evidence for this classification comes 
                                            
3 Alcohol problems were measured on a scale from zero to five. They were a 





from the percentage of use in the night club setting. The author hypothesised 
that there were three main classifications primary, secondary and non-dance 
drugs. Primary dance drugs refer to amphetamines, nitrites (including amyl 
nitrate) and ecstasy, representing those which are most frequently used in the 
night club or dance environment. Secondary dance drugs refer to those drugs 
which can form part of the dance drug repertoire, dependent on availability and 
desired effect. These include alcohol, cocaine, ketamine, LSD and magic 
mushrooms. The non-dance drugs contain the drugs tobacco, cannabis and 
tranquillisers. This was a novel approach. It is self-evident that drug use is 
somewhat situation specific; however, this may be more useful to model drug 
use patterns of those who attend dance events, rather than those who do not 
(such as those in a general population sample). These patterns were formed as 
part of the discussion of this paper, rather than as an integral part of the results. 
As a result, they have not been empirically tested for validity and wider 
applicability. Forsyth (1996) only provided frequencies of single drugs of use, 
and it is unclear to what extent these groupings might express illicit polydrug 
use over the past year, given that an individual may be using illicit drugs in more 
than one location. 
Smit et al. (2002) sampled 6236 adolescent students from the most Dutch 
National School Survey on Drug use at that time using cluster analysis. They 
found three typologies of polydrug users best represented concurrent use of 
drugs in the past four weeks. The first of these, ‘A’ type, represented ‘ordinary’ 
illicit polydrug users and was comprised of individuals were likely to have used 
only the licit drugs alcohol and tobacco. This group comprised 59.9% of the 
sample. ‘B’ type was denoted ‘soft’ illicit polydrug user, endorsing cannabis, 
alcohol and tobacco and comprised 27.4% of the students. The ‘C’ group, 
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comprising of ‘hard’ illicit polydrug users were using ecstasy, cocaine, 
amphetamine or heroin in addition to alcohol, cannabis or tobacco (8.6%). The 
probability of use of a given illicit drug in each group was not clear. The three 
groups were compared on several background variables using abstainers from 
all licit and illicit drugs as a reference category. Type B and C drug users were 
1.80 and 2.51 times more likely to be male. Type A was more likely to be living 
in a non urban area (OR=.62). There was also a significant relationship with age 
in the defined range of 12 to 16 years; as drug use involvement increased so 
did age. The odds ratios were 2.17, 3.09 and 2.58 for type A, type B and type C 
in comparison to the baseline group. They also found that older adolescents are 
more likely to illicit polydrug use than younger adolescents. This is supported by 
studies which examine drug use in young adults such as Pedersen and 
Skrondal (1999), Degenhardt et al. (2004) and McCambridge, Mitcheson, 
Winstock and Hunt (2005) who illustrate that those who are younger but over 
the age of 18 are most likely to be either using in a polydrug use pattern. Whilst 
the Dutch education system is different to that in Great Britain, there was 
evidence that an increased involvement with education reduced the likelihood of 
being an illicit polydrug user (whether type A, B or C) compared with the 
baseline group, of illicit drug and alcohol abstention. In addition, the study was 
strengthened by a high response rate (95.5%).  
 Recent methodological advances in statistical modelling offer an 
alternative approach which can account for different patterns of response. For 
example, a study by Mitchell and Plunkett (2000) used latent class analysis on a 
sample of 2012 American Indian Adolescents determining four groups of users. 
In this analysis, all users were accounted for in the model. Class 1 membership 
was characterised by a fixed, no use response across all drugs, class 2 
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membership by alcohol and cannabis use, class 3 membership by alcohol, 
cannabis and small probabilities of other drugs and the fourth class ‘pleural’ 
drug user- cannabis, alcohol, cocaine, inhalants and other drugs. The profile 
plot illustrating probability of drugs used is given in Figure 8. The largest of 
these was class 2 with 50.2%, with 29.1% in class 3, 16.5% in class 1 and 4.1% 
in class 4. However, this study fails to examine demographic information to 
attempt validation of the classes instead using attitudes to alcohol, community 
and peer values, and thus it is difficult to estimate the demographic 




Figure 8: Profile plot of the four latent classes in the Mitchell and Plunkett (2000) survey.
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 Carlson, Wang, Falck and Siegal (2005) also used latent class analysis 
on a group of 402 adult ecstasy users in Columbus, Ohio sampled using a 
respondent driven strategy. The authors found three types of ecstasy user best 
characterised the patters of response in the sample. These were named limited, 
moderate and wide range drug users. Class 1, ‘limited’ range, was 
characterised by individuals who did not use or used few other drugs with 
Ecstasy in the past six months. As can be seen from Figure 9, any use of drugs 
predominantly reflected non-daily cannabis use and drunkenness beyond the 
mean days of the sample. The individuals in the moderate range group, class 2, 
had a higher rate of other drug use. This class was characteristic of a probability 
of use of non-daily cannabis, opioid and hallucinogen use of greater than 50%.  
An individual in class 3, the ‘wide’ range ecstasy use class, had the highest 
probability of using crack/cocaine, opioids, amphetamines, tranquillisers and 
hallucinogens. Of their ecstasy users, 20% were members of class 1, 52% were 
members of class 2 and 28% were members of class 3.  Most of the sample 
were male (64%), of white ethnic origin (81.6%) and in the age range of 18 to 
30 years. There were no significant differences between gender and 
educational attainment between the members of classes 1 and 2 compared to 
class 3. Those in the wide range class were 9.14 times more likely to be of 
white ethnic origin compared to members of the limited range latent class. In 
addition, significant differences were found between the classes on age. The 
members of the wide range ecstasy use class were also most likely to be the 
youngest (OR= .77) compared with those in the moderate range ecstasy use 
class (OR= .86) relative to the members of the baseline limited range ecstasy 
use class. The mean ages for the members of all three classes from the limited 
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class to the wide range class were 22, 21 and 20 years old, and these were 































Figure 9: Profile plot of the three latent classes in the Carlson et al. (2005) survey.
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 Lynskey et al. (2006) found five groups of lifetime illicit drug users in their 
Australian twin sample (n=6265). These were low use (class 1; 69%), moderate 
use (class 2; 18%), party drugs (class 3; 7%), opiates/sedatives (class 4; 3%) 
and illicit polydrug users (class 5; 4%). The profile plot is replicated from the 
paper in Figure 10. Class 1, low use was characteristic of some cannabis use; 
its endorsement probability just over .4. The moderate use class (2) was 
characterised by a higher probability of cannabis use and some stimulant use. 
The party drug class (3) typically reflected cannabis, stimulant and hallucinogen 
use with a lower probability of using inhalants and cocaine. The opioid and 
sedative class (4) had a moderate probability of cannabis, sedative and opioid 
illicit polydrug use. Finally, the ‘polydrug’ use class (5) had the highest 





Figure 10: Profile plot of the five latent classes in the Lynskey et al. (2006) survey.
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They also assessed gender differences between the five classes. The 
members of moderate use class 2 were 1.6 times more likely to be male than 
those in the baseline class 1. Similarly, those in the party drug (class 3) and 
illicit polydrug using class 4 were significantly more likely to be male with odds 
ratios of 2.0 and 2.7 respectively compared to members of the low use class 1. 
There was no significant relationship between the individuals in the 
opioid/sedative class with respect to gender. Significant differences were also 
found in relation to the use of other drugs. For example the moderate, party, 
opioid and illicit polydrug class members were 3.3, 3.8, 2.8 and 6.9 times more 
likely respectively to be nicotine dependent, or 3.4, 4.2, 2.7, and 7.6 times more 
likely respectively to be alcohol dependent compared to members of the 
baseline class of low use. If these are used as proxy measures for extent of use 
of either of these drugs, this illustrates a strong relationship between illicit drug 
use and extent of either alcohol or nicotine use. 
Whitesell et al. (2006) also estimated patterns of drug consumption using 
the 1999 National Household Survey of Drug Abuse. They found four classes of 
lifetime illicit polydrug use and three classes of past year illicit polydrug use. The 
patterns of these are presented in Figure 11 and Figure 12. 
The fourth lifetime use classes represented a class with no drug use. 
There was one class which was characteristic of alcohol use and a relatively 
low probability of cannabis use (around .35). The third class were predominantly 
alcohol and cannabis users although 30% used hallucinogens and 35% used 
inhalants. Finally, the polydrug class had the highest endorsement probability of 
alcohol and cannabis use. However, they also used cocaine, hallucinogens, 
inhalants, stimulants, tranquillisers and analgesics, with probabilities of between 





















Class 2: Alcohol 
and Cannabis 
use









 Of the three classes of use in the past year, two resemble the patterns of 
endorsement of lifetime use. The first of these was the no use class. The 
second was the alcohol use only class. This was like the alcohol lifetime class; 
there were low probabilities of also using cannabis with a decrease in 
probability of around .1.  Finally, the alcohol and drug use class reflected 
alcohol and cannabis use to a high probability and lower probabilities of 
cocaine, hallucinogens and analgesics. Note that these graphs should be 
interpreted cautiously, as the information was gained from a radar plot, which 
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drug use




Figure 12: Approximate profile plot of three yearly drug use classes in the Whitesell et al. (2006) study. 
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Research with a single drug focus can also reveal further demographic 
differences, which might help to validate proposed models of illicit polydrug use. 
For example, there have also been notable differences between urban and rural 
areas in terms of their drug consumption. In a Scottish study of urban (Dundee) 
and rural (Perth and Kinross) secondary school students, Forsyth and Barnard 
(1999) found 43.9% of their entire sample had tried illicit drugs at least once, 
with the percentage slightly higher for the Dundee adolescents (although the 
differences were not significant). There were also some urban/rural differences 
in terms of specific drug use, with urban adolescents significantly more likely to 
have used ecstasy, LSD, or buprenorphine, and rural adolescents more likely to 
have used magic mushrooms or heroin. However, whilst illuminating, it is 
unclear how these urban and rural differences may be found in illicit polydrug 
users from the research presented. Furthermore, regarding gender differences 
for single drugs, Kelly, Parsons and Wells (2006) in a random time-space 
sampled survey of Manhattan club going adults (n=1914) aged 19-29, found 
that females were significantly less likely to be using ketamine (OR=.64), GHB 
(OR=.61) and crystal methamphetamine (OR=.73), but were more likely to be 
using cocaine than males (OR=1.28). There were no significant gender 
differences for LSD use in this sample. Chivite-Matthews et al. (2005) in a 
recent British Crime Survey of Drug Misuse Declared concluded men were 
twice as likely as women to have used drugs in the past year. This is supported 
by an Australian population survey from a similar time period as the NPMS 
(Degenhardt, Hall & Lynskey, 2001), in samples of university students (Webb et 
al., 1996), and in adolescents (Collins et al., 1998; Smit et al., 2002). However, 
it is notable that other evidence has suggested that gender differences in terms 
of drug consumption are decreasing, particularly in younger, ‘dance drug’ 
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cohorts. A survey of 194 medical students in the UK found similar proportions of 
males and females taking illicit drugs, however, they had a higher proportion of 
females in their sample and no significance tests were performed on the 
proportions (Newbury-Birch, White & Kamali, 2000).  
In a population survey of residents in Cardiff and Merthyr Tydfil by 
Wadsworth, Simpson, et al., (2004) females were found to be significantly less 
likely to be using illicit drugs than males (OR=.58). It is also of note that they 
used a mail out approach, so whilst they have sampled in a representative way 
from the population of these two locations, they had a low response rate at 
27%. However, this population had a very similar gender and age breakdown to 
the NPMS with 58% females and a mean age of 45.61 (SD=18.00).  
They also found several other demographic differences between users of 
illicit drugs in the past year and those who did not. Briefly, those who used illicit 
drugs were significantly more likely to have been in higher education (OR=1.96) 
or unemployed (OR=2.05). Illicit drug users were also less likely to be living in a 
rural setting (OR=.49), retired (OR=.18). Compared with individuals aged in the 
range of 18 to 25 years, those aged between 25 and 40 years old or older than 
40 years were significantly less likely to be illicit drug users (OR=.57 and 
OR=.40 respectively). Illicit drug users were 2.40 times more likely to be 
drinking alcohol over the recommended weekly limits and 5.61 times more likely 
to be current smokers.  
These demographic trends were similar to a recent US population survey 
comparing those who had used at least one illicit drug in the past year (.6% of 
the population and excludes alcohol). Those most likely to have been drug 
users in the past year were young males aged 18-24, representing 20.3% of all 
males in that age range in the US population (Falk et al., 2008). Contrasting this 
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with the female proportion in the same age range, there is a notable decrease in 
the frequency of use of at least one illicit drug for women, with 13.0% 
representing the most frequent age range for females. This study of the US 
general population was collected in 2001-2002, around a similar time to the 
NPMS.   
There have been various attempts to model illicit polydrug use. However, 
there are key limitations to some of these studies, which make it difficult to 
extrapolate the findings to illicit polydrug use typologies in general population 
samples. In many of the featured studies, the sample has been accessed 
opportunistically or through snowball referral (for example, Riley et al., 2001; 
Verheyden, Henry, et al., 2003). Thus, the probability that a person will be 
sampled is impossible to generate. This is important in applying results of a 
sample to the general population. In the absence of random sampling, biases 
between those who actively volunteer and those who do not can affect the 
results (Rosenthal & Rosnow, 1975). Random participant sampling limits the 
effects of biases and enable inferences to be made to the wider population from 
which it was sampled (assuming an acceptable response rate). This chapter will 
analyse a dataset which has been sampled randomly and stratified by socio-
economic status to improve representation to the population of Great Britain 
(Singleton et al., 2001a; 2001b). 
 Age can also influence the ability to infer previous patterns of illicit 
polydrug use to the general population. For example, Mitchell and Plunkett 
(2000) studied a sample of adolescents. It is difficult to determine how 
representative this may be to the general population of Great Britain, as 
adolescent users form a very small subset (aged between 16 and 18 years) of 
this chapter’s dataset. Contextual specificity of some of the studies reported in 
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this introduction might also influence the ability to generalise the findings. 
Samples of dance drug or nightclub populations, such as Kelly et al. (2006) and 
Gross et al. (2002) typically have higher rates of illicit drug use (Lim, Hellard, 
Hocking & Aitken, 2008) and illicit polydrug use (see chapter one) than general 
population samples. This higher use is theoretically applicable to a subset of the 
general population but could not be considered representative to the whole 
population.   
Both the variables analysed, and the method of analysis is also important 
in determining the applicability of patterns of illicit polydrug use. As has been 
shown in this introduction, methodological techniques are not consistently 
applied across either general populations or other alternative samples. This 
chapter proposes the use of latent class analysis, which upon review of the 
evidence appears highly applicable to creating typologies of illicit drug use. 
There is also little consistency with the number and type of drugs included in 
analyses. For example, Mitchell and Plunkett (2000) included alcohol, cannabis, 
cocaine, inhalants and ‘other’ drugs, but a similar study using a different 
methodology assessed the use of cannabis, alcohol, tobacco, amphetamines 
and heroin (Smit et al., 2002). The dataset which will be analysed in this chapter 
will use as many of the illicit drug use variables as possible in this analysis, 
however, will not include those with very low numbers as to increase likelihood 
of model identification. In addition, these represent the majority of the most 
frequent drugs used in the past year in general population samples of Europe 
(EMCDDA, 2008). 
 In summary, this paper has two main aims. The first is to assess 
whether the variability in illicit polydrug use in the general population of Great 
Britain can be expressed in coherent typologies, overcoming some of the 
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limitations of previous research. Given the inconsistencies reported above, it is 
not possible to make a priori predictions of the nature of the classes. The 
secondary aim of this paper will address the association of typologies with 
demographic criteria and compare them to existing literature on illicit polydrug 
use.  The demographic variables to be used in this way are sex, age, 
educational attainment, employment status, area type where the individual 
resides, whether an individual is a current smoker and whether an individual 
drinks hazardously. 
3.3. Method 
3.3.1. Participants, data and sampling 
The data analysed in this chapter was from the NPMS survey (Singleton 
et al., 2001a; 2001b). This was downloaded from the ESRC UK data archive 
hosted at the University of Essex. The total number of participants in this study 
was 8580; however, there were 42 individuals who were excluded. Exclusion 
criteria were not answering any of the drug use questions, or in answering the 
drug use questions they endorsed the fictional drug semeron. These individuals 
were deleted listwise to give a total effective sample size of 8538. All 
participants were resident in England, Scotland or Wales and were sampled 
using a stratified multi-stage random sampling strategy. Most of the sample 
were female (55.08%), and of white ethnic origin (93%). The mean age of the 
sample was 45.34 years old (SD=15.59). Further details of the data included in 




3.3.2.1. Illicit drug use 
Measurement of illicit drug use was based on use of one of nine drugs in 
the past year. The drug use variables included in this analysis were cannabis, 
amphetamines, cocaine, ecstasy, LSD, magic mushrooms, tranquilisers, amyl 
nitrate, and a heroin or crack composite variable. These were coded as no use 
(0) or use (1) in the past year. 
3.3.2.2. Demographic and other drug use variables 
Demographic variables used in the regression model were gender 
(female=0; male=1), employment status (economically active =0; 
unemployed/economically inactive=1), age measured as a continuous variable 
between 16 and 74 years old, educational attainment (beyond GCSE/statutory 
education=0; up to GCSE level or below=1) and area type of the participant’s 
residence (rural/semi-rural=0; 1=urban). In terms of other drug use, the 
probability of an individual in a particular class being a current smoker was 
coded as ‘0’ for those who were not currently smoking and ‘1’ for those who 
were current smokers. In addition, hazardous drinking was a further predictor in 
the model. This is defined as an AUDIT (Saunders & Aasland, 1987) score of 
greater than eight. If a participant scored less than eight on this scale, they were 
not classed as hazardous drinkers and coded ‘0’, those scoring eight or more 
were coded ‘1’.  
3.3.3. Latent class analyses 
Full details of the procedure and outcomes of latent class analyses are 
presented in chapter two and a summary will be given here. The observed 
indicators of illicit drug use from which the latent variable has been estimated 
are nine binary yearly illicit drug use variables reflecting the use of cannabis, 
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amphetamines, cocaine, ecstasy, amyl nitrate, LSD, magic mushrooms, 
tranquillisers and the composite heroin or crack. This is indicated in the 
conceptual model diagram in Figure 13. In this statistical modelling technique, 
classes of drug use behaviour have been estimated to account for relationships 
between categorical observed variables (Hagenaars & McCutcheon, 2002). The 
model parameters generated are class membership probabilities (or class 
percentage estimates) and probabilities of class specific endorsement of illicit 
drug use variables. Fit criteria for models with two through nine classes have 
been presented. Decisions on best fitting models have reflected lowest 
information criterion (AIC, BIC and SSABIC), a Lo Mendell Rubin Likelihood 
Ratio Test (LRT) where the k-1 model is superior when compared with k model, 
an entropy close to one and a minimal number of bivariate residuals. Competing 
models will also be judged on theoretical relevance. Full details of the sources 
of these criteria, the reference works from which they were derived, and the 
latent class method are found in chapter two. 
3.3.4. Multinomial logistic regression 
In the multinomial logistic regression the conditional probabilities of 
membership of each of the classes in the best fitting model have been saved 
and used as a dependent variable in a multinomial logistic regression. As a 
result, the latent classes were formed from drug use variables, and have not 
been influenced by the predictors in the model. Parameters presented from this 
model were odds ratios and confidence intervals. This allows illustration of 
statistical significance of each of the independent variables (whilst controlling for 
the other independent variables) on the conditional probability of class 
membership (dependent variable) where the last class (or class with least drug 
use involvement) was the comparison group. This has provided comparative 
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odds ratios of the other classes with the baseline class. The conceptual 
diagram, Figure 13 illustrates that the predictors used were gender, 
employment status, age, educational attainment, area type, current smoking 
status and hazardous drinking. 
To create a model which both fitted the data and provided a 
parsimonious solution, 2∆ll difference testing was used. This has also illustrated 
whether classes differ from each other in terms of the different predictors. In 
practice, a model was run which estimated the parameters freely for each class 
compared with the baseline class. After this, a fully restricted model was run, 
which essentially constrains the log odds and as such the odds ratios to be the 
same for a predictor for all the classes compared to the baseline class. In order 
to determine which model was best fitting, the 2∆ll difference was compared. To 
compare the significant differences, the 2∆ll approximates the chi square 
distribution. Assessment of chi-square distribution tables will illustrate whether 
there are significant differences between the two groups. If the critical value for 
chi-square is less than the 2∆ll for a given difference in degrees of freedom 
between the two competing models, then the differences are significant. If there 
are no significant differences between the models the more parsimonious 
restricted solution is favoured. Should the two models be significantly different 
from each other, the constraints (i.e. the stipulation that one odds ratio will fit all 
classes for a given predictor compared to the baseline class) has been 
sequentially relaxed using the largest modification index provided by the Mplus 
program for each given model. The 2∆ll difference between these models has 
been assessed for significant differences, with the view that when the two 
competing models are not significantly different from each other, the more 
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parsimonious solution was preferred. Full details with a worked example of a 








































Data was prepared using SPSS version 15 (SPSS Inc, 2006). Latent class 
analyses and multinomial logistic regressions were all performed using Mplus 
version 5.01 (Muthén & Muthén, 2007). 
3.4. Results 
3.4.1. Frequencies of drugs used 
Table 11 illustrates that 91.10% of the population had not used any illicit 
drug (cannabis, amphetamines, cocaine, ecstasy, amyl nitrate, LSD, magic 
mushrooms, tranquillisers, or the composite heroin/crack) during the past year. 
A small percentage, 6.14% of the population had used only one of the above 
drugs in the past year, which is approximately 69% of those who have used a 
drug. In terms of a frequency of illicit polydrug use, 31% of the drug users were 
illicit polydrug users in the past year, equating to 2.76% of the general 
population of Great Britain at the time of the survey. As the number of drugs 




Table 11: Number of illicit drugs used per year (*over 100% through rounding). 
Note shaded area represents those who were not illicit polydrug users in the 
past year 
 
Predictably, the most common pattern of drug use in the past year was 
abstention in the general population, followed by the use of cannabis only (as 
can be seen in Table 12). The use of tranquillisers only was the next most 
frequent, followed by more typically club drug patterns of use involving 
cannabis, ecstasy, amphetamines, and cocaine. Notably 11 patterns are 
reported here given that the last two patterns were equally frequent. There were 
78 different patterns of drug use expressed by the population of Great Britain 
















0 7778 91.10 91.10 - - 
1 524 6.14 97.24 68.95 68.95 
2 93 1.09 98.33 12.24 81.19 
3 73 .86 99.18 9.61 90.80 
4 26 .30 99.48 3.42 94.22 
5 29 .34 99.82 3.82 98.04 
6 11 .13 99.95 1.45 99.49 
7 3 .04 99.99 0.39 99.88 
8 1 .01 100.00 0.13 100.01* 
Total 8538 100.00  100.01*  
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Table 12: Most frequent patterns of response of illicit drug use in the past year. 





Frequency of pattern 
amongst all drug users in the 
sample n=760 
No drug use 7778 (91.10%) N/A 
Cannabis only 458 (5.36%) 60.26% 
Tranquillisers only 28 (.33%) 3.68% 
Cannabis and ecstasy  23 (.27%) 3.03% 
Cannabis and amphetamines 23 (.27%) 3.03% 
Cannabis, amphetamines and ecstasy 22 (.26%) 2.89% 
Cannabis and cocaine 22 (.26%) 2.89% 
Amphetamines only 18 (.21%) 2.37% 
Cannabis, amphetamines and cocaine 11 (.13%) 1.45% 
Cannabis, amphetamines and ecstasy 10 (.12%) 1.32% 
Cocaine only 10 (.12%) 1.32% 
Total number of individuals in the 11 most frequent response patterns 8403 (98.42%) N/A 
Total number of individuals not in the 11 most frequent response patterns 135 (1.58%) N/A 
TOTAL 8538 N/A 
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3.4.2. Latent class analysis 
The fit statistics of two through nine classes are presented below in 
Table 13. The information criteria AIC and BIC conflict, with the former 
suggesting an eight-class solution and the latter a two-class solution. However, 
SSABIC, which is less influenced by sample size, suggested a three-class 
solution was optimal. According to the LRT, the three-class solution is 
preferable, and only one of the residuals in this model (of the top 11 most 
prevalent) was significant. This corresponded to the pattern of cannabis and 
cocaine illicit polydrug use. However, given that most of the patterns are 
replicated, this suggests this model fits the data well. 
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2 -4293.29 (19) 8624.58 8758.58 8698.20 .98 0 2671.01 .00 
3 -4261.22 (29) 8580.45 8784.96 8692.81 .97 1 63.14 .00 
4 -4244.94 (39) 8567.87 8842.91 8718.98 .98 1 32.22 .05 
5 -4240.11 (49) 8578.23 8923.79 8768.07 .97 1 9.54 .30 
6 -4234.52 (59) 8587.03 9003.12 8815.63 .99 0 11.90 .38 
7 -4228.66 (69) 8595.32 9081.92 8862.65 .98 1 11.66 .35 
8 -4223.16 (79) 8604.32 9161.46 8910.41 .98 0 12.15 .74 
9 -4220.36 (89) 8618.72 9246.37 8963.55 .98 0 5.21 .31 
Note: LL(df) loglikelihood value and associated degrees of freedom; LRT Lo-Mendell-Rubin Adjusted likelihood ratio test value; AIC Akaike 






















Class 1: Wide range n=50 (.59%) Class 2: Moderate range n=186 (2.18%) Class 3: No drug use n=8302 (97.4%)
 
 
Figure 14: Profile plot of the three illicit polydrug use classes.
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As can be seen from Figure 14, responses to the items in latent class 1 
indicate a use of cannabis, amphetamines, cocaine, ecstasy and to a lesser 
extent, LSD, mushrooms, tranquillisers, amyl nitrate and the heroin/crack 
composite variable. Because of the wide range of drugs used, this group has 
been labelled as ‘wide range’ illicit polydrug users. Class 2 has a high 
probability of using cannabis and a smaller probability of using amphetamines, 
cocaine and ecstasy, and therefore has been named moderate range illicit 
polydrug users. A very small proportion of the individuals in class two are using 
some of the other drugs. Class 3, the largest class with 8302 members have 
predominantly used no drugs. Consequently, this represents a class with no 
drug use. 
3.4.3. Multinomial logistic regression 
The results of the multinomial logistic regression are presented in Table 
14. The constrained model which fixed the log odds for the predictor variables 
to be equal across classes 1 and 2 compared with class 3 did not fit the data 
well. Two modifications were made to generate the optimal model. This refers to 
relaxation of the constraints on the variables hazardous drinking (as measured 
by AUDIT score greater than eight) and age. As can be seen in the model 
comparisons in Table 14, the p value is less than 0.05 until models 5 and 4 are 




Table 14: The results of the 2Δll test for the model. 
 LL Df Model v Model 
Comparison 
2 Δ ll  Δ df p value 
1.No constraints -4054.20 43 
 
 
2 v 1 
 
3 v 2 
 












































2. Log odds constraints across all predictors -4064.71 36 
3. Constraints on the log odds to be equal except hazardous drinking -4057.54 37 
4. Constraints on the slope to be equal across all except hazardous drinking and age -4054.78 38 






The results of the regression model four are given in the below table 
(Table 15). Individuals in class 2, were over two times more likely to be drinking 
in a hazardous manner, however, members of class 1 were 11 times more likely 
to have a hazardous pattern of drinking. Similarly, as age increased by one 
year, an individual was less likely to be in classes 1 and 2 compared to class 3. 
This suggests members of these classes were more likely to be younger than 
the baseline class. Note that those in the class 1 were the most likely to be the 
youngest with odds ratio .87 compared to .91 for class 2 compared to members 
of class 3. 
Membership of either class 1 or 2 was associated with twice the likelihood 
of being male compared to those in the reference class 3.  Similarly, the 
members of classes 1 and 2 were 6.81 times more likely to be a current 
smoker, and almost 1.5 times more likely to be educated past the age of 16 
compared to the members of class 3. There were no significant differences in 
area type or employment status found between the classes. 
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Table 15: Odds Ratios (95% Confidence Intervals) of the optimum multinomial logistic regression model. 
 
 Odds Ratio (95% CI) 









Currently smoking (yes) 
Educational attainment (GCSE level or below) 
Area type(urban) 
Employment status (economically inactive) 
Hazardous drinking (AUDIT score 8+) 11.00 (5.39-22.42) 2.31 (1.80-2.98) 
Age .87 (.85-.90) .91 (.90-.92) 




This chapter used latent class analysis to create three typologies of illicit 
polydrug use patterns in the general population; two classes displayed illicit 
polydrug use patterns, wide and moderate range users, and one was 
characteristic of no illicit drug use in the past year. This section will first discuss 
how these illicit polydrug patterns found in the general population relate to 
previous research before a consideration of the latent class patterns and their 
relationship with demographic criteria. 
This chapter has illustrated that 8.9% of the population of Great Britain 
were using illicit drugs in the past year, and of this percentage 31% were illicit 
polydrug users. This rate of illicit drug use has previously been compared with 
the Drug Misuse Declared (DMD) surveys (see chapter one), finding greater 
similarities with the most recent DMD in 2008 (Hoare & Flatley, 2008). A recent 
survey of the general population of the United States (from the National 
Epidemiologic Survey of Alcohol and Related Conditions; NESARC), found a 
lower rate of 6.2% of yearly illicit drug use. Notably though, this rate is 
considerably less than populations which are ‘rave’ or ‘dance drug populations’ 
which tend to focus chiefly on drug users in a given environment (Lim et al., 
2008). Consequently, these populations are more likely to illicit polydrug use, 
and their rates of illicit polydrug use tend to be considerably higher than the 
percentages found in this study. Even using a more selective time frame of illicit 
drug use in the past 90 days, Sterk et al. (2007) found an illicit polydrug use rate 
of 98.1% in their opportunistic sample of ecstasy users, which is not reflective of 
trends in a general population.  
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From Table 12, it can be seen that the most frequent observed pattern of 
use was that of cannabis only at 60%. This is consistent with all existing 
estimates of cannabis use compared to the other illicit drugs, which has already 
been described in the introduction. This was the most common pattern of illicit 
drug use in Pederson and Skrondal (1999), with 9.9% of their Oslo youth 
endorsing this pattern of use. If cannabis is the first illicit drug used in the 
gateway theory, it would make sense that there might be a number of 
individuals who stop at this point in the sequence.  
Other frequent patterns of observed use include the use of tranquillisers 
only at 3.68% (or .33% of the total population of Great Britain). A recent study 
by Simoni-Wastila and Strickler (2004) who assessed the percentage of non-
medical use of tranquillisers considered their estimate of 1.45% of the US 
population to be a conservative estimate. They state that given non-medical use 
is any non-prescribed, or non-compliant with GP/Doctor instruction and thus 
statistics relating to tranquillisers may be an underestimate unless this is 
explicitly stated. The remaining patterns in the 11 most frequent centred on the 
traditional club drugs of cannabis, ecstasy, amphetamines and cocaine. These 
drug combinations are the most commonly reported in dance drug samples. 
Despite the focus of research into ecstasy illicit polydrug use, sole use of 
ecstasy was uncommon and did not feature in the 11 most common patterns of 
use. This is supported by previous research including Topp et al. (2004) who 
found an 88-96% rate of illicit polydrug use in their ecstasy populations.  
This chapter has also illustrated that these 78 observed patterns of use 
are best summarised into three distinct classes. Predictably, the smallest class 
represented those who used the widest range of drugs. This is backed up by 
the percentages of individuals using a given number of drugs from Table 11. 
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Class 2, the moderate range class was over three times greater in magnitude 
than class 1. However, the largest class was the non-drug use class.  
Class 1 was characterised by high probability (above 70%) of using the 
drugs cannabis, amphetamines, ecstasy and cocaine, with a lower probability of 
additional use of LSD, magic mushrooms and amyl nitrate. This would appear 
to be a pattern closely associated with dance drug environments and is similar 
to the patterns found by Von Sydow et al. (2002) in Munich, Germany. Their 
study found lifetime ecstasy users were 12 and 17 times more likely to have 
used cannabis and hallucinogens, with the odds ratios increasing considerably 
for more recent (and heavier) ecstasy users.  Furthermore, this pattern of use 
was similar to the simultaneous illicit polydrug users in Riley et al. (2001). This 
study found the use of ‘ecstasy and amphetamines’ and ‘ecstasy, 
amphetamines and other drugs’ (mostly LSD, mushrooms and cocaine) to be 
common. However, as has been previously noted, this does not include 
cannabis, as it is difficult to discretely consume cannabis in a nightclub 
environment. . However, Parker, Aldridge and Measham (1998) illustrated the 
relaxing effects of cannabis compliment stimulant use, being commonly used to 
reduce the high, and facilitate sleep. Thus, it is unsurprising class 1 was highly 
characterised by cannabis use 
Class 2 was characterised by moderate range drug use. Like class 1, it 
had a high probability of cannabis use. However, it differs from class one 
through a lower probability of amphetamines, cocaine and ecstasy use; 
members of this class have a typical probability in the range of 30% to 40%. 
Furthermore, it has extremely low probabilities of use of other illicit drugs which 
were somewhat characteristic of class 1. Class 3 was characteristic of 
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extremely low (or zero) probabilities for yearly use of all illicit drugs entered into 
the analysis. 
The three-class model of illicit polydrug use proposed in this chapter is 
inconsistent with alternative classifications as proposed by Forsyth (1996). In 
this study, the primary dance drugs were amphetamines, nitrites (including amyl 
nitrate) and ecstasy, the secondary dance drugs were alcohol, cocaine, 
ketamine, LSD and magic mushrooms and finally the non-dance drugs were 
tobacco, cannabis and tranquillisers. The divisions Forsyth proposes are not 
reflected in either class 1 or class 2 probabilities of drug use. Potentially, this is 
because the majority of members of the general population are not attending 
events where illicit drug use is common (like a ‘rave’ or ‘night club’). In addition, 
whilst this classification might still hold in dance drug users, the classification 
was based on a relatively small sample. 
The structure of illicit polydrug use presented in this chapter bears some 
similarities to previous latent class analyses reported in the introduction. The 
wide range ecstasy use class identified by Carlson et al. (2005) was somewhat 
similar to class 1 reported in this study in terms of their amphetamine and 
cocaine use. Although it is noted that cocaine use in the Carlson study refers to 
both crack and powder cocaine use; in this study, crack and heroin are 
assessed as one variable due to their low probability of use in the sample and 
behavioural similarities. However, their wide range ecstasy users have 
considerably higher proportions of inhalant, hallucinogen use and opioid 
(heroin) use to this chapter’s class 1. Their moderate range ecstasy users were 




It is difficult to compare with cannabis use between this analysis and that 
of Carlson et al. (2005) due to the different way the use was measured; 
however, this will be addressed in the next chapter addressing the extent of 
use. Generally speaking, it is difficult to meaningfully compare Carlson and 
colleagues classes’ due to the populations used. Whilst there were some 
similarities, only two classes were found in this chapter which were likely to 
have contained ecstasy users. 
The latent class structure proposed by Lynskey et al. (2006) of lifetime use 
in a twin sample was also somewhat similar to the typologies found in this 
chapter. Characteristics of class 1 in this study shared some similarities with the 
party drug and illicit polydrug use classes in Lynskey and colleagues’ solution. 
The members of class 1 had similar probability of using cannabis, stimulants 
(including amphetamines and ecstasy) and cocaine. However, the illicit 
polydrug use class had much higher probabilities of other drug use compared to 
class 1. The party drug class was more similar in sedative (including 
tranquillisers) opiate and inhalant (including amyl nitrate) usage but had much 
higher probabilities associated with hallucinogens (including LSD & magic 
mushrooms). There appeared to be no equivalent to the moderate range illicit 
polydrug use class in this sample. Once again, it is difficult to directly compare 
the samples, as Lynskey and colleagues profiled use in a twin sample, and the 
yearly prevalence of twins in the UK is approximately 15 births in every 1000 
(Office of National Statistics, 2007). In addition, they measured lifetime use 
instead of yearly use. 
The profiles of the three classes were dissimilar to those reported in the 
Mitchell and Plunkett (2000) study. They found two classes which were 
predominated by high probabilities of alcohol with one characterised by a higher 
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probability of using cannabis than the other) and one using a multitude of drugs. 
Notably this ‘pleural’ drug user class had a considerably lower probability of 
cocaine use to class 1. Another difference between these two classes was the 
endorsing the ‘other’ drug use variable in the Mitchell and Plunkett (2000) study, 
which is not directly comparable to variables used in these chapter’s analyses. 
It is also difficult to compare these latent class structures given that the Mitchell 
and Plunkett (2000) study also included alcohol use in its classifications. 
The three classes found in this chapter appear to have some face 
validity. The associations between classes and demographic variables are 
consistent with theory and previous research. From the results class 1 and 2 
can be characterised as more likely to be male, currently smoking and educated 
to GCSE level or below, when compared with our no illicit polydrug use drug 
users. The data also suggests that the only differences between members of 
class 1 and class 2 compared to class 3 represent the likelihood to drink 
hazardously as measured by the AUDIT and the age of the respondent. Both 
the illicit drug use groups were around twice as likely to be male. This is 
supported by Smit et al. (2002). Their clusters of cannabis (with alcohol and 
tobacco) and cannabis and other illicit drugs (with alcohol and tobacco) found 
similar odds ratios (1.8 and 2.5 respectively) to those in this chapter. Lynskey et 
al. (2006) found similar differences in lifetime drug use of an Australian twin 
sample. Their moderate and party drug users were closest to this figure with 
odds ratios of 1.6 and 2.0 respectively compared with those who did not use 
illicit drugs in their lifetime. However, Kelly et al. (2006) found significantly 
higher use in females of cocaine use, and Carlson et al. (2005) found no 
significant differences in gender in their latent classes of ecstasy users living in 
Ohio. Verheyden, Henry, et al. (2003) found that females were using a wider 
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repertoire of drugs than males. However, given that the differences found in this 
chapter were not drug specific, it could be suggested that dissimilarities with 
above mentioned research is to be expected due to the variable way in which 
illicit polydrug use has been measured between studies. It would appear that 
this solution is strongly supported by research into general population samples 
such as Chivite- Matthews et al. (2005) who found a ratio of two males for every 
one female represented in those who used illicit drugs. Similarly, Wadsworth, 
Simpson, et al., (2004) in their population of Cardiff and Merthyr Tydfil found 
their illicit drug users to be .58 times less likely to be female. Finally, data from 
the NESARC study also supports a greater proportion of males than females 
amongst illicit drug users (Falk et al., 2008). 
The membership of illicit polydrug use classes 1 and 2 reflect an 
increased likelihood of being educated to GCSE level or below (OR=1.60). This 
is consistent with previous research such as Lieb et al. (2002) who found that 
their illicit drug users were less likely to have been university educated 
compared with those who did not use illicit drugs. Support also comes from an 
adolescent study which found increased involvement in education was a 
protective factor against the use of illicit drugs (Smit et al., 2002). However, two 
studies have found that education was related to increased education. The first 
of these, Wadsworth, Simpson, et al., (2004) in their study of those living in 
Cardiff and Merthyr Tydfil found those who had used any illicit drug were likely 
to be of a higher education than those who did not use illicit drugs. Furthermore, 
there was a rate of 45% and 46% of cannabis lifetime use in medical students 
(Newbury-Birch et al., 2000) and students from a wide range of faculties (Webb 
et al., 1996), suggesting that the illicit drug use is not confined to those who 
have achieved lower educational attainments. 
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Two of the predictors were not significantly different between class 
memberships; these were employment status and area type. Previous literature 
examining the relationship between drug use and economic activity would 
appear to suggest a relationship. For example, Lieb et al. (2002) found 
economic inactivity to be related to ecstasy and other stimulant use compared 
with both illicit drug users (who did not use these drugs) and lifetime abstainers 
from drug use (OR’s= 4.13 and 3.60 respectively). Given the percentages of 
ecstasy and other stimulant drugs in particularly the members of class 1, this 
finding is somewhat surprising. The finding of no urban/rural differences is more 
expected as Forsyth and Barnard (1999) found drug specific differences in 
comparison of their urban and rural areas, and no significant differences overall. 
Of the drugs the authors found to be significantly different, ecstasy and LSD 
were found to be more associated with urban residents, but magic mushrooms 
and heroin were more related to rural dwellers. Given the relationship of these 
drugs with the latent class typologies in this chapter, further evidence is 
provided to illustrate the importance of measurement in elucidating 
demographic difference. 
This chapter described the membership of either latent class 1 or 2 
appeared to increase the likelihood of smoking by 6.81 times compared to the 
members of the class 3. This is of very similar magnitude to Von Sydow et al. 
(2002) who found their current and regular ecstasy users were 6.9 times more 
likely to smoke. Whilst we cannot estimate the amounts of drugs used by either 
of these two latent classes at this point, the differences in Von Sydow et al. 
(2002) findings could be attributed to either ecstasy or the range of other drugs 
used by this group. As the members of classes 1 and 2 were equally more likely 
to be currently smoking; this is further evidence that illicit drug use relates to 
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tobacco consumption. This is supported by Pedersen and Skrondal (1999). 
They also found odds ratios of around seven between their researcher selected 
group of amphetamines and ecstasy compared to those who did not use illicit 
drugs. This suggests that any drug use increases the risk, as these categories 
had some other differences in terms of their drug use.  
Conversely, there were characteristic differences between the wide and 
moderate latent classes regarding hazardous drinking status. Whilst they were 
both significantly related to this level of alcohol use and related problems, there 
were considerable differences in magnitude between the two classes compared 
to the characteristics of the baseline class. This suggests that the wider the 
range of drug use as was characteristic of class 1, the more likely an individual 
is to be hazardous drinking. Similar results were found by Lynskey et al. (2006) 
where their ‘polydrug’ using class, who had the widest range of lifetime drug use 
were 7.6 times more likely to be alcohol dependent compared to their class of 
lifetime abstainers from illicit polydrug use. Parker et al. (1998) also found that 
of their young adult cohort, almost 35% of their current drug users were also 
drinking every day.  
The magnitude of the odds ratio characteristic of class 2 in relation to 
hazardous drinking was considerably lower (OR= 2.31). However, this is similar 
to those who had used any illicit drugs as found by Wadsworth, Simpson, et al. 
(2004a). The authors concluded that illicit drug users were 2.4 times more likely 
to be drinking alcohol over the recommended limits.  
The finding that ‘moderate’ and ‘wide range’ drug users are 6 times more 
likely to be smokers and between 2 and 12 times more likely to be hazardous 
drinkers would suggest that the tradition of separating the three drugs in 
research (Williams & Parker, 2001) might be simplistic. Whilst in cross-sectional 
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research causal inferences are difficult to establish; nevertheless, the results of 
hazardous drinking, as a mediating variable, between the two more numerous 
classes of drug user indicates an important link between drug use and alcohol. 
Further research may also wish to link alcohol and smoking into these patterns 
of illicit polydrug use. 
 The variables of age and hazardous drinking which differed according to 
whether an individual was in the wide or medium range drug use patterns lend 
tentative support to Williams and Parker’s (2001) statement that ‘delayed 
moderation of use could cause serious health problems’. The ‘moderate range’ 
illicit polydrug users were slightly younger compared with the ‘wide range’ illicit 
polydrug users. This effect of age is reflected in the work of others (Pedersen & 
Skrondal, 1999; Degenhardt et al., 2004; Topp et al., 2004; McCambridge et al., 
2005). 
Whilst self-report data can be falsified in any population or survey-based 
data, this should be less likely to impact this research given that the questions 
on drug abuse were self-completed by the respondent and may eliminate 
expectation bias (Topp et al., 2004). Additionally, inclusion of a fictional drug 
‘semeron’ to attempt to highlight individuals who may report spurious use of 
drugs also offers some safeguard. It is often a criticism of population surveys 
that they neglect student or institution data and thus important patterns of use 
(Ramsey & Percy, 1996; Feigelman et al. 1998). However, this chapter 
illustrates a way for these other populations to be analysed, and in the umbrella 
of surveys carried out by the OCPS, prison inmates and homeless individuals 
were also participating in separate divisions using the same instrument, 
facilitating comparisons. Investigations using similar techniques to this chapter 
could compare these illicit polydrug use patterns. This chapter has drawn from 
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several self-selecting or purposive sampling data from previous published work 
illustrating some similarities and differences to the analyses contained within. 
The methodology used might help to move away from drug specific work, to find 
patterns of use which can explain the multiple varieties of simultaneous and 
concurrent illicit polydrug use. 
In the present analysis yearly use was taken to be the most useful 
indicator of drug taking behaviour. Lifetime use, as Shiner and Newburn (1997) 
concede, often overestimates drug use rates, primarily because someone who 
has tried a drug once is grouped in the same category as a chronic drug user. 
Conversely, occasional drug users are unlikely to be adequately represented in 
monthly reports (Ramsey & Percy, 1996). Furthermore, longer reference 
periods like one year are good for assessing behaviour and problems (Dawson, 
2003). This measure of drug use also falls in line with the British Crime Survey 
reports (Chivite-Matthews et al., 2005).  Using this indicator, concurrent illicit 
polydrug use is the most likely type; however, use in this sample may also 
involve some simultaneous use. In addition, it is regrettable that there is no 
inference of quantity, frequency or duration of use; however, it has been 
tentatively suggested by Carlson et al. (2005) that those who use a wider range 
of drugs tend to use more of each drug in the range. 
Comparisons with similar research often presents conflicting results, as 
the number and type of drugs in the analysis is frequently different.  In this 
chapter, as many drugs as possible were kept in the analysis that would not 
affect model identification (see chapter two). From this study and the possibility 
of others using respondent driven methods there is scope to assess the effect 
of current psychological status of these patterns of illicit polydrug use. 
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Finally, a number of analyses have a priori decided to create a forced 
class of no use (e.g. Mitchell and Plunkett, 2000). Whilst it may have been 
preferable to have forced this class to be no drug users, the deciding of 
characteristics of the ‘control’ group is often fraught with difficulty (Dafters et al., 
2004). However, unlike Dafters and colleagues, whilst we could have enforced 
a no use group on the data, it was considered more appropriate in the context 
of the objectives to allow the heterogeneity of the patterns of illicit drug use to 
shape class characteristics. This represents a move towards a person-centred 
approach to illicit drug use behaviour. 
In conclusion, this chapter has described the extent of heterogeneity in 
patterns of illicit drug use in the population of Great Britain. This can be 
expressed as three different latent classes of illicit drug use behaviour which 
have key demographic criteria, which can provide further information on 
patterns of use.  Future research might wish to examine the extent of drug use 
in these classes to elicit the frequency of involvement and validate the classes 
as being distinctly different from each other in terms of their drug use. The next 
chapter explores each latent class in terms of its use of component drugs. 
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4. Validating the latent class structure of illicit polydrug 
use in Great Britain: Does lifetime consumption of 
drugs differ between classes? 
4.1. Abstract 
Chapter three has proposed illicit polydrug use could be explained in terms 
of three latent classes: ‘no drug’, ‘moderate range’ or ‘wide range’ illicit polydrug 
users. The validity of this model of illicit polydrug use requires assessment in 
terms of its ability to account for different quantities of drug consumption. This 
chapter aimed to determine if there were significant differences in the lifetime 
consumption of four of the most frequently used drugs in the sample. This 
chapter used data from the NPMS study conducted in Great Britain (n=8538). A 
multivariate analysis of covariance (MANCOVA) was used to compare self-
reported estimates of frequency of lifetime drug use. The independent variable 
was illicit polydrug class, of which there were three levels (class 1 ‘wide range’, 
class 2 ‘moderate range’ and class 3 ‘no drug’ users). The dependent variables 
were self-reported lifetime frequency estimates of cannabis, ecstasy, 
amphetamines and cocaine use. Age was entered as a covariate. A significant 
main effect was found for the effect of all drugs used F (8, 17064) = 1494.06; p 
< .000; Pillai’s trace= 0.82; partial η2= 0.41. In addition, a linear contrast was 
found to fit the data with a significant decrease in lifetime frequency of use from 
class 1 to 3. Lifetime frequency of ecstasy use was found to vary most between 
classes, followed by use of amphetamines, cocaine and cannabis. The highest 
frequencies of drug use were found in the wide range drug users. This 
illustrates a continuum of wider drug use relating to greater lifetime frequency of 




In chapter three, illicit polydrug use was defined in the context of use in the 
past year. Three classes emerged from a latent class analysis. The classes 
were labelled ‘wide range’, ‘moderate range’ and ‘no illicit drug’ users. However, 
these profiles describe the range of drugs being used but make no inferences to 
the extent of use of each drug in the three latent classes. The endorsement of a 
drug in one of the latent classes could represent either experimental use or 
prolonged consumption.  
Pharmacological and addiction research suggest that negative 
consequences of drug use, including fatalities are implicated with dose and 
frequency of ingestion (Hammersley et al., 1999). In addition, the impact of drug 
use on mental health is affected by both the range of illicit polydrug use and the 
extent of use of each drug in an illicit polydrug use pattern (Guillot, 2007). Prior 
to further investigation as to the implications of the patterns of illicit polydrug 
use, it will be important to determine broad estimates of the extent to which 
drugs have been used in each of the three classes, i.e. the level of lifetime 
consumption of each drug.  
Whilst there are numerous studies to suggest that wider range drug users 
are consuming more of each drug these have been over multiple time periods 
and use a variety of different techniques. For example, using a bivariate 
approach, Daumann et al. (2004) found higher lifetime dosage of ecstasy use 
was correlated with higher lifetime dosage of amphetamine use (r=.47). Those 
who had used both ecstasy and amphetamines in an illicit polydrug use pattern 
also had a higher mean duration of regular use and a higher mean frequency of 
use than those who did not. The duration of regular ecstasy use was also 
moderately correlated with the duration of regular use of cannabis (r=.42). This 
137 
 
suggests an increase in the extent of other drugs such as cannabis and 
amphetamines. 
Proxy measures of extent the of drug misuse have also been used. 
Lynskey et al. (2006) did not measure the frequency of drug use directly. 
However, they did assess the relationship between at least one symptom of 
abuse or dependence of cannabis, cocaine/stimulants, sedatives or opiates in a 
given latent class membership. It is suggested that certain levels of 
consumption must be present for either abuse or dependence to occur, and, 
this could be considered a proxy measure for extent of use. The classes of 
lifetime drug use found in their Australian twin sample (n=6525) have already 
been described in chapter three; briefly these reflected groups of low use, 
moderate use, party drugs, opioids/sedatives and ‘polydrug’ users. These 
broadly reflect a continuum of number of drugs used in a lifetime increasing as 
move from the low to polydrug use classes. As this continuum increased in 
polydrug use involvement, the percentage of individuals having at least one 
symptom of abuse or dependence also increased. Of the members in the illicit 
polydrug using class, 85% had one or more symptom of abuse or dependence 
on cannabis. Furthermore, 55% and 20% of the members of this class had one 
or more symptom of abuse or dependence on ‘cocaine or stimulants’ and 
sedatives respectively. The opioid class, class four were more likely to have any 
symptoms of opioid abuse or dependence. 
Scholey et al. (2004) in an internet study of night club drug users focussing 
particularly on ecstasy use remarked that if individuals were older they would 
have the potential to use drugs for longer, and thus have consumed a larger 
quantity in their lifetime. This study used chi-square calculations to illustrate 
whether the frequency of ecstasy use was able to predict the frequency of use 
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of other drugs. In these either 2*4 or 3*4 contingency tables, the extent of 
involvement with ecstasy use was significantly related with the extent of 
involvement with other illicit drugs. However, this method is limited in approach, 
as it takes a global view for all items in the contingency table; significances 
were found when some of the percentage differences between two groups were 
1% or less in the table. There was also neither an estimation of the size of the 
significant effect nor any testing pairwise of differences. This may have been 
able to illuminate where the differences lay, facilitating direct comparisons with 
classes of illicit drug use found in chapter three. 
Milani, Parrott, Turner and Fox (2004) compared two groups of ecstasy 
users, heavy (use greater than 20 times) and light (use between one and 20 
times) in terms of differences of other drug use. This study found heavy ecstasy 
users were more likely to use cocaine, amphetamine, LSD, magic mushrooms, 
poppers and ketamine compared to the light ecstasy use group. There were 
also significant gender differences expressed particularly in the heavy 
consumption group with males more likely to be using amphetamines, opiates, 
poppers and ketamine. Whilst the differences between the two groups were 
clear by the percentages presented, the authors only conducted significance 
tests between gender in a given pattern of ecstasy use. They did not test 
statistical differences between patterns of ecstasy illicit polydrug use 
consumption, which makes it difficult to lend weight to their conclusions. 
However, they suggest that heavier ecstasy use is related to a wider range of 
drugs being used. 
In an opportunity sample of young adults (n= 280) Milani, Parrott, Schifano 
and Turner (2005) compared five researcher chosen groups of drug users. 
These groups were based on the extent of their cannabis use, and represented 
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‘cannabis abstinent controls’, ‘current monthly users’, ‘current weekly users’, 
‘current daily users’ and ‘former heavy users’ (no use in the past year, but prior 
daily use). They found a linear trend between extent of cannabis use and that of 
other drugs being used. The highest level of additional drug consumption was 
found in the two groups who were either former or current heavy users (daily 
use). This suggests that frequent use of cannabis predicts frequent use of other 
drugs. 
Dafters et al. (2004) assessed the differences in lifetime consumption 
across four groups, ‘no illicit drug use’ controls, ‘cannabis only’, ‘cannabis and 
ecstasy light’ users and ‘cannabis and ecstasy heavy’ users. Those who were in 
the ecstasy using groups (whether light or heavy) were more likely (by mean 
number of lifetime uses) to have used amphetamines, cocaine and heroin than 
the cannabis use only group. Those in the heavy ecstasy (and cannabis) use 
group had a higher lifetime consumption of LSD compared to the cannabis only 
group. However, not all these differences were tested for statistical significance. 
However, there were similarities in the mean number of lifetime uses of 
cannabis between the cannabis only and the two ecstasy and cannabis use 
groups. Whilst there was an increasing percentage trend as progressed from 
cannabis only to heavy ecstasy and cannabis use, it was not found to be 
significantly different using ANOVA.  
A recent study in adolescents aged 14 to 15 (n=3919) assessed the 
differences in other drug consumption focussing on cannabis use (McCrystal, 
Percy & Higgins, 2007). The authors assessed the frequency of other drug use 
between three groups, no cannabis use, low frequency cannabis users and high 
frequency cannabis users. As the involvement in cannabis use increased, so 
too did percentage rates of the use of other illicit drugs. These trends were 
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found to be significant using chi-squared tests. This suggests that increased 
involvement with cannabis is associated with increased likelihood of the use of 
other drugs. 
Demographic trends associated with heavier drug use might also suggest 
that a wider range of illicit drugs used relates to heavier use patterns. For 
example, in a snowball sample of ecstasy users in Atlanta, Georgia, Sterk et al. 
(2007) found the heaviest patterns of ecstasy use in males. Latent class 
patterns of illicit polydrug use presented in chapter three found the members of 
the wide range illicit polydrug use class were most likely to be male. Therefore, 
this suggests that wider ranges of illicit polydrug use may reflect larger 
consumption patterns in the general population of Great Britain. 
Carlson et al. (2005) also found some evidence for heavier use in wider 
range of drug use patterns. The patterns of drug use found in their sample of 
ecstasy users living in Ohio reflected three patterns of use: ‘wide’, ‘moderate’ 
and ‘limited’ range ecstasy users. Supporting evidence that extent of use relates 
to width of drug use pattern is primarily found in the cannabis and alcohol use 
frequencies. Their wide range ecstasy use class had the greatest probability of 
drunkenness beyond the mean days in the sample per month.  Of the members 
in this class, 62% endorsed this item; a higher probability than the members of 
either the ‘moderate’ range (27%) or the members of the ‘limited; range class 
(19%). The members of the ‘wide’ range ecstasy users also had the highest 
probability of using cannabis daily (56%) compared with 42% and 19% for 
moderate and limited range ecstasy users respectively. 
Furthermore, the authors used multinomial logistic regression to predict 
frequency of ecstasy use between class memberships. Individuals in the wide 
and moderate range groups were 14.66 and 4.13 times more likely respectively 
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to have used ecstasy over 50 times in their lifetime compared with the limited 
range ecstasy use class. In addition, the wide range class was 6.38 times more 
likely to have used ecstasy 10-50 times in their lifetime compared with the 
baseline limited range group. No significant differences were found between the 
moderate range and limited range classes on this lifetime frequency of ecstasy 
use. This is a clear indication that the wider the range of drugs, the greater the 
quantity used of each of the component drugs in the range (as expressed by 
latent class pattern). 
 In conclusion, evidence from both researcher and empirically derived 
patterns of illicit polydrug users would suggest the wider the range in a pattern 
of use, the higher the quantity of each component drug. However, it could be 
that in the general population, wide range illicit polydrug users may either 
extensively use more drugs throughout the year or perhaps using a wider range 
of drugs, but only once in that year. Therefore, inferring that a particular drug 
has influence on any outcome variable may be spurious and the validity of the 
classes could be questioned. This chapter will attempt to quantify drug misuse 
in each of the three latent classes found in the Great British population from 
chapter three, wide range, moderate range and no drug use. It is hypothesised 
that the wider the range of the drugs used, the larger the extent of involvement 
in a particular drug. Given that the older an individual is, the greater the 
exposure opportunity would be to use illicit drugs; therefore, age will also be 




4.3.1. Participants, data and sampling 
The data used in this chapter was taken from the NPMS (Singleton et al., 
2001a; 2001b). This was conducted using a stratified multi-stage probability 
sample of households in England, Scotland and Wales. Analyses were 
performed on 8538 individuals who answered the drug use section, excluding 
the 42 participants in the study who either did not answer the drug use section 
or endorsed the use of ‘semeron’ in their lifetime. The mean age of the sample 
was 45.34 years (SD=15.59 years). Females represented 54.08% of the 
sample. Further details of the survey’s data, participants and sampling 
procedures can be found in chapter two. 
4.3.2. Measures 
A between subjects multivariate analysis of covariance (MANCOVA) was 
performed on four dependent variables. These represented the amount of four 
illicit drugs used by an individual in their lifetime. These were cannabis, 
amphetamines, cocaine and ecstasy. Note that these are the most frequently 
used illicit drugs in the European Union and Norway not just in the UK 
(EMCDDA, 2008).  The question was “How many times have you ever used 
named drug” (p. 74; Singleton et al., 2002). All the dependent variables were 
measured on a scale with ‘0’ indicating no use, ‘1’ less than 10 times, ‘2’ 10-100 
times and ‘3’ more than 100 times.  
The independent variable was illicit polydrug use class, which had three 
levels: ‘wide range’, ‘moderate range’ and ‘no drug’ users. This represents the 
most likely latent class for each participant in the dataset derived from the latent 
class analysis of four illicit drugs provided in chapter four.  
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In addition, the age of participants was controlled for in the analysis as a 
covariate. The older an individual was the higher the potential lifetime total, for 
two reasons. Firstly, there is a greater time opportunity to consume more drugs 
and secondly, there is more time to progress in frequency of use in a given drug 
using career. Using age as covariate in this way reflects a similar 
methodological strategy to other work in the field, for example research by 
Scholey et al. (2004) into extent of illicit polydrug use patterns in ecstasy users. 
Several of the assumptions underlying MANCOVA were violated in this 
study; however, the analysis was intended to be descriptive rather than 
inferential. Firstly, assumptions regarding homogeneity of variance-covariance 
matrices were violated4. Coupled with this, n values for the levels of the 
independent variable were of unequal numbers. Pillai’s trace was used in favour 
of other statistics given its robust nature with data issues such as these 
(Tabachnick & Fidell, 2006). If an overall significant effect was found between 
the levels of latent classes and the level of consumption of drugs, pairwise 
comparisons were performed to illustrate where the significant differences lay. 
To reduce the chance of Type I errors, a Bonferroni adjustment was performed 
giving an adjusted alpha value of .0135 which equates to an overall alpha of .05. 
4.3.3. Software 
All analyses were conducted in SPSS version 15 (SPSS Inc, 2006). 
Graphic illustrations of the Estimated Marginal Means were achieved in 
Microsoft® Excel Vista. 
                                            
4 Box’s M test of equality of covariance matrices was significant (Box’s M=52207.93; F 
(20,67434.78)= 2561.32; p< .005). 





Table 16 shows the frequency of use across the lifespan. Most of the 
sample had never used any of the four illicit drugs, whether cannabis, cocaine, 
ecstasy or amphetamines. Of those who had used illicit drugs during their 
lifetime, the most frequent category illustrating extent of involvement for 
cannabis reflected use over 100 times. For amphetamines, ecstasy and 
cocaine, the pattern was slightly different. For these drugs, the most frequently 
endorsed use category was between 10 and 100 times. There was some 
evidence of experimental use, where use did not exceed 10 times for all four 
drugs.  
 






No use in past 
year 
(0) 









Cannabis 7854 (91.99%) 134 (1.57%) 241 (2.82%) 309 (3.62%) 
Amphetamines 8406 (98.45%) 39 (.46%) 65 (.76%) 28 (.33%) 
Ecstasy 8405 (98.44%) 36 (.42%) 70 (.82%) 27 (.32%) 
Cocaine 8411 (98.51%) 55 (.64%) 58 (.68%) 14 (.16%) 
 
 There was a statistically significant difference of class membership (the 
independent variable) on the four dependent variables representing the amount 
of lifetime use of cannabis, ecstasy, amphetamines and cocaine (F (8,17064)= 
1494.06; p<.000; Pillai’s Trace= .82; partial η2 = .41). The effect of age (as a 
covariate) on the combined effect of the dependent variables also reached 
statistical significance F (4,8531) = 98.86; p<.000; Pillai’s Trace = .04, although 
the effect size was notably low (partial η2 = .04). 
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Dependent Variable Sum of squares df Mean squares F ratio p value  Partial η2  
Class How many times used cannabis? 1121.62 2 560.81 2183.34 .00 .34 
 How many times used amphetamines? 244.19 2 122.10 3600.22 .00 .46 
 How many times used ecstasy? 309.55 2 154.77 5769.06 .00 .58 
 How many times used cocaine? 159.56 2 79.779 2808.43 .00 .40 
Age How many times used cannabis? 100.94 1 100.94 392.99 .00 .04 
 How many times used amphetamines? .05 1 .05 1.53 .22 .00 
 How many times used ecstasy? .10 1 .10 0.39 .05 .00 
 How many times used cocaine? 0.01 1 0.01 3.80 .53 .00 
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The independent variable of illicit polydrug use class had the strongest 
effect on amount of times ever used ecstasy F (2, 8534) = 5769.06; p<.000; 
partial η2 = .58. Class had the weakest effect on the amount of times ever used 
cannabis, however, this was still significant F (2, 8534) = 2183.34; p<.000; 
partial η2 = 0.34. Significant differences were also found across classes for the 
amount of times ever used both cocaine and amphetamines. A polynomial 
contrast was applied to the data.  A linear trend was significant for all dependent 
variables showing a decline in amount of cannabis, amphetamines, cocaine and 
ecstasy used from class 1 to class 3.  An illustration of this significant change in 
estimated marginal means across all variables is given in Figure 15. This also 
showed differences between classes 1 and 2 were slight for times ever used 
cannabis, but more pronounced for the amount of times ever used ecstasy. 
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Note: 0= no use; 1=<10 times used; 2=10-100 times used; 3=>100 times used in lifetime. 
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From these estimated marginal means, class 1, the wide range illicit 
polydrug use class, was characterised as having two drugs with a mean lifetime 
use of over two (i.e.10-100 times used in lifetime). These were ecstasy (M= 
2.06) and cannabis (M=2.51). In class 2, moderate range illicit polydrug use 
class, only the number of times ever used cannabis was above two (M= 2.33). 
Furthermore, only the members in class 1 had all four drugs with lifetime use of 
above one (indicating up to ten times used) but below two (indicating in the 
range of10-100 times used), with amphetamines (M=1.80) and cocaine 
(M=1.18). The amount of all remaining drugs in all remaining classes was less 
than ten times.  
These estimated marginal means were subject to pairwise comparisons 
between classes or levels of the independent variable with a Bonferroni 
adjustment. The mean differences were summarised and are presented in    
Table 18. All comparisons were found to be significantly different amongst 
classes and lifetime use of these drugs, with the only exception being the 
amount of times cannabis was used in lifetime between the members of classes 
1 and 2 (mean difference =.18; 95% CI = -.01-.37; p=.080). The largest 
differences between all three classes and over all four drugs were found 
between classes 1 and 3.
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   Table 18: Mean differences between the three classes in terms of the amount of times ever used one of four drugs. 
   Bonferroni adjustment for 36 comparisons; p value .013
 Comparison between classes Mean difference Standard error P value 
Amount of times ever used cannabis Class 1 Class 2 .18 .08 .08 
Class 1 Class 3 2.39 .07 .00 
Class 2 Class 3 2.22 .04 .00 
Amount of times ever used amphetamines Class 1 Class 2 1.07 .03 .00 
Class 1 Class 3 1.79 .03 .00 
Class 2 Class 3 .73 .01 .00 
Amount of times ever used cocaine Class 1 Class 2 .44 .03 .00 
Class 1 Class 3 1.18 .02 .00 
Class 2 Class 3 .74 .01 .00 
Amount of times ever used ecstasy Class 1 Class 2 1.26 .03 .00 
Class 1 Class 3 2.05 .02 .00 




This chapter has illuminated quantifiable differences in the number of 
times the four most prevalent illicit drugs were ever used in Great Britain 
between the three illicit polydrug use classes. These further validate the 
members of the wide range (1), moderate range (2) and no drug use (3) classes 
as having distinct characteristics which are common to the membership of a 
class, but different between classes. The effect of class was significant, 
suggesting that the characteristic mean amount of drugs used declined when 
moving from class 1 to class 3 whilst controlling for the effects of age.  
Class 3 was found to have the highest level of all four drugs used overall. 
This is strongly supported by previous research. Scholey et al. (2004) found 
significant global chi-square differences of extent of ecstasy use and of other 
illicit drugs. The authors suggested from this that wider range illicit polydrug use 
was associated with higher individual drug consumption. Milani et al. (2004), in 
comparing their light ecstasy users (use between one and 20 times) and 
comparisons of heavy ecstasy users (greater than 20 times used) also lend 
support. Their heavy ecstasy users had a wider range and quantity of other 
drugs used. However, on average those in class 1 were consuming ecstasy and 
cannabis over 100 times in their lifetime. This class also on average consumed 
cocaine and amphetamines between 10 and 100 times during their lifetime. As 
mentioned previously, cannabis is often considered to be more closely related 
to alcohol in terms of its perceived harm (EC, 2008; Nordentoft & Hjortoj, 2007), 
and it is unsurprising that the frequency of lifetime use reflects this. In addition, 
Milani et al. (2005) found their current daily cannabis users were most likely to 
have used additional drugs in greater quantities. Thus, it could be proposed that 
151 
 
high levels of lifetime use of one drug are universally related to high levels of 
other drugs. 
The average lifetime frequencies of use of class 2 provide some counter 
evidence to this statement. Members of class 2 were typically using cannabis 
over 100 times, but amphetamines, cocaine and ecstasy were ingested less 
than 10 times during the lifetime. This suggests that cannabis use was the 
primary drug of use in this class, with a more experimental approach to other 
drugs being used. Consequently, high levels of lifetime use of one drug seem to 
indicate that perhaps there are higher levels of other drugs in a given illicit 
polydrug use pattern.  
Class 3 was distinct from the other two classes. It was characterised by no 
drug use in the past year in chapter three. In this chapter it has been illuminated 
this class is characteristic of extremely low levels of cannabis use, and no 
lifetime use of amphetamines, cocaine, and ecstasy. 
The greatest effect of class was found on the frequency of lifetime ecstasy 
use with the least effect on the frequency of lifetime cannabis use. This would 
suggest that lifetime consumption of ecstasy differs most across classes 
followed by amphetamine, cocaine and cannabis. The frequency of ecstasy use 
found in the wide and moderate ecstasy use latent classes in Carlson et al.’s 
(2005) sample was similar. The authors found these classes were respectively 
15 and four times more likely to use this drug more than 50 times in their 
lifetime than their limited range ecstasy user class. The frequency of ecstasy 
use found in class 1 is somewhat similar to Carlson and colleagues’ wide and 
moderate ecstasy use classes; the mean lifetime frequency of ecstasy use in 
class 1 illustrated use above 10-100 times. The characteristics of those in class 
2, however, would appear to reflect somewhat more experimental use of 
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ecstasy with use, just under 10 times. This would suggest that models of illicit 
polydrug use, which use ecstasy as the basis of a latent class analysis, may 
have limited comparability to general population surveys. Furthermore, Carlson 
et al. (2005) found three patterns of ecstasy user, however, a similar number 
were not found in this current dataset. 
 There is some support for the division of ecstasy by quantity in Milani et 
al. (2004). They grouped their lifetime ecstasy users into groups of heavy (use 
greater than 20 times) and light (less than 20 times but at least once) use. The 
former of these is somewhat alike class 1 and latter more characteristic of class 
2. However, whilst the cut off points might be validated by this research, there 
are some theoretical caveats. The nomenclature of these groups attributes any 
significant relationships that these groups to ecstasy, when both the study by 
Milani et al. (2004) and analyses conducted to date in this thesis have 
described considerable illicit polydrug use in ecstasy users with given lifetime 
quantities of use. Thus the name ecstasy polydrug user does not encompass 
behaviour within a class. 
Note that the proportion of cannabis did not differ between the members of 
latent class 1 and 2. This is supported by Dafters et al. (2004) who found no 
significant differences between cannabis use in their researcher selected 
categories of ‘cannabis only’, ‘cannabis and light ecstasy use’, and ‘cannabis 
and heavy ecstasy use’. In addition, this provides some support for the gateway 
theory (Kandel, 2002; Kandel & Faust, 1975). The sequence suggests cannabis 
is the first illicit drug of use, followed by ecstasy, amphetamines and finally 
cocaine use. This is similar to a pattern derived by Pedersen and Skrondal 
(1999) in a sample of 10812 adolescents living in Oslo, who hypothesised that 
the sequence of use after licit drugs was cannabis, amphetamines, ecstasy and 
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heroin, where the positions of amphetamines and ecstasy are interchangeable 
in the sequence. Cocaine use, which has been assessed in this chapter, was 
not one of the drugs included by the authors in their analysis. 
Scholey et al. (2004) also suggested that age would be related to lifetime 
consumption of illicit drugs. A significant relationship was found between 
quantity of lifetime cannabis use and age in this chapter, although the effect 
size was low. The relationship between lifetime quantity of ecstasy use and age 
was close to significance, however, age was not significantly related to the 
quantity of either lifetime cocaine or amphetamine use.  
In terms of limitations of this approach, we are unable to assess the level 
of drug involvement in the other drugs given the varying size of the drug classes 
proposed, and the low probability of endorsement across all classes. However, 
as stated above the four most frequently used illicit drugs were included which 
enabled comparisons to be made across all three classes.  
In conclusion, this chapter lends support to other work which suggests that 
those who use drugs in a wider pattern of illicit polydrug use are more likely to 
be consuming more of each component drug in their illicit polydrug use pattern. 
Given the hypothesised relationship between dosage of drugs used and 
psychological harm, this chapter has provided context on more common trends 
of extent of use in each of the polydrug use groups. This will contribute to the 
elucidation of relationships between illicit drugs and mental health to be 
considered in the following chapter. 
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5. The latent class structure of illicit polydrug use in 
Great Britain: Relationship with psychological health. 
5.1. Abstract 
Links have been made between poor psychological health and drug use, 
but the relationship is affected by the illicit polydrug nature of drug consumption. 
This chapter aims to use drug use typologies generated through latent class 
analysis from chapter three to determine the relationship between poorer 
psychological status and the three typologies of illicit polydrug use. A latent 
class analysis regression model was run which estimated the relationship 
between current psychological status and the wide range, moderate range and 
no drug use classes. Data used was from the 2000 NPMS (n=8538). Beyond 
predicted relationships with demographic variables found in chapter three, illicit 
polydrug users in classes 1 and 2 were significantly more likely to have mixed 
anxiety and depressive disorder, depressive episode and have attempted 
suicide in their lifetime compared to the no drug use class. Profiles of illicit 
polydrug use derived from data illuminated that both the ‘wide’ and ‘moderate’ 
range illicit polydrug user had the most likely demographic profile for mental 
health disorders, however, the magnitude of this risk did not differ between the 
two typologies in comparison to baseline class of no drug use. Thus, any illicit 
drug use might be considered to increase the risk. 
5.2. Introduction 
The primary work illustrating comorbidity between psychological status in 
the general population and illicit drug use comes from data examining drug 
abuse and dependence (Newcomb, Scheier & Bentler, 1993). A recent review 
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of this area assessing the relationships between common mental disorders and 
abuse or dependence found anxiety and depression particularly common in the 
assessment of comorbidity (Jané-Llopis & Matytsina, 2006). However, some 
epidemiological population surveys such as the NCS and NCS-R have 
illuminated associations between poorer psychological health and any illicit drug 
use excluding abuse and dependence (Kessler et al.,1996; Robins & Regier, 
1991; Merikangas et al., 1998; Degenhardt et al., 2001) with some of the most 
frequently associated being anxiety, depression and suicidal behaviours. 
However, umbrella terms referring to any drug use fail to encompass the wide 
variety of illicit polydrug use patterns which might affect any relationship with 
mental health.  
Some researchers have attempted to elucidate the relationship between 
illicit polydrug use and harm by assessing the relationship with single drugs. 
Kelly and Parsons (2008) in their time-space study comparing illicit polydrug 
and illicit non-polydrug cocaine users in Manhattan found no significant 
differences between their groups of illicit polydrug cocaine users and cocaine 
users who were not illicit-polydrug users. DeWin et al. (2006) found no 
significant differences between ecstasy users and ecstasy naive participants in 
a Netherlands cohort study at either their baseline measurement or at follow up 
using the Beck Depression Inventory (BDI). Furthermore, in an opportunistic 
sample of 22 ecstasy users, Hopper et al., (2006) found that that all participants 
had relatively low mean Beck Anxiety Inventory (BAI) and BDI-II scores, with 
means of 2.68 (SD=2.66) and 6.36 (SD=5.07) illustrating little difference with 
population norms.  
Scheier et al. (2008) in their sample of ecstasy users from Miami and 
Sydney found the average Center for Epidemiologic Studies Depression Scale 
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(CES-D; Radloff, 1977) score was around six for the whole sample. This 
considerably lower than the cut off score of 16 for this scale, which indicates 
depression levels of clinical relevance (Radloff, 1977). Multinomial logistic 
regressions on four latent classes of ecstasy abuse or dependence symptoms 
revealed that the differences between asymptomatic ecstasy users (i.e. no 
symptoms of either abuse or dependence) differed very slightly from those who 
had symptoms. The odds ratios (representing one-unit change in the CES-D) 
were 1.09 and 1.13 for the members of the moderate and severe dependent 
classes. There were no significant differences for those with mild symptoms 
compared to the asymptomatic class.  
Keyes et al. (2008) in their study of 8666 ecstasy users from the National 
Epidemiologic Survey of Alcohol and Related Conditions (NESARC) study 
compared four researcher chosen categories of use. These were ecstasy users 
who used in the past 12 months (current), lifetime ecstasy users who had not 
used in the past year (past), lifetime use of other illicit drugs excluding ecstasy 
(other) and lifetime abstention of illicit drugs (no drugs). Current ecstasy users 
were significantly more likely to have experienced a DSM-IV anxiety disorder 
compared with the no drugs group (OR=3.7). However, the likelihood of 
experiencing either any mood disorder, major depressive disorder (MDD) or 
generalised anxiety disorder (GAD) were not significant compared to the 
baseline no drug use group. The former ecstasy users were 3.5 and 2.5 times 
more likely to have any mood or anxiety disorder diagnosis respectively. 
Specifically, they were 3.6 times more likely to have GAD and 2.2 times more 
likely to have MDD. Other drug users (not ecstasy use) also had an elevated 
risk of mental health conditions. They were 2.4 times more likely to have any 
mood disorder and 2.2 times more likely to have any anxiety disorder. Their risk 
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of MDD was similar to the former ecstasy users being 2.2 times more likely to 
have this condition, however, for GAD the odds ratio for having a GAD 
diagnosis was 2.8, slightly smaller than the former ecstasy users. 
Relationships between psychological status and illicit drugs are 
complicated as some of the illicit drugs produce symptoms of these disorders as 
a temporary effect of the drug. For example, cannabis users can often 
experience anxiety and panic attacks, during and shortly after use. Thomas 
(1996) in a community sample from Hastings, New Zealand found that one in 
five of their 199 lifetime cannabis users had experienced acute panic or anxiety 
following cannabis administration. Moreover, females were significantly more 
likely to have experienced these symptoms compared to males. Chronic high 
doses of cannabis were particularly related (Hill & Gorzalka, 2006), suggesting 
that dose is also relevant to the experience of these negative effects. Patton et 
al. (2002) found daily cannabis use in the past year elevated the risk of anxiety 
or depression in a cohort study of adolescents in Victoria, Australia with an odds 
ratio of 5.6 compared with those who had used cannabis (in the range of zero to 
five times) in the past 12 months. However, it is worth noting that females were 
2.5 times more likely to experience these common mental disorders compared 
with males in the same sample. Withdrawal symptoms of cannabis reflect the 
symptoms of depression, low mood, fatigue, and sleep problems, but potentially 
these effects are transient. Amphetamine users are also commonly associated 
(even if the event is rare) with affective symptomatology (Baker & Dawe, 2005). 
A review on the effects of ecstasy shows links with depression (Green et 
al., 2003). Their review of the literature in this area hypothesises that this is due 
to serotonin depletion and serotonergic neurodegredation, which has the 
potential to create transient and more enduring depressive symptoms in some 
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users. Naughton, Mulrooney and Leonard (2000), in a review of the evidence on 
the range of serotonin receptors further propose that the serotonin system, 
considered by Green et al. (2003) to be affected by the use of ecstasy, is also 
linked to other psychological disorders such as anxiety, OCD and 
schizophrenia. However, once again, given most drug users are not using 
ecstasy in isolation and ecstasy is not the only drug which acts on this system, 
illicit polydrug use affects the conclusions.  
Other attempts to explain the relationship between drug use and mental 
health hypothesise that any suspected transient or enduring change in the 
serotonin system, could be protected against if cannabis is also used. This 
provides further evidence that polydrug use is an important factor in assessing 
relationship between psychological status and drug use. Morley, Li, Hunt, 
Mallett and McGregor (2004) using an animal model found the co-administration 
of ∆9-tetrahydrocannabinol (the primary active ingredient of cannabis) and a 
synthetic cannabinoid CP 55,940 with ecstasy seemed to reduce serotonin 
depletion compared to the rats who were administered ecstasy alone. Parrott, 
Gouzoulis-Mayfrank, Rodgers and Solowij (2004) in a meeting report 
summarising the findings from two previous studies found any 
psychopathological differences were attributable to cannabis use not ecstasy 
use. Research by Morgan, McFie, Fleetwood and Robinson, (2002) in 
comparing their groups of ecstasy users found both anxiety and depression as 
measured by the Symptom Checklist-90-Revised (SCL-90-R; Derogatis, 1977) 
was predicted by the number of cannabis joints used in lifetime, but not ecstasy 
use. They further suggest as their groups were different on several illicit (and 
licit) drugs, it is difficult to isolate the drug responsible due to polydrug use. 
However, Degenhardt et al. (2001) in their review of the relationship between 
159 
 
drug use in Australia concluded cannabis was not associated with anxiety and 
affective disorders. Schifano et al., (1998) in a study of 150 patients 
consecutively presenting to an Addiction clinic who had used ecstasy at least 
once compared the characteristics of ecstasy lifetime users who had at least 
one mental health condition compared with those who did not.  They found 
those with mental health conditions were significantly younger than those who 
did not. In addition, the problematic users had a higher ecstasy lifetime intake, 
higher ecstasy frequency and higher single occasion intake compared with the 
non-problematic users. However, when examining the range of drugs used by 
individuals in those two groups, whilst the problematic users were more likely to 
have used opiates (78% versus 41%), those who were not problematic users 
had higher alcohol problems (47% versus 23%) and other drug use, like amyl 
nitrate and LSD was higher in the non-problematic group (57% versus 30%). 
This might suggest the non-problematic group were more likely to be using a 
wider range of drugs, contrary to expectations.  
Unfortunately, the authors did not provide any statistics for actual drug 
use differences which might illuminate this issue further. Moreover, this was a 
population who had referred themselves to treatment at an addiction clinic. 
There were no details in this paper as to what the individuals were presenting 
for, which may have influenced the results considerably. Furthermore, 53% of 
the sample had at least one existing mental health condition, and any 
consequences found may be related to the treatment population with little 
applicability for a general population sample.  The only significant predictors of 
poorer psychological status in a multinomial logistic regression model 
controlling for demographic factors were that of increased quantity of ecstasy 
used in lifetime, ‘alcohol and ecstasy’ polydrug use and no opiate use. As 
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inclusion criteria for this study was at least one dose of ecstasy, attribution of 
harm for those who might just have used ecstasy once in their lifetime may be 
problematic (Verheyden, Henry, et al., 2003). Primarily the studies’ approaches 
presented above have chosen groups based on either their cocaine, ecstasy or 
cannabis use, and the use of other illicit drugs may have influenced the findings 
to an unknown degree.  
Further evidence of shortcomings of single drug research in assessing 
the relationship with psychological status was illustrated by Guillot (2007) in a 
review examining the relationship with ecstasy use and depression. This study 
concluded that 11 of 22 studies reported significantly elevated depression 
scores with ecstasy use. Notably, these were using a range of instruments, as 
some of the studies illustrated in this introduction have illuminated the range of 
instruments available, four of the significant differences were found using the 
Hamilton Depression Scale (HAM-D; Hamilton, 1960), two using the SCL-90-R, 
three using the Beck Depression Inventory I (BDI-I; Beck, 1987) and two using 
Beck Depression Inventory II (BDI-II; Beck, 1996).  Other key methodological 
confounds are also noted which cast doubt on the findings. These were low 
sample sizes, referring to ecstasy users from clinical populations as relevant to 
the general population of ecstasy users, but most importantly, the lack of 
isolation of ecstasy as a cause. Frequency tables of patterns of use provided in 
the studies clearly illuminate a range of lifetime and more frequent illicit (and 
licit) drug use. As can be seen above, single drug research struggles to find 
methodologically strong evidence for relationships with mental health status. It 
could therefore be suggested if harm is caused by illicit drug use, poor 
methodologies, and the lack of account of illicit polydrug use, make it difficult to 
draw any conclusions about harm. Many researchers have attempted to 
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account for differences (or lack of found differences) through attribution of 
dosage effects, suggesting psychological problems in ecstasy users are 
considered to be dose related (Bolla, McCann & Ricaurte ,1998; Morgan, 2000; 
Gouzoulis-Mayfrank et al., 2000; Reneman et al, 2001; DeWin et al., 2006; 
Soar, Turner and Parrott, 2006). However, as chapter five has revealed, dose is 
additionally related to range of illicit polydrug use, and a more sophisticated 
explanation is needed to understand the relationship. 
There have been some further efforts to assess drug use which make 
attempts to account for illicit polydrug use. Lieb et al. (2002) in a longitudinal 
community study of young adults (aged from 14-24 years old) living in Munich, 
Germany found those who used ecstasy and related drugs (e.g. stimulants and 
hallucinogens) were significantly more likely to have a diagnosis of GAD 
(OR=2.10) or MDD (OR=1.53) compared with a group of those who used other 
illicit drugs. However, despite these differences in likelihood of mental health 
conditions, there were few significant differences between their researcher 
chosen categories in terms of their help seeking. The exception was found 
between ecstasy and related drug use group and no illicit drug group with the 
former, the ecstasy and related drug use group 2.3 times more likely to have 
attended a session with a psychologist than the no illicit drug group. The 
medical practitioners included in the questions were neurologists, psychiatrists, 
psychologists and general practitioners.  
Daumann et al. (2004) found in their opportunity sample of ecstasy users 
and non-ecstasy using controls that as the lifetime dose of amphetamine 
increased, so too did depressive and anxiety symptoms as measured by the 
SCL-90-R. In addition, the average frequency of use of amphetamines and 
cannabis were significantly correlated with anxiety (r=.29 and r=.36 
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respectively). Furthermore, average frequency of cannabis use also correlated 
significantly with depression (r=.30). In comparing their ecstasy users with non-
ecstasy using controls, they found significantly higher anxiety scores for the 
ecstasy users, however, no significant differences were found for depression. 
This study also had a longitudinal component which assessed those who used 
ecstasy at baseline and either used cannabis in the 18 months between time 
points or had not used cannabis between the two time points. They concluded 
that anxiety, measured as the change between SCL-90-R anxiety scores at the 
two time points, significantly decreased for those who had not used cannabis 
during the eighteen month follow up, but significantly increased for cannabis 
users. This relates to a mean decrease of SCL-90-R scores of just over two and 
an increase of anxiety scores just over one. They therefore suggest long-term 
psychological problems may be related to cannabis rather than ecstasy use. 
This was a finding supported by Parrott et al. (2004) and Morgan et al. (2002). 
Furthermore, Verheyden, Henry, et al. (2003) in their opportunistically 
sampled ecstasy users surveyed in Manchester and London, found some 
differences between related consequences dependent on the drugs used with 
ecstasy. Using groups of two drugs, they found ecstasy and cocaine users had 
increased negative effects (usually in 24-48 hours of ingestion) and increased 
positive effects compared with those who did not use cocaine with ecstasy. 
Furthermore, they found those who used amphetamines with ecstasy had 
increased physical problems than those not using amphetamines. Whilst the 
study was not designed to accommodate more sophisticated analyses beyond 
grouping two drugs together, it is of note that the questionnaire was not 
designed by the authors, but rather another psychologist on behalf of the BBC. 
The authors note had they been involved with the dataset from the outset, they 
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might have been able to elucidate more sophisticated patterns of use and illicit 
polydrug use. 
Still, whilst there is some attempt to combine drugs in appropriate illicit 
polydrug use patterns, there are still individuals who will not be accounted for in 
the patterns. However, researchers such as Lynskey et al. (2006) in an 
Australian twin sample use alternative methodologies. They found five classes 
of lifetime drug use, low use, moderate use, party drugs, opioids/sedatives and 
illicit polydrug use. These have been fully described in the introduction to 
chapter three. Compared to those in the baseline low use class 1, members of 
moderate use class 2, opioids/sedatives class 4 and illicit polydrug using class 5 
were all significantly more likely to have experienced social anxieties with odds 
ratios of 1.2, 1.6 and 1.6 respectively. Elevated risk of major depressive 
disorder was found across all classes compared to the members of the baseline 
low use class. The odds ratios ranged from 1.7 times more likely for those in the 
moderate use class to 3.5 times more likely for the members of the 
opioid/sedative class. Furthermore, the moderate use class membership was 
3.7 times more likely to have attempted suicide than the baseline class 
membership. Those in the party drug class had a slightly lower odds ratio (2.1), 
but were still significantly more likely to have attempted suicide in lifetime as 
those individuals in the low use class. However, the opioid/sedative and the 
illicit polydrug class members had the highest risk. They were 7.1 and 9.3 times 
more likely to have attempted suicide in their lifetime compared to those in the 
baseline low use class. 
 Furthermore, in their review of drug use, abuse and dependence and it’s 
comorbidity with mental disorder, Crawford, Crome and Clancy (2003) also 
found drug use was also a risk factor for suicidal behaviour. This was supported 
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by a recent study on convenience samples of adolescents living in Tennessee, 
(n=10273) which found a strong relationship between drug use and suicidal 
behaviours (Dunn, Goodrow, Givens & Austin, 2008). Female suicide attempts 
were predicted by ever trying cigarettes (OR=1.80), cannabis (OR=1.84), 
cocaine (OR=1.58) or inhalants (OR=2.45). Predictors of adolescent suicide in 
males were significantly predicted by ever trying or daily use of cigarettes with 
odds ratios of 1.51 and 1.55 respectively. Lifetime use of illicit drugs predictive 
of male suicide attempts were cocaine (OR=1.6), inhalants (OR=2.26) and 
intravenous drug use (OR=1.50). It is of note the mean ages of the studied 
sample were 12.8 years for females and 12.9 years for males. The rates of 
suicide attempts in this population were extremely high, considering their young 
age, with 12.6% of females and 7.4% of males having attempted suicide at least 
once in their lifetime.  O’Boyle and Brandon (1998) suggest increases on the 
Addiction Severity Index (ASI; McLellan, Luborsky, Woody, & O’Brien, 1980) in 
suicide attempters were found to be related to comorbid psychological problems 
and wider illicit polydrug use patterns. However, it must be noted the 103 
participants in this study were in drug abuse treatment.   
Given the strong relationship found between smoking and hazardous 
drinking from chapter three, it is interesting to note smoking is also associated 
with alcohol and illicit drug use, depression and suicidal behaviours (Alverado & 
Breslau, 2005). This is supported by a recent review of the literature on alcohol 
use and suicide, Baigent (2005) concluded higher AUDIT scores correlate with 
suicidal ideation and behaviour. Consequently, it would appear evident both licit 
and illicit polydrug use may be a risk factor for suicide attempts given the strong 




In conclusion, it is evident relationships between mental health and 
single drug research may be affected by the full profile of drugs used by an 
individual. It can also be hypothesised the relationship between drug use and 
psychological comorbidity is more pronounced dependent on the number of 
drugs used. Finally, it is thought drug use increases the risk in individuals who 
might not already be in an at-risk group. To facilitate this assessment, adjusted 
estimates of relationships with mental health will be used. Consequently, the 
predictors used in chapter three will be controlled for whilst assessing the 
relationship between mental health and illicit drug use. This is more 
methodologically sound than those which do not control for confounding factors 
(Macleod et al., 2004). This study therefore has two aims, to understand the 
relationship between current psychological status, help seeking and differing 
types of illicit polydrug user and secondly, to determine how this relates to their 
potential for risk in considering their sociodemographic profile. 
5.3. Method 
5.3.1. Participants, data and sampling 
There were 8538 participants analysed in this chapter representing those 
who answered all the drug use questions and did not use ‘semeron’ from the 
NPMS survey (Singleton et al., 2001a; 2001b). The data was from a multi-stage 
stratified sample representative of adults living in Scotland, England and Wales. 
Data was accessed via the ESRC UK data archive hosted by the University of 
Essex. Participants were mostly female (55.08%) with a mean age of 45.34 
(SD=15.59). Full details of the participants, data and sampling strategy are 




5.3.2.1. Illicit drug use and the three-class latent variable solution 
Similar to chapter three, the drug use questions asked in the report were 
based on the Diagnostic Interview Schedule (DIS- Robins, Heltzer, Croughan & 
Ratcliff, 1981) and include questions on the past year use of the drugs 
cannabis, ecstasy, cocaine, amphetamines, magic mushrooms, tranquillisers, 
amyl nitrate, LSD and the composite variable heroin or crack. These were all 
binary variables which reflected no use (0) or use of the drug at least once in 
the past year (1). 
The latent structure, as unchanged from chapter three, was only 
determined by these drug use variables, and was not allowed to covary as a 
function of predictor variables. To summarise, chapter three illustrated the 
heterogeneity in drug use could be expressed in three distinct groups; ‘wide 
range’ polydrug users, ‘moderate range’ polydrug users and no drug users. 
Chapter four illuminated that greater involvement in illicit polydrug use also 
reflected an increase in the level of use of each of the drugs in a particular 
class. 
5.3.2.2.  Demographic, other drug use and mental health variables 
The demographic variables used in this chapter were the same as those 
used in chapter three. Briefly, these reflect a participant’s gender (female=0; 
male=1), employment status (economically active=0; unemployed/economically 
inactive=1), age (continuous variable in the range of 16 and 74 years old), 
educational attainment (beyond GCSE level/statutory education=0; up to GCSE 
level or below=1) and area type where the participant lived (rural/semi-rural=0; 
1=urban). The relationship with hazardous alcohol use was measured as an 
AUDIT score of greater than eight. Participants scoring less than eight on the 
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scale were coded ‘0’ and those who scored eight or above were coded ‘1’. 
Current smoking status was measured as ‘0’ for those who were not currently 
smoking and ‘1’ for current smokers.  
Mental health predictors used in this model were generated by 
application of algorithms on answers to the Clinical Interview Schedule Revised 
(CIS-R; Lewis & Pelosi, 1990). This created ICD-10 diagnoses (Lewis et al., 
1992). Further information on the CIS-R is provided in chapter two. The three 
diagnoses of generalised anxiety disorder (GAD), mixed anxiety and depressive 
disorder (MAD) and depressive episode were included in this analysis as 
predictors with ‘0’ representative of no diagnosis and ‘1’ representative of a 
present diagnosis. In addition, whether an individual had attempted suicide in 
their lifetime has been measured (0=no attempts; 1=one or more attempts in 
lifetime). Furthermore, the predictors relating to General Practitioner (GP) 
service utilisation in the past year for either a physical or psychological problem 
have been assessed. These were coded ‘0’ for no visits in the past year and ‘1’ 
for one or more visit to their GP for treatment for either a physical or 
psychological problem in the past year. Further details of these predictors are 
given in section 2.4. 
5.3.3. Multinomial logistic regression  
 Using the conditional probabilities of membership from chapter three of 
each of the three classes for each of the individuals in the dataset have been 
saved and used as the dependent variable the multinomial logistic regression. 
The demographic and other (licit) drug predictors presented in chapter three 
remain in this chapter, as can be seen in the conceptual model diagram 
provided in Figure 16. The mental health predictors have been added to the 
model. This technique produces odds ratios and confidence intervals, and 
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statistically significant predictors have been highlighted. The comparison group 
was the class with the lowest drug use involvement (class 3, no drug use). To 
determine a parsimonious model which fits the data well, 2Δll testing was used. 
 Given the odds ratios of the demographic predictors may change in the 
model where the mental health variables has been added, the 2Δll testing 
begun with a freely estimated model across all predictors. This has been 
compared in terms of fit with a model which constrains the independent 
variables to have the same odds ratio for a particular predictor across all 
classes. Should there be no significant differences between these models the 
most restricted model has been reported. If significant differences between the 
two models were found, restrictions on the fully constrained model have been 
relaxed until there was no significant difference between two competing models. 
In this case, the more restricted of the two was reported as the best fitting 
model. Full details of the 2Δll testing, in addition to a worked example are 
























































Data was prepared for analysis using SPSS version 15 (SPSS Inc, 
2007). Multinomial logistic regressions were performed using Mplus version 
5.01 (Muthén & Muthén, 2007). Graphs were drawn in Microsoft Excel Vista. 
5.4. Results 
5.4.1. Multinomial logistic regression 
The model generated from chapter three was the baseline model to 
which the predictors of generalised anxiety disorder, mixed depressive and 
anxiety disorder, depressive episode, suicide attempt in the past year and GP 
service use for either a physical or psychological complaint were applied.  
Initially the free parameter model (model 1) was estimated, i.e. the log odds 
across both classes 1 and 2 for each of the variables could be freely estimated 
with reference to the baseline class 3. A model with the parameters constrained 
to be of equal log odds across both class 1 and class 2 in reference to baseline 
class 3 was then generated. Through 2Δll testing, the log odds for the mental 
health variables could be held constant between classes 1 and 2 compared to 
the baseline class (see   Table 19). Like chapter three, this reflected a model 
which freely estimated the predictors of hazardous drinking and age.
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  Table 19: The results of the 2Δll test for the model. 
 
Model Ll Df Model v Model 
Comparison 
2Δll  Δ 
df 
p value 
1. No constraints -4040.50 55 
 
 
2 v 1 
3 v 2 
4 v 3 




























2. Log odds constraints across all predictors -4052.00 42 
3. As model 2 but with constraints relaxed on hazardous drinking  -4044.83 43 
4. As model 3 but with constraints relaxed on hazardous drinking and age -4041.92 44 






 The results from this model are shown in Table 20. Members of both 
classes 1 and 2 were 2.11 more likely to be male, 6.27 times more likely to be 
currently smoking and 1.64 times more likely to be educated to GCSE level or 
below compared to the baseline class of no drug use. The predictors, area type 
and employment status remained non-significant. There were some differences 
in the magnitude of these predictors in the context of mental health variables. 
Odds ratios for hazardous drinking and current smoking decreased, however, 
there was a slight increase in the odds ratio for gender and educational 
attainment in magnitude of around .17 and .04 respectively.  
Regarding mental health, an individual in either the moderate or wide 
range classes were more likely to have depressive episode, mixed anxiety and 
depressive disorder and or to have attempted suicide in their lifetime (1.85, 1.51 
and 1.55 respectively). There was no elevated likelihood to seek GP help for 
either a physical or psychological problem than the baseline no drug use, or an 
increased likelihood of generalised anxiety disorder by either of the wide or 
moderate range drug use classes 
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  Note: significant predictors in bold
 Odds Ratio (95% CI) 
 Class 1: Wide range Class 2: Moderate range 











Current smoker (yes) 
Educational attainment (GCSE level or below) 
Area type (urban) 
Employment status (inactive) 
Depressive episode 
Generalised Anxiety Disorder* 
Mixed Anxiety and Depression 
Suicide attempt in lifetime 
GP physical complaint* 
GP psychological complaint* 
Hazardous drinking (AUDIT score 8+) 10.49 (5.14-21.37) 2.20 (1.71-2.83) 




This chapter investigated the relationship between latent classes of illicit 
drug use and the diagnosis of mental health conditions. From the evidence 
presented there was an increased risk of certain mental health conditions 
associated with any illicit drug use. Additionally, there were no differences in the 
likelihood of having a psychological condition between class 1 and class 2 in 
relation to class 3. This would illustrate those who limit drug intake on particular 
drugs may still experience a higher risk of detrimental health. This poses two 
questions: is the risk of mental health conditions related to dose response, or is 
it due to the drugs that are in common across classes? The findings will be 
discussed examining any differences between the classes by psychological 
condition and demographic criteria.  
 Class 1 and class 2 were almost two times more likely to have a 
depressive episode compared with the baseline class 3; however, this was not 
equivocally supported by previous literature. In support, Lieb et al. (2002) found 
users of ecstasy and other related drugs were 1.53 times more likely to have 
major depressive disorder (related to the ICD-10 depressive episode) than 
those who did not take these drugs. Lieb and colleagues, however, did not 
attempt to account for illicit polydrug use and any significant effects could be 
related to the use of other drugs. The majority of other studies either found no 
relationship (DeWin et al., 2006; Hopper et al. 2006; Kelly & Parsons, 2008) or 
no relationship of clinical relevance6 (Scheier et al., 2008). 
                                            
6 The CES-D (Radloff, 1977) is a tool which screens for current depressive symptoms. It is 
designed to be used as a lay instrument, and thus does not provide a diagnosis. However, the 
developer of the scale suggests that a cut off point of around 16 is of clinical relevance, as it 
may highlight those who have a symptomatology which requires treatment from a clinician. 
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Green et al. (2003) propose that any effects of ecstasy on depression are 
related to dose response. Findings in this chapter have illustrated that increased 
risk in the general population of Great Britain does not appear to be related to 
dose of illicit drugs. Even though there was a two-fold risk increase in 
depression, those in class 1 used ecstasy on average more than 100 times 
compared to an average 10-100 times in class 2. The lifetime frequency of 
amphetamine use in class 1 was also higher than class 2. This would imply the 
increased risk of depression and anxiety as suggested by Baker and Dawe 
(2005) in their review of the impact of amphetamine use on mental health, is 
either not dose related or a specific drug is not contributing to the elevated risk. 
 The results of this chapter have illustrated anxiety was not significantly 
related to illicit drug use which would appear somewhat supported by the 
literature. For example Keyes et al. (2008) found their current ecstasy users in 
the NESARC study were 3.7 times more likely to have any anxiety condition, 
but there were no significant differences for the specific condition assessed by 
these analyses (GAD). Furthermore, the authors concluded other drug use (not 
ecstasy) elevated the risk of any anxiety diagnosis (but not GAD specifically) by 
2.2 times. This might suggest other anxiety conditions may be relevant to past 
year drug use patterns. However, this chapter did find a relationship between 
mixed anxiety and depression in both the membership of the class 1 and 2 
compared with those in class 3, with an elevated risk of 1.51 times. This would 
suggest any anxiety expressed by this group might be a manifestation of a 
comorbid condition of mixed anxiety and depression rather than anxiety alone. 
Suicide attempts during the lifetime were also found to be equivalently 
significantly related to the members of classes, with these classes 1 and 2 
being 1.55 times more likely to have attempted suicide compared with those in 
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class 3. Whilst this significantly elevated risk is not unsurprising, it was not 
related to wider range illicit polydrug use as found by O’Boyle and Brandon 
(1998). Alternatively, Baigent (2005) who found higher AUDIT scores correlated 
with suicide ideation and behaviour. This interpreted in the context of the 
relationship of class 1 and hazardous drinking levels is somewhat surprising. 
Given the difference in the odds ratios between the two illicit drug use classes in 
terms of AUDIT score, it is surprising there was no corresponding difference 
between these groups in terms of their suicide attempt risk. 
The elevated risk for depressive ideas, mixed anxiety and depression and 
suicide attempts in the lifetime found in this chapter could warrant higher levels 
of treatment seeking. However, this was not found between the classes; there 
were no significant differences between treatment seeking compared to the 
baseline no drug use class. This may have happened for a number of reasons, 
perhaps these individuals are generally not typical attendees of primary care 
services, or it may relate to perceived problems with disclosure of substance 
use. The finding by Lieb et al. (2002) that their ecstasy and related drugs group 
were more likely to see a psychologist than those not consuming illicit drugs 
would not appear to be supported by this research. However, this work has 
highlighted there could be an unmet need for treatment in illicit drug users, and 
GP’s should be particularly aware those using illicit drugs who may be of an 
elevated risk for psychological conditions are not readily seeking treatment. 
GP’s may wish to consider brief screening of at-risk individuals in their surgeries 
such as young males.  
Whilst there has been some evidence of increased dose of drug use and 
increased risk of mental health conditions from the literature base, evidence 
from this latent class regression analysis would appear to be unsupportive. 
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Given there were no significant differences in the odds ratios between the 
members of these two classes, this could be caused by two possible solutions. 
Firstly, there is no dose response relationship between mental health and drug 
use, and any use elevates the risk, secondly, the significant relationships found 
could be relevant to what the two classes have in common.  
Evidence from Patton et al. (2002) finds regular cannabis users were 5.6 
times more likely to have either anxiety of depression compared to those who 
had only used cannabis between zero and five times in the past 12 months. 
This suggests a strong dose response relationship with cannabis in particular; 
however, the use of other drugs could still be implicated. Parrott et al. (2004) 
also implicated cannabis as being more related to mental health conditions than 
ecstasy, however, this was not found to be responsive to dose. The drug used 
at a similar lifetime level across the membership of the wide and moderate 
latent classes is of cannabis, with both using over one hundred times. This 
similarity may suggest cannabis use might be related to anxiety and mood 
disorders. This contrasts with the findings of Degenhardt et al. (2001) but 
supports Morgan et al. (2002) and Daumann et al. (2004). Gouzoulis- Mayfrank 
and Daumann (2006a) even suggested in ecstasy users, polydrug use in 
ecstasy users of cannabis might protect against mental ill-health; however, this 
does not hold in this chapter. Alternatively, it could be argued the risk may have 
been higher without its use. 
 Whilst it is difficult to conclude which drug was at fault, and somewhat 
futile given widespread illicit polydrug use, it is apparent illicit drug users are 
aware of the elevated risk. Verheyden, Maidment and Curran (2003) found the 
most frequent reason for quitting ecstasy were mental health worries attributed 
to their drug use; 66.9% of the participants thought their concerns regarding the 
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long-term effects of ecstasy use would cause them to cease their use. 
Williamson and Evans (2000) back this finding in cannabis users who originally 
use the drug to relax but paradoxically anxiety attributed to their use was the 
main reason cited for quitting the drug. The awareness of the potential mental 
health impact of their drug use does not translate into more visits to their GP. If 
this is due to individuals being unwilling to disclose substance use activities, 
individuals may wish to avail of more anonymous treatment services, and these 
should be promoted an alternative, second choice to a GP visit. 
Despite the finding any illicit drug use increased the harm compared with 
members of class 3, this research would suggest drug specific harm reduction 
interventions might be unhelpful. Moreover, given class 1 and 2 illicit polydrug 
use patterns are also tobacco smoking and drinking hazardously, it is difficult to 
ascertain which drug or combination is causing the elevated risk of mental 
health problems, without further investigation. Harm reduction strategies should 
move to tailor interventions to particular patterns of polydrug use. 
There may be several reasons for any relationship between illicit 
polydrug use and psychological status. The relationship could be present as the 
causes of both drug use and mental health conditions overlap. Secondly, those 
with psychological conditions might be using illicit drugs to self-medicate against 
their conditions (Khantzian, 1985; 1997). Finally, it could be suggested drug use 
causes mental health changes. Whilst this study is cross sectional and 
therefore, causal relations are problematic, there is some evidence to suggest 
depression exists before drug use (Falck, Carlson, Wang & Siegal, 2006; Guillot 
& Greenway, 2006). This lends some support to the self-medication theory, but 
this does not rule out development of conditions post drug use involvement. 
However, there is contrary evidence from the International Consortium of 
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Psychiatric Epidemiology (ICPE; Merikangas et al., 1998), a collective of 
countries using the CIDI instrument to assess mental health burden. The ICPE 
suggest the temporal relationship between mental health conditions and onset 
of drug use is less conclusive for depressive episodes, but there is evidence 
that more often, anxiety disorders precede illicit drug use. Lieb et al., (2002) in a 
study examining at ecstasy use considered psychiatric conditions to be more 
likely to precede rather than follow the onset of ecstasy use. Additionally, there 
are problems with this approach. Schifano et al. (1998) suggest none of their 
individuals reported their self-reported mental health problems came prior to 
their ecstasy use. They also state one of the advantages of their study over 
other methodologies was by using clinical ratings, their study would be more 
valid. It could be considered by using their drug use as the rationale to attend 
an addiction clinic, they may have perceived biases about which came first. 
Their priority is clearly to secure treatment to reduce symptomatology, and 
responsibility for the condition could be transferred to the drugs of use when a 
more complex aetiology could be at work.   
Despite this, it is widely considered drug misuse is a major cause of 
psychiatric disorders in other settings. For example, Milani et al. (2005) in their 
opportunistic sample of nightclub attendees, found one fifth complained of 
psychological problems which they attributed to their drug use. Of these 
depression and anxiety were the most frequently cited. However, if we are 
unable to isolate single illicit drugs from their other drugs in an illicit polydrug 
use pattern, and research continues to not take account of polydrug use, then 
individuals may well believe or expect their drug use will cause them 
psychological harm. They may also attribute the cause to their drug use. In 
addition, blaming drug use absolves responsibility for a condition which can be 
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caused by multiple biological or psychosocial factors and the interactions 
between these two (Jorm, Christiansen & Griffiths, 2005).  
  If a dose response relationship is implicated in elevated risk of 
psychological disorders, age of onset may not be the same as age of heaviest 
use. If the effects of drug use are related to the dosage (even in a given range 
of drug use), then age of heaviest use may be a better indicator. Future 
research might wish to explore this indicator in relation to patterns of illicit 
polydrug use. 
 Green et al. (2003) hypothesise the relationship between drug use and 
mental health is of concern if the use of the drug increases the risk of 
individuals who would not otherwise be in high-risk groups for developing a 
psychological condition. Therefore, it is important to ascertain the most likely 
profile for the mental health conditions that have been addressed in this paper. 
Numerous studies have illustrated significantly more women are experiencing 
mood or affective disorders (Kessler, 2003; de Graff, Bijl, Smit, Vollebergh & 
Spijker, 2002; Andrews, Henderson & Hall, 2001; Lieb, Becker & Altamura, 
2005). It has been suggested there is no real relationship between mental 
disorders and age (Wittchen & Jacobi, 2005).  In terms of urban and rural 
differences, Kovess-Masfety, Lecoutour and Delavelle (2005) have stated 
although in some studies there have been higher differences for urban dwelling 
individuals, the differences were more likely to be attributed to social norms. 
This is supported by Andrews et al. (2001). Fryers, Melzer and Jenkins (2003) 
in a review of studies concluded four of five studies addressed illustrated a 
significant relationship between lower educational attainments and mental 
health conditions. In addition, in six of seven studies unemployment was 
significantly related to poorer psychological health. This has support from other 
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studies which were not included in this review, including Andrews et al. (2001), 
Hunt, Issakidis and Andrews (2002), de Graff et al. (2002), WHO International 
Consortium in Psychiatric Epidemiology (2000) and Lorant et al., (2003).  
In comparison, our profiled illicit polydrug users were most likely male, 
educated to GCSE level or below with no significant differences in employment 
or urban/rural living status compared to the no drug range drug users. They 
primarily differ from the risk factors above in gender, employment status and 
urbanicity. From this analysis, it is apparent the drug users were not the most at 
risk of mental health conditions and thus may have increased their risk through 
their drug use or associated behaviours.   
The findings suggest the full profiles of drugs used in each of the classes 
were associated with elevated risk of mental health conditions. Illicit polydrug 
users should be made aware of this increased risk. Whether or not they are part 
of a similar aetiology or a causal position, it is difficult to ascertain. Cohort 
studies which account adequately for illicit polydrug use over time might be able 
to elucidate this issue. Whilst this cross-sectional study could not attribute 
causal relations, nor was it possible to conclusively attribute risk to any 
particular drug, it is could be suggested the risk of experiencing mental health 
disorders is elevated in the presence of illicit polydrug use. However, patterns of 
illicit polydrug use found to date were generated from illicit drugs. A strong 
relationship has also been found with licit alcohol use in terms of hazardous 
use. Regarding future directions for research, it will be useful to determine 
whether this alcohol use affects the risk of poorer psychological status, and 
which patterns of use are particularly relevant. With this in mind, the next 
chapter will explore alcohol use patterns. 
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6. Patterns of alcohol consumption and related 
behaviour in Great Britain: a latent class analysis of 
the Alcohol Use Disorder Identification Test7 
6.1. Abstract 
Efforts to create typologies of alcohol use and related behaviours have 
been mostly derived from populations of alcoholics. These illustrate patterns of 
more severe alcohol involvement which do not represent wider alcohol use 
trends in the general population. Therefore, this chapter aims to identify classes 
of alcohol use and related problems in a general population sample of Great 
Britain. These were identified from 7849 respondents in a multi-stage sample of 
the population of Great Britain (NPMS). A latent class analysis was performed 
on 10 indicators of alcohol use and related behaviour from the Alcohol Use 
Disorder Identification Test (AUDIT).  Multinomial logistic regression was used 
to validate and explore the relationship between class membership using key 
demographic and mental health variables. Six distinct typologies best described 
alcohol use and related problems in the population of Great Britain. Three were 
heavy consumption groups. One of these experienced multiple negative 
consequences, one was associated with alcohol related injury and social 
pressures to cut down and an additional class experienced memory loss. A 
single moderate consumption class was found with low probabilities of alcohol 
related problems. The final two classes were mild consumption classes, one 
with no related consequences and one with alcohol related injury and social 
pressures to cut down. Four of these follow a continuum of increased 
                                            
7 Part of this chapter has been published in Alcohol and Alcoholism. Full reference is Smith, 
G.W. & Shevlin, M. (2008) Patterns of Alcohol Consumption and Related Behaviour in Great 
Britain: A latent Class Analysis of the Alcohol Use Disorder Identification Test (AUDIT). Alcohol 
and Alcoholism, 43, 590-594. This can be accessed directly from http://tinyurl.com/9zbgxz  
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consumption leading to increased alcohol related problems and two which do 
not. Differences between alcohol use classes are apparent with an increased 
risk of anxiety disorders, and suicide attempts in lifetime for the highest 
consumers of alcohol and a reduced risk of depressive episode for most 
classes. 
6.2. Introduction 
Most of the research into typologies of alcohol use behaviours has 
tended to focus on alcohol abuse or dependent populations. Empirically 
developed typological schemes used to classify alcoholics have included binge, 
episodic, sporadic and steady typologies (Epstein, Labouvie, McCrady, Jensen 
& Hayaki, 2002). However, there are also numerous others including; type 1 & 2 
(Cloninger, 1987), type A & B (Babor et al., 1992a) and Jellinek’s gamma, delta 
and epsilon subtypes (Jellinek, 1960). Although some of these typologies have 
been found to have predictive and clinical utility, they have been invariably 
derived from relatively small samples of those with alcohol abuse or 
dependence. It is also difficult to extrapolate these patterns to general 
population samples as the percentages of this clinically relevant 
symptomatology in the general population is very low; forming a small subset at 
the most severe end of a hypothesised alcohol use spectrum. The International 
Consortium of Psychiatric Epidemiology found a lifetime prevalence of drug use 
disorders (including both alcohol and illicit drugs) over 28 countries in the range 
of 1.5% in Italy and 15% in the Ukraine (Kessler et al., 2007). This is evidence 
that lifetime prevalence of these conditions represent a small subset of yearly 
alcohol use patterns. 
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Moving from the focus exclusively on problematic alcohol consumption, 
to a wider range of alcohol related behaviours, there have been some attempts 
to develop population-based typologies of alcohol use. Slater, Basil and 
Maibach (1997) performed a k-means cluster analysis of 2910 individuals’ 
representative of the American general population discovering five profiles of 
drinking behaviours. These were non (26%), light (30%), moderate (20%), 
episodic (14%) and heavy (8%) drinkers with fewer than 3% found to be atypical 
of these five patterns. Non-drinkers were characterised by seldom, if ever 
drinking, had a mean age of 62 years old and were mostly female (60%). Light 
drinkers consume one or two drinks per sitting, were on average 32 years old 
and were predominantly female (62%).  The next three categories see a shift in 
the gender proportion. The decrease in proportion of females in the moderate, 
episodic and heavy groups were 41%, 43% and 21% respectively. The group of 
moderate drinkers tended to have two drinks per occasion, slightly more than 
three times per week with an average age of 47 years. Episodic drinkers 
approximately had three or more drinks, two to three times per week and heavy 
drinkers drank over four times per week with over four drinks per occasion. The 
average ages of the episodic and heavy group were 29 and 44 years old. In 
addition, relating alcohol use to current smoking, the heavy drinkers were likely 
to be smoking the heaviest with the mean number cigarettes per day of 10.07. 
Those in the episodic, moderate, light and non-drinking clusters had means of 
approximately 6, 4, 4, and 3 cigarettes per day. This suggests the heavy 
drinking pattern is most likely to be associated with extent of current smoking 
behaviours. Whilst the postal survey methodology utilised in this study generally 
has a lower response rate than other methods which can cast doubt on the 
representativeness of the outcomes, this study counters this caveat with a 
185 
 
response rate of 55%; relatively high for this kind of method. In addition, it could 
be considered except for the episodic group, that this represents a continuum of 
severity in alcohol use behaviour. Using the ‘Health as Personal Value’ index 
(Lau, Hartman & Ware, 1986), moderate and non-drinkers valued health more 
than the other groups (as a proxy for health seeking behaviours).  
Consequently, the authors argue their lifestyle choices may play a protective 
role in maintaining good health (including mental health). 
Rouillier et al. (2004) in a hierarchical agglomerative clustering method 
cluster analysis identified seven clusters based on the amount and type of 
alcohol consumed using a sample of 2150 men aged between 45 and 60 years 
old. The first of these groups, abstainers were a priori determined by the use of 
5g or less of alcohol per day. The following six clusters were determined in the 
analysis, the first being low alcohol use on average 15.7g alcohol per day. The 
next five groups were determined in relation to beverage of choice and are 
presented in increasing quantity format. The high-quality wine group consumed 
31.6g per day on average, followed by the beer and cider group with a mean of 
33.2. The mean alcohol use of the following digestives group was 33.5g per day 
with the final two groups representing local and table wines with means of 36.2g 
and 46.2g respectively8. They also had some key demographic differences. As 
the groups increase in consumption age also increases in a defined age range 
of 45-60 years old. In addition, the first six groups are more likely to live in an 
urban area with a percentage in the range of 63-68% in this category. However, 
the heaviest consumption group were more equally split in terms of the urban 
and rural breakdown. The table wine group was the most likely to be 
unemployed at 11%, with the abstaining class least likely to be unemployed 
                                            
8 For comparison, a typical bottle of wine is approximately 70g.  
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6.5%. In addition, the highest proportion of individuals who currently smoked 
tobacco were also found in the heaviest drinking group at 24%. The limited age 
range of the sample makes it difficult to extrapolate the findings to general 
population surveys; however, it gives an estimation of the variability that can be 
found in this age range. Additionally, the primary focus of this study formed a 
randomised control study of food and supplement intake and the effect on 
health (particularly cardiovascular). Whilst this is not a criticism per se, the 
method of collection, representing the 24hr intake of all food and drink on six 
random days per year (two weekends, and four weekday) may find an under-
reporting of more episodic patterns that could be captured in other survey 
designs.   
 Alternative typological techniques to cluster analysis have also been 
employed. Reboussin, Song, Shrestha, Lohman and Wolfson (2006) in a latent 
class analysis on a sample of 4056 adolescent current drinkers (16-20 years 
old) concluded three types of drinker. These were termed ‘non-problem’, ‘risky 
problem’ and ‘regular problem’ drinkers. As Figure 17 shows, it would appear 
for this population the profiles seem to follow a broad continuum of increased 
consumption leading to increased problems. However, the heaviest two 
consumption groups did not differ greatly between in terms of their percentages 
of problems, suggesting drinking behaviours beyond the lowest group elevate 
the risk of negative consequences. 
 The first class was the largest single group representing 43% of the 
sample and comprised of non-problem drinkers who consumed little alcohol and 
had few problems. The second group (30%), risky problem drinkers would drink 
alcohol to the level of drunkenness two to three days per month (52%) and have 
moderate to low probability (35%) of binge drinking episodes (five or more 
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drinks on at least one occasion in the past two weeks). Finally, the regular 
problem drinkers’ group, representing the remaining 27% of the sample had a 
98% probability of endorsing the binge drinking item. A similar percentage of 
this group were characterised by drunkenness during the past month. They 
were also the most likely to have mental or physical health problems and spent 
on average six days drunk in the past month. Comparing the two problem 
drinking groups (regular and risky), the regular group was 1.5 times more likely 
to be male, almost twice as likely to be 18-20 compared to 16-17 years old, and 
2.6 times more likely to use cannabis. However, despite the progress in the 
area afforded by the methodology, like the Rouillier et al. (2004) study, the age 






































O’Connor and Colder (2005) used latent profile analysis based on 
measures of quantity and frequency of consumption, and alcohol-related 
problems. Based on a sample of 533 first year American college students they 
reported five groups of alcohol related behaviour which are described in terms 
of behaviour of males and females in the group. Only one of their profiles, class 
two, appears as the same for men and women. This group is the largest of the 
entire sample at 42%, comprises of 68% females and reflects a low quantity, 
frequency and problem group. The rest of the groups are presented in Table 21 
below for clarity. 
Table 21: Illustration of the structure of profile membership of O’Connor and 
Colder (2005) 
 





Quantity Frequency Problems 
1 3 65 Moderate/High Very High F: Very high 
M: High 
 





4 15 73 Moderate/High F: High 
M: Moderate/High 
F: High 
M: Very High 
 







Note: M = males; F = females. 
There appeared to be some key gender issues. For females, 
moderate/high drinking styles create problems ranging from moderate to very 
high, with the same descriptive terms for the frequency as for the problems (i.e. 
very high frequency occurs with very high problems). This may suggest the 
frequency is more pertinent for females. The situation for males is slightly more 
ambiguous, their pattern of moderate/high quantity and frequency results in very 
high problems. This appears to be not entirely explained by the consumption 
(as in class 4). Despite this tentative evidence a continuum of increased 
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consumption and problems, particularly in females, O’Connor and Colder 
(2005), consider their work to not follow a broad continuum pattern given the 
differences arising from frequency and quantity in their population. Furthermore, 
Medina-Mora, Carreño and De la Fuente (1998) found alcohol related problems 
and consumption to be moderately correlated (r=.61) in the general population 
of Brazil. However, they identified a group of drinkers who drink less than once 
a month but do drink heavily on occasion (such as a cultural festival), who may 
be at very high risk of problems due to intense acute intoxication rather than 
chronic use. 
It is also important to note the questions which estimate alcohol use play 
a key role in the patterns. Most previous work has focussed on average 
volumes of alcohol use, i.e. typical frequency and typical quantity. This is a 
problematic approach as these (tending to be researcher chosen) groups of 
average volume based on an average number of grams of alcohol or units per 
week could group together those with a very different drinking style. As San 
Jose, Van Oers, Van de Mheen, Garretsen and Mackenbach (2000) colleagues 
conclude, someone consuming one or two glasses per day, everyday, is 
grouped together with someone drinking seven glasses in one sitting, one or 
two times per week.  Furthermore, it makes it difficult to characterise those with 
a varied pattern of use in a specified time period. Consequently, the effects on 
psychological (or other health) status by these patterns depend on effects of the 
level and length of elevated blood alcohol concentration, or social activities of 
drinking which could be either protective or potentially damaging. This study 
also found regular drinkers from their sample of residents of Eindhoven, 
Netherlands (n=18973) at low quantities were often better off than occasional 
drinkers. Specifically, those who drank lower quantities but over six or seven 
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days in a week were significantly less likely than the reference class of one to 
two drinks, one to two days per week to report health burdens (OR=.77). All 
those drinking 6-7 days per week were less likely to perceive their general 
health as less than good (OR=.83), to report three or more health complaints 
(OR= .76) compared to those drinking 1-2 days per week. Thus, the overall 
effect of drinking alcohol could be better described as relating to drinking 
patterns rather than average alcohol intake.  
A review by Rehm et al. (2003) on alcohol consumption and alcohol 
related burden of disease concluded average volume of drinking was related to 
a number of health problems including depression and cancer, however, they 
only found coronary heart disease (CHD), stroke, diabetes and injury risk to be 
related to patterns. Almost equivocally increased involvement in alcohol 
(whether pattern or average volume) increased risk for coronary heart disease, 
stroke and diabetes. However, some alcohol use patterns illustrated a 
protective factor for the burden of disease. In compiling their meta-analysis, the 
definition of ‘patterns of drinking’ did differ between studies, with a general 
paucity of literature assessing what these patterns entail. Additionally, the study 
calls upon researchers to use a standardised approach to measuring alcohol 
use to both conceptualise typical patterns of drinking and better estimate the 
impact on society. The authors suggest advances in alcohol pattern estimation, 
should be able to really determine whether there is an impact. 
 Rodgers et al. (2000) illustrated there was no linear relationship between 
alcohol consumption and depression or anxiety. Instead, they hypothesised that 
the relationship forms a ‘U’ or ‘J’ shaped curve. Evidence for this was gathered 
from their sample of 2,725 Australians aged 18-80 years using the AUDIT 
questionnaire to measure consumption compared with Goldberg’s self-rated 
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anxiety and depression scales (Goldberg et al., 1988) and Delusions-
Symptoms-States Inventory (DSSI/sAD; Bedford, Foulds & Sheffield, 1976; 
Bedford & Deary, 1997). A plot of the estimated marginal means from this study 
is presented in Figure 18. This graph illustrates an elevated risk of higher 
means for both the abstainers and the heaviest drinking groups, with lower 
means for the moderate groups. When the abstaining mean is as high as the 
highest drinking groups, a U shape curve is formed (e.g. DSSI/sAD depression 
males). However, when the elevated mean score is lower for abstainers than for 
the heaviest drinking pattern, a ‘J’ shape curve is formed (e.g. DSSI/sAD 
anxiety males). Moving from these line graphs to significant differences 
between means, female abstainers and hazardous drinkers were significantly 
higher than low level drinkers in terms of DSSI/sAD depression scores. Scores 
on Goldberg’s depression scale illustrated these groups were significantly 
different in addition to the occasional drinker. Female anxiety levels are 
significantly higher for abstainers, hazardous and occasional (Goldberg anxiety 
scale) and only abstainers and hazardous drinkers for the DSSi/sAD anxiety 
scale. Males depression and anxiety scores were both significantly elevated in 
higher level and hazardous drinking (Goldberg) and non-drinkers and 
hazardous for the DSSI/sAD. In terms of demographic criteria, men had higher 
AUDIT scores than females, with mean scores of 6.82 and 4.35 respectively.  
Conversely women had higher anxiety and depression scores. However, both 
mental health and AUDIT scores decreased with increasing age in females. 
Whilst this study opened up the debate commenced by Lipton (1994) and 
Ashley, Ferrence, Room, Rankin and Single (1994) into the protective effects of 
moderate drinking, and the higher level of depression/stress for both abstainers 
and heavy alcohol consumers, it would greatly benefit from a more data driven 
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approach to representing patterns using the AUDIT questionnaire. The a priori 
choice of researcher driven categories is common in this area of research, 
however, recent methodological advances such as latent class analysis attempt 









































Figure 18: Illustration of the non-linear relationship between alcohol consumption and depression and anxiety scores.
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Vanheusden et al. (2008) in a sample of 2,258 young adults aged 19-32 
years old in the Netherlands also found a ‘U’ shaped relationship with self-
reported depression and anxiety symptomatology. In their five groups of 
researcher driven alcohol use behaviours (determined from the AUDIT), their 
non-drinkers (18.2%) and occasional (monthly or less drinkers; 21.7%) both 
were 1.6 times as likely to report depression and anxiety symptoms as the low 
level drinking group (those who drink typically one or two drinks per occasion; 
36.4%). Higher level drinkers, (13.9% of the sample) who drank three or four 
drinks per typical occasion were not significantly different to the low-level group. 
However, they were more likely to report depression or anxiety (OR=1.9). Males 
were typically more prevalent in the higher drinking groups with females more 
likely to be in the ‘non’ or occasional drinking groups. 
Manninen, Poikolainen, Vartianinen and Laatiainen (2006) in a Finnish 
study examining drinking patterns, and in particular controlling for heavy 
drinking occasions assessed Beck Depression Inventory score change across 
groups (BDI; Beck, Steer & Garbin, 1988; Beck, Ward, Mendelson, Mock & 
Erbaugh, 1961). They had eight groups of drinkers, lifelong abstainers, former 
drinkers, two moderate drinking groups, two heavy drinking groups and two 
hazardous drinking groups where each pair represented with and without binge 
drinking episodes. The highest BDI scores were found in former drinkers with a 
mean of 11.8 and in the hazardous binge drinking group a mean of 11.1. The 
lowest means were found in the lifelong abstainers (7.8), and in the moderate 
and heavy non-binge drinking groups, 7.9 and 7.1 respectively. There also 
appeared to be a relationship between patterns, gender, and age on BDI 
scores. In multinomial logistic regressions using no binge drinking occasions in 
ages 25-44, males aged 45-64 who had these occasions were 2.3 times more 
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likely to have a BDI over 10. Those without these occasions were 1.52 times 
more likely. These odds ratios were estimated in addition to some other 
demographic criteria illustrating males with a BDI over 10 were 1.7 times more 
likely to be single, 1.7 times more likely to have a chronic disease and 1.6 times 
more likely to be unemployed (there was no significant effect of education). 
Females appear to be more likely to have to high BDI scores co-occur with 
binge drinking episodes, with odds ratios of 1.7 for the 25-44 year old category 
and 1.9 for the 45-64 year old category (both significant). Non heavy occasions 
were also significantly elevated in risk for the 45-64 year old category with odds 
ratios of 1.7, compared with the baseline females with non-binge drinking 
occasions aged 25-44 years. Again, in terms of the demographic profile of these 
individuals, there was a significant relationship of marital status, with those with 
BDI over 10 being 1.4 times more likely to be single and 1.7 times more likely to 
have a chronic illness. There was no significant relationship with unemployment 
and education for the female group.  
It could be theoretically considered that if there was an increased risk of 
mental health problems with increased alcohol involvement, individuals may be 
more likely to seek primary care treatment as they have a need to do so. If 
conversely, individuals with an elevated risk of mental health problems are less 
likely to seek treatment; this represents an unmet need for care (Demyttenaere 
et al., 2004). Relating back to alcohol use, Ogbourne and DeWit (2001) in an 
Ontario population sample found the only (researcher driven) group of drinkers 
who visited their GP for the median number of visits per year were female 
infrequent drinkers (compared with lifetime abstainers) whilst controlling for a 
range of demographic and mental health variables. However, this was partly 
due to a relatively high proportion of lifetime abstainers who visited their GP 
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more than the median number of visits (females= 38%; males= 31%). Notably 
too, males were less likely to visit their GP than females (although this was not 
tested statistically). Research in a population sample of south east England, 
found similar results (Cryer et al., 1999). This study which utilised a mail 
questionnaire, found a frequency-based trend of decreased time between GP 
visits as alcohol use increased (measured by units). However, significance 
testing failed to illustrate any significant differences between increased alcohol 
involvement in females, whilst in males, the overall chi-square value (5.03) 
bordered on significant (.05 < p < .10). However, the only significant odds ratio 
found for males was between abstainers and safe drinkers, as defined by 
drinking between one and 21 units per week (the recommended limit for men). 
Abstainers had a higher likelihood of a shorter time between the last GP visit 
and the present day (OR=1.1). Notably, this proxy measure of time between GP 
visits is less of a conclusive measure of the relative use of services in each time 
period, as an individual could have easily seen their GP recently, but had not 
seen them for an undefined period after that. Consequently, this evidence 
should be interpreted with caution as to its ability to measure services use. As 
for many studies, the categories for comparison were based on a researcher 
driven approach of average consumption, and as a result, would not take into 
consideration the differing impact patterns can have on the outcome measure. 
This research aimed to develop a population-based typology of alcohol 
drinking based on a large nationally representative sample of British 
participants. It was hypothesised the heterogeneity of alcohol related 
behaviours could be described in distinct patterns of drinking based on both the 
consumption of alcohol and related alcohol use problems. Latent class analysis 
will be used to identify homogeneous classes, or groups, based on answers to a 
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standardised, frequently used measurement scale (Alcohol Use Disorder 
Identification Test: AUDIT). Given the building evidence about the importance of 
patterns of use in assessing alcohol related harm, the nature of the resultant 
patterns (classes) of use will be further examined by examining associations 
with key demographic variables and current mental health status. This chapter 
will investigate the relationship between these patterns and a number of mental 
disorders including mixed anxiety and depression, generalised anxiety disorder, 
depression, psychosis, suicide attempts and help seeking from General 
Practitioners (GPs). 
6.3. Methods 
6.3.1. Participants, data and sampling 
Analyses were performed on participants in the NPMS survey (Singleton 
et al., 2001a; 2001b) accessed via the UK Economic and Social Research 
Council Data Archive. Interviews were successfully conducted with 8580 adults 
living in England, Scotland or Wales using a stratified multi-stage random 
sampling strategy. As indicated in chapter two, the alcohol section commences 
with two questions to determine whether an individual uses alcohol even 
occasionally. Those who stated they did not drink alcohol and clarified they did 
not use even on rare occasions were then screened out of the section. 
Consequently, when these individuals were deleted listwise, the effective 
sample size for this chapter was 7849. The mean age of the sample was 45 
years old (SD= 15.43). Over half (54.1%) of the respondents were female and 
93% of the sample were of white ethnic origin. Further details of the survey 




6.3.2.1. Alcohol use variables 
Alcohol use and related problems were assessed using the Alcohol Use 
Disorders Identification Test (AUDIT: Saunders & Aasland, 1987; Babor et al., 
1992b) a widely used questionnaire measuring hazardous drinking. The scale 
comprises ten items referring to alcohol consumption and alcohol related 
problems in the past 12 months. The AUDIT was originally designed to measure 
three conceptual domains (Saunders & Aasland, 1987). The first of these, 
consumption, contains questions determining how often an individual drinks 
alcohol (how often), the number of drinks on a typical day (typical amount) and 
how often an individual drinks six or more drinks in a single occasion (how often 
6+ drinks). The dependence section (items four to six) contains questions 
relating to the frequency of not being able to stop drinking when started (unable 
to stop), failing to meet expectancies (fail to do), and how often a person needs 
a drink to get going in the morning (drink in morning). The final four questions, 
items seven to ten, refer to alcohol related consequences. These include items 
which ask whether an individual feels guilty after drinking (guilt after drinking), 
how often a person experiences memory loss after consumption (memory loss), 
whether the person (or someone else) had experienced an injury related to 
alcohol use (had injury), and finally whether anyone had suggested the person 
needs to cut down their alcohol intake (suggest cut down). 
Scores on each item, for the purposes of these analyses were collapsed 
into a dichotomous variable (see section 2.4.2 for details). The baseline 
category reflected the answers scoring zero on the scale, reflecting ‘never’ for 
questions one, three, four, five, six, seven and eight, ‘1 or 2 drinks’ for question 
two, and ‘no’ for questions nine and ten. The second category’ represented all 
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other responses for each of the ten questions.  Copies of both the original and 
modified questionnaires are presented in Appendix 1 for reference purposes.  
6.3.2.2. Demographic and Mental Health Variables 
 The demographic variables used in the regression model were gender 
(female=0; male =1), employment status (unemployed/economically inactive=0; 
employed=1), age (continuous variable in the range of 16-74), educational 
attainment (education beyond GCSE=0; up to GCSE level or below=1), area 
type where the participant resides (rural=0; urban=1) and whether the 
participant currently smokes (no=0; yes=1).  
The mental health predictors that have been used in this model were 
measured using the Clinical Interview Schedule Revised (CIS-R; Lewis and 
Pelosi, 1990). When algorithms are applied this questionnaire, ICD-10 criteria 
for research diagnoses can be produced (Lewis et al, 1992). The ICD-10 
diagnoses of generalised anxiety disorder (GAD), mixed anxiety and depressive 
disorder (MAD) and depressive episode were included in this analysis as 
predictors, where ‘0’ represents no diagnosis, and ‘1’ represents a present 
diagnosis.  
Three other related variables will also be investigated, whether an 
individual had attempted suicide in their lifetime and whether an individual had 
visited their general practitioner (GP) for a physical or a psychological complaint 
in the past year. For all three variables, the coding represents ‘0’ for no and ’1’ 
for yes. Further details on all these predictors are given in chapter two. 
6.3.3. Latent class analysis 
Patterns of drinking were generated using latent class analysis (see 
chapter 2 for an in-depth illustration of the LCA method). This is a statistical 
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modelling technique used to estimate the number of classes of an underlying 
categorical latent variable, accounting for the relationships between categorical 
observed variables (Haagenars & McCutcheon, 2002). This method creates 
homogenous subgroups of respondents who answer in a similar way on the 
observed variables of the AUDIT. The model parameters include class 
membership probabilities (or class percentage estimates) and class-specific 
AUDIT question endorsement probabilities. Assignment of individuals to classes 
was based on a probabilistic method and not the most likely latent class (Clogg, 
1995).  
Fit criteria for the two to nine class latent variable solutions using these 
observed variables have been presented, and a decision about the best fitting 
model made on the grounds of fit statistics and the relevance to existing alcohol 
use theory. The fit statistics of the optimal model will have the lowest values of 
the three information criterion (AIC, BIC and SSABIC), a Lo Mendel Rubin 
Likelihood Ratio Test (LRT) where the k-1 class model is superior (when 
compared with k class model generating p>.05), minimal number of significant 
bivariate residuals, and a suitable entropy value (close to 1). Full details of 
these criteria and the reference works from which they derived can be found in 
section 2.5.2.3. 
6.3.4. Multinomial logistic regression 
The conditional probabilities of class membership for each of the 
participants will be saved and used as the dependent variable in a multinomial 
logistic regression. Note that, once again, as similar to chapter three and five 
the latent class model parameters were fixed after generation of the latent 
variable. Thus, the latent class analysis is only influenced by the alcohol 
variables. This procedure will produce odds ratios and confidence intervals 
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illustrating statistical significance of each of the independent variables or 
predictors (whilst controlling for the other predictors) on the dependent variable 
(conditional probability of class membership). The conditional probability of 
being in the lowest alcohol involvement class will be the comparison group. In 
essence, the odds ratios will illustrate a comparison of the other classes to the 
lowest alcohol involvement class. This chapter utilised 2Δll testing to determine 
the model which was both parsimonious and a good fit of the data.  Briefly, a 
model was run which freely estimates the regression parameters. Following this 
a restricted model will be run which constrains the log odds (and thus the odds 
ratios) to be the same for a particular independent variable across all classes. 
The loglikelihood of the models has been compared with the view that if there 
were no significant differences between the models the more restricted 
parsimonious model would be preferred. If the two models were significantly 
different the constraints were sequentially relaxed until there was no significant 
difference between the competing models. When this occurs, the more 
parsimonious solution of the two competing models represents the optimal 
solution. Full details, with a worked example of 2Δll testing are given in chapter 
2.5.3.1. 
The conceptual model tested in this chapter is presented in Figure 19. It 
illustrates the ten AUDIT variables from which the latent variable of alcohol use 
and related problems will be derived. It also illuminates the demographic and 
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Data was prepared for analysis using SPSS version 15.0 (SPSS Inc., 
2006). Both the latent class analysis and the multinomial logistic regression 
were performed using Mplus Version 5.01 (Muthén & Muthén, 2007). 
6.4. Results 
6.4.1. Patterns of response 
Patterns of most frequent response to the AUDIT in the sample were given 
in   Table 22. The most common pattern of endorsement represents those who 
have drunk alcohol in the past year (only). The next most prevalent patterns 
represent an endorsement of the consumption variables without any alcohol 
related harm. However, of all the alcohol related harm variables, those most 
often endorsed were those relating to alcohol related injury, memory loss or 
requests for an individual to cut down on their alcohol intake. There were 208 
different patterns of response for the participants in the study, with the ten most 
frequent patterns accounting for 77% of the entire sample.  Just over 4% of the 
sample had not drank alcohol in the past year, representing a group of past 
year abstainers. However, these individuals must at least be very occasional 
drinkers to have screened into this section. Coupled with the 731 drinkers who 
screened out of the alcohol section (and were excluded from the latent class 





  Table 22: Most frequent patterns of response to the AUDIT questionnaire 
 




Drinking in past year 2014 (25.67%) 
Drinking in past year, Typical amount three or more drinks, Drink 6+ drinks in past year 1459 (18.60%) 
Drinking in past year, Drink 6+ drinks in past year 792 (10.10%) 
Drinking in past year, Typical amount three or more drinks 556 (7.09%) 
None 329 (4.19%) 
Drinking in past year, Typical amount three or more drinks , Drink 6+ drinks in past year, Memory loss in past year 265 (3.38%) 
Drinking in past year, Alcohol related injury experienced, Asked to cut down 185 (2.36%) 
Drinking in past year, Typical amount three or more drinks , Drink 6+ drinks in past year, Alcohol related injury experienced 183 (2.33%) 
Drinking in past year, Alcohol related injury experienced 168 (2.14%) 
Drinking in past year, Typical amount three or more drinks , Drink 6+ drinks in past year, Alcohol related injury experienced , 
Asked to cut down 
90 (1.15%) 
Total Number of Individuals in the 10 most frequent response patterns 6041 (77.00%) 
Total Number of Individuals not in the 10 most frequent response patterns 1804 (23.00%) 




6.4.2. Latent class analysis 
Table 23 shows the fit statistics for the latent class analysis of the ten 
items of the AUDIT questionnaire. In terms of the LRT the optimal number of 
classes was five. However, the information criteria appear to suggest a six-class 
structure. In particular the BIC and SSABIC appear to reach a minimum at six 
classes and begin to increase for the seven-class model. The five-class solution 
had three significant residuals, i.e. three of the most frequent patterns of 
response have a significant difference between observed frequency of pattern 
in the dataset, and the expected frequency as proposed by the five-class 
solution. As the six-class model had no significant residuals, this was additional 
evidence to illustrate a superior fit to the observed data. In addition, on 
inspection of the six-class solution in terms of conditional probabilities, it 
appears that the addition of another class adds a theoretically relevant pattern. 
Based on this, the six-class solution was considered optimal. The profile plot of 
the six-class solution is presented in Figure 20. 
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Table 23: Fit statistics of latent class analysis on the 10 questions of the AUDIT. 
  
Note: LL(df) loglikelihood value and associated degrees of freedom; LRT Lo-Mendel-Rubin Adjusted likelihood ratio test value; AIC Akaike 





AIC BIC SSABIC Entropy LRT p Number of significant 
residuals 
2 -25442.79 (21) 50927.58 51073.90 51007.17 .73 6436.45 .00 10 
3 -24470.82 (32) 49005.64 49228.61 49126.92 .82 1922.50 .00 8 
4 -23872.88 (43) 47831.76 48131.37 47994.73 .83 1182.69 .00 5 
5 -23743.85 (54) 47595.69 47971.94 47800.34 .74 255.48 .00 3 
6 -23681.40 (65) 47492.81 47945.70 47739.15 .73 123.63 .07 0 
7 -23653.03(76) 47458.05 47987.59 47746.08 .74 56.19 .03 0 
8 -23640.98 (87) 47455.95 48062.14 47785.67 .73 23.83 .39 0 




Figure 20: Profile plot of the six alcohol use and related behaviour latent classes.
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The largest class was class 4 (38.51%) and was characterised by a 
moderate probability of having more than three drinks in a typical drinking 
session, and a moderate likelihood of drinking six or more drinks on occasion. 
This class had a very low probability of endorsing any of the indicators 
associated with dependence (items four to six) or alcohol related consequences 
(items seven to ten). Class 3 was smaller (16.29%) and similar in profile to class 
4. However, members of this class were more likely to drink six or more drinks 
or drink more than three drinks on a typical occasion. Approximately 50% of the 
individuals in this class had experienced memory loss because of their 
consumption pattern. In terms of consumption, this class was in an almost 
intermediary position between the heavy and moderate consumption patterns, 
however, the high likelihood of endorsing six or more drinks on occasion, 
suggests it is a heavy consumption class. 
Members of class 1 accounted for the smallest proportion of the sample 
(5.68%), but had the highest probability associated with consumption (items one 
to three), dependence (items four to six) and alcohol related consequences 
(items seven to ten). This class also had the highest probability associated with 
the indicator drinking in the morning, which had a relatively low percentage of 
use in the total sample of respondents. This profile of heavy use was mirrored in 
class 2 (6.38%), however, this class had lower probabilities associated with the 
dependence and consequence indicators. The probabilities associated with the 
consumption indicators were relatively low for class 5 (7.40%) but high for two 
indicators associated with negative consequences (items nine and ten). Class 6 
(25.75%) represented almost a quarter of the sample and had low probabilities 




6.4.3. Multinomial logistic regression 
 The fit of the constrained, relaxed and intermediary multinomial logistic 
regression models are presented in Table 24. The optimal model in the 
multinomial logistic regression of demographic and mental health variables was 








2Δll  Δ df p value 
1. No constraints -26196.72 125  
2 v 1 
3 v 2 
4 v 3 
5 v 4 
6 v 5 
7 v 6 
8 v 7 
9 v 8 
10 v 9 
11 v 10 
12 v 11 
13 v 12 
14 v 13 
15 v 14 
16 v 15 
17 v 16 
18 v 17 
19 v 18 
20 v 19 
21 v 20 



































































2. Log odds constraints across all predictors -26739.67 77 
3. Constraints on the log odds to be equal except class 2 on age -26593.03 78 
4. Constraints as model 3, and class 1 on age relaxed -26490.39 79 
5. Constraints as model 4, and class 3 on age relaxed -26405.37 80 
6. Constraints as model 5 and class 1 on sex relaxed -26374.56 81 
7. Constraints as model 6, and class 5 on sex relaxed -26326.08 82 
8. Constraints as model 7, and class 3 on currently smoking relaxed -26296.67 83 
9. Constraints as model 8, and class 3 on GAD relaxed -26283.51 84 
10. Constraints as model 9, and class 5 on suicide attempt relaxed -26272.91 85 
11. Constraints as model 10, and class 1 on currently smoking relaxed -26262.47 86 
12. Constraints as model 11, and class 3 on sex relaxed -26254.48 87 
13. Constraints as model 12, and class 2 on employment status relaxed -26247.00 88 
14. Constraints as model 13, and class 5 on currently smoking relaxed -26240.98 89 
15. Constraints as model 14, and class 5 on educational attainment relaxed -26233.67 90 
16. Constraints as model 15, and class 5 on GP visit physical relaxed -26228.46 91 
17. Constraints as model 16, and class 3 on MAD relaxed -26224.43 92 
18. Constraints as model 17, and class 1 on employment status relaxed -26220.21 93 
19. Constraints as model 18, and class 3 on suicide attempt relaxed -26216.93 94 
20. Constraints as model 19, and class 4 on GAD relaxed -26214.70 95 
21. Constraints as model 20, and class 4 on area type relaxed -26212.66 96 
22. Constraints as model 21, and class 3 on depressive episode relaxed -26210.97 97 















 Note: All estimates compared to baseline mild consumption group (Class 6) where values in bold illustrate significant predictors 


















with injury and 
suggestion to cut 
down 
Gender (male) 5.97 (4.86-7.33) 3.56 (3.14-4.03) 3.56 (3.14-4.03) 2.14 (1.92-2.38) 1.12 (1.33-1.59) 
Employment status 
(inactive) 
1.48 (1.32-1.65) 1.48 (1.32-1.65) 1.93 (1.66-2.23) 1.48 (1.32-1.65) .98 (.88-1.12) 
Age (continuous) .93 (.92-.93) .97 (.97-.97) .94 (.93-.94) .97(.97-.97) 1.01 (1.00-1.01) 
Educational attainment 
(GCSE level or below) 
1.22 (1.00-1.50) .99 (.88-1.12) .99 (.88-1.12) .82 (.73-.91) 1.08 (.89-1.31) 
Area type (urban) 1.02 (.93-1.13) 1.26 (1.07-1.47) 1.02 (.93-1.13) 1.02 (.93-1.13) 1.02 (.93-1.13) 
Current smoker (yes) 4.14 (3.36-5.10) .97 (.96-.98) 2.42 (2.10-2.79) .97 (.96-.98) 1.25 (1.02-1.53) 
GAD  2.60 (1.71-3.96) 1.67 (1.16-2.40) 1.08 (.84-1.40) 1.08 (.84-1.40) 1.08 (.84-1.40) 
MAD  1.34 (.99-1.82) .88 (.74-1.04) .88 (.74-1.04) .88 (.74-1.04) .88 (.74-1.04) 
Depressive episode 1.02 (.58-1.78) .62 (.45-.86) .62 (.45-.86) .62 (.45-.86) .62 (.45-.86) 
Suicide attempt in 
lifetime 
2.21 (1.48-3.32) 1.41 (1.05-1.88)  1.41 (1.05-1.88) .91 (.69-1.19) 1.41 (1.05-1.88) 
GP psychological 
complaint 
1.01 (.86-1.17) 1.01 (.86-1.17) 1.01 (.86-1.17) 1.01 (.86-1.17) 1.01 (.86-1.17) 
GP physical  
complaint 
1.07 (.95-1.20) 1.07 (.95-1.20) 1.07 (.95-1.20) .91 (.82-1.01) 1.07 (.85-1.20) 
Table 25: Odds Ratios (95% Confidence Intervals) of the optimum multinomial logistic regression model  
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As the classes’ progress in severity of alcohol involvement, Table 25 
illustrates an increase in the likelihood of being male compared to the baseline 
class. Members of class 1 were approximately six times more likely to be male, 
with an odds ratio of 3.56 for other two heavy consumption classes (2 and 3). 
Those in classes 4 and 5 were 2.14 and 1.12 times more likely respectively to 
be male than the baseline class. Classes 1 to 4 had members who were most 
likely to be economically inactive, with the most likely in class 3 with an odds 
ratio of almost two. Classes 1 to 4 illustrate a significant decrease in age 
compared with class 6, suggesting that heavier alcohol involvement was more 
likely to be found in younger people compared with the baseline mild 
consumption class. However, those in class five, mild consumers with injury and 
suggestion to cut down were significantly more likely to be older. Compared to 
class 6, the members of class 4 had higher educational attainments (more likely 
to be educated to above GCSE level) and class 1 was characterised by an 
increased likelihood of being educated to GCSE level or below. The odds ratio 
for this relationship was 1.22. Except for class 2, no significant effects were 
found for urbanicity in this sample. Those in this class had a significantly 
increased likelihood of living in an urban area (OR=1.26). Concerning smoking 
status class 1 was the most likely to be currently smoking followed by class 3, 
and 5, however, classes 2 and 4 have an equally lower likelihood to be currently 
smoking compared with the baseline class. 
In terms of mental health outcomes, there appeared to be a protective 
effect of alcohol use and related behaviours characteristic of classes 2 through 
5 for depressive episode. The odds ratio for this relationship was .62. This 
suggests the risk was approximately halved compared to those in the baseline 
class 6. There were no significant relationships with depressive episode for the 
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members of class 1. Members of classes 1 and 2 were 2.6 and 1.7 times more 
likely to have generalised anxiety disorder (GAD). However, those in the class 
3, 4 and 5 illuminated no significant relationship with the diagnosis of this 
disorder. Across all classes, there was no relationship between mixed anxiety 
and depressive disorder compared to the baseline class. Classes 1, 2, 3 and 5 
were characterised by a higher probability of having attempted suicide in the 
past year. The members of class 1 had the highest likelihood at 2.21 times 
more likely, and characteristics of classes two through four having the same 
significant association, all being 1.41 times more likely. Despite the patterns of 
elevated risk for mental health disorders, the risk of presenting to GP services 
for either a psychological or physical problem did not differ between the classes. 
The results of the multinomial regression lend support to the external validity of 
the classes as distinct from each other, not only on the indicators of the latent 
variable, but also in terms of their relationship with predictors.  
6.5. Discussion 
The findings reported in this chapter have generated a British population 
typology which attempts to profile alcohol use based on a standardised 
measure of alcohol consumption and related problems. This chapter found 208 
patterns of response to the AUDIT questionnaire in the observed data. This 
highlights the variability of alcohol use and related problems in the general 
population of Great Britain. Thus, inferring valid patterns in alcohol and related 
behaviour without using a method such as latent variable analysis would be 
extremely difficult. Overall, including those who screened out of the AUDIT 
section, 12.47% of the general population of Great Britain did not drink any 
alcohol in the past year. This was lower than a similar study by Degenhardt and 
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Hall (2003) who found in their randomly sampled population of Australia a 
quarter of the sample had not consumed alcohol in the past year. It is also lower 
than European trends and specific estimates from the UK (EC, 2007; see 
section 1.2).  
Of those who drank alcohol in the past year, the most frequent pattern of 
endorsement of the AUDIT questionnaire reflected those who drank alcohol, but 
not more than three drinks per typical occasion, and never six or more drinks in 
one sitting in the past year. This represented 25.67% of the general population 
surveyed in this thesis. The most frequent patterns which included an alcohol 
related consequence involved memory loss, alcohol related injury and pressure 
to cut down on alcohol consumption. Similar alcohol related consequences 
loaded highly on their health, legal and dependent dimensions found in a factor 
analysis of the social consequences of drinking (Gmel, Rehm, Room & 
Greenfield, 2000).  
A six-class solution was found to best describe the patterns of 
endorsement of the AUDIT questionnaire. These six classes were heavy 
consumption with multiple negative consequences (class 1), heavy 
consumption with negative consequences (class 2), heavy consumption with 
memory loss (class 3), moderate consumption (class 4), mild consumption with 
injury and suggestion to cut down (class 5) and a final class of baseline or very 
mild consumption (class 6). Three fewer classes were found in the study by 
Reboussin et al. (2006). Their analysis was conducted in a sample of 
adolescent current drinkers, therefore, a little or no consumption class might 
account for at least one of those classes. Classifications of alcohol use 
consumption differed somewhat between this chapter and their study. 
Comparisons could be drawn with their alcohol related consequence of social 
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problems. Their risky and regular problem drinkers had a 40-50% probability of 
endorsing social problems. This bears some resemblance to the AUDIT 
question regarding suggestions to cut down on drinking from friends, family or 
doctors which was most likely to be endorsed by classes 1, 2 and 5. Their social 
problems from drinking included problems at school, and consequences with 
friends/parents. In addition, their regular problem drinkers, who had the highest 
alcohol consumption, were also likely to experience memory loss. Memory loss 
had a high probability of endorsement for two of the heavy consumption classes 
found in this chapter (1 and 3).  
There were also some key differences between the latent profiles 
generated by O’Connor and Colder (2005) of US college students. This study 
found four moderate to high consumption groups representing 58% of their 
sample. In this chapter, 64.16% of the sample were moderate to high alcohol 
consumers; however, there was not the same extent of related problems in this 
group. In contrast, O’Connor and Colder (2005) found their entire moderate to 
high consumption groups to have a range of moderate to high related problems. 
Given the moderate consumption group found in this chapter (class 4) did not 
have a high probability of associated consequences, the comparable 
percentage might be closer to 25.68% (a reduced proportion which excludes the 
moderate consumption class). Differences in patterns of consumption and 
related consequences may be a function of the different characteristics of the 
populations studied. 
Slater et al. (1997) in their cluster analysis of a general population should 
have been the most similar. This appears to be descriptively true. However, 
direct comparisons between the groups were difficult as Slater and colleagues 
did not estimate heavy drinking occasions in their analysis. Given the field has 
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subsequently recognised the importance of heavy drinking occasions in 
determining the risk of harm in a given pattern (San Jose et al. 2000; Rehm et 
al. (2003), analyses in this chapter represent a positive step forward, offering 
new insights beyond what is currently known. 
Classes 1, 3, 4, and 6 tended to differ quantitatively rather than 
qualitatively. This suggests alcohol consumption, dependence and alcohol 
related consequences lie along a continuum although skewed in relation to the 
dependence items (items four to six). These items were not highly endorsed by 
the general population of Great Britain (as might be expected). Support for a 
continuum with exceptions is commonly found in previous research. Slater et al. 
(1997) in their cluster analysis found a continuum, but except for the episodic 
cluster. This cluster drank larger amounts but infrequently, with other clusters 
having similar numbers of drinks on occasion to number of drinking days per 
week. O’Connor and Colder (2005) also found a broad continuum but conceded 
there were some exceptions. Medina-Mora et al. (1998) found a moderate 
Pearson’s correlation of .62 between alcohol consumption and problems. The 
magnitude of this correlation could suggest the continuum relationship is not 
always expressed in their population estimates from Brazil. This also shows 
patterns of use are more useful to understand alcohol related harm rather than 
average volume of consumption. 
Beyond those classes, two classes deviated from the continuum trend. 
The probabilities of endorsement associated with membership of Class 5 
provide clear contradictory evidence. It could be suggested this class 
represents a group of individuals who do not drink a lot, but drink excessively in 
certain situations such as festivals or holiday periods (Medina-Mora et al. 1998). 
Cherpitel, Tam, Midanik, Caetano and Greenfield (1995) in a study of the US 
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National Population, found those who drink heavily on rare occasions have an 
elevated risk for injury.  They suggest quantity on occasion could be a key 
factor in risk.  The authors propose efforts to prevent accidents should not just 
be tailored to those who drink in a heavy use pattern.  Evidence from this 
chapter also identifies a need for preventative intervention. This is particularly 
relevant as heavy consumers tend to be fewer in number than moderate or mild 
consumers, and thus prevention attempts which are aimed widely may have 
more effect.  
Class 2 were characterised by similar consumption probabilities to those 
in classes 1 and 3. However, the probabilities associated with the traditional 
dependence indicators (items four to six) were relatively low and the 
probabilities associated with two negative consequences indicators were 
relatively high (alcohol related injury and suggestions to cut down). For this 
class there was a positive association between consumption and consequences 
without the expected level of dependence. The issue of the validity of the self-
reported dependency is pertinent in determining the robustness of this class, as 
there is evidence of under-reporting of behavioural indicators of dependence 
among heavy alcohol users (Maisto and Connors, 1992).  
The results from the multinomial logistic regression using the 
demographic variables indicated heavier drinking classes (Classes 1, 2 and 3) 
were characteristic of being more likely to be male, young and economically 
inactive (compared to Class 6). Finding greater consumption of alcohol amongst 
young males is supported by previous research in Europe (EC, 2007). This 
study found young males had more frequent drinking occasions, with higher 
typical consumption and higher occasions of binge drinking. The odds ratio of 
being male (compared to female) increased with increasing alcohol involvement 
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in this study. Falk et al. (2008) in a general population survey of the US 
(NESARC) found males were less likely to have abstained from alcohol in the 
past year (71.8% compared with 59.6% in females). In addition, older 
respondents were more likely to abstain from alcohol use. Slater et al. (1997) 
also found their non-drinking group were more likely to be female and older 
Between latent classes, there were characteristic significant differences, 
a finding like Reboussin et al. (2006). This study found a greater likelihood of 
being male between the heavier regular problem drinker and risky problem 
drinkers. This represented a decreasing ratio of females to males as extent of 
alcohol use increased. This pattern was replicated in this chapter. However, 
Reboussin and colleagues found age patterns to be more variable. Their 
moderate and heavy group were the oldest with mean ages of 47 and 44 years 
old respectively. Their youngest group (mean age 29 years) was characterised 
by drinking in an episodic pattern. In contrast, the youngest individuals in this 
analysis were most likely to be members of classes 1 to 4. Only the members of 
class 5 were found to be significantly older than the baseline class 6. 
Significant differences were also found between latent class membership 
and economic activity. Inactivity was significantly associated with all classes 
compared to those in the baseline class with exception of class 5. The largest 
association was found in class 3. This is not unsurprising. A study in a sample 
of unemployed persons by Claussen (1999) illuminated both a significant 
relationship between alcohol abuse and unemployment. Whilst causal 
relationships cannot be inferred in cross sectional data such as this analysis, 
Claussen (1999) suggested unemployment often causes alcohol abuse rather 
than the converse. Manninen et al. (2006) also found significant differences in 
employment. Male, heavy alcohol consumers were 1.55 times more likely to be 
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unemployed. This is very similar in magnitude to the relationship between 
classes 1, 2, and 4 in terms of economic activity. These classes were 1.48 
times more likely to be economically inactive than the baseline class. Manninen 
and colleagues also found this relationship to be exclusive to males. All the 
classes in this analysis were more likely to be male than the baseline class. 
Therefore, this supports the reported gender difference. The paper did not find 
any significant differences with education for either males or females in relation 
to heavy drinking patterns. This chapter only found a significant relationship 
between class 1 and class 4 compared to the baseline class 6. The former was 
1.22 times more likely to be educated to a GCSE level or below, with the latter 
associated with higher education. This would appear contrary to European 
trends in population level alcohol use (EC, 2007). Low education was related to 
lower consumption in Europe and being currently engaged in education was 
associated with higher consumption. Only class 2 was significantly related to 
urban area type. They were 1.26 times more likely to be living in an urban area 
in comparison to class 6. This is supported by a review of social determinants of 
licit and illicit drugs (Galea et al., 2004) who found the relationship between 
alcohol (and other drug use) to be ambiguous. Neighbourhood traits, such as 
peer or family attitudes were considered to affect alcohol use to a greater extent 
than urbanicity. Whilst not directly measured, this appears broadly supported by 
this research.  
The results of the multinomial logistic regression based on the 
psychological variables indicated generalized anxiety disorder and suicide 
attempts were only associated with classes 1 and 2, characterised by high 
consumption. This is consistent with the research literature has identified 
negative psychological consequences of excessive consumption. For example, 
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Rodgers et al. (2000) found elevated mean scores on both the Goldberg and 
DSSI/sAD anxiety questionnaires for both males and females who drank in a 
hazardous or harmful way (measured by AUDIT). However, in the context of 
this study, where three clusters of indicators were modelled (consumption, 
dependence, & consequences) the psychological outcomes may also be 
attributable to related affective states guilt, injuries, or social relations (being 
asked to reduce consumption). The relationship of heavy alcohol consumption 
patterns with lifetime suicide attempts is reflected in trends found in a US 
population study by Dawson (1997). This study found a significant relationship 
between average volume of alcohol and risk for suicide attempts when 
controlling for demographic criteria. 
Depressive episodes were significantly less likely for those drinkers in 
classes 4 and 5. This indicates there may be some protective component 
associated with limiting alcohol consumption to moderate levels or sustained 
but moderate quantities of alcohol use. However, this may be due to the social 
nature of such consumption rather than a psychopharmacological mechanism. 
Furthermore, moderate drinkers may do other things in moderation which could 
protect against harm (Lipton, 1994). Class 2 and 3 were also characterised by a 
decreased risk of depressive episode. These were heavy consumption groups 
and appear to be contrary to hypothesised relationships. However, Manninen et 
al. (2006) lend some support. They found males aged 45 to 64 years who 
engaged in heavy drinking episodes were 2.34 times more likely to have a BDI 
of over 10. However, males in this age range who did not engage in heavy 
drinking episodes were also 1.52 times more likely to have a BDI over 10 (these 
were all compared to a group of males aged 25 to 44 who did not engage in 
heavy drinking episodes). There were no significant differences in depressive 
222 
 
episode risk for heavy alcohol users who were male and aged between 25 to 44 
years. Females aged 25 to 44 years engaging in heavy drinking occasions were 
1.65 times more likely to have a BDI over 10 compared to females aged 25 to 
44 who did not engage in heavy drinking behaviours. Those who did not engage 
in heavy drinking occasions in this age range were also 1.67 times more likely 
to have a BDI over 10. Both this paper and the findings in this chapter support 
the assertion by San Jose et al. (2000) investigations into alcohol related harm 
should relate to overall patterns of use including heavy drinking occasions and 
average quantity and frequency. 
Increased likelihood for depressive episode or MAD appears likely to 
relate to alcohol use patterns in a non-linear curve. Whilst some odds ratios 
were not significant in comparison to the baseline class, their magnitude 
tentatively suggests the highest risks are in class 1 and the baseline, with lower 
odds ratios and risk found in classes 2 through 4. GAD and suicide attempts in 
the lifetime were also likely to be related to alcohol consumption in a non-linear 
way. However, differences were not significant for classes 4 and 5 (suicide 
attempts in lifetime) and classes 3 through 5 (GAD) suggesting these are more 
similar to the characteristics of the baseline class 6. The significant odds ratios 
found for classes 1 and 2 illustrate the increased harm associated with these 
patterns of use.  Non-linear relationships between alcohol use and anxiety and 
depression scores were also found in Rodgers et al. (2000). It is impossible to 
say whether trends in this chapter reflect a ‘U’ shaped or ‘J’ shaped curve, given 
not all relationships were significant. General patterns of decreasing risk of 
mental health conditions from class 1 to class 5 lend further support to an 
underlying continuum of alcohol consumption, dependence, and negative 
consequences at the population level. However, as mentioned above, such an 
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interpretation warrants extreme caution, as not all effects were statistically 
significant.  
Despite any elevated or decreased risk for mental health conditions in 
general population alcohol use and related behaviour classes, there was no 
associated change in treatment seeking. This appears contrary to findings by 
Cryer et al. (1999) and DeWin et al. (2006). Differences between previous 
research and this current chapter may be a function of the measurement of 
alcohol patterns.  
In conclusion, this study found support for a population typology of 
alcohol related behaviour implied, for the most part, an underlying continuum of 
consumption, dependence and negative consequences. Two qualitatively 
different classes were also found. The classes associated with high 
consumption were more likely to have poorer psychological status, and there 
was some evidence of a protective effect for more moderate consumption 
classes. It is clear research that aims to identify homogeneous groups of people 
based on alcohol consumption and related behaviours and identifies resultant 
psychological and/or physical problems would be useful in focusing preventative 
measures and educational programmes. However, it is unclear as to how the 
results of this chapter might relate to elevate risks of harm caused by illicit 
polydrug use.  Many illicit drug users are also consuming alcohol, regardless of 
whether they use more than one illicit drug in either simultaneous or concurrent 
polydrug use patterns. The next chapter will address this problem. It will attempt 
to create a unified model of alcohol and illicit polydrug use, assessing the 
relationship with demographic variables and psychological harm.   
224 
 
7. Towards an integrated model: Can heterogeneity in 
alcohol and illicit polydrug use patterns be expressed 
in one model? 
7.1. Abstract 
 Results from previous chapters suggest that illicit polydrug use, alcohol 
use and related behaviours can be described in homogeneous latent classes.  
However, given most illicit drug users also use alcohol, it is unclear to what 
extent typologies relate to each other. This final chapter aims to examine this 
relationship to create a polydrug use model. Data used was from the NPMS 
survey, a stratified, multi-stage probability sample of the population of Great 
Britain (n=7849). Four approaches were adopted in assessing the relationship 
between licit and illicit drug use. These included inspection of observed patterns 
of use. The second was a correlation between existing latent class structures 
(from chapters three and six). The third involved estimation of a single latent 
variable of all nine yearly drug use indicators and 10 AUDIT questions using 
latent class analysis. The final approach modelled the two (licit and illicit) drug 
use latent variables separately, but allowed them to vary as a function of each 
other. Both latent class models were regressed on demographic criteria and 
variables relating to psychological status. All these approaches illuminated 
strong links between illicit polydrug use and alcohol. The latent structure of illicit 
drug use varied when measured with alcohol use variables. Alcohol use latent 
classes broadly did not change, however, differences were found in relation to 
current psychological status. This suggests the traditional position of separating 
the two drugs in research can affect the nature and magnitude of relationships 
with psychological status. 
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7.2. Introduction  
Chapters three and six have shown illicit polydrug use and alcohol use can 
be profiled into distinct classes. Three classes best explained the variation in 
patterns of illicit polydrug use. Six best explained observed patterns in alcohol 
use and related behaviours. However, almost all illicit drug users use alcohol 
(see section 1.6 for frequencies), and patterns of polydrug use encompassing 
both drugs are understudied in the literature. This chapter will first explore 
reasons why drugs are typically separated. Following this, previous research 
which has attempted to address this problem will be presented.  
One of the key reasons for separation reflects the large volume of 
research in both fields, thus it is difficult to synthesise these entities together 
(Courtwright, 2005). However, there are other reasons. The first concerns 
measurement of alcohol or illicit drugs. Alcohol and illicit drug use are not 
usually measured in a comparable way.  Given the increased frequency of 
alcohol use in the general population (EU, 2007), it is rare for lifetime dosage to 
be measured (Bondy, 1996). Given the variability in alcohol use and related 
behaviour patterns demonstrated in chapter six, any estimate of lifetime alcohol 
consumption would need to span from zero to a very large number of 
occasions. Estimating lifetime frequency of drug use would typically be much 
lower in range. Therefore, even in a basic approach such as lifetime quantity, 
which does not assess patterns of either alcohol or illicit drug use, the ranges of 
response are different. When a more sophisticated approach is taken, an 
increase in the number of variables which would measure patterns will 
compound this problem.  
 Secondly, they have been traditionally separated in policy due to their 
legal status. Primarily, this relates to goals for harm reduction between alcohol 
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and illicit drugs. The most recent alcohol strategy states that “alcohol can play 
an important and positive role in British culture” (pp.5; Department of Health 
[DOH], 2007). This contrasts with the perceived impact of drugs on culture. The 
drug strategy suggests “Drug misuse can damage an individual’s ability to work, 
to maintain relationships and to care for dependants. Drug misuse – whether 
legal or illegal – can have a significant negative impact on the development and 
achievement of young people. This not only affects those who use drugs, but 
also their families, their children and wider society.” (p. 21; DOH, 2008). This 
paints a considerably bleaker picture for drug use compared to alcohol use. It is 
also indicative of the aims of alcohol policy to reflect increased moderation of 
use, and drug policy broad aims of population abstinence (Cheung, 2000; Riley 
et al., 1999; Single, 1995) 
Third, in any given study, only one of alcohol or drug use may be 
measured. This may reflect the separation in policy. Thus, if researchers wish to 
inform policy, they may wish to investigate either alcohol or illicit drugs. Williams 
and Parker (2001) note the traditional practice of the separation of illicit drug 
and alcohol research and subsequent policies reduces quantity of robust 
information on concurrent (and simultaneous) polydrug use.  
The percentages of polydrug use presented in section 1.6 demonstrate the 
use of alcohol and illicit drugs (AOD) is intertwined.  Frequently, the use of 
alcohol is overlooked in the conceptualising of illicit polydrug users (Ives & 
Ghelani, 2006) and this was reflected in the range of illicit polydrug use. As a 
result, there may be some individuals using a single illicit drug, who are really 
illicit and licit polydrug users, and the polydrug use rate is an underestimate. 
Illicit polydrug use was related to alcohol consumption from work in this 
thesis to date. From chapters three and five, the membership of the wider (class 
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1) and moderate range polydrug use (class 2) were demonstrated to be highly 
associated with hazardous drinking compared to those in the baseline no drug 
use (class 3). This is supported by research by Lamers et al. (2006). This paper 
found their two groups ‘ecstasy /cannabis’ and ‘cannabis users’ more likely to 
be experiencing alcohol problems, measured by the ASI compared with no drug 
users. This demonstrates a relationship with hazardous or problem drinking for 
illicit drug users. Allott and Redman (2006) in research focussing on patterns of 
polydrug use in ecstasy users illustrate a high proportion of ecstasy users used 
alcohol before (91%), during (81%) and after (60%) their consumption of 
ecstasy.  
Furthermore, this thesis has demonstrated a strong relationship with 
current smoking status amongst illicit drug and alcohol users. In examining the 
classes of alcohol users from chapter seven, those in classes 1, 3 and 5 were 
4.14, 2.42, and 1.25 times more likely to be currently smoking compared to 
those in the baseline class. However, two groups are atypical to the pattern, 
and suggest the likelihood of being a current smoker is not necessarily 
positively correlated with increased involvement in alcohol use and related 
problems. These were the heavy consumption with negative consequences 
(class 2) and the moderate consumers (class 4) who were found to be slightly 
less likely to be smoking than the baseline low alcohol consumption class 
(chapter seven).  
The relationship found to date between drugs lends some, albeit cross-
sectional support for the longitudinal gateway theory. Briefly, this is a 
progression from alcohol, through tobacco, cannabis and other illicit drugs 
(Kandel and Faust, 1975). Furthermore, the exploration of AOD patterns should 
illustrate particularly whether current drug use is related to heavier consumption 
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patterns of alcohol. Given hazardous or problem drinking patterns are proposed 
to mediate the jump between licit and illicit drugs (Kandel et al., 1992), an 
association with these and stronger involvement with drug use should be 
apparent when addressing the complete picture of drug use. 
Some of the studies which have attempted to measure AOD use focus on 
the use of a single drug comparing this to the use of other licit or illicit drugs. For 
example, O’Grady, Arria, Fitzelle and Wish (2008) in a convenience sample of 
520 undergraduate students in the US, compared the illicit drug use 
consumption between three groups of alcohol consumers. The first of these 
were light drinkers, those who drank one to four drinks on occasion. The second 
group were moderate drinkers who drank five to nine drinks on occasion. The 
final group were heavy drinkers, those who drank 10 or more drinks on 
occasion. Differences in the odds ratios of lifetime use of illicit drugs were 
largest between the light and heavy drinkers. The heavy drinking group were 
5.21 times more likely to be smoking, 10.11 times more likely to use cannabis, 
10.45 times more likely to use analgesics and 9.4 times more likely to be using 
hallucinogens. In addition, the traditional nightclub drugs of amphetamines, 
cocaine, and ecstasy were also more likely to be found in the heavy group 
compared to the light, with odds ratios of 9.68, 8.48 and 7.38 respectively. This 
is a clear indication of heavy alcohol use and its relationship to lifetime use of 
illicit drugs. However, this does not infer any extent of use. Illicit drugs could 
have been tried once or used consistently as there was no indication of the 
extent of consumption of the illicit drugs. This also demonstrates the problems 
of comparable measurement in AOD research. 
Using alcohol as the primary drug from which to compare licit and illicit 
polydrug use is common. This is likely due to the percentage of this drug 
229 
 
compared to other drugs (see chapter one). Degenhardt and Hall (2003) 
followed a similar methodology. They examined 10,641 participants in the 1997 
National Survey of Mental Health and Wellbeing (NSMHWB), a random sample 
of the Australian general population. Cannabis and other drug use was more 
likely in those who used alcohol with odds ratios (adjusted for demographic 
criteria) of 2.95 and 3.61 respectively compared to those who did not use 
alcohol. Similarly, this study also found the odds ratios for alcohol use abuse 
and dependence were highest in those who used cannabis (OR’s=2.95; 7.45 
and 8.99 respectively) compared to those who did not. This proposes cannabis 
use may be linked to problems with alcohol use. It would additionally lend 
support to Kandel et al. (1992) who see hazardous alcohol use patterns as 
being relevant to change between non-use and use of illicit drugs. 
Other approaches to patterns of AOD use have focussed on a single illicit 
drug. For example, Topp et al. (2004) found key differences in polydrug use 
focussing on ecstasy use. The authors compared two subsamples from the 
National Drug Strategy Household Survey (NDSHS) of regular ecstasy users 
(n=48) and recent ecstasy users (n=199) and a purposively sampled group of 
regular ecstasy users (n=163). Regular ecstasy users from the purposive 
sample represented the highest overall frequencies of use (however, this might 
be explained by the time frame of one year, compared to six months for two the 
NDSHS groups). The two regular ecstasy user groups had similar alcohol use 
percentages with the NDSHS group slightly lower at 73% compared to 79% for 
the purposively sampled group. However, the two regular groups become more 
distinct when examining percentages of cannabis use; 82% use of the 
purposive sample used cannabis compared to 62% in the NDSHS. A similar 
result was found for amphetamines with 85% compared to 52% for the 
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purposive and NDSHS samples respectively. Cocaine use was reported by 44% 
of the purposive regular users, 26% of the NDSHS regular users and only 7% of 
the recent ecstasy users from the NDSHS. Cannabis, amphetamines and 
cocaine were used by 34%, 42% and 7% of the recent NDSHS ecstasy users. 
As demonstrated above, these percentages were lower than the other two 
groups. It could be proposed that the greater the frequency of ecstasy use, the 
greater the frequency of other drugs consumed, including alcohol  
There are also demographic differences in patterns of AOD polydrug use. 
Falk et al., (2008) found the highest level of polydrug use in the past year in 
their category of males aged between 18-24 years old (19.4%). As age 
increased the percentage of polydrug use in males decreased, 8% for those 
aged between 25 and 44 years, 3.6% for those aged between 45 and 64 years 
and for those aged over 65 years, the percentage of polydrug use was .7%. For 
females, a similar pattern emerged, although they had notably less polydrug 
use than the corresponding age groups for males. The percentage of polydrug 
for those aged 18-24 years was 12.5%, followed by 5%, 2% and .5% for those 
aged 25-44, 45-64 and 65+ years old respectively. 
Topp et al. (1999) studied a group of 329 ecstasy users from Sydney to 
determine AOD differences in terms of mental health presentation. Note this 
group all had taken ecstasy in the past 6 months. The following drugs were 
used by the group at a frequency of 75% of the cohort or higher tobacco, 
amphetamines, cannabis and alcohol (listed in increasing magnitude). Using 
multinomial logistic regression, they found being female, using drugs to recover 
from a session, extensive polydrug use, and stimulant binge episodes were all 
related to more psychological side effects, accounting for 16% of the variance in 
the model. The most common side effects reported by this group were 
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irritability, trouble sleeping, depression and confusion. The mean number of 
problems experienced was 1.2 (SD=1.1). There was also some evidence of 
primary care help seeking (GP’s) in this sample. Of the surveyed individuals, 
11% said they had visited their GP for a problem self-attributed to their drug 
use.  
Pederson and Skrondal (1999) found differences in Hopkins Symptoms 
Checklist scores (HCL: Derogatis, Lipman, Uhlenhut, & Covi, 1974) between 
groups of illicit drug users. Cannabis only users were significantly higher in their 
HCL symptomatology than those not using illicit drugs. This group had 
significantly lower HCL scores than ‘amphetamine only’, ‘ecstasy only’ and 
‘amphetamines and ecstasy polydrug’ users. Symptomatology for the no drug 
use group was significantly lower than all illicit drug use groups. The authors 
also state all their groups were cannabis users to a large extent. The range of 
the smallest to largest mean number of symptoms endorsed on the scale for the 
researcher chosen groups was .57 to 1.53, and consequently the findings must 
be interpreted in this context. However, AOD use in this sample was common. 
Therefore, these relationships may have been affected by alcohol use patterns 
found in this paper. Alcohol use was highest in the ‘amphetamines and ecstasy 
polydrug’ group compared to the cannabis only or illicit drug abstainers. The 
group with the least alcohol consumption did not consume illicit drugs.   
Newcomb et al. (1993) in a prospective study of adolescents tracked 
over 12 years (on four time points) took a different approach. They found 
adolescent polydrug use could be hypothesised as being part of a continuous 
latent construct (through factor analysis). Adolescent polydrug use was largely 
reflective of cannabis use, followed by alcohol, cigarette, cocaine and other 
hard drug use (in descending order of magnitude of factor loadings). The 
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highest factor loadings of young adult polydrug use (in contrast to adolescent 
polydrug use) reflected cocaine, cannabis, hard drugs and then alcohol and 
cigarettes. Adolescent polydrug use was a significant predictor of young adult 
polydrug use (β=.75). They also found increased polydrug use (the change 
between adolescent and young adult polydrug use) was a significant predictor 
of anxiety and suicide ideation. Some individual (observed) drug frequencies 
were also related to mental health outcomes. Firstly, alcohol and cannabis 
frequency significantly predicted CES-D scores (β=-.12 and β=.17 respectively). 
Regarding suicide, increased cannabis use and increased cocaine use were 
significantly predictive of suicide attempts with β=.15 for cannabis use and 
β=.14 for cocaine use.  
In a later wave of the study, which originated with a sample of seventh to 
ninth grade students in Los Angeles County (first surveyed in 1976), Earleywine 
and Newcomb (1997) constructed two further continuous latent variables of 
concurrent and simultaneous polydrug use through factor analysis. This 
analysis of drug use and consequences refers to wave 13 collected in 1988 and 
follow up consequences were also assessed at year 17 wave in 1992. 
Indicators of concurrent use (presented in order of greatest to least magnitude 
of factor loadings) were cannabis, other illicit drug, cigarette and alcohol use. 
Simultaneous polydrug use was measured by six patterns of drug use 
combination (factor loadings in brackets): cannabis and other illicit drugs (.99), 
alcohol and cannabis (.86), alcohol and illicit drugs (.84), cigarettes and illicit 
drugs (.65) cigarettes and cannabis (.63) and cigarettes and alcohol (.55). 
These continuous factors of simultaneous and concurrent polydrug use were 
significantly correlated with psychological distress but concurrent polydrug use 
explained a higher proportion of the variance (3% and 15% variance explained 
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by simultaneous and concurrent polydrug use respectively). Concurrent 
polydrug use was also related to psychological distress four years later (r=.21). 
There were no significant relationships with health service utilisation at either 
baseline or four years later. 
A study by Midanik et al. (2007) which also separated polydrug use into 
simultaneous and concurrent drug and alcohol use patterns using the National 
Alcohol Survey (n=7612) compared the patterns of ‘cannabis and alcohol’ and 
‘other drugs and alcohol‘ with those who did not fall into either of those two 
groups. Concurrent and simultaneous cannabis and alcohol use was related to 
being young. Concurrent users were 5.05 times more likely to be aged 18-29 
years. Simultaneous users were 5.85 times more likely to be aged 18-29 or 4.63 
times more likely to be aged 30-49 years compared to those aged greater than 
50 years old. Simultaneous cannabis and alcohol users were significantly more 
likely have lower educational attainment (OR=2.32). Both concurrent and 
simultaneous users of other drugs and alcohol excluding cannabis were more 
likely to binge drink (conceptualised as five or more drinks on occasion). 
Simultaneous users were 14.17 times more likely to binge drink monthly and 
2.77 times more likely to be binge drinking yearly compared to those who did 
not use other drugs and alcohol. Concurrent users were 1.85 times more likely 
to binge drink compared with those who did not use other drugs and alcohol in 
the past year. Simultaneous cannabis and alcohol users also had higher odds 
ratios for binge drinking than their concurrent counterparts. This group were 
3.99 times more likely to binge drink at least yearly and 8.64 times more likely to 
binge drink monthly. Those who used cannabis concurrently were 1.78 times 
more likely to drink five or more drinks in a day yearly.  Despite these 
differences in alcohol consumption, all groups were similarly more likely to have 
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depression with odds ratios ranging from 1.8 for simultaneous cannabis and 
alcohol use (compared to those not simultaneously using cannabis and alcohol) 
to simultaneous other drug and alcohol use (compared to those who were nor 
using simultaneously other drugs and alcohol) with an odds ratio of 2.6. This 
proposes there is a global risk for depression for those using illicit drugs 
whether concurrently or simultaneously, which might not necessarily be related 
to binge drinking.  
There are a few patterns of licit and illicit polydrug use which have been 
described in detail in chapter four. However, these will briefly be described for 
reference. Smit et al., (2002) in their cluster analytic study of 6326 adolescents 
found three groups of polydrug user. These were an ‘alcohol and tobacco’ 
cluster, a ‘cannabis, alcohol and tobacco’ cluster, and a ‘cannabis, alcohol, 
tobacco and other drug use’ cluster. Mitchell and Plunkett (2000) found four 
groups of combined AOD polydrug use, ‘no use’, ‘alcohol and cannabis’ use, 
‘alcohol, cannabis and possibility of other drugs’, and ‘alcohol, cannabis and 
multiple drugs’ in their sample of American Indian Adolescents. Another study 
conducted by Whitesell et al., (2006) on two American Indian Reservation 
populations and the National Household Survey of Drug Abuse (n=1244; 
n=1443 and n=39152 respectively) , found four lifetime groups, ‘abstainers’, 
‘alcohol only’, ‘alcohol and cannabis’ and ‘polydrug’ users in their household 
population. Their yearly groups in the same population found groups reflecting 
abstention, primarily alcohol, and alcohol and other drugs.  
In conclusion, given the potential harm previous research has suggested 
derives from AOD use, research needs to be more focussed on polydrug use 
than individual substances (Stockwell, 2007). To date, aside from the Whitesell 
study above (Whitesell et al., 2006) there have been no studies which have 
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examined this polydrug use problem in the general population using a 
categorical latent variable modelling framework (latent class analysis). This 
novel method of deriving empirical patterns will be able to explore the 
characteristics of a polydrug use latent class structure. Therefore, this chapter 
has four aims, the first of these is to profile licit and illicit drugs in a model 
representing AOD polydrug use. The second is to validate these in terms of 
their demographic profile and determine the characteristics of each classes’ 
membership. Third, the resultant latent classes of AOD polydrug use will be 
regressed on mental health criteria to determine their relationship with current 
psychological status, to provide an indication of harm associated with a given 
polydrug use pattern. And finally, to compare the results to the patterns of 
alcohol use and illicit polydrug use previously derived in chapters three and six. 
7.3. Methods 
7.3.1. Participants, data and sampling  
Data used in this paper was taken from 7849 individuals in the NPMS 
survey, a multi-stage stratified sample of households in England, Scotland and 
Wales (Singleton et al., 2001a; 2001b). This was a reduced subset of the 
overall 8580 individuals who took part in this survey, representing those who 
answered both the alcohol use disorders identification test (AUDIT) and the 
drug use in the past year questions which comprised the latent variable from 
chapters three, four and six. The mean age of the sample was 45.38 years old 
(SD=15.61) and 55.12% of the sample were female. Further details of the data, 




7.3.2.1. Alcohol use variables 
Alcohol use was measured using the ten item alcohol use disorders 
identification test scale (AUDIT; Saunders & Aasland, 1987; Babor et al, 
1992b). This is a widely used questionnaire measuring hazardous drinking over 
the past year in a given population. Three conceptual domains are contained in 
this instrument; alcohol consumption, dependence and alcohol related 
problems. The first alcohol consumption question measures how often an 
individual drinks alcohol (how often). If an individual scored one for this question 
this represented drinking alcohol in the past year, where zero represents less 
than this frequency. This is followed by a question asking how many standard 
drinks an individual has on a typical day of drinking (Typical amount; ‘0’ 
represents one or two and ‘1’ three or more drinks) and how often a participant 
had six or more drinks on occasion (How often 6+ drinks; ‘0’ represents never; 
‘1’ less than monthly or more frequently).  
The dependence section also has three questions commencing with 
“During the past year, how often have you found you were not able to stop 
drinking when you started?” (Unable to stop), scored as ‘0’ never or ‘1 could not 
stop drinking when started on an occasion in the past year. The two other 
questions in this section were asking how often individuals failed to meet 
expectations due to drinking (Failed to do) and how often in the past year a 
drink was needed to get going in the morning after a heavy drinking session 
(Drink in morning). Both were coded as zero for never and one for either alcohol 
related behaviour having occurred in the past year. 
The final section, ‘alcohol related problems’ has four questions. The first 
two of these cover how often an individual had a feeling of guilt or remorse after 
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drinking (Guilt after drinking) and how often an individual was unable to 
remember what happened the night before because of a drinking episode 
(Memory loss). A zero response is equivalent to never and one, the experience 
happening at least once in the past year. The final two questions of the 
questionnaire and this section ask whether either the respondent or someone 
else been injured as a result of an individuals’ drinking? (Had injury) or if a 
relative, friend, doctor or other health professional been concerned about your 
drinking or suggested you cut down? (Suggest cut down). A zero response for 
either of these two items reflects this never being true, and one being true at a 
point in the lifetime which may not necessarily have been during the past year. 
In addition, for some analyses using the previously derived latent class 
structure as presented in chapter seven, the saved conditional probabilities of 
the model have been used. These were saved in the same order and 
represented the same patterns of endorsement from the heavy consumption 
and multiple negative consequences to the baseline very mild consumption (the 
sixth class).  
7.3.2.2. Drug use variables 
Measurement of drug use in the past year included the drugs cannabis, 
amphetamines, cocaine, ecstasy, LSD, mushrooms, tranquillisers, amyl nitrate 
and a composite heroin or crack variable. These were all binary variables where 
no use in the past year scored zero and use in the past year scored one.  
For the analyses in this chapter which require use of the drug latent class 
variable generated in chapter four, the conditional probabilities of the three-
class solution have been saved reflecting both the same order in which they 
were presented and the same patterns of endorsement. For ease of 
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interpretation, wide range drug use is now referred to as drug 1, moderate 
range drug use, drug 2 and no drug use, drug 3. 
7.3.2.3. Demographic and mental health variables 
All demographic variables used in this chapter reflect those used in 
chapters three through six, however, a summary has been given below for 
reference. Gender was represented as female ‘0’ and male ‘1’. Employment 
status was coded as economically active scoring zero and individuals who were 
economically inactive scoring one. Other binary variables included educational 
attainment (beyond GCSE level/statutory education=0; up to GCSE level or 
below=1), whether the participant was a current smoker (0=no; 1=yes) and area 
type where the participant lived (rural/semi-rural=0; 1=urban). Age was 
measured as a continuous variable in the range of 16 to 74 years old.  
Predictors illustrating relationships with mental health included diagnoses 
of generalised anxiety disorder (GAD), mixed anxiety and depressive disorder 
(MAD) and depressive episode. These were scored as zero for absent, and one 
if the condition was present. These were measured by answers on the Clinical 
Interview Schedule Revised (CIS-R; Lewis & Pelosi, 1990). When algorithms 
are applied to this questionnaire, ICD-10 diagnoses of the three above 
conditions can be produced (Lewis et al., 1992). Furthermore, questions were 
asked as to whether an individual has visited their General Practitioner (GP) for 
either a physical or psychological problem in the past year. This was coded as 
zero for no visits and one if an individual had made one or more visits in the 
past year. In addition, whether an individual had attempted suicide in their 
lifetime has also been used as a predictor, ‘0’ illustrating no attempts, and ‘1’ as 
one or more attempts. 
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7.3.3. Statistical methods: frequencies, correlations and latent class 
analyses 
This chapter takes four different approaches to integrating alcohol and 
drug use into an overall polydrug use model. First to be considered will be 
observed patterns of illicit drug and alcohol polydrug use. The second approach 
involves correlating existing latent class structures from chapters three and six9. 
The third model will create one latent variable of all licit and illicit drugs using 
latent class analysis. Finally, the last latent class model will determine two latent 
variables, one of illicit drug use, and one licit drug use, although allowing their 
structure to vary as a function of each other. The methods employed in 
generating these models will be considered below. 
7.3.3.1. Patterns of observed response to nine illicit drug use variables and 10 
questions from the AUDIT. 
The 10 most frequently observed patterns of response in the data across 
all 19 indicators will be reported. Should these not contain any of the illicit drug 
use variables, a table will be presented of observed patterns containing at least 
one illicit drug. This is possible as frequencies of illicit drug use are low in 
comparison to estimates of alcohol use in the general population of Great 
Britain. These will be compared to observed patterns from existing chapters. 
7.3.3.2.  Correlation of the conditional probabilities of class membership 
Before fitting a model of licit and illicit polydrug use, correlations were 
used to demonstrate the relationship between the posterior probabilities of class 
membership from the existing latent class models. In practice this represented 
an estimate the strength of the relationship between the three existing drug 
                                            
9 Note that existing latent classes will be referred to in the text as illicit drug class 1, illicit drug 
class 2 and illicit drug class 3 (for the three class illicit polydrug use solution). Existing alcohol 
use classes will be referred to alcohol class 1 through alcohol class 6. This was to improve 
clarity of the results and discussions. The order of the classes remain the same as in the 
original chapters three and six, where either class 1 represents the class with the greatest 
involvement in illicit drug or alcohol use and either class 3 (illicit polydrug use) or class 6 
(alcohol use) represented the least involvement. 
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classes, wide range, moderate range and no (illicit) polydrug use (illicit drug 1 to 
illicit drug 3) with the six alcohol use and related problem classes, heavy 
consumption with multiple negative consequences, heavy consumption with 
negative consequences, moderate/heavy consumption with memory loss, 
moderate consumption, mild consumption with injury and social support 
suggestion to cut down and baseline or very mild consumption (alcohol class 1 
to alcohol class 6). This procedure provided correlation coefficients and an 
illustration of the significant differences between membership of a given illicit 
drug latent class with a given alcohol latent class. Note this is intended to be 
illustrative of similarities rather than providing an interpretable model of polydrug 
use. 
7.3.3.3. Model A: Placing all (19) binary indicators of alcohol and illicit drug 
use into one latent class model 
  By placing all the binary indicators from both latent class analyses 
conducted in chapters’ three and six into a single latent variable, a model has 
been estimated which attempts to account for the heterogeneity in patterns 
observed across all illicit and licit drugs (see Figure 21). This will create one 
latent variable with a number of classes which help to explain variation in the 
dataset. Model parameters generated by the latent class procedure include 
class specific licit and illicit drug endorsement probabilities, in addition to the 
class membership probabilities for a given model. As in all previous models, 
individuals have been assigned to classes using conditional probabilities in 
contrast to the most likely latent class. Models with two through nine classes 
have been estimated and reported. Fit criteria used to select the correct model 
have reflected the lowest values of AIC, BIC, and SSABIC, an LRT where the k-
1 class model is superior (when compared with k class model generating 
p>.05), a minimal number of significant bivariate residuals, and an entropy value 
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close to one. The best fitting structure will also be chosen on the strength of 
relation with existing literature. More details on the latent class method and fit 
criteria are presented in chapter three.  
7.3.3.4. Model B: Estimation of a confirmatory latent class analysis with two 
categorical latent variables 
The second modelling approach drew upon the latent variable structures 
of chapters four and seven, using loglinear parameterisation to correlate the two 
latent variables. A conceptual diagram of the model tested is provided in Figure 
22. Rather than using the previous latent class structures, this approach will 
allow the two latent variables to be estimated as a function of each other. By 
allowing the structure of the alcohol and drug latent variables to covary, this 
could affect the membership of the latent classes. Nine separate models were 
estimated with two to four drug classes and five to seven alcohol use and 
related problem classes, i.e. two drug and five alcohol classes, three drug and 
six alcohol classes, four drug and seven alcohol classes, three drug and five 
alcohol classes, etc. These models were chosen using the three and six class 
solutions from chapters four and seven as anchor points and testing models 
with a class removed and added for each latent variable.  
As with the one latent variable approach, the estimation procedure will 
aim to find the best fitting (two latent variable) model which can encapsulate the 
patterns of response in the dataset. It is assumed these two latent variables 
have been able to explain the variation in the observed nineteen variables of 
licit and illicit drug use. They have also used the same fit criteria as the second 
approach, namely, the lowest values of all three information criterion (AIC, BIC 
and SSABIC), a Lo Mendel Rubin Likelihood Ratio Test (LRT) where the k-1 
class model is superior (when compared with k class model generating p>.05), 
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minimal number of significant bivariate residuals, and a suitable entropy value 
(close to 1). Full details of these criteria can be found in chapter two. 
7.3.4. Multinomial logistic regression 
Should a suitable model be found for modelling strategies A and B, 
multinomial logistic regression has been used to validate and lend weight to 
these analytical approaches. As with all other chapters, the conditional 
probabilities of membership of each of the classes for each of the participants 
have been saved and used as the dependent variable in each model, and as a 
consequence the latent variable can only be determined by the observed 
indicators.  For model A, an individual’s proportional membership of a single 
latent variable has been saved. For model B, a conditional probability of being 
in both a given alcohol latent class and a given drug latent class was generated 
by the model. 
Regardless of which model used, the procedure will provide odds ratios 
and confidence intervals which illustrate the statistical significance of the effect 
of each of the predictors on the latent class membership whilst controlling for 
the other predictors. For model A the class with the lowest licit and illicit drug 
involvement has been used as the comparison or baseline class. For model B, it 
has been the combined group (as membership of a given illicit drug latent class 
and a given alcohol use latent class) which has the lowest overall drug use 
involvement. As with all other chapters employing the multinomial logistic 
regression method, 2∆ loglikelihood difference testing has been employed to 
illustrate the differences between groups. This involves running a fully restricted 
model which constrains the odds ratios to be the same for a particular 
independent variable across all classes and compare this to a freely estimated 
model which allows the regression parameters to be calculated as appropriate 
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for each class. The model loglikelihoods were compared for the two competing 
strategies with the view that if no significant difference was found the more 
restricted model was preferred. If the freely estimated model and the fully 
constrained model were found to be significantly different, the restrictions on the 
fully constrained model would be sequentially relaxed until the most appropriate 
model was found. Full details, and a worked example of this procedure are 
provided in section 2.5.3.1. 
 The conceptual models being tested in both Model A and Model B are 
provided in Figure 21 and Figure 22. These include the same demographic and 


























Figure 21: Conceptual diagram of model A tested in Chapter seven.
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To perform correlations and to prepare data for analysis in this chapter, 
SPSS version 15 was used (SPSS Inc., 2006). Latent class analyses and 
multinomial logistic regressions were performed using the Mplus version 5.01 
(Muthén & Muthén, 2007) or SPSS version 15. 
7.3.5.1. Computational demands 
 Given the computationally demanding nature of the modelling strategy in 
both approaches two and three, starts were modified from the default used by 
this thesis to date. This refers to section 3.5.4 in the methodology chapter which 
discussed the computation process involved in specifying the parameters of the 
latent variable for a given number of latent classes. For all the previous models 
utilising latent class analysis, 100 sets of starting values were used with the 
best 20 optimised, in order to replicate the best loglikelihood. The model with 
the best loglikelihood should best explain the variation in a given number of 
observed variables. Given the advanced nature of the models estimated in this 
chapter, the solutions that 100 20 starts might generate would be unlikely to 
replicate the best loglikelihood. Thus, solutions could be considered unreliable. 
As a consequence of this, the loglikelihood generated by the model could be a 
local maxima, and a product of the choice of starting values. To combat this 
problem, the starts require considerable increase in these modelling strategies 
to attempt replication of the best loglikelihood.  
The following commands were used in succession to replicate the loglikelihood 
representing five sets of analysis where appropriate.  
a. Starts = 600 300 
b. Starts = 3100 2100 
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c. Starts = 10000 9000 
d. Starts = 20000 19000 
e. Starts = 25000 24000 
Should the case arise where there were model identification problems 
after set ‘b’ has been applied, no further increase in starts in the models have 
been run and the model criteria has been reported with the note of model 
nonidentification indicated. Problems with model identification are stated by the 
Mplus programme and are a clear indication of model specification issues. This 
strategy was employed to maximise the chance of replicating the loglikelihood 
for these models, whilst maintaining a sense of perspective on whether a model 
was ever likely to fit the data. If a replication of the best loglikelihood function 
was achieved of great enough magnitude, the process will cease at that step, to 
minimise computational time wastage. 
7.4. Results 
7.4.1. Rates of polydrug use in Great Britain 
 As illustrated in Table 26, most of those who had used illicit drugs had 
done so with alcohol. These were all found to be significantly different using 
either chi-square testing or Fisher’s exact test. Those who were most likely to 
have been using an illicit substance without alcohol were heroin and crack 
users 10.00% or tranquillisers with 7.27%. This suggests that the majority of 
those who use illicit drugs are polydrug users. 
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Table 26: Rates of illicit drug users who do and do not use alcohol 
 Total users in the population Using alcohol Not using alcohol 
 N % N % N % 
Cannabis* 685 8.03 660 96.35  25 3.65 
Amphetamines* 134 1.57% 130 97.01 4 2.99 
Cocaine* 129 1.51 126 97.67 3 2.32 
Ecstasy* 135 1.58 130 96.30 5 3.70 
Mushrooms* 42 .49 40 95.24 2 4.77 
Tranquillisers* 55 .64 51 92.73 4 7.27 
Amyl Nitrates* 44 .51 43 97.73 1 2.27 
LSD* 29 .34 28 96.55 1 3.45 
Heroin/Crack* 20 .23 18 90.00 2 10.00 
* Found to be significantly different using chi-square or Fisher’s Exact test 
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7.4.2. Frequency of patterns of drug and alcohol use 
 The most frequent patterns of response to both the alcohol and drug use 
variables were given in Table 27. The most common pattern of response was 
mild consumption of alcohol, with no associated problems or drug use. Notably 
none of the drug use variables feature in the most frequent patterns of use. In 
addition to this, the ten most frequent patterns of alcohol use from chapter 
seven were also reflected in this chapter in the same order as presented in   
Table 22. For this reason, Table 27 also reflects on the percentage change from 
the original frequency of pattern of use. The difference illustrates the proportion 
of individuals who take illicit drugs that were in the original classification from 
chapter seven (which only considered alcohol use).  
From this the biggest proportional change reflected the response pattern 
‘drinking in the past year, typical amount three or more drinks, drinking six or 
more drinks in the past year and memory loss in the past year’. The second 
largest difference was found in a similar pattern of consumption to the most 
frequent.  However, there were some differences. Instead of memory loss in the 
past year, they had experienced an alcohol related injury. Overall change in 
percentage between the alcohol use patterns expressed in chapter seven and 
the same patterns but excluding illicit drug users from the total reflected a 5.5% 
decrease in the number of individuals in the 10 most frequent patterns of use.  
Given no drug users were represented in the 10 most frequent patterns, 
Table 28 illustrates the most frequent patterns which had some illicit drug use. 
Note this is for illustration only and will not contribute to the overall fit criteria of 
the number of significant residuals. This will maintain consistency with other 
modelling strategies used throughout this thesis. The majority of these were all 
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single users of drugs with the highest proportion being cannabis users (although 
there was one tranquilliser only group).  
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Table 27: Most frequent patterns of response to patterns of licit and illicit drug use indicators in the general population. 
 (Note: 535 different patterns of response in the dataset).
Most frequent patterns of response Frequency of pattern 
(%) 
 Percentage decrease in 
corresponding alcohol 
pattern frequency  
Drug Use Alcohol Use 
No drug use Drinking in past year 1976 (25.19%) -1.89% 
No drug use Drinking in past year, Typical amount three or more drinks, Drink six or more 
drinks in the past year 
1348 (17.18%) -7.61% 
No drug use Drinking in past year, Drink six or more drinks in the past year 728 (9.28%) -8.08% 
No drug use Drinking in past year, Typical amount three or more drinks 541 (6.90%) -2.70% 
No drug use None 321 (4.09%) -2.43% 
No drug use Drinking in past year, Typical amount three or more drinks, Drink six or more 
drinks in the past year, Memory loss in the past year 
210 (2.68%) -20.75% 
No drug use Drinking in past year, Alcohol related injury experienced, Asked to cut down 178 (2.27%) -3.78% 
No drug use Drinking in past year, Typical amount three or more drinks, Drink six or more 
drinks in the past year, Alcohol related injury experienced 
158 (2.01%) -13.66% 
No drug use Drinking in past year, Alcohol related injury experienced 162 (2.07%) -3.57% 
No drug use Drinking in past year, Typical amount three or more drinks, Drink six or more 
drinks in the past year, Alcohol related injury experienced, Asked to cut down 
84 (1.07%) -6.67% 
Total Number of Individuals in the 10 most frequent response patterns 5706 (72.73%) -5.55% 
Total Number of Individuals not in the 10 most frequent response patterns 2139 (27.67%)  
TOTAL 7845 (100%)  
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Table 28: Most frequent patterns of response to patterns of licit and illicit drug use indicators in the general population (including at least 
one illicit drug). 
Most frequent patterns of response 
 
Drug Use            Alcohol Use 
Frequency of pattern 
in complete 
dataset (%) 
As a proportion of 
all drug users (%) 
Cannabis 
 
Drinking in past year, Typical amount three or more drinks, Drink six or more drinks in the 
past year 
74 (9.74%) .94% 
Cannabis Drinking in past year, Drink six or more drinks in the past year 46 (6.05%) .59% 
Cannabis 
 
Drinking in past year, Typical amount three or more drinks, Drink six or more drinks in the 
past year, Guilt after drinking in the past year 
35 (4.61%) .45% 
Cannabis Drinking in the past year 25 (3.29%) .32% 
Cannabis 
 
Drinking in past year, Typical amount three or more drinks, Drink six or more drinks in the 
past year, Guilt after drinking in the past year, Memory loss in the past year  
16 (2.11%) .20% 
Cannabis Drinking in past year, Typical amount three or more drinks, Drink six or more drinks in the 
past year, Memory loss in the past year 
16 (2.11%) .20% 
Cannabis Drinking in past year, Typical amount three or more drinks, Drink six or more drinks in the 
past year, Alcohol related injury experienced  
16 (2.11%) .20% 
Cannabis Drinking in past year, Typical amount three or more drinks, Drink six or more drinks in the 
past year, Memory loss in the past year, Alcohol related injury experienced 
15 (1.97%) .19% 
Cannabis  Drinking in past year, Drink six or more drinks in the past year, Memory loss in the past 
year  
8 (1.05%) .10% 
Tranquillisers Drinking in past year 8 (1.05%) .10% 
Cannabis Drinking in past year, Typical amount three or more drinks 7 (.92%) .09% 
Cannabis  Drinking in past year, Typical amount three or more drinks, Drink six or more drinks in the 




Cannabis Drinking in past year, Typical amount three or more drinks, Drink six or more drinks in the 
past year, Could not stop drinking when started on an occasion in the past year, Memory 






Cannabis Drinking in past year, Typical amount three or more drinks, Drink six or more drinks in the 
past year, Could not stop drinking when started on an occasion in the past year, Failed to 





Cannabis Drinking in past year, Typical amount three or more drinks, Drink six or more drinks in the 
past year, Could not stop drinking when started on an occasion in the past year, Failed to 




Cannabis Drinking in past year, Typical amount three or more drinks, Drink six or more drinks in the 




Total Number of Individuals in the 16 most frequent response patterns (due to tied ranks) 301 (39.60%) 3.83% 
Total Number of Individuals not in the 16 most frequent response patterns 459 (60.39%) 96.16% 
TOTAL 7845 (100%) 
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7.4.3. Correlation of the conditional probabilities of class membership 
The Pearson’s correlations between the two latent variables are given 
below in Table 29. Illicit drug classes 1 and 2 correlate to the greatest 
magnitude with the heavy consumption with negative consequences, alcohol 
class 2. In addition, illicit drug classes 1 and 2 had a significant correlation with 
heavy drinking except for alcohol class 1. However, the magnitude of the 
correlation in some cases was extremely low. Illicit drug class 3 had the 






























Illicit Drug Class 1: Wide range drug use 1         
Illicit Drug Class 2: Moderate range Illicit Drug use .14* 1        
Illicit Drug Class 3: No drug use -.54* -.81* 1       
Alcohol Class 1: Heavy consumption with multiple negative 
consequences 
.02 -.02 -.02* 1      
Alcohol Class 2: Heavy consumption with negative 
consequences 
.17* .23* -.26* -.04* 1     
Alcohol Class 3: Heavy/moderate consumption with memory 
loss 
.06* .13* .03* .03* .04* 1    
Alcohol Class 4: Moderate alcohol consumption -.06* -.08* -.09* -.18* -.29* -.23* 1   
Alcohol Class 5: Mild consumption with injury and 
suggestion to cut down 
-.03* -.04 .04* .02 -.09* -.18* -.25* 1  
Alcohol Class 6: Mild alcohol consumption -.06* .11* -.26* -.19* -.40* -.19* -.44* -.19* 1 
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7.4.4. Model A: Placing all (19) binary indicators of alcohol and drug use 
into one latent class model 
 The fit criteria for the two through nine class models are given in Table 
30 below. The information criteria disagree in their best fitting model, with the 
BIC suggesting the seven-class solution, the AIC and SSABIC illustrating a 
better fit for the eight-class solution. The LRT was also unclear suggesting 
either the six-class solution or the eight-class solution as superior. With this 
disagreement, using the rule of parsimony, it might be better to suggest the six-
class solution is most appropriate. However, there are eight significant residuals 
in the 10 most frequent patterns in the database for the six-class solution, 
compared with two significant residuals for the eight-class solution. In addition, 
upon inspection of both the six and eight class models, it would appear the 
additional two classes add extra information of theoretical relevance. Given the 
large proportion of the database this represents, the eight-class solution was 
preferred and has been presented here.
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Table 30: Fit statistics of latent class analysis on the 19 variables representing illicit drug and alcohol use.  
Note: LL(df) loll (df) loglikelihood value and associated degrees of freedom; LRT Lo-Mendel-Rubin Adjusted likelihood ratio test value; AIC 
Akaike Information Criterion; BIC Bayesian Information Criterion; SSABIC Sample Size Adjusted Bayesian Information Criterion. 
Number of 
classes 
LL (df) AIC BIC SSABIC Entropy LRT p Number of 
significant 
residuals 
2 -30217.97 (39) 60513.94 60785.67 60661.74 .82 7542.96 .00 10 
3 -29080.78 (59) 58279.57 58690.66 58503.17 .87 2275.53 .00 10 
4 -28493.08 (79) 57144.15 57694.60 57443.55 .86 1159.25 .00 7 
5 -27987.57 (99) 56173.14 56862.94 56548.33 .86 1002.42 .00 6 
6 -27874.81 (119) 55987.62 56816.77 56438.61 .76 223.44 .01 8 
7 -27784.11 (139) 55846.22 56814.72 56373.00 .76 180.19 .09 6 
8 -27719.57 (159) 55757.14 56865.00 56359.73 .77 127.89 .03 2 




Figure 23: Profile plot of the eight latent classes from 19 observed variables relating to alcohol and illicit drug use 
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 Given the complexity of the solution, each class in the solution will be 
examined in turn10. Polydrug class 1A was the least frequent pattern in the 
model. It was characterised by multiple illicit polydrug use, having the highest 
probability of all illicit drugs, particularly, cannabis, amphetamines, cocaine and 
ecstasy. In terms of alcohol use, they were like alcohol class 1, characteristic of 
heavy alcohol use consumption with multiple problems. 
Polydrug class 2A had a slightly lower probability of illicit polydrug use as 
class 1A. Characteristically, class 2A were slightly more likely to endorse 
ecstasy use in the past year than amphetamine use, with a probability of just 
over 55% compared to 42%. Cannabis use was also commonly endorsed. 
Alcohol use in this class reflected moderate levels of consumption with a 
moderate probability of memory loss. 
Polydrug class 3A appeared to have a low probability of all illicit drug 
use. However, there was some indication of a low probability of cannabis only 
use, in just over a quarter of the membership. In terms of their alcohol use, they 
were likely to be heavy consumers of alcohol with multiple negative 
consequences. Some of the key features were being unable to stop drinking 
when started, failing to meet expectations, guilt after drinking and memory loss. 
However, this class had a slightly lower probability of endorsing these items in 
comparison with polydrug class 1A. 
The remainder of the latent classes had extremely low probabilities (if at 
all) of endorsing any illicit drugs. Polydrug class 4A was characteristic of the 
previously reported heavy alcohol consumption, injury and suggestion to cut 
down class found in chapter six. Polydrug class 5A was characteristic of no illicit 
drug use, heavy alcohol consumption and memory loss. The largest class in the 
                                            
10 All latent classes in this approach will be named polydrug class 1A to polydrug class 8A for 
ease of comparison with other classes from different models. 
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latent class structure was polydrug class 6A. It was characteristic of no illicit 
drug use and moderate alcohol consumption. Polydrug class 6A also had low 
probabilities of any negative alcohol consequences in the past year. No illicit 
drug use, mild alcohol consumption with injury and suggestion to cut down 
characterised polydrug class 7A. Polydrug class 8A had the lowest probability of 
use of all the illicit drug and alcohol use variables. They also had the lowest 
probability of endorsing any alcohol related consequences in the past year.  
 In summary, there were only two classes which endorsed illicit drug use 
to any extent. Polydrug class 1A endorsed the widest range of illicit drugs. 
Polydrug class 2A primarily focussed on cannabis, but also was characteristic of 
the use of ecstasy, cocaine, and to a lesser extent, amphetamines. The pattern 
of response to the alcohol variables remained relatively constant in Figure 23 to 
those in Figure 20. However, two previous groups seem to split into those who 
take drugs and those who do not; these were the heavy consumption with 
multiple negative consequences (alcohol class 1) and the heavy consumption 
with memory loss (alcohol class 3). 
To validate the model with demographic and mental health criteria, the 
results of the two times loglikelihood difference testing were presented below in   




  Table 31: The results of the 2Δll test for the model. 
 Ll Df Model v  
Model 
Comparison 




1. No constraints -30063.85 243 
 
2 v 1 
3 v 2 
4 v 3 
5 v 4 
6 v 5 
7 v 6 
8 v 7 
9 v 8 
10 v 9 
11 v 10 
12 v 11 
13 v 12 
14 v 13 
15 v 14 
16 v 15 
17 v 16 
18 v 17 
19 v 18 
20 v 19 
21 v 20 
22 v 21 
23 v 22 












































































2. Log odds constraints across all predictors -30813.68 171 
3. Constraints on the log odds to be equal except class 7 on age -30680.11 172 
4. Constraints as model 3, and class 6 on age relaxed -30487.23 173 
5. Constraints as model 4, and class 4 on age relaxed -30418.36 174 
6. Constraints as model 5, and class 1 on currently smoking relaxed -30378.98 175 
7. Constraints as model 6, and class 2 on currently smoking relaxed -30339.20 176 
8. Constraints as model 7, and class 7 on sex relaxed -30307.95 177 
9. Constraints as model 8, and class 6 on sex relaxed -30256.65 178 
10. Constraints as model 9, and class 2 on age -30223.14 179 
11. Constraints as model 10, and class 3 on currently smoking relaxed -30204.95 180 
12. Constraints as model 11, and class 1 on age relaxed -30182.53 181 
13. Constraints as model 12, and class 6 on suicide attempt relaxed -30170.09 182 
14. Constraints as model 13, and class 5 on sex -30160.62 183 
15. Constraints as model 14, and class 1 on GAD -30154.22 184 
16. Constraints as model 15, and class 7 on current smoking relaxed -30145.22 185 
17. Constraints as model 16, and class 3 on GAD relaxed -30138.81 186 
18. Constraints as model 17, and class 6 on educational attainment relaxed -30132.57 187 
19. Constraints as model 18, and class 6 on currently smoking relaxed -30125.12 188 
20. Constraints as model 19, and class 6 on GP visit physical relaxed -30119.28 189 
21. Constraints as model 20, and class 7 on employment status relaxed -30114.12 190 
22. Constraints as model 21, and class 1 on sex relaxed -30108.81 191 
23. Constraints as model 22, and class 3 on MAD relaxed -30104.79 192 
24. Constraints as model 23, and class 5 on employment status relaxed -30100.90 193 
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25. Constraints as model 24, and class 5 on educational attainment relaxed -30097.02 194 25 v 24 
26 v 25 
27 v 26 
28 v 27 
29 v 28 



















26. Constraints as model 25, and class 4 on educational attainment relaxed -30093.73 195 
27. Constraints as model 26, and class 3 on suicide attempt relaxed -30091.00 196 
28. Constraints as model 27, and class 4 on GAD -30088.45 197 
29. Constraints on model 28, and class 2 on suicide attempt relaxed -30085.98 198 
30. Constraints as model 29, and class 2 on MAD relaxed -30084.27 199 
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Table 32: Odds Ratios (95% Confidence Intervals) of the optimum multinomial logistic regression model..  




Odds Ratio (95% confidence intervals) for Polydrug classes 
1A: Multiple illicit 




2A: Multiple illicit 









4A: No drug use, 
heavy alcohol 
consumption, 
injury and suggest 
cut down 








7A: No drug use 
mild alcohol 
consumption with 
injury and suggest 
cut down 
Gender (male) 10.62 (6.64-16.99) 4.80 (4.13-5.58) 4.80 (4.13-5.58) 4.80 (4.13-5.58) 3.26 (2.86-3.72) 2.10 (1.89-2.33) 1.28 (1.07-1.53) 
Current smoker 
(yes) 




1.22 (1.06-1.41) 1.22 (1.06-1.41) 1.22 (1.06-1.41) .88 (.73-1.06) .90 (.79-1.02) .81 (.73-.90) 1.22 (1.06-1.41) 
 Area type (urban)  1.04(.94-1.15) 1.04 (.94-1.15) 1.04 (.94-1.15) 1.04 (.94-1.15) 1.04 (.94-1.15) 1.04 (.94-1.15) 1.04 (.94-1.15) 
Economic activity 
(inactive) 
1.50 (1.34-1.67) 1.50 (1.34-1.67) 1.50 (1.34-1.67) 1.50 (1.34-1.67) 1.89 (1.63-2.18) 1.50 (1.34-1.67) 1.07 (.87-1.31) 
Age .86 (.84-.87) .86 (.84-.97) .93 (.93-.94) .97 (.96-.98) .93 (.93-.94) .97(.97-.98) 1.01 (1.00-1.02) 
Depressive 
Episode 
.66 (.48-.92) .66 (.48-.92) 66 (.48-.92) .66 (.48-.92) 66 (.48-.92) 66 (.48-.92) 66 (.48-.92) 
GAD 5.49 (2.73-11.03) 1.07 (.83-1.37) 2.25 (1.49-3.39) 1.83 (1.23-2.72) 1.07 (.83-1.37) 1.07 (.83-1.37) 1.07 (.83-1.37) 
MAD .88 (.74-1.04) .88 (.74-1.04) 1.30 (.97-1.74) .88 (.74-1.04) .88 (.74-1.04) .88 (.74-1.04) .88 (.74-.1.04) 
Suicide attempt in 
lifetime (yes) 
1.37 (1.03-1.83) 2.73(1.60-4.64) 2.29 (1.55-3.39) 1.37 (1.03-1.83) 1.37 (1.03-1.83) .89 (.68-1.17) 1.37 (1.03-1.83) 
GP psychological 
complaint 
1.02 (.88-1.19) 1.02 (.88-1.19) 1.02 (.88-1.19) 1.02 (.88-1.19) 1.02 (.88-1.19) 1.02 (.88-1.19) 1.02 (.88-1.19) 
GP physical 
complaint 
1.08 (.96-1.21) 1.08 (.96-1.21) 1.08 (.96-1.21) 1.08 (.96-1.21) 1.08 (.96-1.21) .89 (.81-.99) 1.08 (.96-1.21) 
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The results of the multinomial logistic regression are presented in Table 
32. Two variables displayed a continuum of increased likelihood with reference 
to the baseline class, being male (representing an increase in likelihood from 
polydrug class 7A (OR=1.28) to polydrug class 1A (OR=10.62). Equally, the 
heavier the involvement in polydrug use the greater likelihood a person was to 
be currently smoking. This was particularly likely for members of polydrug class 
1A and 2A who used illicit drugs in addition to their drink patterns (OR= 20.85 
and 11.83 respectively). Members of polydrug class 1A, 2A, 3A and 7A were 
more likely to be educated up to statutory level (GCSE) but not beyond. In 
contrast, polydrug class 6A were characterised by higher educational 
attainment than the baseline class. There was also a significant relationship 
with economic inactivity with all classes except polydrug class 7A. Polydrug 
classes 1A, 2A, 3A, 4A and 6A were characterised as 1.50 times more likely to 
be economically inactive. Polydrug class 5A had a slightly higher likelihood of 
economic inactivity. The members of this class were 1.89 times more likely than 
the baseline class to be economically inactive. Most of the classes are also 
significantly younger than the baseline class; again, the exception to this is 
polydrug class 7A, the members of whom were significantly likely to be older 
than the reference class (OR=1.01). The classes which would appear to be the 
youngest in relation to the baseline class were those including illicit drug use 
(polydrug classes 1A and 2A). 
Mental health presentations such as depressive episode was equally 
less likely for all classes compared to the baseline category of polydrug class 
8A. However, there was an increased risk of generalised anxiety disorder for 
members of polydrug classes 1A, 3A and 4A with odds ratios of 5.49, 2.25 and 
1.83 respectively. All classes except for class 6, the no drug use and moderate 
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alcohol consumption class, were characterised by an increased risk to have 
attempted suicide in their lifetime. Despite this increased risk, there was no 
difference in treatment seeking amongst the latent classes for either 
psychological or physical complaints, for all classes except polydrug class 6A. 
This group was significantly less likely to have visited their GP regarding a 
physical complaint in the past year in comparison with those in baseline 
polydrug class 8A. 
7.4.5. Model B: Estimation of a confirmatory latent class analysis with two 
categorical latent variables 
 The fit criteria for model B are given in Table 33. All the models which 
contained four drug classes, in addition to all the models which contained seven 
alcohol classes had serious model identification problems which were not 
solved by increasing the starts in the model. This suggests these more complex 
solutions do not represent the patterns in the data well. This provided four 
solutions where there were no such model identification problems. From these, 
the lowest AIC, BIC, and SSABIC were found in the three drug and six alcohol 
class solution. This also displayed reasonable entropy and found only one 
significant residual in the 10 most frequent patterns of use.  
However, even using the greatly increased number of starts, up to 25000 
24000, could not replicate the loglikelihood in this model (and the other models 
which identified, the two drug and six alcohol, three drug and five alcohol and 
the two drug and five alcohol models). In addition, through personal 
correspondence (Muthén 2008; personal communication 16/07/2008; Appendix 
2), it was suggested if the individual latent class solutions, i.e. the three drug 
class solution found in chapter four, and the six alcohol class solution found in 
chapter seven, had replicated loglikelihoods then it could be suggested the 
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model is unlikely to be particularly representative of the patterns contained in 
the data. Whilst this was some cause for concern, in the last three sets of 
starting values (as stipulated in the methodology, corresponding to sets c, d, 
and e) the same optimum loglikelihood value was found which had the same 
optimum seed. This would suggest some stability of the model solution, and 
given there was a decrease in the difference between the best loglikelihood and 
the next best in the sets c, d, and e, might suggest persevering with the 
increasing starts might find a converging solution with a greatly increased 
number of starts beyond set e. Even so, the resultant three drug class and six 
alcohol class solutions were presented in the following graphs (Figure 24 and 
Figure 25). Examination of the patterns of alcohol use in this analysis suggests 
a similar pattern of endorsement as presented in chapter six in Figure 2011. Any 
minor differences were reflected in the frequency of individuals in the classes. 
There were fewer moderate consumers in this chapter and more baseline, mild 
consumers of alcohol compared to the latent class structure found in chapter 
six. 
                                            
11 All latent classes in this graph are named Alcohol latent class 1B to Alcohol latent class 6B 
when referred to in the text. This is to help distinguish from alcohol latent class patterns which 
have been found in chapter six. Illicit drug use latent classes from model B will be named illicit 
drug class 1B to illicit drug class 3B to distinguish from class structures found in chapter three. 
Combined polydrug use classes will be named polydrug class 1B through polydrug class 18B 
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LL (df) AIC BIC SSABIC Entropy Number of 
significant 
residuals 
3d 6a -27729.80 (104) 55667.60 56392.24 56061.75 .83 1 
2d 6a -27906.31 (89) 55990.62 56610.73 56327.91 .79 4 
4d 6a -27716.68 (119) 55671.36 5650.51 56122.35 .82 N/A 
3d 5a -27774.70 (105) 55759.40 56491.00 56122.35 .83 4 
2d 5a -27964.99 (77) 56083.98 56620.48 56375.79 .80 2 
4d 5a -27774.70 (105) 55759.40 56491.00 56157.33 .85 N/A 
3d 7a -27687.24 (117) 55608.49 56423.70 56651.90 .82 N/A 
2d 7a -27865.76 (101) 55933.52 56637.25 56316.29 .80 N/A 
4d 7a -27670.96 (133) 55607.92 56534.62 56111.97 .80 N/A 
LL(df) loglikelihood value and associated degrees of freedom; LRT Lo-Mendel-Rubin Adjusted likelihood ratio test value; AIC Akaike 
Information Criterion; BIC Bayesian Information Criterion; SSABIC Sample Size Adjusted Bayesian Information Criterion and bold indicates 
































































Figure 25: Profile plot of the three illicit drug latent classes for the six alcohol class, three drug class solution
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 In contrast, Figure 25 illustrated the drug classes have separated 
somewhat in their presentation when estimated allowing the correlation with 
alcohol use variables to influence membership. This makes a clear distinction 
between cannabis users only (illicit drug class 2B), and users of a wider range 
of drugs (Illicit drug class 1B). Consequently, this class can now be considered 
to represent cannabis use only. Both the polydrug using class and the cannabis 
only class are almost certainly using cannabis. However, illicit drug class 1B 
has a greater likelihood of endorsing the other traditional club drugs of 
amphetamines, cocaine and ecstasy than any of the other classes. Illicit drug 
class 1B has similar endorsement probabilities to the graph presented in 
chapter three (Figure 14) representing patterns of endorsement of items in illicit 
drug class 1.  
 In addition to the frequencies of being in each class of a separate latent 
variable for both alcohol and drug use, in this model structure, the percentages 
of individuals who share membership of a given drug and alcohol class can also 
be assessed. This information was presented in Table 34. Of the drug use 
categories, the most frequent illicit polydrug class 1B also had heavy 
consumption with multiple negative consequences (polydrug class 1B). The 
most common pattern of alcohol use and related problems in the cannabis only 
illicit drug 2B class was the heavy consumption with memory loss (polydrug 
class 9B). The no illicit drug use class 3B was most frequently associated with 
little or no alcohol use (polydrug class 18B). 
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Table 34: Frequency of being in a given polydrug class. 
 N % 
Polydrug class 1B: Wide range polydrug use, heavy alcohol consumption and multiple negative consequences  73 .93 
Polydrug class 2B: Wide range polydrug use, heavy alcohol consumption, injury and suggestion to cut down  12 .15 
Polydrug class 3B: Wide range polydrug use, heavy consumption and memory loss  52 .66 
Polydrug class 4B: Wide range polydrug use with moderate alcohol consumption  2 .03 
Polydrug class 5B: Wide range polydrug use, mild alcohol consumption, injury and suggestion to cut down  1 .01 
Polydrug class 6B: Wide range polydrug use with little/mild alcohol consumption  2 .03 
Polydrug class 7B: Cannabis only use, heavy alcohol consumption and multiple negative consequences  118 1.50 
Polydrug class 8B: Cannabis only use, heavy alcohol consumption, injury and suggestion to cut down 2 .03 
Polydrug class 9B: Cannabis only use, heavy consumption and memory loss 296 3.77 
Polydrug class 10B: Cannabis only use with moderate alcohol consumption  63 .80 
Polydrug class 11B: Cannabis only use, mild alcohol consumption, injury and suggestion to cut down 17 .22 
Polydrug class 12B: Cannabis only use with little/mild alcohol consumption  4 .05 
Polydrug class 13B: No drug use, heavy alcohol consumption and multiple negative consequences  231 2.95 
Polydrug class 14B: No drug use, heavy alcohol consumption, injury and suggestion to cut down  344 4.39 
Polydrug class 15B: No drug use, heavy consumption and memory loss 964 12.29 
Polydrug class 16B: No drug use and moderate alcohol consumption 2733 34.84 
Polydrug class 17B: No drug use, mild alcohol consumption, injury and suggestion to cut down 557 7.10 




The multinomial logistic regressions used in this thesis have been 
consistent to date; however, when applying the same methodologies as given in 
chapters four, six and seven, model identification issues were presented. The 
following warnings were given by the Mplus program. 
“THE MODEL ESTIMATION DID NOT TERMINATE NORMALLY DUE 
TO A NON-ZERO DERIVATIVE OF THE OBSERVED-DATA 
LOGLIKELIHOOD. THE MCONVERGENCE CRITERION OF THE EM 
ALGORITHM IS NOT FULFILLED. CHECK YOUR STARTING VALUES 
OR INCREASE THE NUMBER OF MITERATIONS. ESTIMATES 
CANNOT BE TRUSTED. THE LOGLIKELIHOOD DERIVATIVE FOR 
PARAMETER 111 IS -0.31322729D+02.” 
 Given this difficulty in using the conditional probabilities in the regression 
model, an a posteriori decision was then taken to use the most likely latent 
class in place of the conditional probabilities for each of the eighteen groups 
(composed of one of the drug classes and one of the alcohol classes). In this 
way, the multinomial logistic regression could be conducted in SPSS where a 
given baseline category could be specified. Taking this approach could enable 
the loss of the lowest endorsed groups in sequence, until a model was able to 
be identified. SPSS does not have the capabilities to model conditional 
probabilities in the same way to Mplus. Persevering with use of the conditional 
probabilities, but losing those groups which have too low a conditional 
probability would have meant the eighteen conditional probabilities for an 
individual’s membership in one of the eighteen groups would not sum to one, 




However, the logistic regression in SPSS using the most likely class ran 
into problems with low levels of endorsement in suggested models giving rise to 
the following warning: 
‘The loglikelihood value cannot be further increased after max number of 
step-halving. The NOMREG procedure continues despite the above 
warning(s). Subsequent results shown are based on the last iteration. 
Validity of the model fit is uncertain.’ 
To combat this issue, the iterations for the model were increased; 
however, problems remained. Consequently, the class with the lowest number 
was removed until the model was able to terminate normally. This involved the 
removing of classes four, five, six, eight, and twelve in order of increasing 
magnitude, and represents what might be considered as a reduced model to 
guide the reader towards what some of the characteristics of the larger groups 
might be like. The results of this are given in Table 35. Note the table with all 



















































































































level or below) 
    1.21 
(1.00-
1.48) 
      1.29  
(.1.11- 
1.50) 
 Area type (urban)  1.95 
(1.06-
3.58) 
   1.42 
(1.06-
1.91) 
   1.38 
(1.07-
1.77) 
   
Employment status 
(inactive) 
 .23  
(.07- 
.77) 
         .78  
(.67- 
.90) 




































Depressive episode  8.30 
(1.25-
53.31) 













  3.15 
(1.46-
6.79) 






















  1.72  
(1.12- 
2.64) 






Note: Significant OR (95% CI) are given in bold. A table with all significant and non significant odds ratios (95% confidence intervals is 
provided in Appendix 3
Suicide attempt in 
lifetime 
            
GP psychological 
complaint 













All classes were significantly more likely to be male, with the most likely 
being polydrug classes 1B, 2B, 3B, 7B and 13B compared with the 
characteristics of polydrug class 18B. Additionally members of all classes were 
between 1.91 and 2.47 times more likely to be a current smoker compared with 
polydrug class 18B. An exception was polydrug class 17B which showed no 
significant relationship. Additionally, only polydrug class 17B was more likely to 
be older than the polydrug class 18B, with all others more likely to be younger.  
Regarding education, polydrug classes 9B and 17B were more likely to 
be educated up to GCSE level. The only significant relationships with economic 
activity were found in the members of polydrug classes 2B and 17B, which were 
significantly more likely to be economically active than the baseline class. 
Those classes which were characterised as significantly more likely to be living 
in an urban area were polydrug classes 1B, 9B and 14B. 
There was a lower likelihood of having a depressive episode for the 
members of polydrug classes 14B, 15B and 16B. However, those in polydrug 
class 2B were eight times more likely to have a depressive episode diagnosis 
than the baseline. There was also an elevated risk of a generalised anxiety 
disorder diagnosis found characteristic of polydrug classes 1B, 7B, 11B, 13B, 
and 14B. These classes were eight, three, twelve, two and two times more likely 
respectively. A higher probability of having mixed anxiety and depressive 
disorder were also found to be characteristic of polydrug classes 1B, 2B, 7B, 9B 
and 13B. Members of polydrug class 16B were less likely to have mixed anxiety 
and depressive disorder with odds ratio of .74 compared with the baseline 
class. There were no significant relationships between members of polydrug 
classes with reference to the baseline polydrug class 18B in presenting to GP 
services with a psychological problem, or an increased risk of suicide attempts 
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in the lifetime. However, the members of polydrug class 15B were more likely to 
visit their GP for a physical complaint, and the members of polydrug class 16B 
significantly less likely to present to services. 
7.5. Discussion 
From the four strategies employed in this chapter, it is clear alcohol and 
illicit drug use patterns are related. This section will commence with a 
comparison of observed patterns of alcohol and illicit polydrug use. Following 
this, each of the models will be discussed in turn. First to be discussed will be 
the correlation method, followed by model A and model B. These will be 
discussed in the context of previous research, including the results from 
previous chapters in this thesis.  
7.5.1. Patterns in observed response to alcohol and illicit drug use 
Patterns of observed responses in alcohol and illicit drug use share some 
characteristics to observed responses in Table 12 and  Table 22. A lower 
percentage of the Great British population were illicit drug users than alcohol 
users. It is unsurprising the ten most frequent patterns did not contain illicit drug 
use. Patterns of alcohol use reported in Chapter six were the same as found in 
Table 27. However, the frequencies of these patterns changed, through 
inclusion of illicit drug use variables. The percentage decrease represents the 
cost in the univariate approach or the traditional separation of alcohol and illicit 
drug use in research. Two of the largest differences were found in those who 
endorsed all three consumption items (how often, typical amount and how often 
6+ drinks) and either memory loss in the past year (decrease=20.75%) or 
alcohol related injury (decrease=13.66%).  
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This raises some additional questions. Midanik et al. (2007) found 10% 
of their sampled population were alcohol and cannabis polydrug users in the 
past year. If these individuals reported in this chapter were using alcohol and 
illicit drug on a single occasion, it is possible these negative consequences 
could be attributed to both alcohol and illicit drug use. Response to the AUDIT 
questionnaire could be affected by polydrug use, if the polydrug use was 
simultaneous. Midanik et al. (2007) found simultaneous alcohol and cannabis in 
7% of their sample, representing 70% of all alcohol and cannabis polydrug use. 
Given this frequency, the effect of illicit drug use on the AUDIT warrants further 
attention. 
In patterns of observed response containing at least one illicit drug 
(Table 28) cannabis and tranquilliser use appear most frequently. The most 
common pattern was characteristic of cannabis and alcohol use in the past 
year, drinking three or more drinks typically, and drinking six or more drinks on 
an occasion in the past year. It represented almost one tenth of all illicit drug 
users in the dataset. Alcohol related memory loss and alcohol related injury 
were the most common negative consequences. Those who were illicit polydrug 
users had a much less typical pattern of alcohol use. No illicit polydrug users 
featured in the most frequent observed patterns of use. In addition, the 16 most 
frequent patterns only accounted for 39.60% of all drug users. Patterns of licit 
and illicit polydrug use appear to be greatly variable. Consequently, it may be 
suggested that deriving suitable researcher chosen categories of alcohol and 
drug polydrug use would be extremely difficult, and that advanced 
methodologies such as latent class analysis can model these adequately.  
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7.5.2. Correlations between existing latent class structures 
From examination of correlational relationships between illicit polydrug 
use and alcohol use classes, it would appear drug class1 and drug class 2 were 
related to heavy consumption patterns. This is particularly evident in alcohol 
class 2. This was similar to findings in Lamers et al. (2006). They stated heavy 
drinking was associated with wider ranges of drug use such as those found in 
illicit drug use classes 1 and 2. However, illicit drug class 2 was also positively 
related to both alcohol class 3 and alcohol class 6. The relationship with alcohol 
class 6 was unexpected, given the approximately equally magnitude of 
correlational relationship with alcohol class 3. From this correlation method, it is 
suggested studies with an alcohol focus could be suitably estimated outside the 
context of drug use. However, it would appear if drug use is the focus, alcohol 
should be taken into consideration.  
7.5.3. Results of Model A 
Eight latent classes’ best explained patterns of response to the data in 
Great Britain. Two of these had some degree of illicit drug use, and thus were 
likely to be polydrug users (Polydrug classes 1A and 2A). The total 
memberships of these two classes were 2.64%. This is somewhat like the 
percentage found in Table 11 for individuals using two or more illicit drugs 
(2.76%). These classes appear characteristic of illicit polydrug use. They would 
also appear to be similar in illicit drug profile. Polydrug class 1A is characterised 
by slightly higher estimates of illicit drug use than polydrug class 2A and was 
associated with the heaviest level of alcohol related problems. The remaining 
six classes were similar to the profiles found in Figure 20. Two of the alcohol 
classes appear to split into those who take drugs and those who do not; these 
were alcohol classes 2 and 3.   
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The association of illicit polydrug use with heavy alcohol consumption 
was expected given previous literature. Lamers et al. (2006) suggested ecstasy 
and cannabis use, both of which are characteristic of polydrug classes 1A and 
2A were related to higher ASI scores. This supports the finding that drug use 
was related to alcohol problems. Heavy alcohol consumption was also related 
to illicit drug use in a study by O’Grady et al. (2008). This study found heavy 
alcohol use significantly related to likelihood of use of a range of illicit drugs. 
Namely, these were cannabis, hallucinogens, amphetamines, cocaine and 
ecstasy.  
Midanik et al. (2007) found concurrent users of cannabis and alcohol 
were 1.78 times more likely to binge drink. This is reflected in the patterns in 
Model A. There is also some support for the gateway theory. Kandel et al. 
(1992) suggested hazardous consumption of alcohol mediated the difference 
between those who used illicit drugs and those who did not. Given all classes 
with illicit drug use were found to be related to heavier consumption, this is 
somewhat supported. However, it is noted progress to illicit drug use is not 
inevitable, as many heavy alcohol users did not use illicit drugs in the past year. 
It is also beyond the scope of this research to identify trajectories, which 
characterises the gateway theory, however, it is important to note how there is 
some cross-sectional support. 
 The latent classes found in model A will now be compared to previous 
latent class solutions. Mitchell and Plunkett (2000) found four classes of user, 
‘abstainers’, ‘predominantly alcohol’, ‘alcohol and cannabis’ and ‘pleural’ drug 
users. The first two of these classes are represented in Model A (polydrug 
classes 3A-8A). However, the patterns of illicit drug use do not appear to follow 
the trends proposed by this paper. There was no cannabis only class, and the 
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percentage of inhalant use was much higher in the study by Mitchell & Plunkett 
(2000) compared to this solution. Classes of ecstasy users derived in Carlson et 
al. (2005) were dissimilar to classes found in Model A. For example they found 
a ‘limited range’ class which was characteristic of moderate levels of drinking 
(as measured by lower than mean drunkenness days), ecstasy and cannabis 
use. No such class was found in Figure 23. As has been stated in chapter three, 
latent classes based on ecstasy polydrug use do not seem to reflect general 
population trends.  
There are some similarities to Whitesell et al. (2006). This was the only 
study using this latent class analysis on licit and illicit drugs in a general 
population sample. Comparing with their yearly use patterns (see Figure 12). 
Their alcohol and cannabis polydrug use class had a lower probability of 
cannabis use, and a much lower probability of cocaine, ecstasy and 
amphetamine use. However, this class was more likely to use hallucinogens 
than either polydrug class 1A or 2A. Their alcohol only class was similar to 
polydrug class 3A, particularly the magnitude of cannabis use. This was 
reflected in their lifetime alcohol only class (see Figure 11). Their lifetime 
alcohol and cannabis class had similar probabilities of endorsement of cocaine, 
alcohol and cannabis to polydrug class 2A. However, their lifetime polydrug 
class was dissimilar to findings in Model A, having much higher probabilities of 
endorsement of all drugs. 
In terms of demographic differences, this model found young males most 
likely to be in polydrug class 1A and 2A. This is consistent with Falk et al. 
(2008) who found increased age was associated with decreased AOD polydrug 
use. Males were also more likely to be polydrug users in this study. The odds 
ratios reported in Table 32 display a broad trend of increased likelihood being 
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male and young as move from polydrug class 7A to 1A compared with the 
baseline class. This is also reflective of trends reported in chapter three and six. 
Relationships with lower educational attainment were found for polydrug 
classes 1A, 2A, 3A and 7A. Higher educational attainments were significantly 
associated with polydrug class 6A. Previous research suggests illicit drug use 
was associated with lower educational attainment (Lieb et al., 2002; Smit et al., 
2002). However, lower consumption rates were found in European adults who 
had a lower level of education (EC, 2007). This may in part explain the finding 
of polydrug class 7A, but not characteristics of polydrug class 6A. Economic 
inactivity was more likely for all classes compared to 8A. Polydrug class 7A was 
not related to economic activity. Illicit polydrug use modelled in chapter three did 
not have any significant relationship with economic activity. However, chapter 
six found relationships with economic inactivity for all classes with the exception 
of alcohol class 5. This change may well be a consequence of the new 
measurement model and lends support to the inclusion of alcohol in models of 
illicit polydrug use. There were no differences in urban trends in all classes 
compared to the baseline class which is comparable to previous research 
(Forsyth & Barnard, 1999; Galea et al., 2003) and findings in this thesis. 
Current smoking status was strongly associated with both the alcohol 
and illicit polydrug classes (1A and 2A). This is also cross-sectionally supportive 
of the gateway theory which suggests illicit drug use is preceded by tobacco 
and alcohol use. Odds ratios found for the remaining polydrug classes were 
somewhat different to those in chapter six. The membership of the heaviest 
alcohol class 1 was associated with current smoking to a similar degree as the 
membership of polydrug class 3A. This was also reflected in comparisons of 
those in alcohol classes 3 and 5 with those in polydrug classes 5A and 7A. 
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However, the remainder were slightly different. Alcohol classes 2 and 4 were 
less likely to be smokers in chapter six. The equivalent polydrug classes 4A and 
6A were significantly more likely to be smokers with odds ratios of 2.39 and 
1.81 respectively. This suggests relationships into alcohol and smoking should 
also take into consideration illicit drug use. 
All classes were equivalently less likely to have depressive episode than 
the baseline polydrug class 8A. This is supported by previous research in illicit 
drug use (De Win et al., 2006; Guillot, 2007; Hopper et al., 2006; Kelly & 
Parsons, 2008). Manninen et al. (2006) found some evidence for an ambiguous 
relationship between alcohol use and BDI scores which supports the findings of 
this chapter. This paper illustrated heavy drinking occasions were not related to 
elevated BDI scores particularly in males. Lipton (1994) in assessing benefits of 
moderate alcohol consumption suggested other moderating behaviours might 
assist with reducing the risk of depression. However, given the polydrug use 
classes did not differ significantly in their decreased risk, it would appear all 
polydrug use patterns were engaging in higher levels of such behaviours 
compared to the baseline polydrug class 8A. This is unlikely to be the case. 
However, research by Shaper (1995) and later Green and Polen (2001) into the 
‘unhealthy abstainer’ suggest people may quit or reduce their drinking due to 
other illness. The decreased risk could be less of a function of increased use, 
and more of a function of the characteristics of the baseline group which we 
compare all others to. However, recent research by Rehm et al. (2008) 
suggested inclusion of irregular lifetime light drinkers with lifetime abstainers as 
a baseline category was recommended. San Jose et al. (2000) suggested 
patterns of alcohol use might help illuminate relationships with depression, 
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however, this chapter has not illustrated any stronger link than was found in 
chapter six. 
No significant relationships were found between MAD and any of the 
polydrug classes in model A. Similar findings were reported in chapter six. 
However, MAD was significantly related to any illicit polydrug use in chapter 
three (OR=1.51). This difference between models is further evidence polydrug 
use should be measured in terms of licit and illicit drugs. The relationship 
between the polydrug classes and GAD confirms this. Any illicit drug use (from 
chapter three) was not significantly related to GAD. However, those in alcohol 
class 1 and 2 were significantly more likely to have GAD currently with odds 
ratios of 2.60 and 1.67 respectively. Comparable polydrug classes 1A and 3A 
(which were similar to alcohol class 1) were significantly more likely to have 
GAD (OR=5.49 and 2.25 respectively). The odds ratios of those in polydrug 
class 1A demonstrate the presence of polydrug use elevates the risks 
considerably compared to those who just use alcohol. Those in alcohol class 2 
had a comparable odds ratio to members of polydrug class 4A regarding GAD 
risk. Elevated risks for anxiety for both illicit drugs and alcohol use are 
supported by previous research (Keyes et al., 2008; Patton et al., 2002; 
Rodgers et al., 2000). 
The likelihood of an individual attempting suicide in their lifetime was 
significantly related to membership of alcohol classes 1, 2, 3 and 5. This is 
comparable to those in polydrug classes 3A, 4A, 5A and 7A. However, patterns 
of alcohol consumption and related problems found in the members of alcohol 
classes 1 and 3 were also found in polydrug classes 1A and 2A. The risk for 
suicide attempts were lower for those in polydrug class 1A (OR=1.37) compared 
with the corresponding alcohol class 1(OR=2.21). However, the risk was 
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elevated for those in polydrug class 2A (OR=2.73) compared with the members 
of the corresponding alcohol use class (2; OR=2.73). Dawson (1997) also found 
significant differences between average alcohol volume and elevated risk of 
suicide attempts. This was supported by Baigent (2005) who found increased 
AUDIT scores correlated highly with suicide ideation. Elevated risk of suicide 
attempts were also found in wide range polydrug users in a study by O’Boyle 
and Brandon (1998). Whilst this paper was in a treatment sample, it would 
appear to be supported by findings in this chapter. Finally, there were no 
differences in treatment seeking between models in chapters five, six and the 
current chapter.  
In summary, if researchers are interested in the measurement of 
psychological status in relation to drug use, polydrug use needs to be taken into 
consideration. Measurement models in chapters three and five also included 
hazardous drinking as a predictor. However, key differences in current 
psychological status were found across polydrug use patterns which were 
different to those reported to date. This was particularly evident for MAD, GAD 
and suicide attempts in the lifetime. San Jose et al. (2000) suggest patterns of 
alcohol use are important in determining risks of harm. This model has 
demonstrated patterns of alcohol use should also be considered when 
assessing harm attributed to alcohol and illicit polydrug use. 
7.5.4. Results of Model B 
The best fitting model in Model B was comprised of three illicit drug 
classes and six classes of alcohol use and related problems. The three illicit 
drug use classes differed from patterns found in chapter three (Figure 14). Illicit 
drug class 1 from chapter three had high probabilities of cannabis, 
amphetamines, cocaine and ecstasy, with probabilities of greater than .7 for all 
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drugs. Those in the polydrug user class had a similar probability of endorsing 
cannabis use, but a lesser probability of endorsement of the other drugs, 
particularly ecstasy. Members of drug class 2 in chapter three had a low 
probability (in the range of .3-.4) of consuming amphetamines, cocaine and 
ecstasy. However, in this chapter a ‘cannabis only’ class emerged. These were 
all cannabis users, with extremely low probabilities of any other use. Profiles 
found in chapter three, in light of new evidence, appear to be closer to a 
continuum of illicit polydrug use. The latent class structure found in this chapter 
illustrates more distinct qualities. Model A, might also appear to also be 
indicative of a cannabis only trend, although the probability of endorsement was 
relatively low for the classes in question, due to their varying patterns of alcohol 
use.  The frequency in this cannabis only cluster is similar to those reported in 
Table 12. The dataset contains 5.36% of individuals who used cannabis only 
(observed patterns of use). This is slightly less than the corresponding 
percentage of 6.37% in the cannabis only class. Additionally, chapter four 
supports this classification. Assessment of the strength of involvement in four 
common drugs suggested drug class 2 was characterised by cannabis use and 
lifetime experimental use of other drugs. These differences were not so 
pronounced in the profiles assessed in chapter three. However, this chapter in 
assessment of the drugs and alcohol section together that this became clear. 
 Latent classes of alcohol use and related behaviour found in chapter six 
were similar to those expressed in a combined model of alcohol and illicit 
polydrug use. Some percentage differences were found in terms of size of latent 
classes, this was particularly evident for alcohol classes 4 and 6. There were a 
greater number of baseline mild consumers of alcohol and fewer moderate 
consumers in Figure 24 compared to broadly similar classes in Figure 20.  
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 However, these are not standalone latent variable structures. The two 
latent variables are combined in classes found in Table 34. The most frequent 
class which had an illicit polydrug use pattern was polydrug class 1B, which had 
an alcohol use pattern similar to alcohol class 1 (from chapter six). The most 
common pattern of alcohol use and related problems in the cannabis only class 
was polydrug class 9B; similar to alcohol use in alcohol class 3. The no drug 
use class was most frequently associated with little or no alcohol use patterns 
characteristic of alcohol class 6 (polydrug class 18B). 
 The association of heavy alcohol consumption and illicit drug use 
whether cannabis only or wide range polydrug use is supported by previous 
literature. Lamers et al. (2006), O’Grady et al. (2008) and Midanik et al. (2007) 
all found similar links. Again this provides some support for the gateway theory, 
in there were no users of other drugs which were not highly likely to be 
cannabis users. However, it is clear progression from cannabis to other drugs is 
not inevitable, given the presence of the cannabis only class. 
 Classes found in this analysis will now be compared to those from other 
latent class analyses. A study by Mitchell and Plunkett (2000) into the polydrug 
use patterns found in an American Indian adolescent sample found four classes 
of use. These were ‘abstainers’, ‘predominantly alcohol’, ‘alcohol and cannabis’ 
and ‘pleural’ drug users. The first three classes are supported by findings in this 
chapter. There were few similarities with the illicit drugs used in the ‘pleural’ 
drug user class. This was characterised by high levels of ‘inhalant’ and ‘other’ 
drug use, which were not directly comparable to polydrug classes in Model B. 
 Carlson et al. (2005) applied latent class analysis to a sample of ecstasy 
users living in Ohio. They found three classes of ecstasy polydrug use; ‘limited’, 
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‘moderate’, and ‘wide’ range. None of the classes were congruent to the latent 
classes found within this model. 
 Whitesell et al. (2006) derived latent class patterns of both lifetime and 
yearly polydrug patterns in a US population sample. Lifetime patterns of alcohol 
and cannabis polydrug use in this paper were also reflective of polydrug use in 
this chapter (in terms of endorsement probability of alcohol cannabis and 
cocaine). Characteristics of their lifetime polydrug use class, however, were not 
synonymous to classes in this chapter. In terms of yearly patterns, considerable 
evidence was found in this chapter for alcohol use only. However, this thesis 
has consistently demonstrated patterns of alcohol use and related behaviours 
over the past year vary considerably within a general population sample. Their 
alcohol and drug use class was mostly dissimilar to those found in this chapter; 
the exceptions were the endorsement probabilities of amyl nitrate (inhalants) 
and tranquillisers.  The structures found within this chapter are perhaps a little 
more complex than other work in AOD populations, primarily because this 
chapter has considered extent and consequences of alcohol use.  
 As the severity of alcohol use increases in Table 35, so too does the 
odds ratio associated with the likelihood of being male. However, this increase 
in odds ratio is compounded by illicit drug use. For example, class 1B, 7B and 
13B were all characteristic of the same alcohol use pattern (heavy consumption 
with multiple negative consequences). However, the odds ratio ranges from 
13.49 for polydrug users to 6.13 for those who did not use drugs. Cannabis only 
users in polydrug class 7B were 8.47 times more likely to be male. These trends 
are also found when examining class membership and age. The youngest 
individuals in the dataset were also more likely to be polydrug users. This was 
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reflected in both Model A and recent research by Falk et al. (2008) using data 
from the NESARC population survey. 
 All polydrug classes entered into the multiple regression model were 
significantly more likely to be current smokers than the baseline polydrug class 
18B. However, the magnitude of the odds ratio did not increase as a function of 
increased polydrug use. This was somewhat surprising. Pedersen and Skrondal 
(1999) found their illicit polydrug users were approximately seven times more 
likely to have been currently smoking compared to those who did not consume 
illicit drugs. In addition, attempts to create typologies of polydrug use which 
have included tobacco demonstrate increased involvement with alcohol use and 
illicit drugs are indicative of an increased likelihood to be either smoking (Smit et 
al., 2002) or nicotine dependent (Lynskey et al., 2006). 
 Lower educational attainment was significantly associated with 
membership of polydrug classes 9B and 17B compared with the baseline 
polydrug class 18B. The relationship with 17B, a mild alcohol consumption 
group is supported by population studies into European adults (EC, 2007). 
Polydrug classes 2B and 17B were significantly more likely to be in employment 
compared to the baseline class. This differs from some results to date. 
Comparisons with chapter six illustrate economic inactivity was significantly 
related to all classes except alcohol class 5 (which was a component part of 
polydrug class 17B). If this holds in the presence of illicit drug use 
measurement, the majority of the remaining classes should all be significantly 
related to economic inactivity. Model A which found a similar class to polydrug 
class 17B (polydrug class 7A) also found significantly lower associations with 
economic inactivity. However, this relationship does not explain the greatly 
decreased risk of economic activity found in polydrug class 2B. This may be 
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indicative of a ‘work hard, play hard’ class which fits with Parker and Williams 
(2003) study into the lifestyles of young people. They found young adults could 
maintain employment and good relationships, yet still polydrug use at the 
weekend. No relationship was found with any illicit drug use compared to the 
baseline no drug use class in chapter three. This represents a distinct shift in 
trends as a function of the measurement model used. Similarly differences were 
found in urbanicity in Model B which had not been previously found in this 
thesis. Polydrug class 1B, 9B and 14B were all significantly more likely to be 
living in an urban area compared to the baseline class. Whilst previous research 
had broadly found no relationship, Wadsworth, Simpson, et al. (2004) found 
illicit drug users were less likely to be living in a rural area. Another study 
comparing two regions in a geographical area found no difference in illicit drug 
users and non-illicit drug users (Forsyth & Barnard, 1999). Galea et al. (2003) in 
a review of the literature found little relationship between urbanicity and patterns 
of drug, alcohol and tobacco use lending further support for this finding in model 
B.  
 Examining the relationship between model B and depressive episode 
illustrates a significantly decreased risk for those in polydrug classes 14B, 15B, 
and 16B. The risks are approximately halved compared to those in the baseline 
polydrug class 18B. However, polydrug class 2B was characterised by a greatly 
increased risk to any illustrated to date in this thesis with an odds ratio of 8.30. 
This is considerably larger than the odds ratio found in chapter five (2.85) which 
referred to an increased risk for any drug use. However, no other elevated risks 
for this condition were found. The reason any drug use elevated the risk in 
chapter five may be a function of their patterns of alcohol use rather than their 
drug use patterns. 
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 Despite finding no significant differences in risk of MAD in Model A, some 
differences were found in Model B. Those with no drug use and moderate 
alcohol use patterns (members of polydrug class 16B) were significantly less to 
be experiencing this condition. However, elevated risks were found for those in 
polydrug classes 1B, 2B, 7B, 9B and 13B. The largest odds ratios were 
characteristic of polydrug classes 1B and 2B with 2.82 and 5.28 respectively.  
 Differences were apparent when assessing the relationship with GAD. 
Polydrug classes 1B, 7B, 11B, 13B and 14B were all characterised by higher 
risk of GAD compared to those in the baseline class. The highest risk was found 
for the members of classes 1B and 11B. These were characteristic of ‘polydrug 
use, heavy alcohol consumption and multiple negative consequences’, and 
‘cannabis only use, mild consumption with injury and suggestions to cut down’. 
The latter has the greatest risk of this psychological status with an odds ratio of 
12.43. This was considerably higher in magnitude than any of the risks 
identified with polydrug classes 1A to 8A, and those found in chapters five and 
six. Additionally, it does not appear to follow trends in the literature for either 
alcohol use patterns or cannabis use. For example, Degenhardt and Hall (2003) 
found no significant relationship with cannabis use and anxiety disorder. 
Newcomb et al. (1993) found an elevated risk for alcohol and cannabis to be 
found in CED-D (depression scores) but not anxiety. 
 There were no significant differences in suicide attempts during the life 
course for all polydrug ‘B’ classes entered into the analysis compared to the 
baseline class. This is contrary to previous findings. Dawson (1997) and 
Baigent (2005) identified a link with average alcohol consumption and 
increasing AUDIT scores, which was not replicated in Model B. Furthermore, 
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O’Boyle and Brandon (1998) identified a relationship between increased 
involvement in (illicit) polydrug use and suicidal behaviours. 
 Finally, as was found in previous models in this thesis, there was limited 
evidence of any increased treatment seeking in Model B. This was despite any 
increased risk for poorer psychological health for a number of the classes. 
However, there were two exceptions; polydrug classes 15B and 16B. The 
former were characteristically more likely to visit their GP for a physical problem 
in the past year and the latter were characteristically less likely to visit their GP 
in the past year for a physical complaint (compared to the baseline polydrug 
class 18B). In explanation of this finding, perhaps moderation patterns typical of 
alcohol class 4 are evidence of a healthier lifestyle, or overall better health from 
moderate drinking and no illicit drug use (Lipton, 1994). It is unclear what 
characteristics of polydrug class 15B explain the elevated risk due to similarities 
between other classes 
 In summary, Model B has afforded new insights into polydrug use 
patterns in Great Britain. Many of these were unexpected given results of 
previous research and analyses presented in this thesis. However, this could be 
a function of the distinct way in which alcohol and illicit drug use were modelled 
together. 
7.5.5. Which model explains the patterns best? 
Both Model A and Model B demonstrate differences which highlight the 
benefits of modelling illicit and licit drugs together. However, the following is a 
brief discussion on the relative merits of both models and which might be most 
appropriate to adopt in other population samples. The approaches were 
different in not only the way in which the latent variable was measured, but in 
the methods used to perform the multinomial logistic regression. Model A used 
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the same methodology as used in previous chapters, three, five, and six. 
However, given the low percentages of some polydrug ‘B’ classes, this method 
was not possible to replicate. 
Using conditional probabilities in regression gives a better estimate, as 
variation in observed patterns of response can be captured by the conditional 
probability of class membership. However, returning to the issue of 
nomenclature highlighted in the introduction, when generating latent structures 
to explain a phenomenon, labels are assigned which succinctly describe 
patterns within the data. From these labels inferences are made about 
behaviours in classes. Not all studies will be able to use latent class 
methodologies, as a relatively large sample size is required. However, they can 
still infer relationships with previously found latent classes based on their broad 
descriptors. Since these broad descriptors are key to summarising the findings, 
perhaps there is not a problem in using these for analysis purposes. 
Consequently, exclusion of classes with low responses eliminates some 
of the atypical patterns which would be expected in the data. However, one of 
the key advantages to latent class analysis is inclusivity and a person-centred 
approach (DiStefano & Kamphaus, 2005). Perhaps given the diversity of the 
general population in terms of the percentage of alcohol and drug use in the 
past year, dissimilarities should be expected by the very nature of patterns of 
consumption. 
 However, model B does not appear to be widely supported by previous 
literature. This could be a function of the methodological issues in previous 
research and their ability to be compared to latent variable models which exploit 
patterns of use in data better than researcher chosen categories or it could 
resemble a poor fit to reality. It is also of note the best loglikelihood did not 
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replicate in this model. This could be a function of the computing power 
available for this research, and thus improved computing power may be able to 
get the solution to replicate. Model A was somewhat better supported by 
patterns in previous research. Generally, it would appear to be the more robust 
of the two approaches. Therefore, it could tentatively be suggested this model 
should be taken as the best representation of the data. However, this should be 
interpreted with caution and future research is needed using the techniques 
described in this chapter to lend any weight to a given ‘gold standard’ approach, 
to be adopted by the research community. However, despite which model was 
concluded ‘best’ in explaining patterns in the dataset, it is apparent from all 
models tested that the traditional separation in the literature is no longer 
appropriate. Typologies of illicit drug use differ depending on whether typologies 
of alcohol use are measured at the same time. When examining psychological 
status, both illicit and licit drug use appear affected by whether the illicit drugs 
and alcohol use are included in the model. Therefore, anyone interested in 
changes in psychological status for illicit drug use or alcohol use separately, 





 Primarily this research has sought to explore and enhance the 
understanding of the polydrug use phenotype at the general population level. 
This chapter will firstly review how the methods used within this thesis have 
accounted for polydrug use. This will be followed by a summary of the results in 
the context of the aims specified in the introduction. The limitations of the study 
will be highlighted in the context of the hypothesised contribution to the 
literature. This will finish with exploring avenues for future research arising from 
this work, and implications for policy. 
8.2. Accounting for polydrug use: advantages to the latent class 
methodology 
 Latent class analysis is a methodology which is well suited to describing 
polydrug use. Specifically, a number of issues which affect research due to 
polydrug use were identified in section 1.5. Firstly, lack of isolation of one drug 
from another makes it difficult to draw conclusions on single drugs. Second, the 
wide variety of possible combinations of polydrug use makes it difficult to 
categorise individuals into common groups, chosen by inspection of patterns. 
Latent class analysis can address both of these problems. The method provides 
a conditional probability which can indicate membership of a given class by a 
given pattern, even if this pattern is rare in the dataset. When these are 
regressed on other variables, these conditional probabilities enable 
relationships to be estimated which account for the lack of isolation.  
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Furthermore, the data used for analysis was a large, multi-stage, randomly 
sampled survey which had a wide variety of patterns of response. Notably, 
there were 78 patterns of illicit drug use response, 208 patterns of response to 
the AUDIT questionnaire and 535 patterns of polydrug use. Given these figures, 
it is wholly unsurprising researcher driven categories that have not been 
statistically validated are unable to account for the variability in their sample of 
interest. Researchers should be aware choosing categories examined response 
patterns are likely to be inadequate in conceptualising variability.  
Another reason why polydrug use affects drug research regards the 
differing number of drugs being used. This analysis attempted to include as 
many drugs as possible in the analysis which would not affect model 
identification. This also maximises the number of possible patterns in the data 
and retains as much original information from the dataset as possible. Those 
with a low probability of use within the sample (typically less than seven in 8580 
individuals) were excluded. They represent very low percentages of use in the 
general population. It was also difficult to combine tobacco consumption in the 
same way as drug use and alcohol use. These were both measured in a yearly 
time frame which was not captured for tobacco use. However, exclusion from 
the latent class analyses had some utility. In these analyses current smoking 
status was used as a predictor throughout. This was advantageous, as strong 
relationships of polydrug use with smoking are apparent, and thus it is an 
excellent means by which to validate latent class structures. However, given the 
potential for harm, further research may wish to seek a way to include current 
smoking. This makes most sense where smoking status is measured in a 
consistent way to the other variables.  
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 Differing definitions of polydrug use affect comparability across studies. 
As section 1.5.1 has illustrated, polydrug use has been defined in many ways. 
However, this thesis has defined polydrug use clearly to facilitate better 
comparisons with similar work. This has been kept constant throughout 
chapters. General population work is useful to identify key trends in polydrug 
use, however, it is also important to examine percentage rates amongst key 
subpopulations which are particularly prevalent in drug use such as ‘club drug’ 
users (such as Kelly, et al., 2006). The methodologies used in this thesis are 
robust in the context of polydrug use, therefore, latent class analysis may be 
able to elucidate patterns of use in the context of higher frequencies of drug 
use. With the advantages afforded by this methodology in mind, how the 
chapter meets the overall aims of the thesis will now be assessed. 
8.3. Can the variability in polydrug use patterns be accounted for? 
Chapter three revealed 30% of those who used illicit drugs in the past year 
from the population of Great Britain were illicit polydrug users. Three classes 
emerged from observed patterns of illicit polydrug use response, wide range, 
moderate range, and no drug use. The wide range class predictably had the 
smallest membership. The classes represented ranges of drug use rather than 
focussing on named drugs of use. They were ‘wide range’, ‘moderate range’ 
and ‘no use’ classes. These were also found to have quantifiable differences in 
terms of the involvement of each of the component drugs in the pattern (chapter 
four). This was further evidence of the utility of the latent class procedure to 
measure polydrug use adequately and the validity of the solution. 
Alcohol was conceptualised in six latent classes representing alcohol use 
and related behaviours in the past year. These were broadly based on a 
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continuum of increased consumption and problems. However, one of the mild 
consumption classes differed, through a higher than expected relationship with 
negative consequences; in particular, alcohol related injury and suggestions to 
cut down on alcohol use.  
Finally, two integrated models were proposed. The first of these found an 
eight class solution for a single latent variable measured by nine illicit drug 
variables and 10 AUDIT questions. Two of the classes were typically using illicit 
drugs, with a range of drugs being used. The illicit drugs most likely to be used 
were cannabis, amphetamines, cocaine, and ecstasy for both of these groups. 
This represented a departure from the illicit polydrug use classes, as the wide 
range polydrug use pattern was the primary pattern expressed. Both of these 
classes were characterised by heavy alcohol consumption, one with multiple 
negative consequences, and one with memory loss. Largely, the structure of 
alcohol use and related behaviours remained unchanged in this model, but the 
percentages of each pattern differed. This was not unexpected given some of 
the alcohol use patterns now included illicit drug use. 
The second integrated model also found differences between previously 
found structures. In particular, the structure of illicit drug use changed 
dramatically when estimated in the presence of alcohol use. The wide range 
pattern found in chapter three remained, but with slightly lower probabilities of 
use for all illicit drugs except cannabis. The moderate range class found in 
chapter three did not appear to be robust when measured with alcohol use 
behaviours. Instead, a cannabis only class appeared to best describe the data. 
Support for this comes from the findings of chapter five which found the original 
illicit drug class 2 was characterised by cannabis use, and low lifetime usage of 
other drugs. As with model A, the structure of alcohol use remained the same, 
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however, there were larger percentages of the baseline group at the expense of 
the frequency of the moderate range group. If alcohol use is the focus, it may be 
relative to examine it on its own; however, where illicit drug use is the subject of 
interest, it is more advantageous to consider it in the light of alcohol use. 
 Returning to the illustration of ecstasy research in the introduction 
(section 1.6.1) it is clear research into drugs whilst failing to account for 
polydrug use at the illicit level, ought to consider alcohol use in addition to the 
drug of interest. Recent papers highlight polydrug use continues to be described 
as a limitation of research, rather than key to the conclusions drawn. These 
commonly attribute any found relationships with a single drug (for example, 
Keyes et al., 2008) where polydrug use may be at work. In addition, for those 
classes which are polydrug users, there may be some overlap between 
consequences attributed to alcohol in the AUDIT. For example, the 
questionnaire contains an item on memory loss attributed to alcohol use. Where 
an illicit drug is concurrently used with alcohol, this may increase the risk of a 
‘blackout’ experience. The AUDIT questionnaire asks only about alcohol use, 
and it may be that in studies where illicit drug use is not gathered, alcohol could 
be held primarily accountable where a polydrug pattern could be responsible. In 
this way, a single alcohol focus could also be considered unable to account for 
polydrug use. Future research may wish to consider the impact of drug use on 
the alcohol related consequences of the AUDIT. 
8.4. Are these valid in terms of relationships with demographic 
variables? 
 It is considered structures generated from latent classes should be a 
close fit to the data but also theoretically meaningful in the context of previous 
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research. To further validate the latent class structures using variables other 
than those relating to drug use, the classes were compared to demographic 
criteria known to be associated with polydrug use. One of the key findings was 
the elevated risk of hazardous alcohol consumption, particularly in the wide 
range illicit polydrug use class, compared to the baseline class. This was a clear 
indication of the strong relationship between alcohol use and illicit drug use. 
There were also differences in age with the youngest being the most likely to be 
in the wide range polydrug use class, compared to both the moderate range 
polydrug class and the baseline no use class. Significant relationships with 
other demographic variables appeared to be indiscriminately related with any 
illicit drug use regardless of the range of use. Any illicit drug use was related to 
being male, a current smoker, and low educational attainment. 
 Chapter six, also found significant demographic differences with alcohol 
use classes. Heavier rates of consumption were associated with being male 
and young. In addition, moderate to heavy consumers were also more likely to 
be characteristic of economic inactivity compared to the baseline class. Lower 
educational attainment was related to the class with the heaviest alcohol 
involvement, and higher educational attainment was significantly associated 
with moderate consumption. Current smoking patterns were only related to 
heavy consumption with multiple negative consequences and heavy 
consumption with memory loss. 
 However, relationships with demographic variables differed when 
polydrug use was measured as a unified concept. Odds ratios relating to gender 
illustrated illicit drug and alcohol polydrug users were most likely to be male, 
and the magnitude of this odds ratio greatly increased. In addition, the two illicit 
drug use classes in model A (polydrug classes 1A and 2A) were characterised 
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by odds ratios of around 20 and 12 times more likely to be currently smoking. 
This would partly explain some of the differences found between patterns in the 
alcohol use only solution. Those with increased polydrug use involvement were 
also more likely to be young; a finding comparable to those of earlier chapters. 
8.5. How does polydrug use relate to psychological status? 
 In terms of relationships with poorer psychological health, chapter five 
described illicit polydrug use classes as significantly associated with depressive 
episode, mixed anxiety and depression and suicide attempts during the lifetime 
compared to the baseline class. However, any illicit drug use appeared to 
elevate the risk, rather than relating to the range of drugs used. This suggests 
relationships with psychological status may be more attributed to illicit drug use 
than illicit polydrug use. However, it appears illicit drug users are aware of this 
risk, and even in some cases attempt to prevent harm through protective 
behaviours (Verheyden, Maidment, et al., 2003). 
When alcohol use behaviours were modelled separately, an increased 
risk for generalised anxiety disorder in the heavier consumption classes was 
found, and classes 1, 2, 3 and 5 were found to more likely to have committed 
suicide in the past year. In the integrated model, wider range polydrug use was 
related to mixed anxiety and depressive disorder. The relationship with 
generalised anxiety disorder is less clear than in the illicit drug or alcohol only 
latent class solutions. The wide polydrug range class with heavy consumption 
and multiple negative consequences is almost eight times as likely to have this 
condition, as is the cannabis and no drug use classes with the same group of 
alcohol use.  The anomalous class here is the cannabis class with mild 
consumption, with injury and suggestion to cut down, which could perhaps not 
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be predicted by a heavier involvement in drugs leading to more problems 
hypothesis which has the highest probability of all classes. Parrott, Milani, 
Parmar and Turner (2001) suggest where ecstasy and cannabis use are 
combined they are less likely to have somatic symptoms, and the suggestion 
cannabis use has some kind of protective effect perhaps not supported by the 
relationships illustrated in the wide range group (Daumann et al, 2004). 
Degenhardt et al. (2004) has further suggested cannabis is not related to 
anxiety; however, the presented integrated model would suggest the converse. 
The lack of differences found between groups of drug user in the illicit drug use 
patterns found in chapter six, might be due to the lack of adequate modelling of 
alcohol use in a polydrug context. Sumnall et al., (2004) found that elevated 
anxiety levels were found for users of alcohol, amyl nitrate and tobacco use. 
Furthermore, Semple, McIntosh and Lawrie (2005) have suggested that risk is 
increased with early adoption of drug use, however, incorporation of age of 
initiation into drug use did not feature in this investigation, however, it may be 
an avenue for further study. It could be tentatively suggested from the evidence 
by Kushner, Sher and Beitman (1990) that generalised anxiety disorder may 
well occur at the same time or after problem drinking. 
Given the elevated risk of suicidal behaviours in the past year for both 
the alcohol use and illicit polydrug use latent class solutions it is surprising to 
note in the integrated model there was no relationship with suicide ideation of 
any significance. This is contrary to findings by O’Boyle and Brandon (1998) 
which suggests wider drug use involvement is implicated in the elevated risk of 
suicidal behaviour.  
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8.5.1.1. No relationship with depression 
This research found a decreased risk or no relationship compared with 
the baseline group for the alcohol use classes measured separately. In the illicit 
drug use only model, any drug use was elevating the risk to approximately twice 
that of the baseline, no drug use. Lyvers (2006) makes an important point about 
drug use, do we really want to find drug (and ecstasy use in particular) to be 
bad for the users? Evidence given since the popularisation of the internet, anti 
drugs sites scare tactics are ignored, and cast doubt on the credibility of 
research; whereas pro-drug sites and their plethora of incomplete anecdotal or 
false information is equally problematic (Maxwell, 2005). This is reflected in a 
recent study by Keyes et al. (2008) who stated the lack of a finding with 
depression suggested given the ‘percentage of depression is not elevated in 
current ecstasy users warrants further investigation into a possible delayed 
effect of ecstasy on a full-spectrum depression diagnosis’ pp.143. In this way, 
perhaps we should consider another explanation, one of which might be 
polydrug use, social support, gender differences or many other factors. As 
described by Topp et al. (2004) state we have a duty to provide the most 
accurate and methodologically sound to those who choose to use, and to those 
who do not. This is not least because the potential for harm is one of the 
primary concerns for those who choose to quit (Verheyden, Henry, et al., 2003). 
Additionally, If you consider your ecstasy use as problematic, you are more 
likely to have problems as measured by the Brief Symptom Inventory (Soar, 
Turner & Parrott, 2006), demonstrating almost an expectancy effect for users. 
Consequently, researchers need to be objective to their findings.  
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8.5.1.2. Lack of treatment seeking 
Although a risk of psychological disorders is apparent in the context of 
polydrug use, it is also clear that there is not an associated risk of relevant help 
seeking. This is a common problem (Kessler et al., 1996). Often some of the 
reasons to explain this is a low perception of need, less severe symptomatology 
and the absence of comorbid mental health and drug use disorder (Mojtabai, 
Olfson & Mechanic, 2002). Furthermore, given the individuals who are 
experiencing this increased likelihood of harm are more likely to be young. A 
recent study illustrated in a New Zealand birth cohort that only 7% of young 
adults with an alcohol problem were presenting for treatment. Males were also 
more likely in this cohort to fail to see need to seek treatment, or to consider it 
might get better on its own (Wells, Horwood & Fergusson, 2007). Finally, Topp 
et al. (2004) suggested those experiencing problems related to ecstasy use 
may modify their own behaviour without assistance. 
8.6. Methodological concerns and additional findings 
 As with any study, there are some methodological concerns which affect 
the conclusions. These will be detailed below. 
8.6.1. High risk populations 
In the analysis of household surveys, there is the potential to miss some of 
the high-risk individuals, such as those who are homeless or vulnerably housed 
(Ramsey & Percy, 1997). However, this research is concerned with the global 
picture of use in the general population of Great Britain and there will be still be 
individuals in this dataset who use licit and illicit drugs. Additionally, the 
methodologies used in this work are equivalently appropriate to application in 
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more specific populations which are of higher risk, such as the NPMS 
conducted on a sample of homeless individuals, or in prisons. 
8.6.2. Characteristics of responders and non-responders 
 There might also be differences in responders and non-responders, just 
as this work has found differences in those who had participated in this 
research. However, it is unclear as to what these might be. Those who use illicit 
drugs may be less likely to participate in studies of this kind. Unhealthy lifestyle 
choices are not always related to non-response with a study finding males who 
were not hazardously drinking had a higher rate of non-response (Hill, Roberts, 
Ewings & Gunnell, 1997). Other studies have found no differences in alcohol 
use and attrition rates (Cunradi et al., 2005) and heavier smoking and alcohol 
use in absent school students versus present students (Bovet et al., 2006). 
Whilst there is some conflict in the literature on the characteristics of non-
responders, assessments in the methodology section of this thesis described 
lower levels of response to the drug items compared with the DMD of the same 
year. However, the NPMS estimates did appear to be like DMD 2007/8, 
suggesting the research may reflect more contemporary trends. Little research 
to date has focussed on those who do not complete randomly sampled 
household surveys using a similar methodology to the OCPS, particularly in 
terms of their drug and alcohol use, and further research in this area may be 
useful to inform the field. 
8.6.3. Sample size and surveyed group considerations 
It is also understandable on occasion the sample size will not be 
appropriate to conduct latent variable analyses. However, in an Mplus webnote, 
Muthén (2002) illustrated through Monte Carlo simulation studies in latent 
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growth analyses that latent variable analysis is possible even in relatively 
modest sample sizes. The Monte Carlo method would additionally be able to 
assist any researchers to inform whether using latent class methodologies on a 
given sample size would result in lower quality parameter estimates and 
inadequate power.  
Analyses of specific social situations in which drug use might occur, for 
example rave or nightclub populations will likely have higher percentage rates, 
and may find different patterns of use, given the effects of drug, set and setting 
(Zinburg, 1984). Exploitation of these methods would be useful to compare to 
this research. Results from chapter eight have suggested that rave or nightclub 
populations could be hypothesised as an expansion of the use found in the 
Great British population, providing a more general form of drug use, from which 
there might be some more defined subsets. Research by Topp et al. (2004) has 
suggested results from purposive sampling and general population surveys 
have similarities, although these were assisted by differing time frames. 
8.6.4. The issue of nomenclature 
In contrast to using the term ’ecstasy’ user or ecstasy polydrug user, 
researchers may wish to name their groups in a way which encapsulates the 
spectrum of use. This should be applied either as a collective of the most likely 
drugs reported, or as an indication of the range of drugs. This problem with 
naming is not exclusive to the drug use literature, but where any latent variables 
are being described (Bollen, 1989; Cliff, 1983) whether generated from a latent 
variable analysis or just simply a latent conceptualisation.  
For names to be accurate, they might also be unfavourably long, and not 
very catchy. As mentioned in section 2, it is simpler and more memorable to call 
groups ‘ecstasy users’, than, for example ‘ecstasy, amphetamine, cocaine, 
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cannabis, tobacco, mushrooms and LSD user’. Care must be taken to fully 
assess the properties of any described empirically or researcher driven classes, 
and as this thesis has shown, the names can and do change according to what 
is known about their membership. Chapter three found wide range, moderate 
range and no drug use, but upon further investigation the nomenclature 
changed. The moderate range illicit polydrug user became a cannabis only user 
when measured with alcohol use in chapter seven. 
8.6.5. Abuse and Dependence 
The patterns of usage in this thesis do not extend to either alcohol or 
drug abuse or dependence. Whilst this is an important area for research, it is 
also important to describe patterns of use for the whole population of Great 
Britain to assess a more global view for policy and other purposes. The 
inclusion of abuse or dependence measurements would provide a cyclical 
argument given progress into the abuse or dependent questions of the 
questionnaire was through crossing a threshold in the use section. But, as a 
guideline, Gmel, Heeb and Rehm (2001) described the depth of involvement in 
terms of the frequency of use of drugs is often a good illustration of the 
experience of problems. 
8.6.6. Who are the baseline group? 
Midanik et al., (2007) suggest it is obvious to create a typology 
comprised of zeros across all drug use indicators. However, in this thesis we 
sought to conceptualise patterns from the data, and as stated by Simon and 
Mattick (2003), baseline groups with some psychoactive substance use are not 
rare. The baseline group in chapter four comprised of some cannabis only 
users, however, differences were still found in relation to demographic and 
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mental health criteria compared with this baseline group. Furthermore, Lyvers 
(2006) suggests control groups should be matched in terms of their IQ, age, 
educational attainment, or other demographic criteria. In regression models, 
such as the multinomial logistic regressions performed in this thesis, the effect 
of variation in these variables are controlled for when assessing the contribution 
of the variable of interest. Lyvers (2006) also suggests in drug research, alcohol 
use should also be matched.  Yet, this research has illustrated the patterns of 
alcohol use in drug users may be extremely variable, even amongst a group of 
drug users with a homogeneous pattern of use.  Latent variable analyses offer 
an opportunity to both capitalise on the differences found in the population, 
providing models which are more accurate representations of real life, and 
control for these differences when examining at other variables. 
8.6.7. Relationship with the gateway theory 
To briefly summarise, this considers drug use as a developmental issue, 
considering a progressive sequence of alcohol, tobacco, cannabis and other 
drugs (Kandel & Faust, 1975). It has been further suggested that there is little 
progress to illicit drugs without the use of cannabis first (Kandel et al., 1992), 
and this may also be potentially mediated by problem drinking (Donovan & 
Jessor, 1983). The relationship of the illicit drug only latent variable, illustrates a 
predictably greater risk of smoking, and hazardous drinking as measured by a 
score of eight or more on the AUDIT also appeared to be characteristic of the 
wide and moderate range polydrug users in comparison to the baseline group. 
When patterns of alcohol use behaviours were assessed in greater depth as in 
chapter eight, it would appear heavier alcohol consumption was related to illicit 
drug use (over and above cannabis only use) in the eight-class solution.  
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The two latent variable solution also provided some evidence to support 
the theory with the wide range polydrug users having a generally heavier 
pattern of alcohol use consumption; although there were five individuals that did 
not fit this pattern (3.5% of the total group). By comparison, the cannabis only 
group were also traditionally associated with heavy alcohol use, with the most 
prevalent in the heavy/moderate consumption with memory loss group. This 
would suggest it is not an inevitable that heavy consumption would lead to 
further drug involvement. There is also evidence that cannabis use can also be 
associated with moderate to mild consumption with almost 17% of the cannabis 
using group in polydrug classes 10B through 12B. Like Midanik et al., (2007) 
there were no classes found which either had hard drug (i.e. illicit excluding 
cannabis) without cannabis and alcohol. Kandel et al. (1992) further iterate one 
of the characteristics of individuals’ progression in drug history might be 
mediated by firstly, their age of initiation into the drug, and finally the extent of 
their use. Whilst it was not possible to assess the age of initiation into drug use, 
there is tentative support for this in the research of this thesis. Those using illicit 
drugs are more likely to be younger than the little or no alcohol consumption 
and no illicit drugs groups. As it is beyond the scope of this research to confirm 
this may be an avenue for further study. Research also suggests that 
individuals tend to mature and grow out of drug use as they progress in age 
(Carlson et al., 2005; O’Malley, Bachman & Johnston, 1984; Substance Abuse 
and Mental Health Services Administration [SAMHSA], 2007; Von-Sydow et al., 
2002). It is worth noting however, that given the gateway theory is essentially 
longitudinal in it’s nature, there can only be limited evidence to support it 
through cross-sectional research. 
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8.6.8. Females: A group of abstainers? 
This research unequivocally found that men were more likely to be licit 
and illicit polydrug users, and to a higher extent than the baseline groups for 
respective chapters. So, what does this tell about the experiences of females 
with regard to drug use? As mentioned previously males are more likely to be 
taking illicit drugs (Chivite-Matthews et al., 2005; Collins et al.,1998; Webb et 
al., 1996), but the finding that the gap is narrowing by Newbury-Birch et al. 
(2000) and Wadsworth, Simpson et al. (2004) does not appear to be replicated 
by this group. 
 As suggested by Measham (1995) the experiences of females using 
drugs cannot be discounted. This is supported by Hinchcliff (2001) who states 
the need for pleasure or altered states is as valid and normative for women as 
for men. Perhaps more research focussed on women, or the replication of these 
methodologies but allowing the determination of the latent variable to be a 
function of gender (as predictor) might provide a better expression of the 
experiences of women. In addition, women are more likely to experience the 
midweek low (Curran & Travill, 1997) and have a higher rate of injury at 
equivalent consumption rates to males (McLeod et al., 2004). 
8.6.9. Polydrug use; both worthy of study, and better accounted for by latent 
variable analyses 
This research has described distinct patterns of polydrug use in the 
general population. Through exploring these, estimates of the relationship 
between polydrug use and psychological status can be determined. As Byquist 
(2006) has stated “it is now more appropriate to speak of different types of 
polydrug user than the users of only one drug” (p. 216). 
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However, it is worth revisiting the definition of polydrug use as either 
simultaneous or concurrent considering the findings. Whilst the early 
considerations of polydrug use suggested the nature of this could only be 
adequately described as concurrent use, it may be additionally likely that those 
who consume illicit drugs are likely to be simultaneously combining this with 
alcohol. Evidence to support this includes the statistic that 99% of illicit drug 
users have also used alcohol in the past year. Given that alcohol is consumed 
more often than illicit drug use (for the majority), it may be less relevant to 
assume all alcohol consumption occasions have also involved illicit drug use. 
This is supported by the finding that 10% of alcohol users in the past year were 
illicit drug users. Perhaps it is less relevant as a distinction than previously 
considered in section 1.5.1 
 Latent variable analysis can model to exact probabilities in the variability 
in expression of reported drug use. Furthermore, the reliance of single drug 
research to assess demographic risk factors and poorer psychological health 
has been shown to be unable to account for polydrug use in their conclusions. 
The measurement of illicit drug and alcohol use patterns separately has been 
considered as related to serious consequences for study outcomes. 
Consequently, if an AOD approach is adopted, the research field can better 
estimate how patterns, rather than drugs can impact individuals’ lives. This is 
already an approach adopted by clinical practitioners seeking to treat multiple 
drug abuse or dependence. The symptoms that are shared (and also unique) to 
a particular drug or drugs are treated for maximum chance of achieving goals 
for treatment (Gossop et al., 2002). In addition, the phenotypes derived in this 
person-centred approach could also inform the search for genetic markers for 
drug use, or to inform prevention and harm minimisation intervention strategies. 
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Further research might wish to assess whether these phenotypes endure in 
other populations or over time.  
8.7. Further recommendations for research to assess changes in 
contextual drug use over time  
Aside from some of the recommendations given above, there are 
additional recommendations for further study. It is recommended changes in 
contextual drug use over time are assessed. This research has provided a 
guide to the polydrug patterns of use from a study with data collected in 2000. 
In the introduction, recent European trends were assessed in relation to both 
alcohol and illicit drug use. Cross-sectional views of drug and alcohol 
percentage rates naturally fluctuate over periods of time (Collins et al., 1998), 
and there has been evidence of this in European drug trends with some drugs 
falling in and out of popularity, for example the increase in cocaine use 
(EMCDDA, 2008).  However, there have been fewer notable explorations of 
trends either measuring a cohort over time, or shifts in cross-sectional 
measurement. A longitudinal analysis of the work contained in the NPMS 
surveys including the next wave of data being currently collected, would enable 
a wider reflection of trends in the past 20 years. As nationally representative 
data from a random, stratified sample, this would provide interesting information 
on trends in the UK using standardised measurements.  Furthermore, analysing 
data from EMCDDA situation of the drug use situation in the EU and Norway, 
which is provided yearly in a similar manner, would be able to first illustrate 
whether patterns are consistent over time or over different countries. This would 
expand both the knowledge and implications of polydrug use in Europe. 
However, this would only provide trends in illicit polydrug use rather than 
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polydrug use as a general concept. The importance of addressing this issue of 
trends is an important indicator to highlight needs for policy, but also to assess 
the impact of policy and attitudinal shifts in terms of their impact on polydrug 
use. 
In addition, with the problems of causation arising from cross sectional 
research, this approach may be able to flesh out the relationship between drug 
use, harm and demographic criteria in a way which better estimates causation. 
For example, longitudinal research may be able to assess the viability of the 
self-medication hypothesis (Khantzian, 1997); the assertion that depression is 
often medicated with stimulants, and anxiety with depressants such as alcohol 
or heroin. It can be stated from this research polydrug use and harm are not 
independent of each other.  
In conclusion this research has described theoretically valid homogenous 
subgroups of alcohol and drug use present in the general population, which can 
approximate to and aim to understand the concept of polydrug use. It is also 
plausible, methodologies such as this, may assist with the demystifying some of 
the disparities in both the relationship of drugs with demographic criteria and 
psychological harm. However, to imply causation, further research, preferably 
longitudinal analyses using this method would help illuminate the impact of 
polydrug use further. As Neale et al., (2006) state ‘Efforts to understand the 
causes of drug misuse – and thereby to prevent and reduce its negative effects 
– depend critically on our ability to measure it’ p.1011. It is sincerely hoped the 
methodologies contained in this thesis are adopted where possible, to aim to 
both account for, and open the debate on the nature of polydrug use, the 
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Appendix 1: The Audit Questionnaire 
 
1. How often do you have a drink containing alcohol? (How often) 
Never 
Monthly or less 
24 times a month 
23 times a week 
4 or more times a week 
 
2. How many standard drinks containing alcohol do you have on a typical day when 
drinking? 
1 or 2 
3 or 4 
5 or 6 
7 to 9 
10 or more 
 
3. How often do you have six or more drinks on one occasion? 
Never 
Less than monthly 
Monthly 
Weekly 
Daily or almost daily 
 
4. During the past year, how often have you found that you were not able to stop 
drinking once you had started? 
Never 
Less than monthly 
Monthly 
Weekly 
Daily or almost daily 
 
5. During the past year, how often have you failed to do what was normally 
expected of you because of drinking? 
Never 
Less than monthly 
Monthly 
Weekly 
Daily or almost daily 
 
6. During the past year, how often have you needed a drink in the morning to get 
yourself going after a heavy drinking session? 
Never 
Less than monthly 
Monthly 
Weekly 
Daily or almost daily 
 





Less than monthly 
Monthly 
Weekly 
Daily or almost daily 
 
8. During the past year, have you been unable to remember what happened the 
night before because you had been drinking? 
Never 
Less than monthly 
Monthly 
Weekly 
Daily or almost daily 
 
9. Have you or someone else been injured as a result of your drinking? 
No 
Yes, but not in the past year 
Yes, during the past year 
 
10. Has a relative or friend, doctor or other health worker been concerned about 
your drinking or suggested you cut down? 
No 
Yes, but not in the past year 
Yes, during the past year 
MODIFIED AUDIT (CHAPTER SIX) 
1. How often do you have a drink containing alcohol? (How often) 
 (0) never; (1) monthly or more 
 
2. How many standard drinks containing alcohol do you have on a typical day’s 
drinking? (Typical amount) 
 (0) 1 or 2; (1) 3 or more 
 
3. How often do you have six or more drinks on occasion? (How often 6+ 
drinks) 
 (0) never; (1) less than monthly or more frequently 
 
4. During the past year, how often have you found that you were not able to 
stop drinking when you started? (Unable to stop) 
 (0) never; (1) less than monthly or more frequently 
 
5. During the past year, how often have you failed to do what was normally 
expected of you because of drinking? (Failed to do) 
 (0) never; (1) less than monthly or more frequently 
 
6. During the past year, how often have you needed a drink in the morning to 
get yourself going after a heavy drinking session? (Drink in morning) 
 (0) never; (1) less than monthly or more frequently 
 
7. During the past year, how often have you had a feeling of guilt or remorse 
after drinking? (Guilt after drinking) 




8. During the past year, have you been unable to remember what happened the 
night before because you had been drinking? (Memory loss) 
 (0) never; (1) less than monthly or more frequently 
 
9. Have you or someone else been injured as a result of your drinking? (Had 
injury) 
 (0) no; (1) yes 
 
Has a relative or friend, doctor or other health worker been concerned about 
your drinking or suggested you cut down? (Suggest cut down) 





Appendix 2: Personal Communication Muthén , 2008. 
 
From: Mplus Product Support [mailto:support@statmodel.com] 
Sent: Wed 16/07/2008 22:05 
To: 'Smith Gillian' 
Subject: RE: latent class models (Licence No: SABC50058807) 
 
Gillian, 
 Here are Bengt’s comments: 
 “It is often the case that difficulty in replicating the best loglikelihood suggests 
that the model is more complex than the signals in the data can support. Have 
you been able to replicate your best loglikelihood in the separate analyses of 
the 2 sets of items? 6 classes seems like a lot for only for 10 binary items - was 
that solution well replicated? If yes on both those questions, perhaps the joint 
model does not fit the data well. Perhaps there are some items in the 2 sets that 
are directly related, beyond the correlation via their latent class variables. You 




Linda K. Muthen 
Muthen & Muthen            Phone: (310) 391-9971 
3463 Stoner Ave.             Fax: (310) 391-8971 
Los Angeles, CA 90066        website: www.statmodel.com  
From: Smith Gillian [mailto:GW.Smith@ulster.ac.uk]  




Subject: latent class models (Licence No: SABC50058807) 
  
Hello, 
I have run two separate latent class models of drug use (3 classes: 9 binary 
indicators) and alcohol use (6 classes: 10 binary indicators) using Mplus. I am 
attempting to correlate the latent variables upon each other to determine how 
the structure may/may not change, and how the latent classes relate to each 
other. I have been unable to replicate the loglikelihood even when I have upped 
the starts to 5000 with 3000 optimisations, and thus I do not trust the solution. I 
have also tried to run similar models illustrating ranges of classes from 2-4 for 
drug use and 5-7 for alcohol use to determine whether this might be an issue 
that is a result of the structure of the latent variables changing in the presence 
of the other latent variable, but find the same problem for these models. I note 
that in the attached model, there are a number of loglikelihoods that have been 
replicated on many occasions but these are not the 'optimum' loglikelihood e.g. 
-34129.64. Should I continue to up the starts or perhaps try using something 
like the optseed command using some of these loglikelihoods. Is there a cut off 
point to which you have to accept a solution cannot be found? 
  









































































































































































































































































































































MAD 2.82 5.28 1.93 2.01 1.61 1.31  2.17  1.72  1.05  1.00  .74  .79  
350 
 

































































GP psychological  
 
 
1.04  
(.87- 
1.25) 
.60  
(.10- 
3.45) 
1.04  
(.87- 
1.25) 
1.04  
(.84- 
1.30) 
1.04  
(.88- 
1.24) 
1.04  
(.88- 
1.24) 
.43  
(.10- 
1.83) 
1.04  
(.88- 
1.24) 
1.00  
(.69- 
1.47) 
.84  
(.65- 
1.10) 
1.04  
(.88- 
1.24) 
1.04  
(.86- 
1.25) 
GP physical 
 
1.03  
(.66- 
1.61) 
.70  
(.22- 
2.28) 
1.04 
(.62-
1.77) 
.78 
(.53- 
1.15) 
1.05 
(.82-
1.34) 
1.16 
(.71-
1.88) 
1.26 
 (.52-
3.07) 
1.02  
(.81- 
1.28) 
.95  
(.75- 
1.21) 
1.29 
(1.09-
1.51) 
.86  
(.76- 
.97) 
1.06  
(.67- 
1.30 
